Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nab\u00e9ra C, Chapiro E, Collonge-Rame MA, Cuccuini W, Douet-Guilbert N, Eclache V, Luquet I, Michaux L, Nadal N, Penther D, Quilichini B<\/strong>, Terre C, Lefebvre C, Troadec MB, V\u00e9ron\u00e8se L. Leukemia. 2022 Jun;36(6):1451-1466. doi: 10.1038\/s41375-022-01561-w. Epub 2022 Apr 16.PMID: 35430613 Review.<\/p>\n"},{"title":"The impact of introducing combined first-trimester trisomy 21 screening in the French population","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26628633","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Eur J Public Health 2015 ; Nov 30"},{"title":"The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34284044\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Maxime Espi, Xavier Charmetant, Thomas Barba, Laetitia Koppe, Caroline Pelletier, Emilie Kalbacher, Elodie Chalencon, Virginie Mathias, Anne Ovize, Emmanuelle Cart-Tanneur, Christine Bouz, Laurence Pellegrina, Emmanuel Morelon, Denis Fouque, Laurent Juillard, Olivier Thaunat\nKidney International 2021 Oct;100(4):928-936. doi: 10.1016\/j.kint.2021.07.005."},{"title":"Thrombop\u00e9nie induite par l\u2019h\u00e9parine (TIH) : \u00e0 propos d\u2019un casLe Flem L, Emile C","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Le Flem L, Emile C, Spectra Biologie 2016 ; 220:49-50<\/p>\n"},{"title":"Une interf\u00e9rence dans le dosage de l\u2019insuline r\u00e9v\u00e8le un syndrome auto-immun anti-insuline","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27492703","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Lamy PJ, Sault C, Renard E\nAnn Biol Clin 2016 ; 74:490-494"},{"title":"Vector-borne Transmission of Zika Virus in Europe, Southern France, August 2019","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31718742\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Sandra Giron, Florian Franke, Anne Decoppet, Bernard Cadiou, Thierry Travaglini, Laurence Thirion, Guillaume Durand, Charles Jeannin, Gr\u00e9gory L\u2019Ambert, Gilda Grard, Harold No\u00ebl, Nelly Fournet, Michelle Auzet-Caillaud, Christine Zandotti, Samer Abouka\u00efs, Pascal Chaud, Saby Guedj, Lakri Hamouda, Xavier Naudot, Anne Ovize, Cl\u00e9ment Lazarus, Henriette de Valk, Marie-Claire Paty, Isabelle Leparc-Goffart\nEuro Surveill. 2019 Nov;24(45):1900655."},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Faux-positif-ADNlcT21_L-Druart_012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Faux positif d\u2019ADNlcT21 avec diff\u00e9rentes anomalies chromosomiques confin\u00e9es au placenta\nL Druart, H Dessuant, JF Taly, M Nouchy, L Raymond, S Tapia"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Developpement-panel-15-marqueurs_F.-Rousseau-et-al.-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9veloppement d\u2019un panel de 15 marqueurs pour une identitovigilance\ndes \u00e9chantillons analys\u00e9s par s\u00e9quen\u00e7age haut d\u00e9bit ou sur puces \u00e0 SNP\nF Rousseau, J-F Taly, C Ploton Nicollet, M Taoudi, A Perdriau, L Raymond"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20359-Assises-de-Genetique-2020_B-Quilichini_012020.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Mise en place d\u2019un panel de g\u00e8nes cibl\u00e9s pour les h\u00e9mopathies\nmalignes (NMP-LMMC-SMD-LAM) par NGS : Enjeux M\u00e9dical \/ Scientifique et d\u2019Assurance Qualit\u00e9.\nV Geromel, E Fayolle, P Mouty, R Moulin, N Batail, M-H Felix, B Adde, S Mouty, L Raymond, B Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20362-Assises-de-Gntique-2020_B_Quilichini-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Impact diagnostique, pronostique et th\u00e9ranostique d\u2019un panel de g\u00e8nes\n\u00ab H\u00e9mopathies My\u00e9lo\u00efdes \u00bb r\u00e9alis\u00e9 par NGS : l\u2019exp\u00e9rience du laboratoire Eurofins Biomnis en 2019.\nV. Geromel, P. Mouty, C. Chal, J . Delaunay, S. Sadot-Lebouvier, R. Kaphan, J. Vigvari, J.P. Coadic, E.A. Marin La Meslee, O. Roualdes, C. Bourdin, A. Petit, M. Roumigui\u00e8res, L. Raymond, B.Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 4","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Les_assises_2020_RadoslavaSARAEVA_LAMRI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"21-24 janvier 2020, Tours\nDiagnostics g\u00e9n\u00e9tiques multiples (double hits) par s\u00e9quen\u00e7age Whole Exome (WES) : \u00e0 propos de deux cas.\nR. SARAEVA-LAMRI, A. DORELLE, V. GEROMEL, A. S. LEBRE, P. MOUTY, M. E. NAUD BARREYRE, F. ROUSSEAU, M. TAOUDI, L. MESNARD, L. RAYMOND"},{"title":"10th International Congress on Autoimmunity, Leipzig, April 6-10, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_4.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Should Dense Fine Speckled 70 (DFS70) pattern be reported? Biomnis reference lab experience on 12 619 ANA screening consecutive sera\nGuis L, Ebel A, Leroy J, Michaud S, Pomaredes A, Marcenaro C, Chalouas L"},{"title":"12\u00e8me CFA, Paris, avril 25-28, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":""},{"title":"12\u00e8me Congr\u00e8s de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Paris, mars 22-23, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Jacomo_3.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Les Liquides C\u00e9phalo-Rachidiens : conservation pr\u00e9-analytique \u00e0+ 4 \u00b0C ou \u2013 20 \u00b0C ?\nJacomo V, Schaal O, Fournier P"},{"title":"17\u00e8mes Journ\u00e9es Francophones de Virologie, Paris, avril 9, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"R\u00e9solution des \u00e9checs de g\u00e9notypage de la technique Abbott RealTime HCV Genotype II par un test temps r\u00e9el additionnel\nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ly_8.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of a new high sensitive, qualitative and quantitative Hepatitis B surface antigen assay\nLy TD, Coignard C"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Characterization of samples with genotype 1 without subtype results by Abbott RealTime HCV genotype II using the new Abbott HCV Genotype Plus RUO test \nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"19th Annual Meeting of the European Society for Clinical Virology (ESCV), Lisbon, september, 14\u201317, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/09\/Biomnis_Poster_2016_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to COBAS\u00ae AmpliPrep\/OBAS\u00ae TaqMan\u00ae HIV-1 and HBV tests\nEbel A, Bali C, Guis L, Merlin S"},{"title":"20\u00e8mes Journ\u00e9es de M\u00e9decine Foetale, Morzine, mars 26-28, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015__Becker_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Int\u00e9r\u00eat du D\u00e9pistage Pr\u00e9natal Non Invasif dans le diagnostic des aneuplo\u00efdies 13, 18 et 21 \nBecker M, Eg\u00e9a G, Taoud M, Ahmed Chaouch D, El Mouatassim S"},{"title":"20Th Congress European Hematology Association, Vienna, June 11-14, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Rigollet_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Characterization of normal and pathological lymphoid populations: validation of a 10-colors flow cytometry protocol for routine diagnosis \nRigollet L, Stagnara J, Milhau A, Pellegrina L"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/10\/Biomnis_Poster-Aptima-HIV-1-HBV_Ebel_Sept18.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV-1 Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to Cobas\u00ae 6800\/8800 HIV-1 and HBV tests\nA. Ebel, C. Bali, L. Guis, S. Merlin"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/11\/Poster-IgM-Measles-ESCV-TD-LY-.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of new IgM Measles assay\nT.D. Ly, C. Coignard"},{"title":"24e Journ\u00e9es de m\u00e9decine f\u0153tale, Marseille, 4-5-6 avril 2019","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9pistage de la trisomie 21 par analyse de l\u2019ADN f\u0153tal libre circulant dans le sang maternel : Application dans le cas des grossesses g\u00e9mellaires\nMarc NOUCHY, Nicolas CHATRON, Pascal MOUTY, Francis ROUSSEAU, Barbara ADD\u00c9, Mohamed Taoudi, Caroline DUMONT, Jean-Fran\u00e7ois TALY, Luc DRUART, Sylvie TAPIA, Damien SANLAVILLE, Laure RAYMOND"},{"title":"25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, April 25-28, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of three fully automated assays for the detection of cytomegalovirus IgM and IgG: DiaSorin LIAISON\u00ae XL, Abbott Architect \u00ae and Roche Cobas 6000\u00ae\nBouthry E, Ly TD, Vauloup-Fellous C"},{"title":"27th ECCMID, Vienna Austria, April 22-25, 2017","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Strain-specific estimation of epidemic success provides insights into the transmission dynamics of tuberculosis Rasigade\nJP, Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, P\u00e9rouse de Montclos M, Flandrois JP, Ader F, Supply P, Lina G, Wirth T"},{"title":"29th IUSTI European Conference on Sexually Transmitted Infections, Sitges (Barcelona), 24-26 September, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Prevalence of Mycoplasma genitalium in France and comparison with Chlamydia trachomatis and Neisseria gonorrhoeae as determined by the Mycoplasma genitalium TMA assay \nEbel A, Venard C, Brunengo D, Merlin S"},{"title":"31st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbon, June 14-17, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Force_7.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Blastocysts vitrification during 2 consecutive years: before and after its start significant delivery rate increase within the 1st year \nForce A, Nicollet B, Chomier M, Sergeant P, Lescaille M, Rochigneux S, Robert F, Ginon J, Sergeant MV, Baucher S, Schubert B"},{"title":"35e congr\u00e8s de la SFH, CNIT Paris la D\u00e9fense, avril 1-3, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Becker_4.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"La SNP array : un outil compl\u00e9mentaire pour la caract\u00e9risation des h\u00e9mopathies malignes \nBecker M, Eg\u00e9a G, Camilli K, Robin M, Roumigui\u00e8res M, Rigollet L, Stagnara J, El Mouatassim S"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_14.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Evaluation du nouveau test LAISON\u00ae H. pylori IgG\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_15.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Borr\u00e9liose et index de synth\u00e8se intrath\u00e9cale : bilan biologique r\u00e9trospectif de l\u2019ann\u00e9e 2015\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Ebel_16.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation des performances de la trousse Aptima\u00ae HBV Quant (Hologic)\nEbel A, Bali C, Guis L, Merlin S"},{"title":"37\u00e8me RICAI, Paris, d\u00e9cembre 18-19, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/12\/Biomnis_Poster_2017_Coignard_13.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Confirmation VIH : donn\u00e9es biologiques et \u00e9pid\u00e9miologiques des 3 derni\u00e8res ann\u00e9es dans un laboratoire de biologie sp\u00e9cialis\u00e9e\nCoignard C, Ly TD"},{"title":"38e RICAI, Paris 17-18 d\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-COIGNARD-ROUGEOLE.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Epid\u00e9mie de rougeole 2018 : le s\u00e9rodiagnostic un marqueur simple et performant.\nT.D. Ly, C. Coignard"},{"title":"3e Journ\u00e9e Francophone de Biologie M\u00e9dicale, Monaco, 6-7-8 novembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/11\/1911_poster_A.Ebel_JFBM.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"D\u00e9pistage syst\u00e9matique de Neisseria gonorrhoeae et de C. trachomatis par test d\u2019amplification g\u00e9nique : bilan d\u2019une ann\u00e9e d\u2019exp\u00e9rience\nL. Mine, L. Guis, S. Merlin, A. Ebel"},{"title":"40e RICAI \u2013 R\u00e9union Interdisciplinaire de Chimioth\u00e9rapie Anti-Infectieuse, 14-15 d\u00e9cembre","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Posters\/2012_Poster_SARS-CoV-2_RICAI_C.Coignard.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"S\u00e9rologie SARS-CoV-2 : \u00e9valuation, qualification et choix d\u2019une m\u00e9thode\nCatherine Coignard, Anne EBEL, Yanis BOUAMRA, Didier RIDEY, Carla MARCENARO"},{"title":"42es Journ\u00e9es Nationales \u2013 Congr\u00e8s CNGOF, Strasbourg, 4-7 D\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-EMILE-DPNI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"\u00c9tude de l\u2019usage du DPNI (d\u00e9pistage pr\u00e9natal non invasif) des aneuplo\u00efdies en milieu lib\u00e9ral\nC. Emile, L. Raymond, L. Pellegrina"},{"title":"45\u00e8me Colloque National des Biologistes des H\u00f4pitaux, Paris, juin 22-24, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/06\/Biomnis_Poster_2016-Rabut_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Interf\u00e9rence du traitement par daratumumab (anti-CD38) dans le suivi biologique du my\u00e9lome multiple et dans la recherche d\u2019anticorps anti-\u00e9rythrocytaires : \u00e0 propos d\u2019un cas\nRabut E, Castro-Fernandez A, Le Gall V, Meknache N"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Raymond_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport diagnostique de l\u2019utilisation des puces SNP dans l\u2019\u00e9tude chromosomique des morts f\u0153tales\nRaymond L, Dherbey JL, Rebeyrat-Pichon I, El-Mouatassim S, Egea G"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier, 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_11.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Cas rare d\u2019X-fragile pr\u00e9natal avec r\u00e9traction d\u2019expansion de triplet CGG ? \nMouty P, Raymond L, El Mouatassim S, Liquier A, Druart L, Paris A, Dorian V, Pichon I, Dherbey JL, Eg\u00e9a G"},{"title":"CGRF Ile de R\u00e9, septembre 28-29, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Brunengo_11.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Epid\u00e9miologie qualitative des variants rares de l\u2019H\u00e9moglobine en France m\u00e9tropolitaine au travers de la collaboration HCL \u2013 Eurofins Biomnis\nBrunengo D, Veyrenche N, Louis Chillotti L, Le Flem L"},{"title":"COGEN, Paris, Septembre 25-27, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_El-Mouatassim_11.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"French experience of Non-Invasive Prenatal Testing of trisomy 21, 18 and 13 \nEl Mouatassim S, Taoudi M, Eg\u00e9a G"},{"title":"Congr\u00e8s SFP \/ SFMM, Toulouse, mars 29-31, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/03\/Biomnis_Poster_2017_Chydriotis_1-1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport de 2 tests de d\u00e9pistage pour le diagnostic de la bilharziose et place du Western blot\nChyd\u00e9riotis G, Cart-Tanneur E, Lecuelle C, F\u00e9lix MH"},{"title":"Congr\u00e8s SFTA, Avignon, mai 10-12, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_Petit_2.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Dosage de la Ciclosporine, Tacrolimus, Ev\u00e9rolimus et Sirolimus en LCMSMS avec le coffret MassTox Chromsystems sur Api 4500 ABSciex avec pr\u00e9paration automatis\u00e9e sur T\u00e9can EVO 150\nPetit I, Moussa C, Bonnet K, Bezol A. Havrez S, Gerrier P"},{"title":"EAACI, Helsinki, June 17-21, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_6.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Bp14, an allergen from cupressus sempervirens pollen related to the family of snakin\/gibberellin-regulated proteins\nS\u00e9n\u00e9chal H, Santrucek J, Melcova M, Svoboda P, Zidkova J, Guilloux L, Aizawa T, Couderc R, Charpin D, Poncet P"},{"title":"ESCAIDE 2015, Stockholm, November 11-13, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Chyderiotis_14.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Re-emergence of urinary schistosomiasis in Europe ? Infections acquired in Southern Corsica \u2013 Investigation of a cluster of Schistosoma haematobium infections in 2014\nRamalli L, No\u00ebl H, Ruello M, Maccary A, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Denoyel GA, Succo T, Armengaud A, Paty MC, Heuz\u00e9 G, Mattei J, Th\u00e9ron A, Berry A"},{"title":"ESCV, Stresa, Lake Maggiore, September 13-16, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/10\/Biomnis_Poster_2017_LY_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new chemiluminescent assay to detect and quantify anti-HBs antibodies\nMaillard A, Ly TD, Thibault V"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_LY_3.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new LIAISON\u00ae H. pylori IgG\nLy TD, Coignard C"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Rabut_4.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Red blood cell antibody assays in DARA-treated patients\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"EuroMedLab, Paris, June 22-24, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Early Performance Evaluation of cobas\u00ae HBV, cobas\u00ae HCV and cobas\u00ae HIV-1Quantitative Nucleic Acid Tests for use on the new cobas\u00ae 6800\/8800 Systems\nEbel A, Merlin S, Marins ED G, Canchola J, Njoya M, Simon CO"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/poster-FFER-2018-callec.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Impact de la chirurgie bariatrique sur les param\u00e8tres spermatiques : Revue de la litt\u00e9rature\nR. Callec, B. Schubert, F. Robert, A. Force"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/POSTER-FFER-2018-Force.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Crit\u00e8res d\u2019interpr\u00e9tation du msome pour une optimisation de la prise en charge des patients\nA. Force, M. Chomier, P. Sergeant, J. Ginon, S. Rochigneux, M. Lechatton, M. Pont, R. Callec, F. Robert, B. Schubert"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Lopez.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation externe de la qualit\u00e9 en spermiologie : un nouveau programme pour une \u00e9valuation globale de l\u2019examen\nMarie LOPEZ, Bernard POGGI, Jean Christophe EYNARD, Marie LETY, Benoit SCHUBERT, Andr\u00e9 FORCE"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Schubert.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Influence des conditions de culture sur les r\u00e9sultats en AMP dans une \u00e9tude multicentrique : comparaison d\u2019un incubateur Time Lapse avec les incubateurs tradictionnels\nBeno\u00eet SCHUBERT, Alexandre MARCILLY, Andr\u00e9 FORCE"},{"title":"FFER, Tours, septembre 13-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Force_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Comparaison de la performance de 2 incubateurs (Geri versus Planer) apr\u00e8s randomisation de la cohorte ovocytaire pour chaque patiente\nForce A, Martine Chomier, Philippe Sergeant, Jacqueline Ginon, St\u00e9phanie Rochigneux, Soizic Baucher, M\u00e9lanie Le Chatton, M\u00e9lanie Pont, Beno\u00eet Schubert"},{"title":"FIBA 2016, Dakar, January 13-14, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"ANCA associated HIV infection in Senegal: a serological trap\nArouna O, Niang A, Abiola A, Guis L, Le Flem L, Diene JF, Mboup S"},{"title":"Fort Collins (USA), May 31-June 3, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/05\/Biomnis_Poster_2016_Jacomo_5.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Seoul Virus Infection in Human, France, 2014-2016\nReynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, Nussbaumer T, Jacomo V, Rapt MP, Septfons A, Rollin PE"},{"title":"ISMA, Lisbon, November 19-21, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2015_Guilloux_16.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Ige-cross-reactivity between european hymenoptera and asian hornet (vespa velutina) venom allergens\nLong\u00e9 C, Brazdova A, Brunet JL, Schwartz C, Girodet B, Lavaud F, Birnbaum J, Pham-Thi N, Duchateau M, Chamot-Rooke J, Guilloux L, Selva MA, Couderc R, S\u00e9n\u00e9chal H, Sutra JP, Poncet P"},{"title":"Journ\u00e9es Nationales CNGOF, Montpellier, d\u00e9cembre 7-9, 2016","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Etude pr\u00e9liminaire sur le d\u00e9pistage de la pr\u00e9-\u00e9clampsie au 1er trimestre de la grossesse (Predictor\u00ae)\nWalder R, Galland A, Sault C, Huissoud C"},{"title":"Journ\u00e9es Nationales d\u2019Infectiologie, Nantes, 13-15 juin, 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/05\/Biomnis_Poster_2018_Ebel_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Infections \u00e0 Chlamydia trachomatis : donn\u00e9es \u00e9pid\u00e9miologiques r\u00e9centes dans un laboratoire sp\u00e9cialis\u00e9\nEbel A, Guis L, Merlin S"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Poster-Lyme-RICAI-C.-Coignard-TD-Ly-dec-2019-800x1200.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of the BioPlex 2200 Lyme IgG\/IgM immunoassay system\nC. Coignard, C. Cl\u00e9ment-Vincent, Td. Ly, A. L\u2019hotellier"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/12\/2019-12-17_RICAI.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Sp\u00e9cificit\u00e9 de la s\u00e9rologie chikungunya et surveillance \u00e9pid\u00e9miologique\nC. Calba, F. Franke, E. Brottet, G. Terpant, N. Fournet, A. Ovize, J.D. Poveda, I. Leparc-Goffart, M.C. Paty"},{"title":"SFE, Bordeaux, octobre 5-8, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Sault_13.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Influence de la nature du liquide de rin\u00e7age d\u2019aiguille de cytoponction sur le dosage de la thyroglobuline\nBoux De Casson F, Moal V, Gauchez AS, Moineau MP, Sault C, Schlageter MH, Massart C"},{"title":"SFTS, Bordeaux, septembre 20-22, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Rabut_10.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Recherche et quantification de l\u2019h\u00e9morragie f\u0153to-maternelle par cytom\u00e9trie en flux avec double marquage anti-h\u00e9moglobine F et anti-anhydrase carbonique\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"XXIIIe Colloque ACLF, Montpellier, septembre 20-21, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Syndrome de Currarino atypique avec hexadactylie pr\u00e9-axiale : remaniement complexe en 7q36.3 en pr\u00e9natal\nLiquier A, Becker M, Raymond L, Bourgain A, Amat S, Broussin B, Andr\u00e9 G, Escande F, Nouchy M, Eg\u00e9a G"}]));
sessionStorage.setItem('currentLang', 'fr');render(html`<${RessourcesDynamiques} name="World" />`, document.getElementById('resdyncontainer'));
\n
Hamdi SM, Sault C<\/strong>, Piver E, Genoux A, Masson D, Guibourdenche J. Presse Med. (2019)<\/p>\n"},{"title":"Preliminary report of an autochthonous Chikungunya outbreak in France, July to September 2017","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29019313","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Calba C, Guerbois-Galla M, Franke F, Jeannin C, Auzet-Caillaud M, Grard G, Pigaglio L, Decoppet A, Weicherding J, Savaill MC, Munoz-Riviero M, Chaud P, Cadiou B, Ramalli L, Fournier P, Noel H, De Lamballerie X, Paty MC, Leparc-Goffart I\nEuro Surveill 2017 ; 22(39):pii=17-00647"},{"title":"Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance","media_link":"https:\/\/www.nature.com\/articles\/s41467-021-23233-6","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"St\u00e9phane Le Vu,\u00a0Gabrielle Jones,\u00a0Fran\u00e7ois Anna,\u00a0Thierry Rose,\u00a0Jean-Baptiste Richard,\u00a0Sibylle Bernard-Stoecklin,\u00a0Sophie Goyard,\u00a0Caroline Demeret,\u00a0Olivier Helynck,\u00a0Nicolas Escriou,\u00a0Marion Gransagne,\u00a0St\u00e9phane Petres,\u00a0Corinne Robin,\u00a0Virgile Monnet,\u00a0Louise Perrin de Facci,\u00a0Marie-Noelle Ungeheuer,\u00a0Lucie L\u00e9on,\u00a0Yvonnick Guillois,\u00a0Laurent Filleul,\u00a0Pierre Charneau,\u00a0Daniel L\u00e9vy-Bruhl,\u00a0Sylvie van der Werf\u00a0&\u00a0Harold Noel\u00a0\nNature Communications volume 21\/05\/2021 12, Article number: 3025 (2021)"},{"title":"Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/30789329\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Tatai C, Berland JL, Claude JB, Westeel E, Hodille E, Fredenucci I, Rasigade JP, Ponsoda M, Jacomo V, Vach\u00e9e A, Gaudart A, Gaillard JL, Roux AL, Ader F, Tararbit K, Terpant G, Bryant JE, Lina G, Dumitrescu O; Lyon TB Study Group.Genestet C, et al.\nEmerg Infect Dis. 2019 Mar;25(3):589-592. doi: 10.3201\/eid2503.181124 - PMID: 30789329"},{"title":"R\u00e9activit\u00e9 crois\u00e9e in silico, in vitro, in vivo","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Guilloux L, Ricard-Blum S\nAllergies alimentaires 2017 ; chapitre 7.5:97-102"},{"title":"Recherche et identification des anticorps antinucl\u00e9aires : analyse du questionnaire europ\u00e9en de l\u2019EASI groupe et confrontation des pratiques fran\u00e7aises aux recommandations internationales","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29623889","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Musset L, Fabien N, Chyderiotis G, Olsson NO, Pham BN, Durey Dragon MA\nAnn Biol Clin 2018, 76 :185-195"},{"title":"Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission.","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31806715\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Paret R, Pichat C, Berland JL, Jacomo V, Carret G, Fredenucci I, Hodille E, Rasigade JP, Boisset S, Carricajo A, Lina G, Ronnaux-Baron AS, Mornex JF, Grando J, S\u00e9n\u00e9chal A, Ader F, Dumitrescu O; Lyon TB study group.Genestet C, et al.\nEur Respir J. 2020 Mar 20;55(3):1901888. doi: 10.1183\/13993003.01888-2019. Print 2020 Mar"},{"title":"Schistosomose en Corse : chronique d\u2019une histoire annonc\u00e9e","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Berry A, Iriart X, Boissier J, Chyd\u00e9riotis G, Debruyne M, Magnaval JF, Fillaux J, Grech-Angelini S, Barr\u00e9-Cardi H, Termignon JL, Macarry A, Noel H\nLa Lettre de l'Infectiologue 2016 ; XXXI n\u00b02:60-64"},{"title":"Screening and identification of antinuclear antibodies (ANA): analysis of the European EASI survey and confrontation of the French routine practice to the international recommandations","media_link":null,"date":null,"media_type":"document","profils":"579,575,574,","document_type":"publication","content":"Musset L, Fabien N, Chyd\u00e9riotis G, Olsson NO, Pham BN, Dragon-Durey MA\nAnn Biol Clin 2017 ;"},{"title":"Surveillance des infections humaines par hantavirus en France m\u00e9tropolitaine, 2012-2016","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Reynes JM, Carli D, Renaudin B, Fizet A, Bour JB, Brodard V, Cart-Tanneur E, Dewilde A, El Hamri M, Fleury H, Hecquet D, Jeulin H, Lechat S, Lemarquand-Bardini M, Lepiller Q, Poveda JD, Raulin O, Twizeyimana E, Van Cauteren D, Velay A, Septfons A, Baize S\nBEH 2017 ; 23:492-499"},{"title":"Surveillance du chikungunya et de la dengue en France m\u00e9tropolitaine, 2014","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resume_Septfons-A_2016_330-70-77.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Septfons A, No\u00ebl H, Leparc-Goffart I, Giron S, Delisle E, Chappert JL, Catelinois O, Franke F, Servas V, Guinard A, Debruyne M, Schaal O, Brichler S, Ninove L, Prat C, Flusin O, Poujol I, Letort MJ, Deniau J, Six C, Rousseau C, De Valk H, Paty MC\nLes Feuillets de Biologie 2016 ; 330:70-77"},{"title":"Surveillance du chikungunya, de la dengue et des infections \u00e0 virus Zika en France m\u00e9tropolitaine, 2017","media_link":"http:\/\/invs.santepubliquefrance.fr\/beh\/2018\/24\/pdf\/2018_24_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fournet N, Franke F, Chaud P, Raguenaud ME, Calba C, Septfons A, Cart-Tanneur E. et al.\nBull Epid\u00e9miol Hebd. 2018;(24):494-503."},{"title":"Testing anti-neutrophil cytoplasmic antibodies (ANCA): analysis of the European EASI survey on the daily practice of the French laboratories","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28958962","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dragon-Durey MA, Fabien N, Chyd\u00e9riotis G, Musset L, Pham BN, Olsson N\nAnn Biol Clin 2017 ; 75:531-541"},{"title":"The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)","media_link":"","date":"06\/09\/2022","media_type":"document","profils":"579,575,574,","document_type":"publication","content":"\n
Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nab\u00e9ra C, Chapiro E, Collonge-Rame MA, Cuccuini W, Douet-Guilbert N, Eclache V, Luquet I, Michaux L, Nadal N, Penther D, Quilichini B<\/strong>, Terre C, Lefebvre C, Troadec MB, V\u00e9ron\u00e8se L. Leukemia. 2022 Jun;36(6):1451-1466. doi: 10.1038\/s41375-022-01561-w. Epub 2022 Apr 16.PMID: 35430613 Review.<\/p>\n"},{"title":"The impact of introducing combined first-trimester trisomy 21 screening in the French population","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26628633","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Eur J Public Health 2015 ; Nov 30"},{"title":"The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34284044\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Maxime Espi, Xavier Charmetant, Thomas Barba, Laetitia Koppe, Caroline Pelletier, Emilie Kalbacher, Elodie Chalencon, Virginie Mathias, Anne Ovize, Emmanuelle Cart-Tanneur, Christine Bouz, Laurence Pellegrina, Emmanuel Morelon, Denis Fouque, Laurent Juillard, Olivier Thaunat\nKidney International 2021 Oct;100(4):928-936. doi: 10.1016\/j.kint.2021.07.005."},{"title":"Thrombop\u00e9nie induite par l\u2019h\u00e9parine (TIH) : \u00e0 propos d\u2019un casLe Flem L, Emile C","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Le Flem L, Emile C, Spectra Biologie 2016 ; 220:49-50<\/p>\n"},{"title":"Une interf\u00e9rence dans le dosage de l\u2019insuline r\u00e9v\u00e8le un syndrome auto-immun anti-insuline","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27492703","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Lamy PJ, Sault C, Renard E\nAnn Biol Clin 2016 ; 74:490-494"},{"title":"Vector-borne Transmission of Zika Virus in Europe, Southern France, August 2019","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31718742\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Sandra Giron, Florian Franke, Anne Decoppet, Bernard Cadiou, Thierry Travaglini, Laurence Thirion, Guillaume Durand, Charles Jeannin, Gr\u00e9gory L\u2019Ambert, Gilda Grard, Harold No\u00ebl, Nelly Fournet, Michelle Auzet-Caillaud, Christine Zandotti, Samer Abouka\u00efs, Pascal Chaud, Saby Guedj, Lakri Hamouda, Xavier Naudot, Anne Ovize, Cl\u00e9ment Lazarus, Henriette de Valk, Marie-Claire Paty, Isabelle Leparc-Goffart\nEuro Surveill. 2019 Nov;24(45):1900655."},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Faux-positif-ADNlcT21_L-Druart_012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Faux positif d\u2019ADNlcT21 avec diff\u00e9rentes anomalies chromosomiques confin\u00e9es au placenta\nL Druart, H Dessuant, JF Taly, M Nouchy, L Raymond, S Tapia"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Developpement-panel-15-marqueurs_F.-Rousseau-et-al.-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9veloppement d\u2019un panel de 15 marqueurs pour une identitovigilance\ndes \u00e9chantillons analys\u00e9s par s\u00e9quen\u00e7age haut d\u00e9bit ou sur puces \u00e0 SNP\nF Rousseau, J-F Taly, C Ploton Nicollet, M Taoudi, A Perdriau, L Raymond"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20359-Assises-de-Genetique-2020_B-Quilichini_012020.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Mise en place d\u2019un panel de g\u00e8nes cibl\u00e9s pour les h\u00e9mopathies\nmalignes (NMP-LMMC-SMD-LAM) par NGS : Enjeux M\u00e9dical \/ Scientifique et d\u2019Assurance Qualit\u00e9.\nV Geromel, E Fayolle, P Mouty, R Moulin, N Batail, M-H Felix, B Adde, S Mouty, L Raymond, B Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20362-Assises-de-Gntique-2020_B_Quilichini-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Impact diagnostique, pronostique et th\u00e9ranostique d\u2019un panel de g\u00e8nes\n\u00ab H\u00e9mopathies My\u00e9lo\u00efdes \u00bb r\u00e9alis\u00e9 par NGS : l\u2019exp\u00e9rience du laboratoire Eurofins Biomnis en 2019.\nV. Geromel, P. Mouty, C. Chal, J . Delaunay, S. Sadot-Lebouvier, R. Kaphan, J. Vigvari, J.P. Coadic, E.A. Marin La Meslee, O. Roualdes, C. Bourdin, A. Petit, M. Roumigui\u00e8res, L. Raymond, B.Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 4","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Les_assises_2020_RadoslavaSARAEVA_LAMRI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"21-24 janvier 2020, Tours\nDiagnostics g\u00e9n\u00e9tiques multiples (double hits) par s\u00e9quen\u00e7age Whole Exome (WES) : \u00e0 propos de deux cas.\nR. SARAEVA-LAMRI, A. DORELLE, V. GEROMEL, A. S. LEBRE, P. MOUTY, M. E. NAUD BARREYRE, F. ROUSSEAU, M. TAOUDI, L. MESNARD, L. RAYMOND"},{"title":"10th International Congress on Autoimmunity, Leipzig, April 6-10, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_4.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Should Dense Fine Speckled 70 (DFS70) pattern be reported? Biomnis reference lab experience on 12 619 ANA screening consecutive sera\nGuis L, Ebel A, Leroy J, Michaud S, Pomaredes A, Marcenaro C, Chalouas L"},{"title":"12\u00e8me CFA, Paris, avril 25-28, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":""},{"title":"12\u00e8me Congr\u00e8s de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Paris, mars 22-23, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Jacomo_3.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Les Liquides C\u00e9phalo-Rachidiens : conservation pr\u00e9-analytique \u00e0+ 4 \u00b0C ou \u2013 20 \u00b0C ?\nJacomo V, Schaal O, Fournier P"},{"title":"17\u00e8mes Journ\u00e9es Francophones de Virologie, Paris, avril 9, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"R\u00e9solution des \u00e9checs de g\u00e9notypage de la technique Abbott RealTime HCV Genotype II par un test temps r\u00e9el additionnel\nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ly_8.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of a new high sensitive, qualitative and quantitative Hepatitis B surface antigen assay\nLy TD, Coignard C"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Characterization of samples with genotype 1 without subtype results by Abbott RealTime HCV genotype II using the new Abbott HCV Genotype Plus RUO test \nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"19th Annual Meeting of the European Society for Clinical Virology (ESCV), Lisbon, september, 14\u201317, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/09\/Biomnis_Poster_2016_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to COBAS\u00ae AmpliPrep\/OBAS\u00ae TaqMan\u00ae HIV-1 and HBV tests\nEbel A, Bali C, Guis L, Merlin S"},{"title":"20\u00e8mes Journ\u00e9es de M\u00e9decine Foetale, Morzine, mars 26-28, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015__Becker_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Int\u00e9r\u00eat du D\u00e9pistage Pr\u00e9natal Non Invasif dans le diagnostic des aneuplo\u00efdies 13, 18 et 21 \nBecker M, Eg\u00e9a G, Taoud M, Ahmed Chaouch D, El Mouatassim S"},{"title":"20Th Congress European Hematology Association, Vienna, June 11-14, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Rigollet_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Characterization of normal and pathological lymphoid populations: validation of a 10-colors flow cytometry protocol for routine diagnosis \nRigollet L, Stagnara J, Milhau A, Pellegrina L"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/10\/Biomnis_Poster-Aptima-HIV-1-HBV_Ebel_Sept18.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV-1 Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to Cobas\u00ae 6800\/8800 HIV-1 and HBV tests\nA. Ebel, C. Bali, L. Guis, S. Merlin"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/11\/Poster-IgM-Measles-ESCV-TD-LY-.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of new IgM Measles assay\nT.D. Ly, C. Coignard"},{"title":"24e Journ\u00e9es de m\u00e9decine f\u0153tale, Marseille, 4-5-6 avril 2019","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9pistage de la trisomie 21 par analyse de l\u2019ADN f\u0153tal libre circulant dans le sang maternel : Application dans le cas des grossesses g\u00e9mellaires\nMarc NOUCHY, Nicolas CHATRON, Pascal MOUTY, Francis ROUSSEAU, Barbara ADD\u00c9, Mohamed Taoudi, Caroline DUMONT, Jean-Fran\u00e7ois TALY, Luc DRUART, Sylvie TAPIA, Damien SANLAVILLE, Laure RAYMOND"},{"title":"25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, April 25-28, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of three fully automated assays for the detection of cytomegalovirus IgM and IgG: DiaSorin LIAISON\u00ae XL, Abbott Architect \u00ae and Roche Cobas 6000\u00ae\nBouthry E, Ly TD, Vauloup-Fellous C"},{"title":"27th ECCMID, Vienna Austria, April 22-25, 2017","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Strain-specific estimation of epidemic success provides insights into the transmission dynamics of tuberculosis Rasigade\nJP, Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, P\u00e9rouse de Montclos M, Flandrois JP, Ader F, Supply P, Lina G, Wirth T"},{"title":"29th IUSTI European Conference on Sexually Transmitted Infections, Sitges (Barcelona), 24-26 September, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Prevalence of Mycoplasma genitalium in France and comparison with Chlamydia trachomatis and Neisseria gonorrhoeae as determined by the Mycoplasma genitalium TMA assay \nEbel A, Venard C, Brunengo D, Merlin S"},{"title":"31st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbon, June 14-17, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Force_7.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Blastocysts vitrification during 2 consecutive years: before and after its start significant delivery rate increase within the 1st year \nForce A, Nicollet B, Chomier M, Sergeant P, Lescaille M, Rochigneux S, Robert F, Ginon J, Sergeant MV, Baucher S, Schubert B"},{"title":"35e congr\u00e8s de la SFH, CNIT Paris la D\u00e9fense, avril 1-3, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Becker_4.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"La SNP array : un outil compl\u00e9mentaire pour la caract\u00e9risation des h\u00e9mopathies malignes \nBecker M, Eg\u00e9a G, Camilli K, Robin M, Roumigui\u00e8res M, Rigollet L, Stagnara J, El Mouatassim S"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_14.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Evaluation du nouveau test LAISON\u00ae H. pylori IgG\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_15.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Borr\u00e9liose et index de synth\u00e8se intrath\u00e9cale : bilan biologique r\u00e9trospectif de l\u2019ann\u00e9e 2015\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Ebel_16.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation des performances de la trousse Aptima\u00ae HBV Quant (Hologic)\nEbel A, Bali C, Guis L, Merlin S"},{"title":"37\u00e8me RICAI, Paris, d\u00e9cembre 18-19, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/12\/Biomnis_Poster_2017_Coignard_13.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Confirmation VIH : donn\u00e9es biologiques et \u00e9pid\u00e9miologiques des 3 derni\u00e8res ann\u00e9es dans un laboratoire de biologie sp\u00e9cialis\u00e9e\nCoignard C, Ly TD"},{"title":"38e RICAI, Paris 17-18 d\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-COIGNARD-ROUGEOLE.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Epid\u00e9mie de rougeole 2018 : le s\u00e9rodiagnostic un marqueur simple et performant.\nT.D. Ly, C. Coignard"},{"title":"3e Journ\u00e9e Francophone de Biologie M\u00e9dicale, Monaco, 6-7-8 novembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/11\/1911_poster_A.Ebel_JFBM.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"D\u00e9pistage syst\u00e9matique de Neisseria gonorrhoeae et de C. trachomatis par test d\u2019amplification g\u00e9nique : bilan d\u2019une ann\u00e9e d\u2019exp\u00e9rience\nL. Mine, L. Guis, S. Merlin, A. Ebel"},{"title":"40e RICAI \u2013 R\u00e9union Interdisciplinaire de Chimioth\u00e9rapie Anti-Infectieuse, 14-15 d\u00e9cembre","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Posters\/2012_Poster_SARS-CoV-2_RICAI_C.Coignard.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"S\u00e9rologie SARS-CoV-2 : \u00e9valuation, qualification et choix d\u2019une m\u00e9thode\nCatherine Coignard, Anne EBEL, Yanis BOUAMRA, Didier RIDEY, Carla MARCENARO"},{"title":"42es Journ\u00e9es Nationales \u2013 Congr\u00e8s CNGOF, Strasbourg, 4-7 D\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-EMILE-DPNI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"\u00c9tude de l\u2019usage du DPNI (d\u00e9pistage pr\u00e9natal non invasif) des aneuplo\u00efdies en milieu lib\u00e9ral\nC. Emile, L. Raymond, L. Pellegrina"},{"title":"45\u00e8me Colloque National des Biologistes des H\u00f4pitaux, Paris, juin 22-24, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/06\/Biomnis_Poster_2016-Rabut_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Interf\u00e9rence du traitement par daratumumab (anti-CD38) dans le suivi biologique du my\u00e9lome multiple et dans la recherche d\u2019anticorps anti-\u00e9rythrocytaires : \u00e0 propos d\u2019un cas\nRabut E, Castro-Fernandez A, Le Gall V, Meknache N"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Raymond_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport diagnostique de l\u2019utilisation des puces SNP dans l\u2019\u00e9tude chromosomique des morts f\u0153tales\nRaymond L, Dherbey JL, Rebeyrat-Pichon I, El-Mouatassim S, Egea G"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier, 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_11.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Cas rare d\u2019X-fragile pr\u00e9natal avec r\u00e9traction d\u2019expansion de triplet CGG ? \nMouty P, Raymond L, El Mouatassim S, Liquier A, Druart L, Paris A, Dorian V, Pichon I, Dherbey JL, Eg\u00e9a G"},{"title":"CGRF Ile de R\u00e9, septembre 28-29, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Brunengo_11.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Epid\u00e9miologie qualitative des variants rares de l\u2019H\u00e9moglobine en France m\u00e9tropolitaine au travers de la collaboration HCL \u2013 Eurofins Biomnis\nBrunengo D, Veyrenche N, Louis Chillotti L, Le Flem L"},{"title":"COGEN, Paris, Septembre 25-27, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_El-Mouatassim_11.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"French experience of Non-Invasive Prenatal Testing of trisomy 21, 18 and 13 \nEl Mouatassim S, Taoudi M, Eg\u00e9a G"},{"title":"Congr\u00e8s SFP \/ SFMM, Toulouse, mars 29-31, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/03\/Biomnis_Poster_2017_Chydriotis_1-1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport de 2 tests de d\u00e9pistage pour le diagnostic de la bilharziose et place du Western blot\nChyd\u00e9riotis G, Cart-Tanneur E, Lecuelle C, F\u00e9lix MH"},{"title":"Congr\u00e8s SFTA, Avignon, mai 10-12, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_Petit_2.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Dosage de la Ciclosporine, Tacrolimus, Ev\u00e9rolimus et Sirolimus en LCMSMS avec le coffret MassTox Chromsystems sur Api 4500 ABSciex avec pr\u00e9paration automatis\u00e9e sur T\u00e9can EVO 150\nPetit I, Moussa C, Bonnet K, Bezol A. Havrez S, Gerrier P"},{"title":"EAACI, Helsinki, June 17-21, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_6.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Bp14, an allergen from cupressus sempervirens pollen related to the family of snakin\/gibberellin-regulated proteins\nS\u00e9n\u00e9chal H, Santrucek J, Melcova M, Svoboda P, Zidkova J, Guilloux L, Aizawa T, Couderc R, Charpin D, Poncet P"},{"title":"ESCAIDE 2015, Stockholm, November 11-13, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Chyderiotis_14.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Re-emergence of urinary schistosomiasis in Europe ? Infections acquired in Southern Corsica \u2013 Investigation of a cluster of Schistosoma haematobium infections in 2014\nRamalli L, No\u00ebl H, Ruello M, Maccary A, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Denoyel GA, Succo T, Armengaud A, Paty MC, Heuz\u00e9 G, Mattei J, Th\u00e9ron A, Berry A"},{"title":"ESCV, Stresa, Lake Maggiore, September 13-16, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/10\/Biomnis_Poster_2017_LY_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new chemiluminescent assay to detect and quantify anti-HBs antibodies\nMaillard A, Ly TD, Thibault V"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_LY_3.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new LIAISON\u00ae H. pylori IgG\nLy TD, Coignard C"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Rabut_4.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Red blood cell antibody assays in DARA-treated patients\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"EuroMedLab, Paris, June 22-24, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Early Performance Evaluation of cobas\u00ae HBV, cobas\u00ae HCV and cobas\u00ae HIV-1Quantitative Nucleic Acid Tests for use on the new cobas\u00ae 6800\/8800 Systems\nEbel A, Merlin S, Marins ED G, Canchola J, Njoya M, Simon CO"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/poster-FFER-2018-callec.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Impact de la chirurgie bariatrique sur les param\u00e8tres spermatiques : Revue de la litt\u00e9rature\nR. Callec, B. Schubert, F. Robert, A. Force"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/POSTER-FFER-2018-Force.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Crit\u00e8res d\u2019interpr\u00e9tation du msome pour une optimisation de la prise en charge des patients\nA. Force, M. Chomier, P. Sergeant, J. Ginon, S. Rochigneux, M. Lechatton, M. Pont, R. Callec, F. Robert, B. Schubert"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Lopez.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation externe de la qualit\u00e9 en spermiologie : un nouveau programme pour une \u00e9valuation globale de l\u2019examen\nMarie LOPEZ, Bernard POGGI, Jean Christophe EYNARD, Marie LETY, Benoit SCHUBERT, Andr\u00e9 FORCE"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Schubert.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Influence des conditions de culture sur les r\u00e9sultats en AMP dans une \u00e9tude multicentrique : comparaison d\u2019un incubateur Time Lapse avec les incubateurs tradictionnels\nBeno\u00eet SCHUBERT, Alexandre MARCILLY, Andr\u00e9 FORCE"},{"title":"FFER, Tours, septembre 13-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Force_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Comparaison de la performance de 2 incubateurs (Geri versus Planer) apr\u00e8s randomisation de la cohorte ovocytaire pour chaque patiente\nForce A, Martine Chomier, Philippe Sergeant, Jacqueline Ginon, St\u00e9phanie Rochigneux, Soizic Baucher, M\u00e9lanie Le Chatton, M\u00e9lanie Pont, Beno\u00eet Schubert"},{"title":"FIBA 2016, Dakar, January 13-14, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"ANCA associated HIV infection in Senegal: a serological trap\nArouna O, Niang A, Abiola A, Guis L, Le Flem L, Diene JF, Mboup S"},{"title":"Fort Collins (USA), May 31-June 3, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/05\/Biomnis_Poster_2016_Jacomo_5.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Seoul Virus Infection in Human, France, 2014-2016\nReynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, Nussbaumer T, Jacomo V, Rapt MP, Septfons A, Rollin PE"},{"title":"ISMA, Lisbon, November 19-21, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2015_Guilloux_16.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Ige-cross-reactivity between european hymenoptera and asian hornet (vespa velutina) venom allergens\nLong\u00e9 C, Brazdova A, Brunet JL, Schwartz C, Girodet B, Lavaud F, Birnbaum J, Pham-Thi N, Duchateau M, Chamot-Rooke J, Guilloux L, Selva MA, Couderc R, S\u00e9n\u00e9chal H, Sutra JP, Poncet P"},{"title":"Journ\u00e9es Nationales CNGOF, Montpellier, d\u00e9cembre 7-9, 2016","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Etude pr\u00e9liminaire sur le d\u00e9pistage de la pr\u00e9-\u00e9clampsie au 1er trimestre de la grossesse (Predictor\u00ae)\nWalder R, Galland A, Sault C, Huissoud C"},{"title":"Journ\u00e9es Nationales d\u2019Infectiologie, Nantes, 13-15 juin, 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/05\/Biomnis_Poster_2018_Ebel_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Infections \u00e0 Chlamydia trachomatis : donn\u00e9es \u00e9pid\u00e9miologiques r\u00e9centes dans un laboratoire sp\u00e9cialis\u00e9\nEbel A, Guis L, Merlin S"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Poster-Lyme-RICAI-C.-Coignard-TD-Ly-dec-2019-800x1200.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of the BioPlex 2200 Lyme IgG\/IgM immunoassay system\nC. Coignard, C. Cl\u00e9ment-Vincent, Td. Ly, A. L\u2019hotellier"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/12\/2019-12-17_RICAI.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Sp\u00e9cificit\u00e9 de la s\u00e9rologie chikungunya et surveillance \u00e9pid\u00e9miologique\nC. Calba, F. Franke, E. Brottet, G. Terpant, N. Fournet, A. Ovize, J.D. Poveda, I. Leparc-Goffart, M.C. Paty"},{"title":"SFE, Bordeaux, octobre 5-8, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Sault_13.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Influence de la nature du liquide de rin\u00e7age d\u2019aiguille de cytoponction sur le dosage de la thyroglobuline\nBoux De Casson F, Moal V, Gauchez AS, Moineau MP, Sault C, Schlageter MH, Massart C"},{"title":"SFTS, Bordeaux, septembre 20-22, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Rabut_10.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Recherche et quantification de l\u2019h\u00e9morragie f\u0153to-maternelle par cytom\u00e9trie en flux avec double marquage anti-h\u00e9moglobine F et anti-anhydrase carbonique\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"XXIIIe Colloque ACLF, Montpellier, septembre 20-21, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Syndrome de Currarino atypique avec hexadactylie pr\u00e9-axiale : remaniement complexe en 7q36.3 en pr\u00e9natal\nLiquier A, Becker M, Raymond L, Bourgain A, Amat S, Broussin B, Andr\u00e9 G, Escande F, Nouchy M, Eg\u00e9a G"}]));
sessionStorage.setItem('currentLang', 'fr');render(html`<${RessourcesDynamiques} name="World" />`, document.getElementById('resdyncontainer'));
\n
Emile C, Sault C<\/strong>. Spectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49.<\/p>\n"},{"title":"Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Potential+value+of+placental+angiogenic+factors+as+biomarkers+in+preeclampsia+for+clinical+physicians","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Boulanger H, Lef\u00e8vre G, Ahriz Saksi S, Achiche J, Bailleul S, Ekoukou D, Drouin D, Sault C, Stawiarski N, Dupuis E.\nNephrol Ther. 2019 Mar 29"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0755498219304178?via%3Dihub","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Hamdi SM, Sault C, Piver E, Genoux A, Masson D, Guibourdenche J.\nPresse Med . 2019 Oct 29. pii: S0755-4982(19)30417-8. doi: 10.1016\/j.lpm.2019.09.029. PMID:31676218"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/doi.org\/10.1016\/j.lpm.2019.09.029","date":"12\/12\/2019","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Hamdi SM, Sault C<\/strong>, Piver E, Genoux A, Masson D, Guibourdenche J. Presse Med. (2019)<\/p>\n"},{"title":"Preliminary report of an autochthonous Chikungunya outbreak in France, July to September 2017","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29019313","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Calba C, Guerbois-Galla M, Franke F, Jeannin C, Auzet-Caillaud M, Grard G, Pigaglio L, Decoppet A, Weicherding J, Savaill MC, Munoz-Riviero M, Chaud P, Cadiou B, Ramalli L, Fournier P, Noel H, De Lamballerie X, Paty MC, Leparc-Goffart I\nEuro Surveill 2017 ; 22(39):pii=17-00647"},{"title":"Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance","media_link":"https:\/\/www.nature.com\/articles\/s41467-021-23233-6","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"St\u00e9phane Le Vu,\u00a0Gabrielle Jones,\u00a0Fran\u00e7ois Anna,\u00a0Thierry Rose,\u00a0Jean-Baptiste Richard,\u00a0Sibylle Bernard-Stoecklin,\u00a0Sophie Goyard,\u00a0Caroline Demeret,\u00a0Olivier Helynck,\u00a0Nicolas Escriou,\u00a0Marion Gransagne,\u00a0St\u00e9phane Petres,\u00a0Corinne Robin,\u00a0Virgile Monnet,\u00a0Louise Perrin de Facci,\u00a0Marie-Noelle Ungeheuer,\u00a0Lucie L\u00e9on,\u00a0Yvonnick Guillois,\u00a0Laurent Filleul,\u00a0Pierre Charneau,\u00a0Daniel L\u00e9vy-Bruhl,\u00a0Sylvie van der Werf\u00a0&\u00a0Harold Noel\u00a0\nNature Communications volume 21\/05\/2021 12, Article number: 3025 (2021)"},{"title":"Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/30789329\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Tatai C, Berland JL, Claude JB, Westeel E, Hodille E, Fredenucci I, Rasigade JP, Ponsoda M, Jacomo V, Vach\u00e9e A, Gaudart A, Gaillard JL, Roux AL, Ader F, Tararbit K, Terpant G, Bryant JE, Lina G, Dumitrescu O; Lyon TB Study Group.Genestet C, et al.\nEmerg Infect Dis. 2019 Mar;25(3):589-592. doi: 10.3201\/eid2503.181124 - PMID: 30789329"},{"title":"R\u00e9activit\u00e9 crois\u00e9e in silico, in vitro, in vivo","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Guilloux L, Ricard-Blum S\nAllergies alimentaires 2017 ; chapitre 7.5:97-102"},{"title":"Recherche et identification des anticorps antinucl\u00e9aires : analyse du questionnaire europ\u00e9en de l\u2019EASI groupe et confrontation des pratiques fran\u00e7aises aux recommandations internationales","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29623889","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Musset L, Fabien N, Chyderiotis G, Olsson NO, Pham BN, Durey Dragon MA\nAnn Biol Clin 2018, 76 :185-195"},{"title":"Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission.","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31806715\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Paret R, Pichat C, Berland JL, Jacomo V, Carret G, Fredenucci I, Hodille E, Rasigade JP, Boisset S, Carricajo A, Lina G, Ronnaux-Baron AS, Mornex JF, Grando J, S\u00e9n\u00e9chal A, Ader F, Dumitrescu O; Lyon TB study group.Genestet C, et al.\nEur Respir J. 2020 Mar 20;55(3):1901888. doi: 10.1183\/13993003.01888-2019. Print 2020 Mar"},{"title":"Schistosomose en Corse : chronique d\u2019une histoire annonc\u00e9e","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Berry A, Iriart X, Boissier J, Chyd\u00e9riotis G, Debruyne M, Magnaval JF, Fillaux J, Grech-Angelini S, Barr\u00e9-Cardi H, Termignon JL, Macarry A, Noel H\nLa Lettre de l'Infectiologue 2016 ; XXXI n\u00b02:60-64"},{"title":"Screening and identification of antinuclear antibodies (ANA): analysis of the European EASI survey and confrontation of the French routine practice to the international recommandations","media_link":null,"date":null,"media_type":"document","profils":"579,575,574,","document_type":"publication","content":"Musset L, Fabien N, Chyd\u00e9riotis G, Olsson NO, Pham BN, Dragon-Durey MA\nAnn Biol Clin 2017 ;"},{"title":"Surveillance des infections humaines par hantavirus en France m\u00e9tropolitaine, 2012-2016","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Reynes JM, Carli D, Renaudin B, Fizet A, Bour JB, Brodard V, Cart-Tanneur E, Dewilde A, El Hamri M, Fleury H, Hecquet D, Jeulin H, Lechat S, Lemarquand-Bardini M, Lepiller Q, Poveda JD, Raulin O, Twizeyimana E, Van Cauteren D, Velay A, Septfons A, Baize S\nBEH 2017 ; 23:492-499"},{"title":"Surveillance du chikungunya et de la dengue en France m\u00e9tropolitaine, 2014","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resume_Septfons-A_2016_330-70-77.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Septfons A, No\u00ebl H, Leparc-Goffart I, Giron S, Delisle E, Chappert JL, Catelinois O, Franke F, Servas V, Guinard A, Debruyne M, Schaal O, Brichler S, Ninove L, Prat C, Flusin O, Poujol I, Letort MJ, Deniau J, Six C, Rousseau C, De Valk H, Paty MC\nLes Feuillets de Biologie 2016 ; 330:70-77"},{"title":"Surveillance du chikungunya, de la dengue et des infections \u00e0 virus Zika en France m\u00e9tropolitaine, 2017","media_link":"http:\/\/invs.santepubliquefrance.fr\/beh\/2018\/24\/pdf\/2018_24_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fournet N, Franke F, Chaud P, Raguenaud ME, Calba C, Septfons A, Cart-Tanneur E. et al.\nBull Epid\u00e9miol Hebd. 2018;(24):494-503."},{"title":"Testing anti-neutrophil cytoplasmic antibodies (ANCA): analysis of the European EASI survey on the daily practice of the French laboratories","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28958962","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dragon-Durey MA, Fabien N, Chyd\u00e9riotis G, Musset L, Pham BN, Olsson N\nAnn Biol Clin 2017 ; 75:531-541"},{"title":"The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)","media_link":"","date":"06\/09\/2022","media_type":"document","profils":"579,575,574,","document_type":"publication","content":"\n
Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nab\u00e9ra C, Chapiro E, Collonge-Rame MA, Cuccuini W, Douet-Guilbert N, Eclache V, Luquet I, Michaux L, Nadal N, Penther D, Quilichini B<\/strong>, Terre C, Lefebvre C, Troadec MB, V\u00e9ron\u00e8se L. Leukemia. 2022 Jun;36(6):1451-1466. doi: 10.1038\/s41375-022-01561-w. Epub 2022 Apr 16.PMID: 35430613 Review.<\/p>\n"},{"title":"The impact of introducing combined first-trimester trisomy 21 screening in the French population","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26628633","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Eur J Public Health 2015 ; Nov 30"},{"title":"The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34284044\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Maxime Espi, Xavier Charmetant, Thomas Barba, Laetitia Koppe, Caroline Pelletier, Emilie Kalbacher, Elodie Chalencon, Virginie Mathias, Anne Ovize, Emmanuelle Cart-Tanneur, Christine Bouz, Laurence Pellegrina, Emmanuel Morelon, Denis Fouque, Laurent Juillard, Olivier Thaunat\nKidney International 2021 Oct;100(4):928-936. doi: 10.1016\/j.kint.2021.07.005."},{"title":"Thrombop\u00e9nie induite par l\u2019h\u00e9parine (TIH) : \u00e0 propos d\u2019un casLe Flem L, Emile C","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Le Flem L, Emile C, Spectra Biologie 2016 ; 220:49-50<\/p>\n"},{"title":"Une interf\u00e9rence dans le dosage de l\u2019insuline r\u00e9v\u00e8le un syndrome auto-immun anti-insuline","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27492703","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Lamy PJ, Sault C, Renard E\nAnn Biol Clin 2016 ; 74:490-494"},{"title":"Vector-borne Transmission of Zika Virus in Europe, Southern France, August 2019","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31718742\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Sandra Giron, Florian Franke, Anne Decoppet, Bernard Cadiou, Thierry Travaglini, Laurence Thirion, Guillaume Durand, Charles Jeannin, Gr\u00e9gory L\u2019Ambert, Gilda Grard, Harold No\u00ebl, Nelly Fournet, Michelle Auzet-Caillaud, Christine Zandotti, Samer Abouka\u00efs, Pascal Chaud, Saby Guedj, Lakri Hamouda, Xavier Naudot, Anne Ovize, Cl\u00e9ment Lazarus, Henriette de Valk, Marie-Claire Paty, Isabelle Leparc-Goffart\nEuro Surveill. 2019 Nov;24(45):1900655."},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Faux-positif-ADNlcT21_L-Druart_012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Faux positif d\u2019ADNlcT21 avec diff\u00e9rentes anomalies chromosomiques confin\u00e9es au placenta\nL Druart, H Dessuant, JF Taly, M Nouchy, L Raymond, S Tapia"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Developpement-panel-15-marqueurs_F.-Rousseau-et-al.-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9veloppement d\u2019un panel de 15 marqueurs pour une identitovigilance\ndes \u00e9chantillons analys\u00e9s par s\u00e9quen\u00e7age haut d\u00e9bit ou sur puces \u00e0 SNP\nF Rousseau, J-F Taly, C Ploton Nicollet, M Taoudi, A Perdriau, L Raymond"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20359-Assises-de-Genetique-2020_B-Quilichini_012020.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Mise en place d\u2019un panel de g\u00e8nes cibl\u00e9s pour les h\u00e9mopathies\nmalignes (NMP-LMMC-SMD-LAM) par NGS : Enjeux M\u00e9dical \/ Scientifique et d\u2019Assurance Qualit\u00e9.\nV Geromel, E Fayolle, P Mouty, R Moulin, N Batail, M-H Felix, B Adde, S Mouty, L Raymond, B Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20362-Assises-de-Gntique-2020_B_Quilichini-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Impact diagnostique, pronostique et th\u00e9ranostique d\u2019un panel de g\u00e8nes\n\u00ab H\u00e9mopathies My\u00e9lo\u00efdes \u00bb r\u00e9alis\u00e9 par NGS : l\u2019exp\u00e9rience du laboratoire Eurofins Biomnis en 2019.\nV. Geromel, P. Mouty, C. Chal, J . Delaunay, S. Sadot-Lebouvier, R. Kaphan, J. Vigvari, J.P. Coadic, E.A. Marin La Meslee, O. Roualdes, C. Bourdin, A. Petit, M. Roumigui\u00e8res, L. Raymond, B.Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 4","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Les_assises_2020_RadoslavaSARAEVA_LAMRI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"21-24 janvier 2020, Tours\nDiagnostics g\u00e9n\u00e9tiques multiples (double hits) par s\u00e9quen\u00e7age Whole Exome (WES) : \u00e0 propos de deux cas.\nR. SARAEVA-LAMRI, A. DORELLE, V. GEROMEL, A. S. LEBRE, P. MOUTY, M. E. NAUD BARREYRE, F. ROUSSEAU, M. TAOUDI, L. MESNARD, L. RAYMOND"},{"title":"10th International Congress on Autoimmunity, Leipzig, April 6-10, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_4.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Should Dense Fine Speckled 70 (DFS70) pattern be reported? Biomnis reference lab experience on 12 619 ANA screening consecutive sera\nGuis L, Ebel A, Leroy J, Michaud S, Pomaredes A, Marcenaro C, Chalouas L"},{"title":"12\u00e8me CFA, Paris, avril 25-28, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":""},{"title":"12\u00e8me Congr\u00e8s de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Paris, mars 22-23, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Jacomo_3.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Les Liquides C\u00e9phalo-Rachidiens : conservation pr\u00e9-analytique \u00e0+ 4 \u00b0C ou \u2013 20 \u00b0C ?\nJacomo V, Schaal O, Fournier P"},{"title":"17\u00e8mes Journ\u00e9es Francophones de Virologie, Paris, avril 9, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"R\u00e9solution des \u00e9checs de g\u00e9notypage de la technique Abbott RealTime HCV Genotype II par un test temps r\u00e9el additionnel\nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ly_8.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of a new high sensitive, qualitative and quantitative Hepatitis B surface antigen assay\nLy TD, Coignard C"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Characterization of samples with genotype 1 without subtype results by Abbott RealTime HCV genotype II using the new Abbott HCV Genotype Plus RUO test \nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"19th Annual Meeting of the European Society for Clinical Virology (ESCV), Lisbon, september, 14\u201317, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/09\/Biomnis_Poster_2016_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to COBAS\u00ae AmpliPrep\/OBAS\u00ae TaqMan\u00ae HIV-1 and HBV tests\nEbel A, Bali C, Guis L, Merlin S"},{"title":"20\u00e8mes Journ\u00e9es de M\u00e9decine Foetale, Morzine, mars 26-28, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015__Becker_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Int\u00e9r\u00eat du D\u00e9pistage Pr\u00e9natal Non Invasif dans le diagnostic des aneuplo\u00efdies 13, 18 et 21 \nBecker M, Eg\u00e9a G, Taoud M, Ahmed Chaouch D, El Mouatassim S"},{"title":"20Th Congress European Hematology Association, Vienna, June 11-14, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Rigollet_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Characterization of normal and pathological lymphoid populations: validation of a 10-colors flow cytometry protocol for routine diagnosis \nRigollet L, Stagnara J, Milhau A, Pellegrina L"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/10\/Biomnis_Poster-Aptima-HIV-1-HBV_Ebel_Sept18.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV-1 Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to Cobas\u00ae 6800\/8800 HIV-1 and HBV tests\nA. Ebel, C. Bali, L. Guis, S. Merlin"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/11\/Poster-IgM-Measles-ESCV-TD-LY-.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of new IgM Measles assay\nT.D. Ly, C. Coignard"},{"title":"24e Journ\u00e9es de m\u00e9decine f\u0153tale, Marseille, 4-5-6 avril 2019","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9pistage de la trisomie 21 par analyse de l\u2019ADN f\u0153tal libre circulant dans le sang maternel : Application dans le cas des grossesses g\u00e9mellaires\nMarc NOUCHY, Nicolas CHATRON, Pascal MOUTY, Francis ROUSSEAU, Barbara ADD\u00c9, Mohamed Taoudi, Caroline DUMONT, Jean-Fran\u00e7ois TALY, Luc DRUART, Sylvie TAPIA, Damien SANLAVILLE, Laure RAYMOND"},{"title":"25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, April 25-28, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of three fully automated assays for the detection of cytomegalovirus IgM and IgG: DiaSorin LIAISON\u00ae XL, Abbott Architect \u00ae and Roche Cobas 6000\u00ae\nBouthry E, Ly TD, Vauloup-Fellous C"},{"title":"27th ECCMID, Vienna Austria, April 22-25, 2017","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Strain-specific estimation of epidemic success provides insights into the transmission dynamics of tuberculosis Rasigade\nJP, Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, P\u00e9rouse de Montclos M, Flandrois JP, Ader F, Supply P, Lina G, Wirth T"},{"title":"29th IUSTI European Conference on Sexually Transmitted Infections, Sitges (Barcelona), 24-26 September, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Prevalence of Mycoplasma genitalium in France and comparison with Chlamydia trachomatis and Neisseria gonorrhoeae as determined by the Mycoplasma genitalium TMA assay \nEbel A, Venard C, Brunengo D, Merlin S"},{"title":"31st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbon, June 14-17, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Force_7.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Blastocysts vitrification during 2 consecutive years: before and after its start significant delivery rate increase within the 1st year \nForce A, Nicollet B, Chomier M, Sergeant P, Lescaille M, Rochigneux S, Robert F, Ginon J, Sergeant MV, Baucher S, Schubert B"},{"title":"35e congr\u00e8s de la SFH, CNIT Paris la D\u00e9fense, avril 1-3, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Becker_4.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"La SNP array : un outil compl\u00e9mentaire pour la caract\u00e9risation des h\u00e9mopathies malignes \nBecker M, Eg\u00e9a G, Camilli K, Robin M, Roumigui\u00e8res M, Rigollet L, Stagnara J, El Mouatassim S"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_14.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Evaluation du nouveau test LAISON\u00ae H. pylori IgG\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_15.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Borr\u00e9liose et index de synth\u00e8se intrath\u00e9cale : bilan biologique r\u00e9trospectif de l\u2019ann\u00e9e 2015\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Ebel_16.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation des performances de la trousse Aptima\u00ae HBV Quant (Hologic)\nEbel A, Bali C, Guis L, Merlin S"},{"title":"37\u00e8me RICAI, Paris, d\u00e9cembre 18-19, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/12\/Biomnis_Poster_2017_Coignard_13.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Confirmation VIH : donn\u00e9es biologiques et \u00e9pid\u00e9miologiques des 3 derni\u00e8res ann\u00e9es dans un laboratoire de biologie sp\u00e9cialis\u00e9e\nCoignard C, Ly TD"},{"title":"38e RICAI, Paris 17-18 d\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-COIGNARD-ROUGEOLE.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Epid\u00e9mie de rougeole 2018 : le s\u00e9rodiagnostic un marqueur simple et performant.\nT.D. Ly, C. Coignard"},{"title":"3e Journ\u00e9e Francophone de Biologie M\u00e9dicale, Monaco, 6-7-8 novembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/11\/1911_poster_A.Ebel_JFBM.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"D\u00e9pistage syst\u00e9matique de Neisseria gonorrhoeae et de C. trachomatis par test d\u2019amplification g\u00e9nique : bilan d\u2019une ann\u00e9e d\u2019exp\u00e9rience\nL. Mine, L. Guis, S. Merlin, A. Ebel"},{"title":"40e RICAI \u2013 R\u00e9union Interdisciplinaire de Chimioth\u00e9rapie Anti-Infectieuse, 14-15 d\u00e9cembre","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Posters\/2012_Poster_SARS-CoV-2_RICAI_C.Coignard.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"S\u00e9rologie SARS-CoV-2 : \u00e9valuation, qualification et choix d\u2019une m\u00e9thode\nCatherine Coignard, Anne EBEL, Yanis BOUAMRA, Didier RIDEY, Carla MARCENARO"},{"title":"42es Journ\u00e9es Nationales \u2013 Congr\u00e8s CNGOF, Strasbourg, 4-7 D\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-EMILE-DPNI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"\u00c9tude de l\u2019usage du DPNI (d\u00e9pistage pr\u00e9natal non invasif) des aneuplo\u00efdies en milieu lib\u00e9ral\nC. Emile, L. Raymond, L. Pellegrina"},{"title":"45\u00e8me Colloque National des Biologistes des H\u00f4pitaux, Paris, juin 22-24, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/06\/Biomnis_Poster_2016-Rabut_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Interf\u00e9rence du traitement par daratumumab (anti-CD38) dans le suivi biologique du my\u00e9lome multiple et dans la recherche d\u2019anticorps anti-\u00e9rythrocytaires : \u00e0 propos d\u2019un cas\nRabut E, Castro-Fernandez A, Le Gall V, Meknache N"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Raymond_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport diagnostique de l\u2019utilisation des puces SNP dans l\u2019\u00e9tude chromosomique des morts f\u0153tales\nRaymond L, Dherbey JL, Rebeyrat-Pichon I, El-Mouatassim S, Egea G"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier, 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_11.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Cas rare d\u2019X-fragile pr\u00e9natal avec r\u00e9traction d\u2019expansion de triplet CGG ? \nMouty P, Raymond L, El Mouatassim S, Liquier A, Druart L, Paris A, Dorian V, Pichon I, Dherbey JL, Eg\u00e9a G"},{"title":"CGRF Ile de R\u00e9, septembre 28-29, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Brunengo_11.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Epid\u00e9miologie qualitative des variants rares de l\u2019H\u00e9moglobine en France m\u00e9tropolitaine au travers de la collaboration HCL \u2013 Eurofins Biomnis\nBrunengo D, Veyrenche N, Louis Chillotti L, Le Flem L"},{"title":"COGEN, Paris, Septembre 25-27, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_El-Mouatassim_11.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"French experience of Non-Invasive Prenatal Testing of trisomy 21, 18 and 13 \nEl Mouatassim S, Taoudi M, Eg\u00e9a G"},{"title":"Congr\u00e8s SFP \/ SFMM, Toulouse, mars 29-31, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/03\/Biomnis_Poster_2017_Chydriotis_1-1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport de 2 tests de d\u00e9pistage pour le diagnostic de la bilharziose et place du Western blot\nChyd\u00e9riotis G, Cart-Tanneur E, Lecuelle C, F\u00e9lix MH"},{"title":"Congr\u00e8s SFTA, Avignon, mai 10-12, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_Petit_2.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Dosage de la Ciclosporine, Tacrolimus, Ev\u00e9rolimus et Sirolimus en LCMSMS avec le coffret MassTox Chromsystems sur Api 4500 ABSciex avec pr\u00e9paration automatis\u00e9e sur T\u00e9can EVO 150\nPetit I, Moussa C, Bonnet K, Bezol A. Havrez S, Gerrier P"},{"title":"EAACI, Helsinki, June 17-21, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_6.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Bp14, an allergen from cupressus sempervirens pollen related to the family of snakin\/gibberellin-regulated proteins\nS\u00e9n\u00e9chal H, Santrucek J, Melcova M, Svoboda P, Zidkova J, Guilloux L, Aizawa T, Couderc R, Charpin D, Poncet P"},{"title":"ESCAIDE 2015, Stockholm, November 11-13, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Chyderiotis_14.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Re-emergence of urinary schistosomiasis in Europe ? Infections acquired in Southern Corsica \u2013 Investigation of a cluster of Schistosoma haematobium infections in 2014\nRamalli L, No\u00ebl H, Ruello M, Maccary A, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Denoyel GA, Succo T, Armengaud A, Paty MC, Heuz\u00e9 G, Mattei J, Th\u00e9ron A, Berry A"},{"title":"ESCV, Stresa, Lake Maggiore, September 13-16, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/10\/Biomnis_Poster_2017_LY_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new chemiluminescent assay to detect and quantify anti-HBs antibodies\nMaillard A, Ly TD, Thibault V"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_LY_3.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new LIAISON\u00ae H. pylori IgG\nLy TD, Coignard C"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Rabut_4.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Red blood cell antibody assays in DARA-treated patients\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"EuroMedLab, Paris, June 22-24, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Early Performance Evaluation of cobas\u00ae HBV, cobas\u00ae HCV and cobas\u00ae HIV-1Quantitative Nucleic Acid Tests for use on the new cobas\u00ae 6800\/8800 Systems\nEbel A, Merlin S, Marins ED G, Canchola J, Njoya M, Simon CO"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/poster-FFER-2018-callec.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Impact de la chirurgie bariatrique sur les param\u00e8tres spermatiques : Revue de la litt\u00e9rature\nR. Callec, B. Schubert, F. Robert, A. Force"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/POSTER-FFER-2018-Force.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Crit\u00e8res d\u2019interpr\u00e9tation du msome pour une optimisation de la prise en charge des patients\nA. Force, M. Chomier, P. Sergeant, J. Ginon, S. Rochigneux, M. Lechatton, M. Pont, R. Callec, F. Robert, B. Schubert"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Lopez.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation externe de la qualit\u00e9 en spermiologie : un nouveau programme pour une \u00e9valuation globale de l\u2019examen\nMarie LOPEZ, Bernard POGGI, Jean Christophe EYNARD, Marie LETY, Benoit SCHUBERT, Andr\u00e9 FORCE"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Schubert.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Influence des conditions de culture sur les r\u00e9sultats en AMP dans une \u00e9tude multicentrique : comparaison d\u2019un incubateur Time Lapse avec les incubateurs tradictionnels\nBeno\u00eet SCHUBERT, Alexandre MARCILLY, Andr\u00e9 FORCE"},{"title":"FFER, Tours, septembre 13-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Force_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Comparaison de la performance de 2 incubateurs (Geri versus Planer) apr\u00e8s randomisation de la cohorte ovocytaire pour chaque patiente\nForce A, Martine Chomier, Philippe Sergeant, Jacqueline Ginon, St\u00e9phanie Rochigneux, Soizic Baucher, M\u00e9lanie Le Chatton, M\u00e9lanie Pont, Beno\u00eet Schubert"},{"title":"FIBA 2016, Dakar, January 13-14, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"ANCA associated HIV infection in Senegal: a serological trap\nArouna O, Niang A, Abiola A, Guis L, Le Flem L, Diene JF, Mboup S"},{"title":"Fort Collins (USA), May 31-June 3, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/05\/Biomnis_Poster_2016_Jacomo_5.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Seoul Virus Infection in Human, France, 2014-2016\nReynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, Nussbaumer T, Jacomo V, Rapt MP, Septfons A, Rollin PE"},{"title":"ISMA, Lisbon, November 19-21, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2015_Guilloux_16.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Ige-cross-reactivity between european hymenoptera and asian hornet (vespa velutina) venom allergens\nLong\u00e9 C, Brazdova A, Brunet JL, Schwartz C, Girodet B, Lavaud F, Birnbaum J, Pham-Thi N, Duchateau M, Chamot-Rooke J, Guilloux L, Selva MA, Couderc R, S\u00e9n\u00e9chal H, Sutra JP, Poncet P"},{"title":"Journ\u00e9es Nationales CNGOF, Montpellier, d\u00e9cembre 7-9, 2016","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Etude pr\u00e9liminaire sur le d\u00e9pistage de la pr\u00e9-\u00e9clampsie au 1er trimestre de la grossesse (Predictor\u00ae)\nWalder R, Galland A, Sault C, Huissoud C"},{"title":"Journ\u00e9es Nationales d\u2019Infectiologie, Nantes, 13-15 juin, 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/05\/Biomnis_Poster_2018_Ebel_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Infections \u00e0 Chlamydia trachomatis : donn\u00e9es \u00e9pid\u00e9miologiques r\u00e9centes dans un laboratoire sp\u00e9cialis\u00e9\nEbel A, Guis L, Merlin S"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Poster-Lyme-RICAI-C.-Coignard-TD-Ly-dec-2019-800x1200.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of the BioPlex 2200 Lyme IgG\/IgM immunoassay system\nC. Coignard, C. Cl\u00e9ment-Vincent, Td. Ly, A. L\u2019hotellier"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/12\/2019-12-17_RICAI.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Sp\u00e9cificit\u00e9 de la s\u00e9rologie chikungunya et surveillance \u00e9pid\u00e9miologique\nC. Calba, F. Franke, E. Brottet, G. Terpant, N. Fournet, A. Ovize, J.D. Poveda, I. Leparc-Goffart, M.C. Paty"},{"title":"SFE, Bordeaux, octobre 5-8, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Sault_13.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Influence de la nature du liquide de rin\u00e7age d\u2019aiguille de cytoponction sur le dosage de la thyroglobuline\nBoux De Casson F, Moal V, Gauchez AS, Moineau MP, Sault C, Schlageter MH, Massart C"},{"title":"SFTS, Bordeaux, septembre 20-22, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Rabut_10.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Recherche et quantification de l\u2019h\u00e9morragie f\u0153to-maternelle par cytom\u00e9trie en flux avec double marquage anti-h\u00e9moglobine F et anti-anhydrase carbonique\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"XXIIIe Colloque ACLF, Montpellier, septembre 20-21, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Syndrome de Currarino atypique avec hexadactylie pr\u00e9-axiale : remaniement complexe en 7q36.3 en pr\u00e9natal\nLiquier A, Becker M, Raymond L, Bourgain A, Amat S, Broussin B, Andr\u00e9 G, Escande F, Nouchy M, Eg\u00e9a G"}]));
sessionStorage.setItem('currentLang', 'fr');render(html`<${RessourcesDynamiques} name="World" />`, document.getElementById('resdyncontainer'));
\n
B. Quilichini Journal de Biologie M\u00e9dicale \/ Volume 11-Num\u00e9ro 42 \/ Juil-Sept 2022<\/p>\n"},{"title":"Interf\u00e9rences s\u00e9rologiques du traitement du my\u00e9lome multiple par daratumumab (anti-CD38) : \u00e0 propos d\u2019un cas","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28540859","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Rabut E, Castro-Fernandez A, Le Gall V, Meknache\nAnn Biol Clin 2017 ; 75:351-355"},{"title":"Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31379011","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Penther D, Etancelin P, Lusina D, Bidet A, Quilichini B, Gaillard B, Rafdord-Weiss I, Mozziconacci MJ, Ittel A, Roche-Lestienne C, Barin C, Soler G, Daudignon A, Nadal N, Chapiro E, Lefebvre C, Godon C, Nadeau G, Mugneret F, Richebourg S, Viailly PJ, Ferret Y, Nguyen-Khac F, Eclache V; Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique\nAm J Hematol 2019 Aug 4. doi: 10.1002\/ajh.25601."},{"title":"Large outbreak of urogenital schistosomiasis acquired in Southern Corsica: monitoring the early signs of the endemicization?","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28669843","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"No\u00ebl H, Ruello M, Maccary A, Pellat C, Sommen C, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Durand J, Ramalli L, Chiappini JD , Malfait P, Berry\nClin Microbiol Infect 2017 ; pii: S1198-743X(17)30350-6. doi: 10.1016\/j.cmi"},{"title":"Les niveaux de preuve des biomarqueurs utilis\u00e9s pour la d\u00e9tection pr\u00e9coce des cancers de la prostate","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27029727","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Lamy PJ, Gauchez AS, Salomon L et al et le Groupe de biologie de la prostate : Sault C et al\nAnn Biol Clin 2016 ; 74:227-232"},{"title":"Marqueurs de d\u00e9pistage et de pr\u00e9diction de la pr\u00e9-\u00e9clampsie : place de la biologie","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Sault C\nJ Biol Med 2017 ; 6:186-190"},{"title":"Non-invasive prenatal testing: what are we missing?\u00a0","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32119166","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fries N, Le Garrec S, Egloff M, Sault C, Dreux S, Mangione R, Salomon LJ, Ville Y. \nUltrasound Obstet Gynecol. Mars 2020 - 2. doi: 10.1002\/uog.22005."},{"title":"Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28189936","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Thibault V, Servant-Delmas A, Ly TD, Roque-Afonso AM, Laperche S\nJ Clin Virol 2017 ; 89:14-21"},{"title":"Persistence of Zika virus in gradient sperm preparation","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29510270","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Cassuto NG, Marras G, Jacomo V, Bouret D\nJ Gynecol Obstet Hum Reprod 2018, pii: S2468-7847(18)30038-2"},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Emile C, Sault C\nSpectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49."},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"12\/12\/2022","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Emile C, Sault C<\/strong>. Spectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49.<\/p>\n"},{"title":"Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Potential+value+of+placental+angiogenic+factors+as+biomarkers+in+preeclampsia+for+clinical+physicians","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Boulanger H, Lef\u00e8vre G, Ahriz Saksi S, Achiche J, Bailleul S, Ekoukou D, Drouin D, Sault C, Stawiarski N, Dupuis E.\nNephrol Ther. 2019 Mar 29"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0755498219304178?via%3Dihub","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Hamdi SM, Sault C, Piver E, Genoux A, Masson D, Guibourdenche J.\nPresse Med . 2019 Oct 29. pii: S0755-4982(19)30417-8. doi: 10.1016\/j.lpm.2019.09.029. PMID:31676218"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/doi.org\/10.1016\/j.lpm.2019.09.029","date":"12\/12\/2019","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Hamdi SM, Sault C<\/strong>, Piver E, Genoux A, Masson D, Guibourdenche J. Presse Med. (2019)<\/p>\n"},{"title":"Preliminary report of an autochthonous Chikungunya outbreak in France, July to September 2017","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29019313","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Calba C, Guerbois-Galla M, Franke F, Jeannin C, Auzet-Caillaud M, Grard G, Pigaglio L, Decoppet A, Weicherding J, Savaill MC, Munoz-Riviero M, Chaud P, Cadiou B, Ramalli L, Fournier P, Noel H, De Lamballerie X, Paty MC, Leparc-Goffart I\nEuro Surveill 2017 ; 22(39):pii=17-00647"},{"title":"Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance","media_link":"https:\/\/www.nature.com\/articles\/s41467-021-23233-6","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"St\u00e9phane Le Vu,\u00a0Gabrielle Jones,\u00a0Fran\u00e7ois Anna,\u00a0Thierry Rose,\u00a0Jean-Baptiste Richard,\u00a0Sibylle Bernard-Stoecklin,\u00a0Sophie Goyard,\u00a0Caroline Demeret,\u00a0Olivier Helynck,\u00a0Nicolas Escriou,\u00a0Marion Gransagne,\u00a0St\u00e9phane Petres,\u00a0Corinne Robin,\u00a0Virgile Monnet,\u00a0Louise Perrin de Facci,\u00a0Marie-Noelle Ungeheuer,\u00a0Lucie L\u00e9on,\u00a0Yvonnick Guillois,\u00a0Laurent Filleul,\u00a0Pierre Charneau,\u00a0Daniel L\u00e9vy-Bruhl,\u00a0Sylvie van der Werf\u00a0&\u00a0Harold Noel\u00a0\nNature Communications volume 21\/05\/2021 12, Article number: 3025 (2021)"},{"title":"Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/30789329\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Tatai C, Berland JL, Claude JB, Westeel E, Hodille E, Fredenucci I, Rasigade JP, Ponsoda M, Jacomo V, Vach\u00e9e A, Gaudart A, Gaillard JL, Roux AL, Ader F, Tararbit K, Terpant G, Bryant JE, Lina G, Dumitrescu O; Lyon TB Study Group.Genestet C, et al.\nEmerg Infect Dis. 2019 Mar;25(3):589-592. doi: 10.3201\/eid2503.181124 - PMID: 30789329"},{"title":"R\u00e9activit\u00e9 crois\u00e9e in silico, in vitro, in vivo","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Guilloux L, Ricard-Blum S\nAllergies alimentaires 2017 ; chapitre 7.5:97-102"},{"title":"Recherche et identification des anticorps antinucl\u00e9aires : analyse du questionnaire europ\u00e9en de l\u2019EASI groupe et confrontation des pratiques fran\u00e7aises aux recommandations internationales","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29623889","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Musset L, Fabien N, Chyderiotis G, Olsson NO, Pham BN, Durey Dragon MA\nAnn Biol Clin 2018, 76 :185-195"},{"title":"Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission.","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31806715\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Paret R, Pichat C, Berland JL, Jacomo V, Carret G, Fredenucci I, Hodille E, Rasigade JP, Boisset S, Carricajo A, Lina G, Ronnaux-Baron AS, Mornex JF, Grando J, S\u00e9n\u00e9chal A, Ader F, Dumitrescu O; Lyon TB study group.Genestet C, et al.\nEur Respir J. 2020 Mar 20;55(3):1901888. doi: 10.1183\/13993003.01888-2019. Print 2020 Mar"},{"title":"Schistosomose en Corse : chronique d\u2019une histoire annonc\u00e9e","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Berry A, Iriart X, Boissier J, Chyd\u00e9riotis G, Debruyne M, Magnaval JF, Fillaux J, Grech-Angelini S, Barr\u00e9-Cardi H, Termignon JL, Macarry A, Noel H\nLa Lettre de l'Infectiologue 2016 ; XXXI n\u00b02:60-64"},{"title":"Screening and identification of antinuclear antibodies (ANA): analysis of the European EASI survey and confrontation of the French routine practice to the international recommandations","media_link":null,"date":null,"media_type":"document","profils":"579,575,574,","document_type":"publication","content":"Musset L, Fabien N, Chyd\u00e9riotis G, Olsson NO, Pham BN, Dragon-Durey MA\nAnn Biol Clin 2017 ;"},{"title":"Surveillance des infections humaines par hantavirus en France m\u00e9tropolitaine, 2012-2016","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Reynes JM, Carli D, Renaudin B, Fizet A, Bour JB, Brodard V, Cart-Tanneur E, Dewilde A, El Hamri M, Fleury H, Hecquet D, Jeulin H, Lechat S, Lemarquand-Bardini M, Lepiller Q, Poveda JD, Raulin O, Twizeyimana E, Van Cauteren D, Velay A, Septfons A, Baize S\nBEH 2017 ; 23:492-499"},{"title":"Surveillance du chikungunya et de la dengue en France m\u00e9tropolitaine, 2014","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resume_Septfons-A_2016_330-70-77.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Septfons A, No\u00ebl H, Leparc-Goffart I, Giron S, Delisle E, Chappert JL, Catelinois O, Franke F, Servas V, Guinard A, Debruyne M, Schaal O, Brichler S, Ninove L, Prat C, Flusin O, Poujol I, Letort MJ, Deniau J, Six C, Rousseau C, De Valk H, Paty MC\nLes Feuillets de Biologie 2016 ; 330:70-77"},{"title":"Surveillance du chikungunya, de la dengue et des infections \u00e0 virus Zika en France m\u00e9tropolitaine, 2017","media_link":"http:\/\/invs.santepubliquefrance.fr\/beh\/2018\/24\/pdf\/2018_24_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fournet N, Franke F, Chaud P, Raguenaud ME, Calba C, Septfons A, Cart-Tanneur E. et al.\nBull Epid\u00e9miol Hebd. 2018;(24):494-503."},{"title":"Testing anti-neutrophil cytoplasmic antibodies (ANCA): analysis of the European EASI survey on the daily practice of the French laboratories","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28958962","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dragon-Durey MA, Fabien N, Chyd\u00e9riotis G, Musset L, Pham BN, Olsson N\nAnn Biol Clin 2017 ; 75:531-541"},{"title":"The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)","media_link":"","date":"06\/09\/2022","media_type":"document","profils":"579,575,574,","document_type":"publication","content":"\n
Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nab\u00e9ra C, Chapiro E, Collonge-Rame MA, Cuccuini W, Douet-Guilbert N, Eclache V, Luquet I, Michaux L, Nadal N, Penther D, Quilichini B<\/strong>, Terre C, Lefebvre C, Troadec MB, V\u00e9ron\u00e8se L. Leukemia. 2022 Jun;36(6):1451-1466. doi: 10.1038\/s41375-022-01561-w. Epub 2022 Apr 16.PMID: 35430613 Review.<\/p>\n"},{"title":"The impact of introducing combined first-trimester trisomy 21 screening in the French population","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26628633","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Eur J Public Health 2015 ; Nov 30"},{"title":"The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34284044\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Maxime Espi, Xavier Charmetant, Thomas Barba, Laetitia Koppe, Caroline Pelletier, Emilie Kalbacher, Elodie Chalencon, Virginie Mathias, Anne Ovize, Emmanuelle Cart-Tanneur, Christine Bouz, Laurence Pellegrina, Emmanuel Morelon, Denis Fouque, Laurent Juillard, Olivier Thaunat\nKidney International 2021 Oct;100(4):928-936. doi: 10.1016\/j.kint.2021.07.005."},{"title":"Thrombop\u00e9nie induite par l\u2019h\u00e9parine (TIH) : \u00e0 propos d\u2019un casLe Flem L, Emile C","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Le Flem L, Emile C, Spectra Biologie 2016 ; 220:49-50<\/p>\n"},{"title":"Une interf\u00e9rence dans le dosage de l\u2019insuline r\u00e9v\u00e8le un syndrome auto-immun anti-insuline","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27492703","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Lamy PJ, Sault C, Renard E\nAnn Biol Clin 2016 ; 74:490-494"},{"title":"Vector-borne Transmission of Zika Virus in Europe, Southern France, August 2019","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31718742\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Sandra Giron, Florian Franke, Anne Decoppet, Bernard Cadiou, Thierry Travaglini, Laurence Thirion, Guillaume Durand, Charles Jeannin, Gr\u00e9gory L\u2019Ambert, Gilda Grard, Harold No\u00ebl, Nelly Fournet, Michelle Auzet-Caillaud, Christine Zandotti, Samer Abouka\u00efs, Pascal Chaud, Saby Guedj, Lakri Hamouda, Xavier Naudot, Anne Ovize, Cl\u00e9ment Lazarus, Henriette de Valk, Marie-Claire Paty, Isabelle Leparc-Goffart\nEuro Surveill. 2019 Nov;24(45):1900655."},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Faux-positif-ADNlcT21_L-Druart_012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Faux positif d\u2019ADNlcT21 avec diff\u00e9rentes anomalies chromosomiques confin\u00e9es au placenta\nL Druart, H Dessuant, JF Taly, M Nouchy, L Raymond, S Tapia"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Developpement-panel-15-marqueurs_F.-Rousseau-et-al.-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9veloppement d\u2019un panel de 15 marqueurs pour une identitovigilance\ndes \u00e9chantillons analys\u00e9s par s\u00e9quen\u00e7age haut d\u00e9bit ou sur puces \u00e0 SNP\nF Rousseau, J-F Taly, C Ploton Nicollet, M Taoudi, A Perdriau, L Raymond"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20359-Assises-de-Genetique-2020_B-Quilichini_012020.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Mise en place d\u2019un panel de g\u00e8nes cibl\u00e9s pour les h\u00e9mopathies\nmalignes (NMP-LMMC-SMD-LAM) par NGS : Enjeux M\u00e9dical \/ Scientifique et d\u2019Assurance Qualit\u00e9.\nV Geromel, E Fayolle, P Mouty, R Moulin, N Batail, M-H Felix, B Adde, S Mouty, L Raymond, B Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20362-Assises-de-Gntique-2020_B_Quilichini-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Impact diagnostique, pronostique et th\u00e9ranostique d\u2019un panel de g\u00e8nes\n\u00ab H\u00e9mopathies My\u00e9lo\u00efdes \u00bb r\u00e9alis\u00e9 par NGS : l\u2019exp\u00e9rience du laboratoire Eurofins Biomnis en 2019.\nV. Geromel, P. Mouty, C. Chal, J . Delaunay, S. Sadot-Lebouvier, R. Kaphan, J. Vigvari, J.P. Coadic, E.A. Marin La Meslee, O. Roualdes, C. Bourdin, A. Petit, M. Roumigui\u00e8res, L. Raymond, B.Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 4","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Les_assises_2020_RadoslavaSARAEVA_LAMRI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"21-24 janvier 2020, Tours\nDiagnostics g\u00e9n\u00e9tiques multiples (double hits) par s\u00e9quen\u00e7age Whole Exome (WES) : \u00e0 propos de deux cas.\nR. SARAEVA-LAMRI, A. DORELLE, V. GEROMEL, A. S. LEBRE, P. MOUTY, M. E. NAUD BARREYRE, F. ROUSSEAU, M. TAOUDI, L. MESNARD, L. RAYMOND"},{"title":"10th International Congress on Autoimmunity, Leipzig, April 6-10, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_4.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Should Dense Fine Speckled 70 (DFS70) pattern be reported? Biomnis reference lab experience on 12 619 ANA screening consecutive sera\nGuis L, Ebel A, Leroy J, Michaud S, Pomaredes A, Marcenaro C, Chalouas L"},{"title":"12\u00e8me CFA, Paris, avril 25-28, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":""},{"title":"12\u00e8me Congr\u00e8s de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Paris, mars 22-23, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Jacomo_3.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Les Liquides C\u00e9phalo-Rachidiens : conservation pr\u00e9-analytique \u00e0+ 4 \u00b0C ou \u2013 20 \u00b0C ?\nJacomo V, Schaal O, Fournier P"},{"title":"17\u00e8mes Journ\u00e9es Francophones de Virologie, Paris, avril 9, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"R\u00e9solution des \u00e9checs de g\u00e9notypage de la technique Abbott RealTime HCV Genotype II par un test temps r\u00e9el additionnel\nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ly_8.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of a new high sensitive, qualitative and quantitative Hepatitis B surface antigen assay\nLy TD, Coignard C"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Characterization of samples with genotype 1 without subtype results by Abbott RealTime HCV genotype II using the new Abbott HCV Genotype Plus RUO test \nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"19th Annual Meeting of the European Society for Clinical Virology (ESCV), Lisbon, september, 14\u201317, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/09\/Biomnis_Poster_2016_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to COBAS\u00ae AmpliPrep\/OBAS\u00ae TaqMan\u00ae HIV-1 and HBV tests\nEbel A, Bali C, Guis L, Merlin S"},{"title":"20\u00e8mes Journ\u00e9es de M\u00e9decine Foetale, Morzine, mars 26-28, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015__Becker_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Int\u00e9r\u00eat du D\u00e9pistage Pr\u00e9natal Non Invasif dans le diagnostic des aneuplo\u00efdies 13, 18 et 21 \nBecker M, Eg\u00e9a G, Taoud M, Ahmed Chaouch D, El Mouatassim S"},{"title":"20Th Congress European Hematology Association, Vienna, June 11-14, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Rigollet_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Characterization of normal and pathological lymphoid populations: validation of a 10-colors flow cytometry protocol for routine diagnosis \nRigollet L, Stagnara J, Milhau A, Pellegrina L"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/10\/Biomnis_Poster-Aptima-HIV-1-HBV_Ebel_Sept18.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV-1 Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to Cobas\u00ae 6800\/8800 HIV-1 and HBV tests\nA. Ebel, C. Bali, L. Guis, S. Merlin"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/11\/Poster-IgM-Measles-ESCV-TD-LY-.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of new IgM Measles assay\nT.D. Ly, C. Coignard"},{"title":"24e Journ\u00e9es de m\u00e9decine f\u0153tale, Marseille, 4-5-6 avril 2019","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9pistage de la trisomie 21 par analyse de l\u2019ADN f\u0153tal libre circulant dans le sang maternel : Application dans le cas des grossesses g\u00e9mellaires\nMarc NOUCHY, Nicolas CHATRON, Pascal MOUTY, Francis ROUSSEAU, Barbara ADD\u00c9, Mohamed Taoudi, Caroline DUMONT, Jean-Fran\u00e7ois TALY, Luc DRUART, Sylvie TAPIA, Damien SANLAVILLE, Laure RAYMOND"},{"title":"25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, April 25-28, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of three fully automated assays for the detection of cytomegalovirus IgM and IgG: DiaSorin LIAISON\u00ae XL, Abbott Architect \u00ae and Roche Cobas 6000\u00ae\nBouthry E, Ly TD, Vauloup-Fellous C"},{"title":"27th ECCMID, Vienna Austria, April 22-25, 2017","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Strain-specific estimation of epidemic success provides insights into the transmission dynamics of tuberculosis Rasigade\nJP, Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, P\u00e9rouse de Montclos M, Flandrois JP, Ader F, Supply P, Lina G, Wirth T"},{"title":"29th IUSTI European Conference on Sexually Transmitted Infections, Sitges (Barcelona), 24-26 September, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Prevalence of Mycoplasma genitalium in France and comparison with Chlamydia trachomatis and Neisseria gonorrhoeae as determined by the Mycoplasma genitalium TMA assay \nEbel A, Venard C, Brunengo D, Merlin S"},{"title":"31st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbon, June 14-17, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Force_7.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Blastocysts vitrification during 2 consecutive years: before and after its start significant delivery rate increase within the 1st year \nForce A, Nicollet B, Chomier M, Sergeant P, Lescaille M, Rochigneux S, Robert F, Ginon J, Sergeant MV, Baucher S, Schubert B"},{"title":"35e congr\u00e8s de la SFH, CNIT Paris la D\u00e9fense, avril 1-3, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Becker_4.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"La SNP array : un outil compl\u00e9mentaire pour la caract\u00e9risation des h\u00e9mopathies malignes \nBecker M, Eg\u00e9a G, Camilli K, Robin M, Roumigui\u00e8res M, Rigollet L, Stagnara J, El Mouatassim S"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_14.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Evaluation du nouveau test LAISON\u00ae H. pylori IgG\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_15.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Borr\u00e9liose et index de synth\u00e8se intrath\u00e9cale : bilan biologique r\u00e9trospectif de l\u2019ann\u00e9e 2015\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Ebel_16.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation des performances de la trousse Aptima\u00ae HBV Quant (Hologic)\nEbel A, Bali C, Guis L, Merlin S"},{"title":"37\u00e8me RICAI, Paris, d\u00e9cembre 18-19, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/12\/Biomnis_Poster_2017_Coignard_13.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Confirmation VIH : donn\u00e9es biologiques et \u00e9pid\u00e9miologiques des 3 derni\u00e8res ann\u00e9es dans un laboratoire de biologie sp\u00e9cialis\u00e9e\nCoignard C, Ly TD"},{"title":"38e RICAI, Paris 17-18 d\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-COIGNARD-ROUGEOLE.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Epid\u00e9mie de rougeole 2018 : le s\u00e9rodiagnostic un marqueur simple et performant.\nT.D. Ly, C. Coignard"},{"title":"3e Journ\u00e9e Francophone de Biologie M\u00e9dicale, Monaco, 6-7-8 novembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/11\/1911_poster_A.Ebel_JFBM.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"D\u00e9pistage syst\u00e9matique de Neisseria gonorrhoeae et de C. trachomatis par test d\u2019amplification g\u00e9nique : bilan d\u2019une ann\u00e9e d\u2019exp\u00e9rience\nL. Mine, L. Guis, S. Merlin, A. Ebel"},{"title":"40e RICAI \u2013 R\u00e9union Interdisciplinaire de Chimioth\u00e9rapie Anti-Infectieuse, 14-15 d\u00e9cembre","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Posters\/2012_Poster_SARS-CoV-2_RICAI_C.Coignard.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"S\u00e9rologie SARS-CoV-2 : \u00e9valuation, qualification et choix d\u2019une m\u00e9thode\nCatherine Coignard, Anne EBEL, Yanis BOUAMRA, Didier RIDEY, Carla MARCENARO"},{"title":"42es Journ\u00e9es Nationales \u2013 Congr\u00e8s CNGOF, Strasbourg, 4-7 D\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-EMILE-DPNI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"\u00c9tude de l\u2019usage du DPNI (d\u00e9pistage pr\u00e9natal non invasif) des aneuplo\u00efdies en milieu lib\u00e9ral\nC. Emile, L. Raymond, L. Pellegrina"},{"title":"45\u00e8me Colloque National des Biologistes des H\u00f4pitaux, Paris, juin 22-24, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/06\/Biomnis_Poster_2016-Rabut_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Interf\u00e9rence du traitement par daratumumab (anti-CD38) dans le suivi biologique du my\u00e9lome multiple et dans la recherche d\u2019anticorps anti-\u00e9rythrocytaires : \u00e0 propos d\u2019un cas\nRabut E, Castro-Fernandez A, Le Gall V, Meknache N"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Raymond_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport diagnostique de l\u2019utilisation des puces SNP dans l\u2019\u00e9tude chromosomique des morts f\u0153tales\nRaymond L, Dherbey JL, Rebeyrat-Pichon I, El-Mouatassim S, Egea G"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier, 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_11.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Cas rare d\u2019X-fragile pr\u00e9natal avec r\u00e9traction d\u2019expansion de triplet CGG ? \nMouty P, Raymond L, El Mouatassim S, Liquier A, Druart L, Paris A, Dorian V, Pichon I, Dherbey JL, Eg\u00e9a G"},{"title":"CGRF Ile de R\u00e9, septembre 28-29, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Brunengo_11.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Epid\u00e9miologie qualitative des variants rares de l\u2019H\u00e9moglobine en France m\u00e9tropolitaine au travers de la collaboration HCL \u2013 Eurofins Biomnis\nBrunengo D, Veyrenche N, Louis Chillotti L, Le Flem L"},{"title":"COGEN, Paris, Septembre 25-27, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_El-Mouatassim_11.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"French experience of Non-Invasive Prenatal Testing of trisomy 21, 18 and 13 \nEl Mouatassim S, Taoudi M, Eg\u00e9a G"},{"title":"Congr\u00e8s SFP \/ SFMM, Toulouse, mars 29-31, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/03\/Biomnis_Poster_2017_Chydriotis_1-1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport de 2 tests de d\u00e9pistage pour le diagnostic de la bilharziose et place du Western blot\nChyd\u00e9riotis G, Cart-Tanneur E, Lecuelle C, F\u00e9lix MH"},{"title":"Congr\u00e8s SFTA, Avignon, mai 10-12, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_Petit_2.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Dosage de la Ciclosporine, Tacrolimus, Ev\u00e9rolimus et Sirolimus en LCMSMS avec le coffret MassTox Chromsystems sur Api 4500 ABSciex avec pr\u00e9paration automatis\u00e9e sur T\u00e9can EVO 150\nPetit I, Moussa C, Bonnet K, Bezol A. Havrez S, Gerrier P"},{"title":"EAACI, Helsinki, June 17-21, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_6.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Bp14, an allergen from cupressus sempervirens pollen related to the family of snakin\/gibberellin-regulated proteins\nS\u00e9n\u00e9chal H, Santrucek J, Melcova M, Svoboda P, Zidkova J, Guilloux L, Aizawa T, Couderc R, Charpin D, Poncet P"},{"title":"ESCAIDE 2015, Stockholm, November 11-13, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Chyderiotis_14.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Re-emergence of urinary schistosomiasis in Europe ? Infections acquired in Southern Corsica \u2013 Investigation of a cluster of Schistosoma haematobium infections in 2014\nRamalli L, No\u00ebl H, Ruello M, Maccary A, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Denoyel GA, Succo T, Armengaud A, Paty MC, Heuz\u00e9 G, Mattei J, Th\u00e9ron A, Berry A"},{"title":"ESCV, Stresa, Lake Maggiore, September 13-16, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/10\/Biomnis_Poster_2017_LY_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new chemiluminescent assay to detect and quantify anti-HBs antibodies\nMaillard A, Ly TD, Thibault V"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_LY_3.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new LIAISON\u00ae H. pylori IgG\nLy TD, Coignard C"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Rabut_4.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Red blood cell antibody assays in DARA-treated patients\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"EuroMedLab, Paris, June 22-24, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Early Performance Evaluation of cobas\u00ae HBV, cobas\u00ae HCV and cobas\u00ae HIV-1Quantitative Nucleic Acid Tests for use on the new cobas\u00ae 6800\/8800 Systems\nEbel A, Merlin S, Marins ED G, Canchola J, Njoya M, Simon CO"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/poster-FFER-2018-callec.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Impact de la chirurgie bariatrique sur les param\u00e8tres spermatiques : Revue de la litt\u00e9rature\nR. Callec, B. Schubert, F. Robert, A. Force"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/POSTER-FFER-2018-Force.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Crit\u00e8res d\u2019interpr\u00e9tation du msome pour une optimisation de la prise en charge des patients\nA. Force, M. Chomier, P. Sergeant, J. Ginon, S. Rochigneux, M. Lechatton, M. Pont, R. Callec, F. Robert, B. Schubert"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Lopez.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation externe de la qualit\u00e9 en spermiologie : un nouveau programme pour une \u00e9valuation globale de l\u2019examen\nMarie LOPEZ, Bernard POGGI, Jean Christophe EYNARD, Marie LETY, Benoit SCHUBERT, Andr\u00e9 FORCE"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Schubert.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Influence des conditions de culture sur les r\u00e9sultats en AMP dans une \u00e9tude multicentrique : comparaison d\u2019un incubateur Time Lapse avec les incubateurs tradictionnels\nBeno\u00eet SCHUBERT, Alexandre MARCILLY, Andr\u00e9 FORCE"},{"title":"FFER, Tours, septembre 13-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Force_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Comparaison de la performance de 2 incubateurs (Geri versus Planer) apr\u00e8s randomisation de la cohorte ovocytaire pour chaque patiente\nForce A, Martine Chomier, Philippe Sergeant, Jacqueline Ginon, St\u00e9phanie Rochigneux, Soizic Baucher, M\u00e9lanie Le Chatton, M\u00e9lanie Pont, Beno\u00eet Schubert"},{"title":"FIBA 2016, Dakar, January 13-14, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"ANCA associated HIV infection in Senegal: a serological trap\nArouna O, Niang A, Abiola A, Guis L, Le Flem L, Diene JF, Mboup S"},{"title":"Fort Collins (USA), May 31-June 3, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/05\/Biomnis_Poster_2016_Jacomo_5.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Seoul Virus Infection in Human, France, 2014-2016\nReynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, Nussbaumer T, Jacomo V, Rapt MP, Septfons A, Rollin PE"},{"title":"ISMA, Lisbon, November 19-21, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2015_Guilloux_16.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Ige-cross-reactivity between european hymenoptera and asian hornet (vespa velutina) venom allergens\nLong\u00e9 C, Brazdova A, Brunet JL, Schwartz C, Girodet B, Lavaud F, Birnbaum J, Pham-Thi N, Duchateau M, Chamot-Rooke J, Guilloux L, Selva MA, Couderc R, S\u00e9n\u00e9chal H, Sutra JP, Poncet P"},{"title":"Journ\u00e9es Nationales CNGOF, Montpellier, d\u00e9cembre 7-9, 2016","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Etude pr\u00e9liminaire sur le d\u00e9pistage de la pr\u00e9-\u00e9clampsie au 1er trimestre de la grossesse (Predictor\u00ae)\nWalder R, Galland A, Sault C, Huissoud C"},{"title":"Journ\u00e9es Nationales d\u2019Infectiologie, Nantes, 13-15 juin, 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/05\/Biomnis_Poster_2018_Ebel_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Infections \u00e0 Chlamydia trachomatis : donn\u00e9es \u00e9pid\u00e9miologiques r\u00e9centes dans un laboratoire sp\u00e9cialis\u00e9\nEbel A, Guis L, Merlin S"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Poster-Lyme-RICAI-C.-Coignard-TD-Ly-dec-2019-800x1200.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of the BioPlex 2200 Lyme IgG\/IgM immunoassay system\nC. Coignard, C. Cl\u00e9ment-Vincent, Td. Ly, A. L\u2019hotellier"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/12\/2019-12-17_RICAI.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Sp\u00e9cificit\u00e9 de la s\u00e9rologie chikungunya et surveillance \u00e9pid\u00e9miologique\nC. Calba, F. Franke, E. Brottet, G. Terpant, N. Fournet, A. Ovize, J.D. Poveda, I. Leparc-Goffart, M.C. Paty"},{"title":"SFE, Bordeaux, octobre 5-8, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Sault_13.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Influence de la nature du liquide de rin\u00e7age d\u2019aiguille de cytoponction sur le dosage de la thyroglobuline\nBoux De Casson F, Moal V, Gauchez AS, Moineau MP, Sault C, Schlageter MH, Massart C"},{"title":"SFTS, Bordeaux, septembre 20-22, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Rabut_10.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Recherche et quantification de l\u2019h\u00e9morragie f\u0153to-maternelle par cytom\u00e9trie en flux avec double marquage anti-h\u00e9moglobine F et anti-anhydrase carbonique\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"XXIIIe Colloque ACLF, Montpellier, septembre 20-21, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Syndrome de Currarino atypique avec hexadactylie pr\u00e9-axiale : remaniement complexe en 7q36.3 en pr\u00e9natal\nLiquier A, Becker M, Raymond L, Bourgain A, Amat S, Broussin B, Andr\u00e9 G, Escande F, Nouchy M, Eg\u00e9a G"}]));
sessionStorage.setItem('currentLang', 'fr');render(html`<${RessourcesDynamiques} name="World" />`, document.getElementById('resdyncontainer'));
\n
Rabut E, Ahmetkadic D, Malataverne J, Le Flem L Spectra Biologie 2016 ; 223:45-54<\/p>\n"},{"title":"\u00c9valuation de la valeur seuil la plus co\u00fbt-efficace des marqueurs s\u00e9riques du 1er\u00a0trimestre pour l\u2019emploi du test d\u2019ADN circulant dans le d\u00e9pistage de la trisomie\u00a021\u00a0: une analyse m\u00e9dico-\u00e9conomique","media_link":"https:\/\/www.jle.com\/fr\/revues\/abc\/e-docs\/cost_effectiveness_threshold_of_first_trimester_down_syndrome_maternal_serum_screening_for_the_use_of_cell_free_dna_as_a_second_tier_screening_test_320573\/article.phtml","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Marie Blanquet, Sophie Dreux, St\u00e9phanie L\u00e9ger,\u00a0Corinne Sault,\u00a0Charline Mourgues, H\u00e9l\u00e8ne Laurichesse, Didier L\u00e9mery, Fran\u00e7oise Vendittelli, Anne Debost-Legrand, Fran\u00e7oise Muller\nAnnales de Biologie Clinique Volume 79, num\u00e9ro 4, Juillet-Ao\u00fbt 2021"},{"title":"Evaluation of the performance of a new automated HIV combination assay","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29020658","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Ghisetti V, Coignard C, Allice T, Ly TD\nJ Clin Virol 2017 ; 96:80-83"},{"title":"Evaluation of the SLOMYCO Sensititre\u00ae panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27150659","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Chazel M, Marchandin H, Keck N, Terru D, Carri\u00e8re C, Ponsoda M, Jacomo V, Panteix G, Bouzinbi N, Ba\u00f1uls AL, Choisy M, Solassol J, Aubry, Godreuil S\nAnn Clin Microbiol Antimicrob 2016 ; 15:30"},{"title":"Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities","media_link":"http:\/\/www.bloodjournal.org\/content\/132\/Suppl_1\/943?sso-checked=true","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"On Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group\nElise Chapiro, Elodie Pramil, M\u2019boyba Diop, Damien Roos-Weil, Cl\u00e9mentine Dillard, Cl\u00e9mentine Gabillaud, Karim Maloum, Catherine Settegrana, Lucile Baseggio, Jean-Fran\u00e7ois Lesesve, M\u00e9lanie Yon, Ludovic Jondreville, Claude Lesty, Fr\u00e9d\u00e9ric Davi, Magali Le Garff-Tavernier, Nathalie Droin, Philippe Dessen, Caroline Algrin, V\u00e9ronique Leblond, Jean Gabarre, Simon Bouzy, Virginie Eclache, Baptiste Gaillard, Evelyne Callet-Bauchu, Marc Muller, Christine Lefebvre, Nathalie Nadal, Antoine Ittel, St\u00e9phanie Struski, Marie-Agn\u00e8s Collonge-Rame, Benoit Quilichini, Sandra Fert-Ferrer, Nathalie Auger, Isabelle Radford-Weiss, Lena Wagner, Sebastian Scheinost, Thorsten Zenz, Santos A. Susin, Olivier A. Bernard, Florence Nguyen-Khac\nBlood 2018 132:943; doi:"},{"title":"Identification of a polygalacturonase (Cup s 2) as the major CCD-bearing allergen in Cupressus sempervirens pollen","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28439939","date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Shahali Y, Sutra JP, Hilger C, Swiontek K, Haddad I, Vinh J, Guilloux L, Charpin D, S\u00e9n\u00e9chal H, Poncet\nAllergy 2017 ; doi: 10.1111\/all.13191"},{"title":"Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. \u2013 Trends over 10 years","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26518058","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bailly S, Maubon D,\u00a0Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF\nJ Infect\u00a02015 ; Oct 28. pii: S0163-4453(15)00342-4. doi: 10.1016\/j.jinf.2015.09.041"},{"title":"Impact of Including or Removing Nuchal Translucency Measurement on the Detection and False-Positive Rates of First-Trimester Down Syndrome Screening","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26656919","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Spaggiari E, Czerkiewicz I, Sault C, Dreux S, Galland A, Salomon LJ, Ville Y, Muller F\nFetal Diagn Ther 2015 ; Dec 12"},{"title":"Int\u00e9r\u00eat du s\u00e9quen\u00e7age haut d\u00e9bit dans les h\u00e9mopathies my\u00e9lo\u00efdes chroniques : quelles actualit\u00e9s en 2022 ?","media_link":"","date":"01\/09\/2022","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
B. Quilichini Journal de Biologie M\u00e9dicale \/ Volume 11-Num\u00e9ro 42 \/ Juil-Sept 2022<\/p>\n"},{"title":"Interf\u00e9rences s\u00e9rologiques du traitement du my\u00e9lome multiple par daratumumab (anti-CD38) : \u00e0 propos d\u2019un cas","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28540859","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Rabut E, Castro-Fernandez A, Le Gall V, Meknache\nAnn Biol Clin 2017 ; 75:351-355"},{"title":"Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31379011","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Penther D, Etancelin P, Lusina D, Bidet A, Quilichini B, Gaillard B, Rafdord-Weiss I, Mozziconacci MJ, Ittel A, Roche-Lestienne C, Barin C, Soler G, Daudignon A, Nadal N, Chapiro E, Lefebvre C, Godon C, Nadeau G, Mugneret F, Richebourg S, Viailly PJ, Ferret Y, Nguyen-Khac F, Eclache V; Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique\nAm J Hematol 2019 Aug 4. doi: 10.1002\/ajh.25601."},{"title":"Large outbreak of urogenital schistosomiasis acquired in Southern Corsica: monitoring the early signs of the endemicization?","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28669843","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"No\u00ebl H, Ruello M, Maccary A, Pellat C, Sommen C, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Durand J, Ramalli L, Chiappini JD , Malfait P, Berry\nClin Microbiol Infect 2017 ; pii: S1198-743X(17)30350-6. doi: 10.1016\/j.cmi"},{"title":"Les niveaux de preuve des biomarqueurs utilis\u00e9s pour la d\u00e9tection pr\u00e9coce des cancers de la prostate","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27029727","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Lamy PJ, Gauchez AS, Salomon L et al et le Groupe de biologie de la prostate : Sault C et al\nAnn Biol Clin 2016 ; 74:227-232"},{"title":"Marqueurs de d\u00e9pistage et de pr\u00e9diction de la pr\u00e9-\u00e9clampsie : place de la biologie","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Sault C\nJ Biol Med 2017 ; 6:186-190"},{"title":"Non-invasive prenatal testing: what are we missing?\u00a0","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32119166","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fries N, Le Garrec S, Egloff M, Sault C, Dreux S, Mangione R, Salomon LJ, Ville Y. \nUltrasound Obstet Gynecol. Mars 2020 - 2. doi: 10.1002\/uog.22005."},{"title":"Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28189936","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Thibault V, Servant-Delmas A, Ly TD, Roque-Afonso AM, Laperche S\nJ Clin Virol 2017 ; 89:14-21"},{"title":"Persistence of Zika virus in gradient sperm preparation","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29510270","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Cassuto NG, Marras G, Jacomo V, Bouret D\nJ Gynecol Obstet Hum Reprod 2018, pii: S2468-7847(18)30038-2"},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Emile C, Sault C\nSpectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49."},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"12\/12\/2022","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Emile C, Sault C<\/strong>. Spectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49.<\/p>\n"},{"title":"Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Potential+value+of+placental+angiogenic+factors+as+biomarkers+in+preeclampsia+for+clinical+physicians","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Boulanger H, Lef\u00e8vre G, Ahriz Saksi S, Achiche J, Bailleul S, Ekoukou D, Drouin D, Sault C, Stawiarski N, Dupuis E.\nNephrol Ther. 2019 Mar 29"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0755498219304178?via%3Dihub","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Hamdi SM, Sault C, Piver E, Genoux A, Masson D, Guibourdenche J.\nPresse Med . 2019 Oct 29. pii: S0755-4982(19)30417-8. doi: 10.1016\/j.lpm.2019.09.029. PMID:31676218"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/doi.org\/10.1016\/j.lpm.2019.09.029","date":"12\/12\/2019","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Hamdi SM, Sault C<\/strong>, Piver E, Genoux A, Masson D, Guibourdenche J. Presse Med. (2019)<\/p>\n"},{"title":"Preliminary report of an autochthonous Chikungunya outbreak in France, July to September 2017","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29019313","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Calba C, Guerbois-Galla M, Franke F, Jeannin C, Auzet-Caillaud M, Grard G, Pigaglio L, Decoppet A, Weicherding J, Savaill MC, Munoz-Riviero M, Chaud P, Cadiou B, Ramalli L, Fournier P, Noel H, De Lamballerie X, Paty MC, Leparc-Goffart I\nEuro Surveill 2017 ; 22(39):pii=17-00647"},{"title":"Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance","media_link":"https:\/\/www.nature.com\/articles\/s41467-021-23233-6","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"St\u00e9phane Le Vu,\u00a0Gabrielle Jones,\u00a0Fran\u00e7ois Anna,\u00a0Thierry Rose,\u00a0Jean-Baptiste Richard,\u00a0Sibylle Bernard-Stoecklin,\u00a0Sophie Goyard,\u00a0Caroline Demeret,\u00a0Olivier Helynck,\u00a0Nicolas Escriou,\u00a0Marion Gransagne,\u00a0St\u00e9phane Petres,\u00a0Corinne Robin,\u00a0Virgile Monnet,\u00a0Louise Perrin de Facci,\u00a0Marie-Noelle Ungeheuer,\u00a0Lucie L\u00e9on,\u00a0Yvonnick Guillois,\u00a0Laurent Filleul,\u00a0Pierre Charneau,\u00a0Daniel L\u00e9vy-Bruhl,\u00a0Sylvie van der Werf\u00a0&\u00a0Harold Noel\u00a0\nNature Communications volume 21\/05\/2021 12, Article number: 3025 (2021)"},{"title":"Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/30789329\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Tatai C, Berland JL, Claude JB, Westeel E, Hodille E, Fredenucci I, Rasigade JP, Ponsoda M, Jacomo V, Vach\u00e9e A, Gaudart A, Gaillard JL, Roux AL, Ader F, Tararbit K, Terpant G, Bryant JE, Lina G, Dumitrescu O; Lyon TB Study Group.Genestet C, et al.\nEmerg Infect Dis. 2019 Mar;25(3):589-592. doi: 10.3201\/eid2503.181124 - PMID: 30789329"},{"title":"R\u00e9activit\u00e9 crois\u00e9e in silico, in vitro, in vivo","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Guilloux L, Ricard-Blum S\nAllergies alimentaires 2017 ; chapitre 7.5:97-102"},{"title":"Recherche et identification des anticorps antinucl\u00e9aires : analyse du questionnaire europ\u00e9en de l\u2019EASI groupe et confrontation des pratiques fran\u00e7aises aux recommandations internationales","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29623889","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Musset L, Fabien N, Chyderiotis G, Olsson NO, Pham BN, Durey Dragon MA\nAnn Biol Clin 2018, 76 :185-195"},{"title":"Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission.","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31806715\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Paret R, Pichat C, Berland JL, Jacomo V, Carret G, Fredenucci I, Hodille E, Rasigade JP, Boisset S, Carricajo A, Lina G, Ronnaux-Baron AS, Mornex JF, Grando J, S\u00e9n\u00e9chal A, Ader F, Dumitrescu O; Lyon TB study group.Genestet C, et al.\nEur Respir J. 2020 Mar 20;55(3):1901888. doi: 10.1183\/13993003.01888-2019. Print 2020 Mar"},{"title":"Schistosomose en Corse : chronique d\u2019une histoire annonc\u00e9e","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Berry A, Iriart X, Boissier J, Chyd\u00e9riotis G, Debruyne M, Magnaval JF, Fillaux J, Grech-Angelini S, Barr\u00e9-Cardi H, Termignon JL, Macarry A, Noel H\nLa Lettre de l'Infectiologue 2016 ; XXXI n\u00b02:60-64"},{"title":"Screening and identification of antinuclear antibodies (ANA): analysis of the European EASI survey and confrontation of the French routine practice to the international recommandations","media_link":null,"date":null,"media_type":"document","profils":"579,575,574,","document_type":"publication","content":"Musset L, Fabien N, Chyd\u00e9riotis G, Olsson NO, Pham BN, Dragon-Durey MA\nAnn Biol Clin 2017 ;"},{"title":"Surveillance des infections humaines par hantavirus en France m\u00e9tropolitaine, 2012-2016","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Reynes JM, Carli D, Renaudin B, Fizet A, Bour JB, Brodard V, Cart-Tanneur E, Dewilde A, El Hamri M, Fleury H, Hecquet D, Jeulin H, Lechat S, Lemarquand-Bardini M, Lepiller Q, Poveda JD, Raulin O, Twizeyimana E, Van Cauteren D, Velay A, Septfons A, Baize S\nBEH 2017 ; 23:492-499"},{"title":"Surveillance du chikungunya et de la dengue en France m\u00e9tropolitaine, 2014","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resume_Septfons-A_2016_330-70-77.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Septfons A, No\u00ebl H, Leparc-Goffart I, Giron S, Delisle E, Chappert JL, Catelinois O, Franke F, Servas V, Guinard A, Debruyne M, Schaal O, Brichler S, Ninove L, Prat C, Flusin O, Poujol I, Letort MJ, Deniau J, Six C, Rousseau C, De Valk H, Paty MC\nLes Feuillets de Biologie 2016 ; 330:70-77"},{"title":"Surveillance du chikungunya, de la dengue et des infections \u00e0 virus Zika en France m\u00e9tropolitaine, 2017","media_link":"http:\/\/invs.santepubliquefrance.fr\/beh\/2018\/24\/pdf\/2018_24_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fournet N, Franke F, Chaud P, Raguenaud ME, Calba C, Septfons A, Cart-Tanneur E. et al.\nBull Epid\u00e9miol Hebd. 2018;(24):494-503."},{"title":"Testing anti-neutrophil cytoplasmic antibodies (ANCA): analysis of the European EASI survey on the daily practice of the French laboratories","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28958962","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dragon-Durey MA, Fabien N, Chyd\u00e9riotis G, Musset L, Pham BN, Olsson N\nAnn Biol Clin 2017 ; 75:531-541"},{"title":"The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)","media_link":"","date":"06\/09\/2022","media_type":"document","profils":"579,575,574,","document_type":"publication","content":"\n
Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nab\u00e9ra C, Chapiro E, Collonge-Rame MA, Cuccuini W, Douet-Guilbert N, Eclache V, Luquet I, Michaux L, Nadal N, Penther D, Quilichini B<\/strong>, Terre C, Lefebvre C, Troadec MB, V\u00e9ron\u00e8se L. Leukemia. 2022 Jun;36(6):1451-1466. doi: 10.1038\/s41375-022-01561-w. Epub 2022 Apr 16.PMID: 35430613 Review.<\/p>\n"},{"title":"The impact of introducing combined first-trimester trisomy 21 screening in the French population","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26628633","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Eur J Public Health 2015 ; Nov 30"},{"title":"The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34284044\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Maxime Espi, Xavier Charmetant, Thomas Barba, Laetitia Koppe, Caroline Pelletier, Emilie Kalbacher, Elodie Chalencon, Virginie Mathias, Anne Ovize, Emmanuelle Cart-Tanneur, Christine Bouz, Laurence Pellegrina, Emmanuel Morelon, Denis Fouque, Laurent Juillard, Olivier Thaunat\nKidney International 2021 Oct;100(4):928-936. doi: 10.1016\/j.kint.2021.07.005."},{"title":"Thrombop\u00e9nie induite par l\u2019h\u00e9parine (TIH) : \u00e0 propos d\u2019un casLe Flem L, Emile C","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Le Flem L, Emile C, Spectra Biologie 2016 ; 220:49-50<\/p>\n"},{"title":"Une interf\u00e9rence dans le dosage de l\u2019insuline r\u00e9v\u00e8le un syndrome auto-immun anti-insuline","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27492703","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Lamy PJ, Sault C, Renard E\nAnn Biol Clin 2016 ; 74:490-494"},{"title":"Vector-borne Transmission of Zika Virus in Europe, Southern France, August 2019","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31718742\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Sandra Giron, Florian Franke, Anne Decoppet, Bernard Cadiou, Thierry Travaglini, Laurence Thirion, Guillaume Durand, Charles Jeannin, Gr\u00e9gory L\u2019Ambert, Gilda Grard, Harold No\u00ebl, Nelly Fournet, Michelle Auzet-Caillaud, Christine Zandotti, Samer Abouka\u00efs, Pascal Chaud, Saby Guedj, Lakri Hamouda, Xavier Naudot, Anne Ovize, Cl\u00e9ment Lazarus, Henriette de Valk, Marie-Claire Paty, Isabelle Leparc-Goffart\nEuro Surveill. 2019 Nov;24(45):1900655."},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Faux-positif-ADNlcT21_L-Druart_012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Faux positif d\u2019ADNlcT21 avec diff\u00e9rentes anomalies chromosomiques confin\u00e9es au placenta\nL Druart, H Dessuant, JF Taly, M Nouchy, L Raymond, S Tapia"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Developpement-panel-15-marqueurs_F.-Rousseau-et-al.-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9veloppement d\u2019un panel de 15 marqueurs pour une identitovigilance\ndes \u00e9chantillons analys\u00e9s par s\u00e9quen\u00e7age haut d\u00e9bit ou sur puces \u00e0 SNP\nF Rousseau, J-F Taly, C Ploton Nicollet, M Taoudi, A Perdriau, L Raymond"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20359-Assises-de-Genetique-2020_B-Quilichini_012020.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Mise en place d\u2019un panel de g\u00e8nes cibl\u00e9s pour les h\u00e9mopathies\nmalignes (NMP-LMMC-SMD-LAM) par NGS : Enjeux M\u00e9dical \/ Scientifique et d\u2019Assurance Qualit\u00e9.\nV Geromel, E Fayolle, P Mouty, R Moulin, N Batail, M-H Felix, B Adde, S Mouty, L Raymond, B Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20362-Assises-de-Gntique-2020_B_Quilichini-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Impact diagnostique, pronostique et th\u00e9ranostique d\u2019un panel de g\u00e8nes\n\u00ab H\u00e9mopathies My\u00e9lo\u00efdes \u00bb r\u00e9alis\u00e9 par NGS : l\u2019exp\u00e9rience du laboratoire Eurofins Biomnis en 2019.\nV. Geromel, P. Mouty, C. Chal, J . Delaunay, S. Sadot-Lebouvier, R. Kaphan, J. Vigvari, J.P. Coadic, E.A. Marin La Meslee, O. Roualdes, C. Bourdin, A. Petit, M. Roumigui\u00e8res, L. Raymond, B.Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 4","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Les_assises_2020_RadoslavaSARAEVA_LAMRI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"21-24 janvier 2020, Tours\nDiagnostics g\u00e9n\u00e9tiques multiples (double hits) par s\u00e9quen\u00e7age Whole Exome (WES) : \u00e0 propos de deux cas.\nR. SARAEVA-LAMRI, A. DORELLE, V. GEROMEL, A. S. LEBRE, P. MOUTY, M. E. NAUD BARREYRE, F. ROUSSEAU, M. TAOUDI, L. MESNARD, L. RAYMOND"},{"title":"10th International Congress on Autoimmunity, Leipzig, April 6-10, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_4.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Should Dense Fine Speckled 70 (DFS70) pattern be reported? Biomnis reference lab experience on 12 619 ANA screening consecutive sera\nGuis L, Ebel A, Leroy J, Michaud S, Pomaredes A, Marcenaro C, Chalouas L"},{"title":"12\u00e8me CFA, Paris, avril 25-28, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":""},{"title":"12\u00e8me Congr\u00e8s de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Paris, mars 22-23, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Jacomo_3.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Les Liquides C\u00e9phalo-Rachidiens : conservation pr\u00e9-analytique \u00e0+ 4 \u00b0C ou \u2013 20 \u00b0C ?\nJacomo V, Schaal O, Fournier P"},{"title":"17\u00e8mes Journ\u00e9es Francophones de Virologie, Paris, avril 9, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"R\u00e9solution des \u00e9checs de g\u00e9notypage de la technique Abbott RealTime HCV Genotype II par un test temps r\u00e9el additionnel\nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ly_8.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of a new high sensitive, qualitative and quantitative Hepatitis B surface antigen assay\nLy TD, Coignard C"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Characterization of samples with genotype 1 without subtype results by Abbott RealTime HCV genotype II using the new Abbott HCV Genotype Plus RUO test \nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"19th Annual Meeting of the European Society for Clinical Virology (ESCV), Lisbon, september, 14\u201317, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/09\/Biomnis_Poster_2016_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to COBAS\u00ae AmpliPrep\/OBAS\u00ae TaqMan\u00ae HIV-1 and HBV tests\nEbel A, Bali C, Guis L, Merlin S"},{"title":"20\u00e8mes Journ\u00e9es de M\u00e9decine Foetale, Morzine, mars 26-28, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015__Becker_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Int\u00e9r\u00eat du D\u00e9pistage Pr\u00e9natal Non Invasif dans le diagnostic des aneuplo\u00efdies 13, 18 et 21 \nBecker M, Eg\u00e9a G, Taoud M, Ahmed Chaouch D, El Mouatassim S"},{"title":"20Th Congress European Hematology Association, Vienna, June 11-14, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Rigollet_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Characterization of normal and pathological lymphoid populations: validation of a 10-colors flow cytometry protocol for routine diagnosis \nRigollet L, Stagnara J, Milhau A, Pellegrina L"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/10\/Biomnis_Poster-Aptima-HIV-1-HBV_Ebel_Sept18.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV-1 Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to Cobas\u00ae 6800\/8800 HIV-1 and HBV tests\nA. Ebel, C. Bali, L. Guis, S. Merlin"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/11\/Poster-IgM-Measles-ESCV-TD-LY-.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of new IgM Measles assay\nT.D. Ly, C. Coignard"},{"title":"24e Journ\u00e9es de m\u00e9decine f\u0153tale, Marseille, 4-5-6 avril 2019","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9pistage de la trisomie 21 par analyse de l\u2019ADN f\u0153tal libre circulant dans le sang maternel : Application dans le cas des grossesses g\u00e9mellaires\nMarc NOUCHY, Nicolas CHATRON, Pascal MOUTY, Francis ROUSSEAU, Barbara ADD\u00c9, Mohamed Taoudi, Caroline DUMONT, Jean-Fran\u00e7ois TALY, Luc DRUART, Sylvie TAPIA, Damien SANLAVILLE, Laure RAYMOND"},{"title":"25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, April 25-28, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of three fully automated assays for the detection of cytomegalovirus IgM and IgG: DiaSorin LIAISON\u00ae XL, Abbott Architect \u00ae and Roche Cobas 6000\u00ae\nBouthry E, Ly TD, Vauloup-Fellous C"},{"title":"27th ECCMID, Vienna Austria, April 22-25, 2017","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Strain-specific estimation of epidemic success provides insights into the transmission dynamics of tuberculosis Rasigade\nJP, Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, P\u00e9rouse de Montclos M, Flandrois JP, Ader F, Supply P, Lina G, Wirth T"},{"title":"29th IUSTI European Conference on Sexually Transmitted Infections, Sitges (Barcelona), 24-26 September, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Prevalence of Mycoplasma genitalium in France and comparison with Chlamydia trachomatis and Neisseria gonorrhoeae as determined by the Mycoplasma genitalium TMA assay \nEbel A, Venard C, Brunengo D, Merlin S"},{"title":"31st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbon, June 14-17, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Force_7.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Blastocysts vitrification during 2 consecutive years: before and after its start significant delivery rate increase within the 1st year \nForce A, Nicollet B, Chomier M, Sergeant P, Lescaille M, Rochigneux S, Robert F, Ginon J, Sergeant MV, Baucher S, Schubert B"},{"title":"35e congr\u00e8s de la SFH, CNIT Paris la D\u00e9fense, avril 1-3, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Becker_4.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"La SNP array : un outil compl\u00e9mentaire pour la caract\u00e9risation des h\u00e9mopathies malignes \nBecker M, Eg\u00e9a G, Camilli K, Robin M, Roumigui\u00e8res M, Rigollet L, Stagnara J, El Mouatassim S"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_14.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Evaluation du nouveau test LAISON\u00ae H. pylori IgG\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_15.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Borr\u00e9liose et index de synth\u00e8se intrath\u00e9cale : bilan biologique r\u00e9trospectif de l\u2019ann\u00e9e 2015\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Ebel_16.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation des performances de la trousse Aptima\u00ae HBV Quant (Hologic)\nEbel A, Bali C, Guis L, Merlin S"},{"title":"37\u00e8me RICAI, Paris, d\u00e9cembre 18-19, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/12\/Biomnis_Poster_2017_Coignard_13.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Confirmation VIH : donn\u00e9es biologiques et \u00e9pid\u00e9miologiques des 3 derni\u00e8res ann\u00e9es dans un laboratoire de biologie sp\u00e9cialis\u00e9e\nCoignard C, Ly TD"},{"title":"38e RICAI, Paris 17-18 d\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-COIGNARD-ROUGEOLE.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Epid\u00e9mie de rougeole 2018 : le s\u00e9rodiagnostic un marqueur simple et performant.\nT.D. Ly, C. Coignard"},{"title":"3e Journ\u00e9e Francophone de Biologie M\u00e9dicale, Monaco, 6-7-8 novembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/11\/1911_poster_A.Ebel_JFBM.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"D\u00e9pistage syst\u00e9matique de Neisseria gonorrhoeae et de C. trachomatis par test d\u2019amplification g\u00e9nique : bilan d\u2019une ann\u00e9e d\u2019exp\u00e9rience\nL. Mine, L. Guis, S. Merlin, A. Ebel"},{"title":"40e RICAI \u2013 R\u00e9union Interdisciplinaire de Chimioth\u00e9rapie Anti-Infectieuse, 14-15 d\u00e9cembre","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Posters\/2012_Poster_SARS-CoV-2_RICAI_C.Coignard.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"S\u00e9rologie SARS-CoV-2 : \u00e9valuation, qualification et choix d\u2019une m\u00e9thode\nCatherine Coignard, Anne EBEL, Yanis BOUAMRA, Didier RIDEY, Carla MARCENARO"},{"title":"42es Journ\u00e9es Nationales \u2013 Congr\u00e8s CNGOF, Strasbourg, 4-7 D\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-EMILE-DPNI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"\u00c9tude de l\u2019usage du DPNI (d\u00e9pistage pr\u00e9natal non invasif) des aneuplo\u00efdies en milieu lib\u00e9ral\nC. Emile, L. Raymond, L. Pellegrina"},{"title":"45\u00e8me Colloque National des Biologistes des H\u00f4pitaux, Paris, juin 22-24, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/06\/Biomnis_Poster_2016-Rabut_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Interf\u00e9rence du traitement par daratumumab (anti-CD38) dans le suivi biologique du my\u00e9lome multiple et dans la recherche d\u2019anticorps anti-\u00e9rythrocytaires : \u00e0 propos d\u2019un cas\nRabut E, Castro-Fernandez A, Le Gall V, Meknache N"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Raymond_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport diagnostique de l\u2019utilisation des puces SNP dans l\u2019\u00e9tude chromosomique des morts f\u0153tales\nRaymond L, Dherbey JL, Rebeyrat-Pichon I, El-Mouatassim S, Egea G"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier, 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_11.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Cas rare d\u2019X-fragile pr\u00e9natal avec r\u00e9traction d\u2019expansion de triplet CGG ? \nMouty P, Raymond L, El Mouatassim S, Liquier A, Druart L, Paris A, Dorian V, Pichon I, Dherbey JL, Eg\u00e9a G"},{"title":"CGRF Ile de R\u00e9, septembre 28-29, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Brunengo_11.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Epid\u00e9miologie qualitative des variants rares de l\u2019H\u00e9moglobine en France m\u00e9tropolitaine au travers de la collaboration HCL \u2013 Eurofins Biomnis\nBrunengo D, Veyrenche N, Louis Chillotti L, Le Flem L"},{"title":"COGEN, Paris, Septembre 25-27, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_El-Mouatassim_11.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"French experience of Non-Invasive Prenatal Testing of trisomy 21, 18 and 13 \nEl Mouatassim S, Taoudi M, Eg\u00e9a G"},{"title":"Congr\u00e8s SFP \/ SFMM, Toulouse, mars 29-31, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/03\/Biomnis_Poster_2017_Chydriotis_1-1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport de 2 tests de d\u00e9pistage pour le diagnostic de la bilharziose et place du Western blot\nChyd\u00e9riotis G, Cart-Tanneur E, Lecuelle C, F\u00e9lix MH"},{"title":"Congr\u00e8s SFTA, Avignon, mai 10-12, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_Petit_2.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Dosage de la Ciclosporine, Tacrolimus, Ev\u00e9rolimus et Sirolimus en LCMSMS avec le coffret MassTox Chromsystems sur Api 4500 ABSciex avec pr\u00e9paration automatis\u00e9e sur T\u00e9can EVO 150\nPetit I, Moussa C, Bonnet K, Bezol A. Havrez S, Gerrier P"},{"title":"EAACI, Helsinki, June 17-21, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_6.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Bp14, an allergen from cupressus sempervirens pollen related to the family of snakin\/gibberellin-regulated proteins\nS\u00e9n\u00e9chal H, Santrucek J, Melcova M, Svoboda P, Zidkova J, Guilloux L, Aizawa T, Couderc R, Charpin D, Poncet P"},{"title":"ESCAIDE 2015, Stockholm, November 11-13, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Chyderiotis_14.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Re-emergence of urinary schistosomiasis in Europe ? Infections acquired in Southern Corsica \u2013 Investigation of a cluster of Schistosoma haematobium infections in 2014\nRamalli L, No\u00ebl H, Ruello M, Maccary A, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Denoyel GA, Succo T, Armengaud A, Paty MC, Heuz\u00e9 G, Mattei J, Th\u00e9ron A, Berry A"},{"title":"ESCV, Stresa, Lake Maggiore, September 13-16, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/10\/Biomnis_Poster_2017_LY_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new chemiluminescent assay to detect and quantify anti-HBs antibodies\nMaillard A, Ly TD, Thibault V"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_LY_3.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new LIAISON\u00ae H. pylori IgG\nLy TD, Coignard C"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Rabut_4.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Red blood cell antibody assays in DARA-treated patients\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"EuroMedLab, Paris, June 22-24, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Early Performance Evaluation of cobas\u00ae HBV, cobas\u00ae HCV and cobas\u00ae HIV-1Quantitative Nucleic Acid Tests for use on the new cobas\u00ae 6800\/8800 Systems\nEbel A, Merlin S, Marins ED G, Canchola J, Njoya M, Simon CO"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/poster-FFER-2018-callec.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Impact de la chirurgie bariatrique sur les param\u00e8tres spermatiques : Revue de la litt\u00e9rature\nR. Callec, B. Schubert, F. Robert, A. Force"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/POSTER-FFER-2018-Force.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Crit\u00e8res d\u2019interpr\u00e9tation du msome pour une optimisation de la prise en charge des patients\nA. Force, M. Chomier, P. Sergeant, J. Ginon, S. Rochigneux, M. Lechatton, M. Pont, R. Callec, F. Robert, B. Schubert"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Lopez.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation externe de la qualit\u00e9 en spermiologie : un nouveau programme pour une \u00e9valuation globale de l\u2019examen\nMarie LOPEZ, Bernard POGGI, Jean Christophe EYNARD, Marie LETY, Benoit SCHUBERT, Andr\u00e9 FORCE"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Schubert.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Influence des conditions de culture sur les r\u00e9sultats en AMP dans une \u00e9tude multicentrique : comparaison d\u2019un incubateur Time Lapse avec les incubateurs tradictionnels\nBeno\u00eet SCHUBERT, Alexandre MARCILLY, Andr\u00e9 FORCE"},{"title":"FFER, Tours, septembre 13-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Force_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Comparaison de la performance de 2 incubateurs (Geri versus Planer) apr\u00e8s randomisation de la cohorte ovocytaire pour chaque patiente\nForce A, Martine Chomier, Philippe Sergeant, Jacqueline Ginon, St\u00e9phanie Rochigneux, Soizic Baucher, M\u00e9lanie Le Chatton, M\u00e9lanie Pont, Beno\u00eet Schubert"},{"title":"FIBA 2016, Dakar, January 13-14, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"ANCA associated HIV infection in Senegal: a serological trap\nArouna O, Niang A, Abiola A, Guis L, Le Flem L, Diene JF, Mboup S"},{"title":"Fort Collins (USA), May 31-June 3, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/05\/Biomnis_Poster_2016_Jacomo_5.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Seoul Virus Infection in Human, France, 2014-2016\nReynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, Nussbaumer T, Jacomo V, Rapt MP, Septfons A, Rollin PE"},{"title":"ISMA, Lisbon, November 19-21, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2015_Guilloux_16.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Ige-cross-reactivity between european hymenoptera and asian hornet (vespa velutina) venom allergens\nLong\u00e9 C, Brazdova A, Brunet JL, Schwartz C, Girodet B, Lavaud F, Birnbaum J, Pham-Thi N, Duchateau M, Chamot-Rooke J, Guilloux L, Selva MA, Couderc R, S\u00e9n\u00e9chal H, Sutra JP, Poncet P"},{"title":"Journ\u00e9es Nationales CNGOF, Montpellier, d\u00e9cembre 7-9, 2016","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Etude pr\u00e9liminaire sur le d\u00e9pistage de la pr\u00e9-\u00e9clampsie au 1er trimestre de la grossesse (Predictor\u00ae)\nWalder R, Galland A, Sault C, Huissoud C"},{"title":"Journ\u00e9es Nationales d\u2019Infectiologie, Nantes, 13-15 juin, 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/05\/Biomnis_Poster_2018_Ebel_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Infections \u00e0 Chlamydia trachomatis : donn\u00e9es \u00e9pid\u00e9miologiques r\u00e9centes dans un laboratoire sp\u00e9cialis\u00e9\nEbel A, Guis L, Merlin S"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Poster-Lyme-RICAI-C.-Coignard-TD-Ly-dec-2019-800x1200.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of the BioPlex 2200 Lyme IgG\/IgM immunoassay system\nC. Coignard, C. Cl\u00e9ment-Vincent, Td. Ly, A. L\u2019hotellier"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/12\/2019-12-17_RICAI.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Sp\u00e9cificit\u00e9 de la s\u00e9rologie chikungunya et surveillance \u00e9pid\u00e9miologique\nC. Calba, F. Franke, E. Brottet, G. Terpant, N. Fournet, A. Ovize, J.D. Poveda, I. Leparc-Goffart, M.C. Paty"},{"title":"SFE, Bordeaux, octobre 5-8, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Sault_13.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Influence de la nature du liquide de rin\u00e7age d\u2019aiguille de cytoponction sur le dosage de la thyroglobuline\nBoux De Casson F, Moal V, Gauchez AS, Moineau MP, Sault C, Schlageter MH, Massart C"},{"title":"SFTS, Bordeaux, septembre 20-22, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Rabut_10.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Recherche et quantification de l\u2019h\u00e9morragie f\u0153to-maternelle par cytom\u00e9trie en flux avec double marquage anti-h\u00e9moglobine F et anti-anhydrase carbonique\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"XXIIIe Colloque ACLF, Montpellier, septembre 20-21, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Syndrome de Currarino atypique avec hexadactylie pr\u00e9-axiale : remaniement complexe en 7q36.3 en pr\u00e9natal\nLiquier A, Becker M, Raymond L, Bourgain A, Amat S, Broussin B, Andr\u00e9 G, Escande F, Nouchy M, Eg\u00e9a G"}]));
sessionStorage.setItem('currentLang', 'fr');render(html`<${RessourcesDynamiques} name="World" />`, document.getElementById('resdyncontainer'));
\n
B. Schubert, M Badiou, A. Force First International Journal of Andrology \u2013 Andrologia 06\/2019 - DOI: 10.1111\/and.13417<\/p>\n"},{"title":"Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytog\u00e9n\u00e9tique h\u00e9matologique (GFCH)","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27707673","date":null,"media_type":"document","profils":"579,574,575,","document_type":"publication","content":"Daudignon A, Quilichini B, Ameye G, Poirel H, Bastard C, Terr\u00e9 C\nAnn Biol Clin 2016 ; 74:588-595"},{"title":"D\u00e9pistage combin\u00e9 de la trisomie 21 au premier trimestre : \u00e9valuation du sur-risque en cas de \u00df-hCG libre entre 5 et 10 MoM","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Th\u00e8se de M\u00e9decine, Universit\u00e9 Claude Bernar 1;2016,71p\nEtude r\u00e9alis\u00e9e avec les donn\u00e9es du laboratoire Biomnis\nLeport H"},{"title":"D\u00e9pistage multiparam\u00e9trique de la pr\u00e9-\u00e9clampsie au premier trimestre de grossesse : \u00e9tude pr\u00e9liminaire","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Th\u00e8se de m\u00e9decine, UCBL soutenue le 5 juillet 2016\nEtude r\u00e9alis\u00e9e \u00e0 partir des r\u00e9sultats du laboratoire Biomnis (Service T21 Lyon)\nWalder R"},{"title":"Dosage de la ciclosporine, du tacrolimus, de l\u2019\u00e9v\u00e9lorimus et du sirolimus en LC-MS\/MS","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2018_Petit_1-1.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Petit I, Bezol A, Ghacham S, Clavaud K, Havrez S, Moussa C, Emile C, Gerrier P\nSpectra Bio 2018, 234:61-66"},{"title":"Dosages des st\u00e9ro\u00efdes par spectrom\u00e9trie de masse","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25582724","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dufour-Rainfray D, Moal V, Cloix L, Mathieu E, Gauchez AS, Brossaud J, Corcuff JB, Fraissinet F, Collet C, Boux de Casson F, Guilloteau D, Emond P, Reynier P, Groupe de Biologie Sp\u00e9cialis\u00e9e de la SFMN : Agin A, Bach K, Charri\u00e9 A, Chikh K, Desb\u00e8ne C, Dousset B, Georges A, Guenet D, Lacroix I, Lamy PJ, Leban M, Leloupp AG, Massart C, Masson D, Moineau MP, Piketty M, Reix N, Sault C, Schlageter MH, Tse C. \nAnn Biol Clin 2015 ; 73:70-8"},{"title":"Down syndrome maternal serum markers in oocyte donation and other assisted reproductive technologies","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28921586","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Bonnin A, Muller F, Senat MV, Sault C, Galland A, Taieb J, Dreux S, Bouyer J, Benachi A\nPrenat Diagn 2017 ; 37:1155-1159"},{"title":"Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I\/501Y.V1 (B.1.1.7, variant of concern 202012\/01) in France","media_link":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2021.26.9.2100133","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Alexandre Gaymard, Paolo Bosetti, Adeline Feri, Gregory Destras, Vincent Enouf, Alessio Andronico, Sonia Burrel, Sylvie Behillil, Claire Sauvage, Antonin Bal, Florence Morfin, Sylvie Van Der Werf, Laurence Josset, ANRS MIE AC43 COVID-198, French viro COVID group (including Catherine Coignard), Fran\u00e7ois Blanquart, Bruno Coignard, Simon Cauchemez, Bruno Lina\nEurosurveillance 04\/03\/2021 - Volume 26, Issue 9"},{"title":"\u00c9mergence de la leptospirose humaine en France m\u00e9tropolitaine ? Actualit\u00e9s sur la surveillance","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bourhy P, Picardeau M, Septfons A, Trombert S, Cart-Tanneur E\nMed Mal Infect 2017 ; 47 (4s):s150"},{"title":"Evaluation de l\u2019automate Neo\u00ae (Immucor) pour l\u2019immuno-h\u00e9matologie \u00e9rythrocytaire","media_link":"","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
Rabut E, Ahmetkadic D, Malataverne J, Le Flem L Spectra Biologie 2016 ; 223:45-54<\/p>\n"},{"title":"\u00c9valuation de la valeur seuil la plus co\u00fbt-efficace des marqueurs s\u00e9riques du 1er\u00a0trimestre pour l\u2019emploi du test d\u2019ADN circulant dans le d\u00e9pistage de la trisomie\u00a021\u00a0: une analyse m\u00e9dico-\u00e9conomique","media_link":"https:\/\/www.jle.com\/fr\/revues\/abc\/e-docs\/cost_effectiveness_threshold_of_first_trimester_down_syndrome_maternal_serum_screening_for_the_use_of_cell_free_dna_as_a_second_tier_screening_test_320573\/article.phtml","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Marie Blanquet, Sophie Dreux, St\u00e9phanie L\u00e9ger,\u00a0Corinne Sault,\u00a0Charline Mourgues, H\u00e9l\u00e8ne Laurichesse, Didier L\u00e9mery, Fran\u00e7oise Vendittelli, Anne Debost-Legrand, Fran\u00e7oise Muller\nAnnales de Biologie Clinique Volume 79, num\u00e9ro 4, Juillet-Ao\u00fbt 2021"},{"title":"Evaluation of the performance of a new automated HIV combination assay","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29020658","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Ghisetti V, Coignard C, Allice T, Ly TD\nJ Clin Virol 2017 ; 96:80-83"},{"title":"Evaluation of the SLOMYCO Sensititre\u00ae panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27150659","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Chazel M, Marchandin H, Keck N, Terru D, Carri\u00e8re C, Ponsoda M, Jacomo V, Panteix G, Bouzinbi N, Ba\u00f1uls AL, Choisy M, Solassol J, Aubry, Godreuil S\nAnn Clin Microbiol Antimicrob 2016 ; 15:30"},{"title":"Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities","media_link":"http:\/\/www.bloodjournal.org\/content\/132\/Suppl_1\/943?sso-checked=true","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"On Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group\nElise Chapiro, Elodie Pramil, M\u2019boyba Diop, Damien Roos-Weil, Cl\u00e9mentine Dillard, Cl\u00e9mentine Gabillaud, Karim Maloum, Catherine Settegrana, Lucile Baseggio, Jean-Fran\u00e7ois Lesesve, M\u00e9lanie Yon, Ludovic Jondreville, Claude Lesty, Fr\u00e9d\u00e9ric Davi, Magali Le Garff-Tavernier, Nathalie Droin, Philippe Dessen, Caroline Algrin, V\u00e9ronique Leblond, Jean Gabarre, Simon Bouzy, Virginie Eclache, Baptiste Gaillard, Evelyne Callet-Bauchu, Marc Muller, Christine Lefebvre, Nathalie Nadal, Antoine Ittel, St\u00e9phanie Struski, Marie-Agn\u00e8s Collonge-Rame, Benoit Quilichini, Sandra Fert-Ferrer, Nathalie Auger, Isabelle Radford-Weiss, Lena Wagner, Sebastian Scheinost, Thorsten Zenz, Santos A. Susin, Olivier A. Bernard, Florence Nguyen-Khac\nBlood 2018 132:943; doi:"},{"title":"Identification of a polygalacturonase (Cup s 2) as the major CCD-bearing allergen in Cupressus sempervirens pollen","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28439939","date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Shahali Y, Sutra JP, Hilger C, Swiontek K, Haddad I, Vinh J, Guilloux L, Charpin D, S\u00e9n\u00e9chal H, Poncet\nAllergy 2017 ; doi: 10.1111\/all.13191"},{"title":"Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. \u2013 Trends over 10 years","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26518058","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bailly S, Maubon D,\u00a0Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF\nJ Infect\u00a02015 ; Oct 28. pii: S0163-4453(15)00342-4. doi: 10.1016\/j.jinf.2015.09.041"},{"title":"Impact of Including or Removing Nuchal Translucency Measurement on the Detection and False-Positive Rates of First-Trimester Down Syndrome Screening","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26656919","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Spaggiari E, Czerkiewicz I, Sault C, Dreux S, Galland A, Salomon LJ, Ville Y, Muller F\nFetal Diagn Ther 2015 ; Dec 12"},{"title":"Int\u00e9r\u00eat du s\u00e9quen\u00e7age haut d\u00e9bit dans les h\u00e9mopathies my\u00e9lo\u00efdes chroniques : quelles actualit\u00e9s en 2022 ?","media_link":"","date":"01\/09\/2022","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
B. Quilichini Journal de Biologie M\u00e9dicale \/ Volume 11-Num\u00e9ro 42 \/ Juil-Sept 2022<\/p>\n"},{"title":"Interf\u00e9rences s\u00e9rologiques du traitement du my\u00e9lome multiple par daratumumab (anti-CD38) : \u00e0 propos d\u2019un cas","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28540859","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Rabut E, Castro-Fernandez A, Le Gall V, Meknache\nAnn Biol Clin 2017 ; 75:351-355"},{"title":"Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31379011","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Penther D, Etancelin P, Lusina D, Bidet A, Quilichini B, Gaillard B, Rafdord-Weiss I, Mozziconacci MJ, Ittel A, Roche-Lestienne C, Barin C, Soler G, Daudignon A, Nadal N, Chapiro E, Lefebvre C, Godon C, Nadeau G, Mugneret F, Richebourg S, Viailly PJ, Ferret Y, Nguyen-Khac F, Eclache V; Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique\nAm J Hematol 2019 Aug 4. doi: 10.1002\/ajh.25601."},{"title":"Large outbreak of urogenital schistosomiasis acquired in Southern Corsica: monitoring the early signs of the endemicization?","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28669843","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"No\u00ebl H, Ruello M, Maccary A, Pellat C, Sommen C, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Durand J, Ramalli L, Chiappini JD , Malfait P, Berry\nClin Microbiol Infect 2017 ; pii: S1198-743X(17)30350-6. doi: 10.1016\/j.cmi"},{"title":"Les niveaux de preuve des biomarqueurs utilis\u00e9s pour la d\u00e9tection pr\u00e9coce des cancers de la prostate","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27029727","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Lamy PJ, Gauchez AS, Salomon L et al et le Groupe de biologie de la prostate : Sault C et al\nAnn Biol Clin 2016 ; 74:227-232"},{"title":"Marqueurs de d\u00e9pistage et de pr\u00e9diction de la pr\u00e9-\u00e9clampsie : place de la biologie","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Sault C\nJ Biol Med 2017 ; 6:186-190"},{"title":"Non-invasive prenatal testing: what are we missing?\u00a0","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32119166","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fries N, Le Garrec S, Egloff M, Sault C, Dreux S, Mangione R, Salomon LJ, Ville Y. \nUltrasound Obstet Gynecol. Mars 2020 - 2. doi: 10.1002\/uog.22005."},{"title":"Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28189936","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Thibault V, Servant-Delmas A, Ly TD, Roque-Afonso AM, Laperche S\nJ Clin Virol 2017 ; 89:14-21"},{"title":"Persistence of Zika virus in gradient sperm preparation","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29510270","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Cassuto NG, Marras G, Jacomo V, Bouret D\nJ Gynecol Obstet Hum Reprod 2018, pii: S2468-7847(18)30038-2"},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Emile C, Sault C\nSpectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49."},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"12\/12\/2022","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Emile C, Sault C<\/strong>. Spectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49.<\/p>\n"},{"title":"Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Potential+value+of+placental+angiogenic+factors+as+biomarkers+in+preeclampsia+for+clinical+physicians","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Boulanger H, Lef\u00e8vre G, Ahriz Saksi S, Achiche J, Bailleul S, Ekoukou D, Drouin D, Sault C, Stawiarski N, Dupuis E.\nNephrol Ther. 2019 Mar 29"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0755498219304178?via%3Dihub","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Hamdi SM, Sault C, Piver E, Genoux A, Masson D, Guibourdenche J.\nPresse Med . 2019 Oct 29. pii: S0755-4982(19)30417-8. doi: 10.1016\/j.lpm.2019.09.029. PMID:31676218"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/doi.org\/10.1016\/j.lpm.2019.09.029","date":"12\/12\/2019","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Hamdi SM, Sault C<\/strong>, Piver E, Genoux A, Masson D, Guibourdenche J. Presse Med. (2019)<\/p>\n"},{"title":"Preliminary report of an autochthonous Chikungunya outbreak in France, July to September 2017","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29019313","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Calba C, Guerbois-Galla M, Franke F, Jeannin C, Auzet-Caillaud M, Grard G, Pigaglio L, Decoppet A, Weicherding J, Savaill MC, Munoz-Riviero M, Chaud P, Cadiou B, Ramalli L, Fournier P, Noel H, De Lamballerie X, Paty MC, Leparc-Goffart I\nEuro Surveill 2017 ; 22(39):pii=17-00647"},{"title":"Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance","media_link":"https:\/\/www.nature.com\/articles\/s41467-021-23233-6","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"St\u00e9phane Le Vu,\u00a0Gabrielle Jones,\u00a0Fran\u00e7ois Anna,\u00a0Thierry Rose,\u00a0Jean-Baptiste Richard,\u00a0Sibylle Bernard-Stoecklin,\u00a0Sophie Goyard,\u00a0Caroline Demeret,\u00a0Olivier Helynck,\u00a0Nicolas Escriou,\u00a0Marion Gransagne,\u00a0St\u00e9phane Petres,\u00a0Corinne Robin,\u00a0Virgile Monnet,\u00a0Louise Perrin de Facci,\u00a0Marie-Noelle Ungeheuer,\u00a0Lucie L\u00e9on,\u00a0Yvonnick Guillois,\u00a0Laurent Filleul,\u00a0Pierre Charneau,\u00a0Daniel L\u00e9vy-Bruhl,\u00a0Sylvie van der Werf\u00a0&\u00a0Harold Noel\u00a0\nNature Communications volume 21\/05\/2021 12, Article number: 3025 (2021)"},{"title":"Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/30789329\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Tatai C, Berland JL, Claude JB, Westeel E, Hodille E, Fredenucci I, Rasigade JP, Ponsoda M, Jacomo V, Vach\u00e9e A, Gaudart A, Gaillard JL, Roux AL, Ader F, Tararbit K, Terpant G, Bryant JE, Lina G, Dumitrescu O; Lyon TB Study Group.Genestet C, et al.\nEmerg Infect Dis. 2019 Mar;25(3):589-592. doi: 10.3201\/eid2503.181124 - PMID: 30789329"},{"title":"R\u00e9activit\u00e9 crois\u00e9e in silico, in vitro, in vivo","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Guilloux L, Ricard-Blum S\nAllergies alimentaires 2017 ; chapitre 7.5:97-102"},{"title":"Recherche et identification des anticorps antinucl\u00e9aires : analyse du questionnaire europ\u00e9en de l\u2019EASI groupe et confrontation des pratiques fran\u00e7aises aux recommandations internationales","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29623889","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Musset L, Fabien N, Chyderiotis G, Olsson NO, Pham BN, Durey Dragon MA\nAnn Biol Clin 2018, 76 :185-195"},{"title":"Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission.","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31806715\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Paret R, Pichat C, Berland JL, Jacomo V, Carret G, Fredenucci I, Hodille E, Rasigade JP, Boisset S, Carricajo A, Lina G, Ronnaux-Baron AS, Mornex JF, Grando J, S\u00e9n\u00e9chal A, Ader F, Dumitrescu O; Lyon TB study group.Genestet C, et al.\nEur Respir J. 2020 Mar 20;55(3):1901888. doi: 10.1183\/13993003.01888-2019. Print 2020 Mar"},{"title":"Schistosomose en Corse : chronique d\u2019une histoire annonc\u00e9e","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Berry A, Iriart X, Boissier J, Chyd\u00e9riotis G, Debruyne M, Magnaval JF, Fillaux J, Grech-Angelini S, Barr\u00e9-Cardi H, Termignon JL, Macarry A, Noel H\nLa Lettre de l'Infectiologue 2016 ; XXXI n\u00b02:60-64"},{"title":"Screening and identification of antinuclear antibodies (ANA): analysis of the European EASI survey and confrontation of the French routine practice to the international recommandations","media_link":null,"date":null,"media_type":"document","profils":"579,575,574,","document_type":"publication","content":"Musset L, Fabien N, Chyd\u00e9riotis G, Olsson NO, Pham BN, Dragon-Durey MA\nAnn Biol Clin 2017 ;"},{"title":"Surveillance des infections humaines par hantavirus en France m\u00e9tropolitaine, 2012-2016","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Reynes JM, Carli D, Renaudin B, Fizet A, Bour JB, Brodard V, Cart-Tanneur E, Dewilde A, El Hamri M, Fleury H, Hecquet D, Jeulin H, Lechat S, Lemarquand-Bardini M, Lepiller Q, Poveda JD, Raulin O, Twizeyimana E, Van Cauteren D, Velay A, Septfons A, Baize S\nBEH 2017 ; 23:492-499"},{"title":"Surveillance du chikungunya et de la dengue en France m\u00e9tropolitaine, 2014","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resume_Septfons-A_2016_330-70-77.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Septfons A, No\u00ebl H, Leparc-Goffart I, Giron S, Delisle E, Chappert JL, Catelinois O, Franke F, Servas V, Guinard A, Debruyne M, Schaal O, Brichler S, Ninove L, Prat C, Flusin O, Poujol I, Letort MJ, Deniau J, Six C, Rousseau C, De Valk H, Paty MC\nLes Feuillets de Biologie 2016 ; 330:70-77"},{"title":"Surveillance du chikungunya, de la dengue et des infections \u00e0 virus Zika en France m\u00e9tropolitaine, 2017","media_link":"http:\/\/invs.santepubliquefrance.fr\/beh\/2018\/24\/pdf\/2018_24_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fournet N, Franke F, Chaud P, Raguenaud ME, Calba C, Septfons A, Cart-Tanneur E. et al.\nBull Epid\u00e9miol Hebd. 2018;(24):494-503."},{"title":"Testing anti-neutrophil cytoplasmic antibodies (ANCA): analysis of the European EASI survey on the daily practice of the French laboratories","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28958962","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dragon-Durey MA, Fabien N, Chyd\u00e9riotis G, Musset L, Pham BN, Olsson N\nAnn Biol Clin 2017 ; 75:531-541"},{"title":"The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)","media_link":"","date":"06\/09\/2022","media_type":"document","profils":"579,575,574,","document_type":"publication","content":"\n
Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nab\u00e9ra C, Chapiro E, Collonge-Rame MA, Cuccuini W, Douet-Guilbert N, Eclache V, Luquet I, Michaux L, Nadal N, Penther D, Quilichini B<\/strong>, Terre C, Lefebvre C, Troadec MB, V\u00e9ron\u00e8se L. Leukemia. 2022 Jun;36(6):1451-1466. doi: 10.1038\/s41375-022-01561-w. Epub 2022 Apr 16.PMID: 35430613 Review.<\/p>\n"},{"title":"The impact of introducing combined first-trimester trisomy 21 screening in the French population","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26628633","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Eur J Public Health 2015 ; Nov 30"},{"title":"The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34284044\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Maxime Espi, Xavier Charmetant, Thomas Barba, Laetitia Koppe, Caroline Pelletier, Emilie Kalbacher, Elodie Chalencon, Virginie Mathias, Anne Ovize, Emmanuelle Cart-Tanneur, Christine Bouz, Laurence Pellegrina, Emmanuel Morelon, Denis Fouque, Laurent Juillard, Olivier Thaunat\nKidney International 2021 Oct;100(4):928-936. doi: 10.1016\/j.kint.2021.07.005."},{"title":"Thrombop\u00e9nie induite par l\u2019h\u00e9parine (TIH) : \u00e0 propos d\u2019un casLe Flem L, Emile C","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Le Flem L, Emile C, Spectra Biologie 2016 ; 220:49-50<\/p>\n"},{"title":"Une interf\u00e9rence dans le dosage de l\u2019insuline r\u00e9v\u00e8le un syndrome auto-immun anti-insuline","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27492703","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Lamy PJ, Sault C, Renard E\nAnn Biol Clin 2016 ; 74:490-494"},{"title":"Vector-borne Transmission of Zika Virus in Europe, Southern France, August 2019","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31718742\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Sandra Giron, Florian Franke, Anne Decoppet, Bernard Cadiou, Thierry Travaglini, Laurence Thirion, Guillaume Durand, Charles Jeannin, Gr\u00e9gory L\u2019Ambert, Gilda Grard, Harold No\u00ebl, Nelly Fournet, Michelle Auzet-Caillaud, Christine Zandotti, Samer Abouka\u00efs, Pascal Chaud, Saby Guedj, Lakri Hamouda, Xavier Naudot, Anne Ovize, Cl\u00e9ment Lazarus, Henriette de Valk, Marie-Claire Paty, Isabelle Leparc-Goffart\nEuro Surveill. 2019 Nov;24(45):1900655."},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Faux-positif-ADNlcT21_L-Druart_012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Faux positif d\u2019ADNlcT21 avec diff\u00e9rentes anomalies chromosomiques confin\u00e9es au placenta\nL Druart, H Dessuant, JF Taly, M Nouchy, L Raymond, S Tapia"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Developpement-panel-15-marqueurs_F.-Rousseau-et-al.-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9veloppement d\u2019un panel de 15 marqueurs pour une identitovigilance\ndes \u00e9chantillons analys\u00e9s par s\u00e9quen\u00e7age haut d\u00e9bit ou sur puces \u00e0 SNP\nF Rousseau, J-F Taly, C Ploton Nicollet, M Taoudi, A Perdriau, L Raymond"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20359-Assises-de-Genetique-2020_B-Quilichini_012020.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Mise en place d\u2019un panel de g\u00e8nes cibl\u00e9s pour les h\u00e9mopathies\nmalignes (NMP-LMMC-SMD-LAM) par NGS : Enjeux M\u00e9dical \/ Scientifique et d\u2019Assurance Qualit\u00e9.\nV Geromel, E Fayolle, P Mouty, R Moulin, N Batail, M-H Felix, B Adde, S Mouty, L Raymond, B Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20362-Assises-de-Gntique-2020_B_Quilichini-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Impact diagnostique, pronostique et th\u00e9ranostique d\u2019un panel de g\u00e8nes\n\u00ab H\u00e9mopathies My\u00e9lo\u00efdes \u00bb r\u00e9alis\u00e9 par NGS : l\u2019exp\u00e9rience du laboratoire Eurofins Biomnis en 2019.\nV. Geromel, P. Mouty, C. Chal, J . Delaunay, S. Sadot-Lebouvier, R. Kaphan, J. Vigvari, J.P. Coadic, E.A. Marin La Meslee, O. Roualdes, C. Bourdin, A. Petit, M. Roumigui\u00e8res, L. Raymond, B.Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 4","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Les_assises_2020_RadoslavaSARAEVA_LAMRI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"21-24 janvier 2020, Tours\nDiagnostics g\u00e9n\u00e9tiques multiples (double hits) par s\u00e9quen\u00e7age Whole Exome (WES) : \u00e0 propos de deux cas.\nR. SARAEVA-LAMRI, A. DORELLE, V. GEROMEL, A. S. LEBRE, P. MOUTY, M. E. NAUD BARREYRE, F. ROUSSEAU, M. TAOUDI, L. MESNARD, L. RAYMOND"},{"title":"10th International Congress on Autoimmunity, Leipzig, April 6-10, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_4.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Should Dense Fine Speckled 70 (DFS70) pattern be reported? Biomnis reference lab experience on 12 619 ANA screening consecutive sera\nGuis L, Ebel A, Leroy J, Michaud S, Pomaredes A, Marcenaro C, Chalouas L"},{"title":"12\u00e8me CFA, Paris, avril 25-28, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":""},{"title":"12\u00e8me Congr\u00e8s de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Paris, mars 22-23, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Jacomo_3.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Les Liquides C\u00e9phalo-Rachidiens : conservation pr\u00e9-analytique \u00e0+ 4 \u00b0C ou \u2013 20 \u00b0C ?\nJacomo V, Schaal O, Fournier P"},{"title":"17\u00e8mes Journ\u00e9es Francophones de Virologie, Paris, avril 9, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"R\u00e9solution des \u00e9checs de g\u00e9notypage de la technique Abbott RealTime HCV Genotype II par un test temps r\u00e9el additionnel\nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ly_8.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of a new high sensitive, qualitative and quantitative Hepatitis B surface antigen assay\nLy TD, Coignard C"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Characterization of samples with genotype 1 without subtype results by Abbott RealTime HCV genotype II using the new Abbott HCV Genotype Plus RUO test \nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"19th Annual Meeting of the European Society for Clinical Virology (ESCV), Lisbon, september, 14\u201317, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/09\/Biomnis_Poster_2016_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to COBAS\u00ae AmpliPrep\/OBAS\u00ae TaqMan\u00ae HIV-1 and HBV tests\nEbel A, Bali C, Guis L, Merlin S"},{"title":"20\u00e8mes Journ\u00e9es de M\u00e9decine Foetale, Morzine, mars 26-28, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015__Becker_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Int\u00e9r\u00eat du D\u00e9pistage Pr\u00e9natal Non Invasif dans le diagnostic des aneuplo\u00efdies 13, 18 et 21 \nBecker M, Eg\u00e9a G, Taoud M, Ahmed Chaouch D, El Mouatassim S"},{"title":"20Th Congress European Hematology Association, Vienna, June 11-14, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Rigollet_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Characterization of normal and pathological lymphoid populations: validation of a 10-colors flow cytometry protocol for routine diagnosis \nRigollet L, Stagnara J, Milhau A, Pellegrina L"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/10\/Biomnis_Poster-Aptima-HIV-1-HBV_Ebel_Sept18.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV-1 Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to Cobas\u00ae 6800\/8800 HIV-1 and HBV tests\nA. Ebel, C. Bali, L. Guis, S. Merlin"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/11\/Poster-IgM-Measles-ESCV-TD-LY-.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of new IgM Measles assay\nT.D. Ly, C. Coignard"},{"title":"24e Journ\u00e9es de m\u00e9decine f\u0153tale, Marseille, 4-5-6 avril 2019","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9pistage de la trisomie 21 par analyse de l\u2019ADN f\u0153tal libre circulant dans le sang maternel : Application dans le cas des grossesses g\u00e9mellaires\nMarc NOUCHY, Nicolas CHATRON, Pascal MOUTY, Francis ROUSSEAU, Barbara ADD\u00c9, Mohamed Taoudi, Caroline DUMONT, Jean-Fran\u00e7ois TALY, Luc DRUART, Sylvie TAPIA, Damien SANLAVILLE, Laure RAYMOND"},{"title":"25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, April 25-28, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of three fully automated assays for the detection of cytomegalovirus IgM and IgG: DiaSorin LIAISON\u00ae XL, Abbott Architect \u00ae and Roche Cobas 6000\u00ae\nBouthry E, Ly TD, Vauloup-Fellous C"},{"title":"27th ECCMID, Vienna Austria, April 22-25, 2017","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Strain-specific estimation of epidemic success provides insights into the transmission dynamics of tuberculosis Rasigade\nJP, Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, P\u00e9rouse de Montclos M, Flandrois JP, Ader F, Supply P, Lina G, Wirth T"},{"title":"29th IUSTI European Conference on Sexually Transmitted Infections, Sitges (Barcelona), 24-26 September, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Prevalence of Mycoplasma genitalium in France and comparison with Chlamydia trachomatis and Neisseria gonorrhoeae as determined by the Mycoplasma genitalium TMA assay \nEbel A, Venard C, Brunengo D, Merlin S"},{"title":"31st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbon, June 14-17, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Force_7.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Blastocysts vitrification during 2 consecutive years: before and after its start significant delivery rate increase within the 1st year \nForce A, Nicollet B, Chomier M, Sergeant P, Lescaille M, Rochigneux S, Robert F, Ginon J, Sergeant MV, Baucher S, Schubert B"},{"title":"35e congr\u00e8s de la SFH, CNIT Paris la D\u00e9fense, avril 1-3, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Becker_4.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"La SNP array : un outil compl\u00e9mentaire pour la caract\u00e9risation des h\u00e9mopathies malignes \nBecker M, Eg\u00e9a G, Camilli K, Robin M, Roumigui\u00e8res M, Rigollet L, Stagnara J, El Mouatassim S"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_14.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Evaluation du nouveau test LAISON\u00ae H. pylori IgG\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_15.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Borr\u00e9liose et index de synth\u00e8se intrath\u00e9cale : bilan biologique r\u00e9trospectif de l\u2019ann\u00e9e 2015\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Ebel_16.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation des performances de la trousse Aptima\u00ae HBV Quant (Hologic)\nEbel A, Bali C, Guis L, Merlin S"},{"title":"37\u00e8me RICAI, Paris, d\u00e9cembre 18-19, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/12\/Biomnis_Poster_2017_Coignard_13.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Confirmation VIH : donn\u00e9es biologiques et \u00e9pid\u00e9miologiques des 3 derni\u00e8res ann\u00e9es dans un laboratoire de biologie sp\u00e9cialis\u00e9e\nCoignard C, Ly TD"},{"title":"38e RICAI, Paris 17-18 d\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-COIGNARD-ROUGEOLE.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Epid\u00e9mie de rougeole 2018 : le s\u00e9rodiagnostic un marqueur simple et performant.\nT.D. Ly, C. Coignard"},{"title":"3e Journ\u00e9e Francophone de Biologie M\u00e9dicale, Monaco, 6-7-8 novembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/11\/1911_poster_A.Ebel_JFBM.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"D\u00e9pistage syst\u00e9matique de Neisseria gonorrhoeae et de C. trachomatis par test d\u2019amplification g\u00e9nique : bilan d\u2019une ann\u00e9e d\u2019exp\u00e9rience\nL. Mine, L. Guis, S. Merlin, A. Ebel"},{"title":"40e RICAI \u2013 R\u00e9union Interdisciplinaire de Chimioth\u00e9rapie Anti-Infectieuse, 14-15 d\u00e9cembre","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Posters\/2012_Poster_SARS-CoV-2_RICAI_C.Coignard.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"S\u00e9rologie SARS-CoV-2 : \u00e9valuation, qualification et choix d\u2019une m\u00e9thode\nCatherine Coignard, Anne EBEL, Yanis BOUAMRA, Didier RIDEY, Carla MARCENARO"},{"title":"42es Journ\u00e9es Nationales \u2013 Congr\u00e8s CNGOF, Strasbourg, 4-7 D\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-EMILE-DPNI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"\u00c9tude de l\u2019usage du DPNI (d\u00e9pistage pr\u00e9natal non invasif) des aneuplo\u00efdies en milieu lib\u00e9ral\nC. Emile, L. Raymond, L. Pellegrina"},{"title":"45\u00e8me Colloque National des Biologistes des H\u00f4pitaux, Paris, juin 22-24, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/06\/Biomnis_Poster_2016-Rabut_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Interf\u00e9rence du traitement par daratumumab (anti-CD38) dans le suivi biologique du my\u00e9lome multiple et dans la recherche d\u2019anticorps anti-\u00e9rythrocytaires : \u00e0 propos d\u2019un cas\nRabut E, Castro-Fernandez A, Le Gall V, Meknache N"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Raymond_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport diagnostique de l\u2019utilisation des puces SNP dans l\u2019\u00e9tude chromosomique des morts f\u0153tales\nRaymond L, Dherbey JL, Rebeyrat-Pichon I, El-Mouatassim S, Egea G"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier, 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_11.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Cas rare d\u2019X-fragile pr\u00e9natal avec r\u00e9traction d\u2019expansion de triplet CGG ? \nMouty P, Raymond L, El Mouatassim S, Liquier A, Druart L, Paris A, Dorian V, Pichon I, Dherbey JL, Eg\u00e9a G"},{"title":"CGRF Ile de R\u00e9, septembre 28-29, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Brunengo_11.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Epid\u00e9miologie qualitative des variants rares de l\u2019H\u00e9moglobine en France m\u00e9tropolitaine au travers de la collaboration HCL \u2013 Eurofins Biomnis\nBrunengo D, Veyrenche N, Louis Chillotti L, Le Flem L"},{"title":"COGEN, Paris, Septembre 25-27, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_El-Mouatassim_11.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"French experience of Non-Invasive Prenatal Testing of trisomy 21, 18 and 13 \nEl Mouatassim S, Taoudi M, Eg\u00e9a G"},{"title":"Congr\u00e8s SFP \/ SFMM, Toulouse, mars 29-31, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/03\/Biomnis_Poster_2017_Chydriotis_1-1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport de 2 tests de d\u00e9pistage pour le diagnostic de la bilharziose et place du Western blot\nChyd\u00e9riotis G, Cart-Tanneur E, Lecuelle C, F\u00e9lix MH"},{"title":"Congr\u00e8s SFTA, Avignon, mai 10-12, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_Petit_2.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Dosage de la Ciclosporine, Tacrolimus, Ev\u00e9rolimus et Sirolimus en LCMSMS avec le coffret MassTox Chromsystems sur Api 4500 ABSciex avec pr\u00e9paration automatis\u00e9e sur T\u00e9can EVO 150\nPetit I, Moussa C, Bonnet K, Bezol A. Havrez S, Gerrier P"},{"title":"EAACI, Helsinki, June 17-21, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_6.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Bp14, an allergen from cupressus sempervirens pollen related to the family of snakin\/gibberellin-regulated proteins\nS\u00e9n\u00e9chal H, Santrucek J, Melcova M, Svoboda P, Zidkova J, Guilloux L, Aizawa T, Couderc R, Charpin D, Poncet P"},{"title":"ESCAIDE 2015, Stockholm, November 11-13, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Chyderiotis_14.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Re-emergence of urinary schistosomiasis in Europe ? Infections acquired in Southern Corsica \u2013 Investigation of a cluster of Schistosoma haematobium infections in 2014\nRamalli L, No\u00ebl H, Ruello M, Maccary A, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Denoyel GA, Succo T, Armengaud A, Paty MC, Heuz\u00e9 G, Mattei J, Th\u00e9ron A, Berry A"},{"title":"ESCV, Stresa, Lake Maggiore, September 13-16, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/10\/Biomnis_Poster_2017_LY_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new chemiluminescent assay to detect and quantify anti-HBs antibodies\nMaillard A, Ly TD, Thibault V"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_LY_3.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new LIAISON\u00ae H. pylori IgG\nLy TD, Coignard C"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Rabut_4.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Red blood cell antibody assays in DARA-treated patients\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"EuroMedLab, Paris, June 22-24, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Early Performance Evaluation of cobas\u00ae HBV, cobas\u00ae HCV and cobas\u00ae HIV-1Quantitative Nucleic Acid Tests for use on the new cobas\u00ae 6800\/8800 Systems\nEbel A, Merlin S, Marins ED G, Canchola J, Njoya M, Simon CO"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/poster-FFER-2018-callec.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Impact de la chirurgie bariatrique sur les param\u00e8tres spermatiques : Revue de la litt\u00e9rature\nR. Callec, B. Schubert, F. Robert, A. Force"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/POSTER-FFER-2018-Force.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Crit\u00e8res d\u2019interpr\u00e9tation du msome pour une optimisation de la prise en charge des patients\nA. Force, M. Chomier, P. Sergeant, J. Ginon, S. Rochigneux, M. Lechatton, M. Pont, R. Callec, F. Robert, B. Schubert"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Lopez.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation externe de la qualit\u00e9 en spermiologie : un nouveau programme pour une \u00e9valuation globale de l\u2019examen\nMarie LOPEZ, Bernard POGGI, Jean Christophe EYNARD, Marie LETY, Benoit SCHUBERT, Andr\u00e9 FORCE"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Schubert.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Influence des conditions de culture sur les r\u00e9sultats en AMP dans une \u00e9tude multicentrique : comparaison d\u2019un incubateur Time Lapse avec les incubateurs tradictionnels\nBeno\u00eet SCHUBERT, Alexandre MARCILLY, Andr\u00e9 FORCE"},{"title":"FFER, Tours, septembre 13-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Force_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Comparaison de la performance de 2 incubateurs (Geri versus Planer) apr\u00e8s randomisation de la cohorte ovocytaire pour chaque patiente\nForce A, Martine Chomier, Philippe Sergeant, Jacqueline Ginon, St\u00e9phanie Rochigneux, Soizic Baucher, M\u00e9lanie Le Chatton, M\u00e9lanie Pont, Beno\u00eet Schubert"},{"title":"FIBA 2016, Dakar, January 13-14, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"ANCA associated HIV infection in Senegal: a serological trap\nArouna O, Niang A, Abiola A, Guis L, Le Flem L, Diene JF, Mboup S"},{"title":"Fort Collins (USA), May 31-June 3, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/05\/Biomnis_Poster_2016_Jacomo_5.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Seoul Virus Infection in Human, France, 2014-2016\nReynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, Nussbaumer T, Jacomo V, Rapt MP, Septfons A, Rollin PE"},{"title":"ISMA, Lisbon, November 19-21, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2015_Guilloux_16.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Ige-cross-reactivity between european hymenoptera and asian hornet (vespa velutina) venom allergens\nLong\u00e9 C, Brazdova A, Brunet JL, Schwartz C, Girodet B, Lavaud F, Birnbaum J, Pham-Thi N, Duchateau M, Chamot-Rooke J, Guilloux L, Selva MA, Couderc R, S\u00e9n\u00e9chal H, Sutra JP, Poncet P"},{"title":"Journ\u00e9es Nationales CNGOF, Montpellier, d\u00e9cembre 7-9, 2016","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Etude pr\u00e9liminaire sur le d\u00e9pistage de la pr\u00e9-\u00e9clampsie au 1er trimestre de la grossesse (Predictor\u00ae)\nWalder R, Galland A, Sault C, Huissoud C"},{"title":"Journ\u00e9es Nationales d\u2019Infectiologie, Nantes, 13-15 juin, 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/05\/Biomnis_Poster_2018_Ebel_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Infections \u00e0 Chlamydia trachomatis : donn\u00e9es \u00e9pid\u00e9miologiques r\u00e9centes dans un laboratoire sp\u00e9cialis\u00e9\nEbel A, Guis L, Merlin S"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Poster-Lyme-RICAI-C.-Coignard-TD-Ly-dec-2019-800x1200.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of the BioPlex 2200 Lyme IgG\/IgM immunoassay system\nC. Coignard, C. Cl\u00e9ment-Vincent, Td. Ly, A. L\u2019hotellier"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/12\/2019-12-17_RICAI.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Sp\u00e9cificit\u00e9 de la s\u00e9rologie chikungunya et surveillance \u00e9pid\u00e9miologique\nC. Calba, F. Franke, E. Brottet, G. Terpant, N. Fournet, A. Ovize, J.D. Poveda, I. Leparc-Goffart, M.C. Paty"},{"title":"SFE, Bordeaux, octobre 5-8, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Sault_13.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Influence de la nature du liquide de rin\u00e7age d\u2019aiguille de cytoponction sur le dosage de la thyroglobuline\nBoux De Casson F, Moal V, Gauchez AS, Moineau MP, Sault C, Schlageter MH, Massart C"},{"title":"SFTS, Bordeaux, septembre 20-22, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Rabut_10.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Recherche et quantification de l\u2019h\u00e9morragie f\u0153to-maternelle par cytom\u00e9trie en flux avec double marquage anti-h\u00e9moglobine F et anti-anhydrase carbonique\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"XXIIIe Colloque ACLF, Montpellier, septembre 20-21, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Syndrome de Currarino atypique avec hexadactylie pr\u00e9-axiale : remaniement complexe en 7q36.3 en pr\u00e9natal\nLiquier A, Becker M, Raymond L, Bourgain A, Amat S, Broussin B, Andr\u00e9 G, Escande F, Nouchy M, Eg\u00e9a G"}]));
sessionStorage.setItem('currentLang', 'fr');render(html`<${RessourcesDynamiques} name="World" />`, document.getElementById('resdyncontainer'));
\n
Corinne SAULT Rev Med Gene Fam. 2018;2(7):194-8.<\/p>\n"},{"title":"Analyse immunoprot\u00e9omique des allerg\u00e8nes non-hydrosolubles de farines de quatre l\u00e9gumineuses : arachide, soja, s\u00e9same et lentille","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26635049","date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Bouakkadia H, Boutebba A, Haddad I, Vinh J, Guilloux L, Sutra JP, S\u00e9n\u00e9chal H, Poncet P\nAnn Biol Clin 2015 ; 73:690-704"},{"title":"Anticoagulant circulant (ACC) : \u00e0 propos de deux cas","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Le Flem L, Emile C\nSpectra Biologie 2016 ; 220:51-53"},{"title":"Automation of ALK gene rearrangement testing with fluorescence in situ hybridization (FISH): A feasibility study","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25576649","date":"","media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Zwaenepoel k, Merkle D, Cabillic F, Berg E, Belaud-Rotureau MA, Grazioli V, Herelle O, Hummel M, Le Calve M, Lenze D, Mende S, Pauwels P, Quilichini B, Repetti E\nExp Mol Pathol 2015 ; 98:113-118"},{"title":"Characterization of a de novo Supernumerary Neocentric Ring Chromosome Derived from Chromosome 7","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26669311","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Louvrier C, Egea G, Labalme A, Des Portes V, Gazzo S, Callet-Bauchu E, Till M, Sanlaville D, Edery P, Schluth-Bolard C\nCytogenet Genome Res 2015 ; Dec 16"},{"title":"Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays","media_link":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.639675\/full","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Geoffroy Poulet, Fanny Garlan, Sonia Garrigou, Eleonora Zonta, Leonor Benhaim, Marie-Jennifer Carrillon, Audrey Didelot, Delphine Le Corre, Claire Mulot, Philippe Nizard, Frederic Ginot, Audrey Boutonnet-Rodat, Helene Blons, Jean-Baptiste Bachet, Julien Ta\u00efeb, Aziz Zaanan, Vanna Geromel, Laurence Pellegrina, Pierre Laurent-Puig, Shu-Fang Wang-Renault and Valerie Taly\nFrontiers in Oncology 06\/05\/2021"},{"title":"Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26582834","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Mokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM\nJ Clin Microbiol 2016 ; 54:296-299"},{"title":"Chronic hepatitis E in absence of severe immune deficiency","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31327621\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Colson P, Schleinitz N, Vely F, Poveda JD,\u00a0Jacomo V, Demerle C, Borentain P, Gerolami R.Colson P, et al.\nClin Res Hepatol Gastroenterol. 2020 Feb;44(1):e1-e4. doi: 10.1016\/j.clinre.2019.06.015. \nEpub 2019 Jul 18 - PMID: 31327621"},{"title":"Combined Genotypic, Phylogenetic, and Epidemiologic Analyses of Mycobacterium tuberculosis Genetic Diversity in the Rh\u00f4ne Alpes Region, France","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27128522","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Pichat C, Couvin D, Carret G, Fr\u00e9d\u00e9nucci I, Jacomo V, Carricajo A, Boisset S, Dumitrescu O, Flandrois JP, LinaG, Rastogin N\nPlos One 2016"},{"title":"Comparative performance of three rapid HBsAg assays for detection of HBs diagnostic escape mutants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26378274","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Servant-Delmas A,\u00a0Ly TD, Hamon C, Kassim Houdah A, Laperche S\nJ Clin Microbiol 2015 ; 53:3954-3955"},{"title":"Computer-aided sperm analysis, the new key player in routine sperm assessment","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Schubert-Badiou-Force-2019.pdf","date":"","media_type":"document","profils":"579,574,575,","document_type":"publication","content":"\n
B. Schubert, M Badiou, A. Force First International Journal of Andrology \u2013 Andrologia 06\/2019 - DOI: 10.1111\/and.13417<\/p>\n"},{"title":"Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytog\u00e9n\u00e9tique h\u00e9matologique (GFCH)","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27707673","date":null,"media_type":"document","profils":"579,574,575,","document_type":"publication","content":"Daudignon A, Quilichini B, Ameye G, Poirel H, Bastard C, Terr\u00e9 C\nAnn Biol Clin 2016 ; 74:588-595"},{"title":"D\u00e9pistage combin\u00e9 de la trisomie 21 au premier trimestre : \u00e9valuation du sur-risque en cas de \u00df-hCG libre entre 5 et 10 MoM","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Th\u00e8se de M\u00e9decine, Universit\u00e9 Claude Bernar 1;2016,71p\nEtude r\u00e9alis\u00e9e avec les donn\u00e9es du laboratoire Biomnis\nLeport H"},{"title":"D\u00e9pistage multiparam\u00e9trique de la pr\u00e9-\u00e9clampsie au premier trimestre de grossesse : \u00e9tude pr\u00e9liminaire","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Th\u00e8se de m\u00e9decine, UCBL soutenue le 5 juillet 2016\nEtude r\u00e9alis\u00e9e \u00e0 partir des r\u00e9sultats du laboratoire Biomnis (Service T21 Lyon)\nWalder R"},{"title":"Dosage de la ciclosporine, du tacrolimus, de l\u2019\u00e9v\u00e9lorimus et du sirolimus en LC-MS\/MS","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2018_Petit_1-1.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Petit I, Bezol A, Ghacham S, Clavaud K, Havrez S, Moussa C, Emile C, Gerrier P\nSpectra Bio 2018, 234:61-66"},{"title":"Dosages des st\u00e9ro\u00efdes par spectrom\u00e9trie de masse","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25582724","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dufour-Rainfray D, Moal V, Cloix L, Mathieu E, Gauchez AS, Brossaud J, Corcuff JB, Fraissinet F, Collet C, Boux de Casson F, Guilloteau D, Emond P, Reynier P, Groupe de Biologie Sp\u00e9cialis\u00e9e de la SFMN : Agin A, Bach K, Charri\u00e9 A, Chikh K, Desb\u00e8ne C, Dousset B, Georges A, Guenet D, Lacroix I, Lamy PJ, Leban M, Leloupp AG, Massart C, Masson D, Moineau MP, Piketty M, Reix N, Sault C, Schlageter MH, Tse C. \nAnn Biol Clin 2015 ; 73:70-8"},{"title":"Down syndrome maternal serum markers in oocyte donation and other assisted reproductive technologies","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28921586","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Bonnin A, Muller F, Senat MV, Sault C, Galland A, Taieb J, Dreux S, Bouyer J, Benachi A\nPrenat Diagn 2017 ; 37:1155-1159"},{"title":"Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I\/501Y.V1 (B.1.1.7, variant of concern 202012\/01) in France","media_link":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2021.26.9.2100133","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Alexandre Gaymard, Paolo Bosetti, Adeline Feri, Gregory Destras, Vincent Enouf, Alessio Andronico, Sonia Burrel, Sylvie Behillil, Claire Sauvage, Antonin Bal, Florence Morfin, Sylvie Van Der Werf, Laurence Josset, ANRS MIE AC43 COVID-198, French viro COVID group (including Catherine Coignard), Fran\u00e7ois Blanquart, Bruno Coignard, Simon Cauchemez, Bruno Lina\nEurosurveillance 04\/03\/2021 - Volume 26, Issue 9"},{"title":"\u00c9mergence de la leptospirose humaine en France m\u00e9tropolitaine ? Actualit\u00e9s sur la surveillance","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bourhy P, Picardeau M, Septfons A, Trombert S, Cart-Tanneur E\nMed Mal Infect 2017 ; 47 (4s):s150"},{"title":"Evaluation de l\u2019automate Neo\u00ae (Immucor) pour l\u2019immuno-h\u00e9matologie \u00e9rythrocytaire","media_link":"","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
Rabut E, Ahmetkadic D, Malataverne J, Le Flem L Spectra Biologie 2016 ; 223:45-54<\/p>\n"},{"title":"\u00c9valuation de la valeur seuil la plus co\u00fbt-efficace des marqueurs s\u00e9riques du 1er\u00a0trimestre pour l\u2019emploi du test d\u2019ADN circulant dans le d\u00e9pistage de la trisomie\u00a021\u00a0: une analyse m\u00e9dico-\u00e9conomique","media_link":"https:\/\/www.jle.com\/fr\/revues\/abc\/e-docs\/cost_effectiveness_threshold_of_first_trimester_down_syndrome_maternal_serum_screening_for_the_use_of_cell_free_dna_as_a_second_tier_screening_test_320573\/article.phtml","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Marie Blanquet, Sophie Dreux, St\u00e9phanie L\u00e9ger,\u00a0Corinne Sault,\u00a0Charline Mourgues, H\u00e9l\u00e8ne Laurichesse, Didier L\u00e9mery, Fran\u00e7oise Vendittelli, Anne Debost-Legrand, Fran\u00e7oise Muller\nAnnales de Biologie Clinique Volume 79, num\u00e9ro 4, Juillet-Ao\u00fbt 2021"},{"title":"Evaluation of the performance of a new automated HIV combination assay","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29020658","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Ghisetti V, Coignard C, Allice T, Ly TD\nJ Clin Virol 2017 ; 96:80-83"},{"title":"Evaluation of the SLOMYCO Sensititre\u00ae panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27150659","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Chazel M, Marchandin H, Keck N, Terru D, Carri\u00e8re C, Ponsoda M, Jacomo V, Panteix G, Bouzinbi N, Ba\u00f1uls AL, Choisy M, Solassol J, Aubry, Godreuil S\nAnn Clin Microbiol Antimicrob 2016 ; 15:30"},{"title":"Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities","media_link":"http:\/\/www.bloodjournal.org\/content\/132\/Suppl_1\/943?sso-checked=true","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"On Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group\nElise Chapiro, Elodie Pramil, M\u2019boyba Diop, Damien Roos-Weil, Cl\u00e9mentine Dillard, Cl\u00e9mentine Gabillaud, Karim Maloum, Catherine Settegrana, Lucile Baseggio, Jean-Fran\u00e7ois Lesesve, M\u00e9lanie Yon, Ludovic Jondreville, Claude Lesty, Fr\u00e9d\u00e9ric Davi, Magali Le Garff-Tavernier, Nathalie Droin, Philippe Dessen, Caroline Algrin, V\u00e9ronique Leblond, Jean Gabarre, Simon Bouzy, Virginie Eclache, Baptiste Gaillard, Evelyne Callet-Bauchu, Marc Muller, Christine Lefebvre, Nathalie Nadal, Antoine Ittel, St\u00e9phanie Struski, Marie-Agn\u00e8s Collonge-Rame, Benoit Quilichini, Sandra Fert-Ferrer, Nathalie Auger, Isabelle Radford-Weiss, Lena Wagner, Sebastian Scheinost, Thorsten Zenz, Santos A. Susin, Olivier A. Bernard, Florence Nguyen-Khac\nBlood 2018 132:943; doi:"},{"title":"Identification of a polygalacturonase (Cup s 2) as the major CCD-bearing allergen in Cupressus sempervirens pollen","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28439939","date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Shahali Y, Sutra JP, Hilger C, Swiontek K, Haddad I, Vinh J, Guilloux L, Charpin D, S\u00e9n\u00e9chal H, Poncet\nAllergy 2017 ; doi: 10.1111\/all.13191"},{"title":"Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. \u2013 Trends over 10 years","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26518058","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bailly S, Maubon D,\u00a0Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF\nJ Infect\u00a02015 ; Oct 28. pii: S0163-4453(15)00342-4. doi: 10.1016\/j.jinf.2015.09.041"},{"title":"Impact of Including or Removing Nuchal Translucency Measurement on the Detection and False-Positive Rates of First-Trimester Down Syndrome Screening","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26656919","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Spaggiari E, Czerkiewicz I, Sault C, Dreux S, Galland A, Salomon LJ, Ville Y, Muller F\nFetal Diagn Ther 2015 ; Dec 12"},{"title":"Int\u00e9r\u00eat du s\u00e9quen\u00e7age haut d\u00e9bit dans les h\u00e9mopathies my\u00e9lo\u00efdes chroniques : quelles actualit\u00e9s en 2022 ?","media_link":"","date":"01\/09\/2022","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
B. Quilichini Journal de Biologie M\u00e9dicale \/ Volume 11-Num\u00e9ro 42 \/ Juil-Sept 2022<\/p>\n"},{"title":"Interf\u00e9rences s\u00e9rologiques du traitement du my\u00e9lome multiple par daratumumab (anti-CD38) : \u00e0 propos d\u2019un cas","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28540859","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Rabut E, Castro-Fernandez A, Le Gall V, Meknache\nAnn Biol Clin 2017 ; 75:351-355"},{"title":"Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31379011","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Penther D, Etancelin P, Lusina D, Bidet A, Quilichini B, Gaillard B, Rafdord-Weiss I, Mozziconacci MJ, Ittel A, Roche-Lestienne C, Barin C, Soler G, Daudignon A, Nadal N, Chapiro E, Lefebvre C, Godon C, Nadeau G, Mugneret F, Richebourg S, Viailly PJ, Ferret Y, Nguyen-Khac F, Eclache V; Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique\nAm J Hematol 2019 Aug 4. doi: 10.1002\/ajh.25601."},{"title":"Large outbreak of urogenital schistosomiasis acquired in Southern Corsica: monitoring the early signs of the endemicization?","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28669843","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"No\u00ebl H, Ruello M, Maccary A, Pellat C, Sommen C, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Durand J, Ramalli L, Chiappini JD , Malfait P, Berry\nClin Microbiol Infect 2017 ; pii: S1198-743X(17)30350-6. doi: 10.1016\/j.cmi"},{"title":"Les niveaux de preuve des biomarqueurs utilis\u00e9s pour la d\u00e9tection pr\u00e9coce des cancers de la prostate","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27029727","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Lamy PJ, Gauchez AS, Salomon L et al et le Groupe de biologie de la prostate : Sault C et al\nAnn Biol Clin 2016 ; 74:227-232"},{"title":"Marqueurs de d\u00e9pistage et de pr\u00e9diction de la pr\u00e9-\u00e9clampsie : place de la biologie","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Sault C\nJ Biol Med 2017 ; 6:186-190"},{"title":"Non-invasive prenatal testing: what are we missing?\u00a0","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32119166","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fries N, Le Garrec S, Egloff M, Sault C, Dreux S, Mangione R, Salomon LJ, Ville Y. \nUltrasound Obstet Gynecol. Mars 2020 - 2. doi: 10.1002\/uog.22005."},{"title":"Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28189936","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Thibault V, Servant-Delmas A, Ly TD, Roque-Afonso AM, Laperche S\nJ Clin Virol 2017 ; 89:14-21"},{"title":"Persistence of Zika virus in gradient sperm preparation","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29510270","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Cassuto NG, Marras G, Jacomo V, Bouret D\nJ Gynecol Obstet Hum Reprod 2018, pii: S2468-7847(18)30038-2"},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Emile C, Sault C\nSpectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49."},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"12\/12\/2022","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Emile C, Sault C<\/strong>. Spectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49.<\/p>\n"},{"title":"Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Potential+value+of+placental+angiogenic+factors+as+biomarkers+in+preeclampsia+for+clinical+physicians","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Boulanger H, Lef\u00e8vre G, Ahriz Saksi S, Achiche J, Bailleul S, Ekoukou D, Drouin D, Sault C, Stawiarski N, Dupuis E.\nNephrol Ther. 2019 Mar 29"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0755498219304178?via%3Dihub","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Hamdi SM, Sault C, Piver E, Genoux A, Masson D, Guibourdenche J.\nPresse Med . 2019 Oct 29. pii: S0755-4982(19)30417-8. doi: 10.1016\/j.lpm.2019.09.029. PMID:31676218"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/doi.org\/10.1016\/j.lpm.2019.09.029","date":"12\/12\/2019","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Hamdi SM, Sault C<\/strong>, Piver E, Genoux A, Masson D, Guibourdenche J. Presse Med. (2019)<\/p>\n"},{"title":"Preliminary report of an autochthonous Chikungunya outbreak in France, July to September 2017","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29019313","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Calba C, Guerbois-Galla M, Franke F, Jeannin C, Auzet-Caillaud M, Grard G, Pigaglio L, Decoppet A, Weicherding J, Savaill MC, Munoz-Riviero M, Chaud P, Cadiou B, Ramalli L, Fournier P, Noel H, De Lamballerie X, Paty MC, Leparc-Goffart I\nEuro Surveill 2017 ; 22(39):pii=17-00647"},{"title":"Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance","media_link":"https:\/\/www.nature.com\/articles\/s41467-021-23233-6","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"St\u00e9phane Le Vu,\u00a0Gabrielle Jones,\u00a0Fran\u00e7ois Anna,\u00a0Thierry Rose,\u00a0Jean-Baptiste Richard,\u00a0Sibylle Bernard-Stoecklin,\u00a0Sophie Goyard,\u00a0Caroline Demeret,\u00a0Olivier Helynck,\u00a0Nicolas Escriou,\u00a0Marion Gransagne,\u00a0St\u00e9phane Petres,\u00a0Corinne Robin,\u00a0Virgile Monnet,\u00a0Louise Perrin de Facci,\u00a0Marie-Noelle Ungeheuer,\u00a0Lucie L\u00e9on,\u00a0Yvonnick Guillois,\u00a0Laurent Filleul,\u00a0Pierre Charneau,\u00a0Daniel L\u00e9vy-Bruhl,\u00a0Sylvie van der Werf\u00a0&\u00a0Harold Noel\u00a0\nNature Communications volume 21\/05\/2021 12, Article number: 3025 (2021)"},{"title":"Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/30789329\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Tatai C, Berland JL, Claude JB, Westeel E, Hodille E, Fredenucci I, Rasigade JP, Ponsoda M, Jacomo V, Vach\u00e9e A, Gaudart A, Gaillard JL, Roux AL, Ader F, Tararbit K, Terpant G, Bryant JE, Lina G, Dumitrescu O; Lyon TB Study Group.Genestet C, et al.\nEmerg Infect Dis. 2019 Mar;25(3):589-592. doi: 10.3201\/eid2503.181124 - PMID: 30789329"},{"title":"R\u00e9activit\u00e9 crois\u00e9e in silico, in vitro, in vivo","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Guilloux L, Ricard-Blum S\nAllergies alimentaires 2017 ; chapitre 7.5:97-102"},{"title":"Recherche et identification des anticorps antinucl\u00e9aires : analyse du questionnaire europ\u00e9en de l\u2019EASI groupe et confrontation des pratiques fran\u00e7aises aux recommandations internationales","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29623889","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Musset L, Fabien N, Chyderiotis G, Olsson NO, Pham BN, Durey Dragon MA\nAnn Biol Clin 2018, 76 :185-195"},{"title":"Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission.","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31806715\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Paret R, Pichat C, Berland JL, Jacomo V, Carret G, Fredenucci I, Hodille E, Rasigade JP, Boisset S, Carricajo A, Lina G, Ronnaux-Baron AS, Mornex JF, Grando J, S\u00e9n\u00e9chal A, Ader F, Dumitrescu O; Lyon TB study group.Genestet C, et al.\nEur Respir J. 2020 Mar 20;55(3):1901888. doi: 10.1183\/13993003.01888-2019. Print 2020 Mar"},{"title":"Schistosomose en Corse : chronique d\u2019une histoire annonc\u00e9e","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Berry A, Iriart X, Boissier J, Chyd\u00e9riotis G, Debruyne M, Magnaval JF, Fillaux J, Grech-Angelini S, Barr\u00e9-Cardi H, Termignon JL, Macarry A, Noel H\nLa Lettre de l'Infectiologue 2016 ; XXXI n\u00b02:60-64"},{"title":"Screening and identification of antinuclear antibodies (ANA): analysis of the European EASI survey and confrontation of the French routine practice to the international recommandations","media_link":null,"date":null,"media_type":"document","profils":"579,575,574,","document_type":"publication","content":"Musset L, Fabien N, Chyd\u00e9riotis G, Olsson NO, Pham BN, Dragon-Durey MA\nAnn Biol Clin 2017 ;"},{"title":"Surveillance des infections humaines par hantavirus en France m\u00e9tropolitaine, 2012-2016","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Reynes JM, Carli D, Renaudin B, Fizet A, Bour JB, Brodard V, Cart-Tanneur E, Dewilde A, El Hamri M, Fleury H, Hecquet D, Jeulin H, Lechat S, Lemarquand-Bardini M, Lepiller Q, Poveda JD, Raulin O, Twizeyimana E, Van Cauteren D, Velay A, Septfons A, Baize S\nBEH 2017 ; 23:492-499"},{"title":"Surveillance du chikungunya et de la dengue en France m\u00e9tropolitaine, 2014","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resume_Septfons-A_2016_330-70-77.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Septfons A, No\u00ebl H, Leparc-Goffart I, Giron S, Delisle E, Chappert JL, Catelinois O, Franke F, Servas V, Guinard A, Debruyne M, Schaal O, Brichler S, Ninove L, Prat C, Flusin O, Poujol I, Letort MJ, Deniau J, Six C, Rousseau C, De Valk H, Paty MC\nLes Feuillets de Biologie 2016 ; 330:70-77"},{"title":"Surveillance du chikungunya, de la dengue et des infections \u00e0 virus Zika en France m\u00e9tropolitaine, 2017","media_link":"http:\/\/invs.santepubliquefrance.fr\/beh\/2018\/24\/pdf\/2018_24_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fournet N, Franke F, Chaud P, Raguenaud ME, Calba C, Septfons A, Cart-Tanneur E. et al.\nBull Epid\u00e9miol Hebd. 2018;(24):494-503."},{"title":"Testing anti-neutrophil cytoplasmic antibodies (ANCA): analysis of the European EASI survey on the daily practice of the French laboratories","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28958962","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dragon-Durey MA, Fabien N, Chyd\u00e9riotis G, Musset L, Pham BN, Olsson N\nAnn Biol Clin 2017 ; 75:531-541"},{"title":"The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)","media_link":"","date":"06\/09\/2022","media_type":"document","profils":"579,575,574,","document_type":"publication","content":"\n
Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nab\u00e9ra C, Chapiro E, Collonge-Rame MA, Cuccuini W, Douet-Guilbert N, Eclache V, Luquet I, Michaux L, Nadal N, Penther D, Quilichini B<\/strong>, Terre C, Lefebvre C, Troadec MB, V\u00e9ron\u00e8se L. Leukemia. 2022 Jun;36(6):1451-1466. doi: 10.1038\/s41375-022-01561-w. Epub 2022 Apr 16.PMID: 35430613 Review.<\/p>\n"},{"title":"The impact of introducing combined first-trimester trisomy 21 screening in the French population","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26628633","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Eur J Public Health 2015 ; Nov 30"},{"title":"The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34284044\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Maxime Espi, Xavier Charmetant, Thomas Barba, Laetitia Koppe, Caroline Pelletier, Emilie Kalbacher, Elodie Chalencon, Virginie Mathias, Anne Ovize, Emmanuelle Cart-Tanneur, Christine Bouz, Laurence Pellegrina, Emmanuel Morelon, Denis Fouque, Laurent Juillard, Olivier Thaunat\nKidney International 2021 Oct;100(4):928-936. doi: 10.1016\/j.kint.2021.07.005."},{"title":"Thrombop\u00e9nie induite par l\u2019h\u00e9parine (TIH) : \u00e0 propos d\u2019un casLe Flem L, Emile C","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Le Flem L, Emile C, Spectra Biologie 2016 ; 220:49-50<\/p>\n"},{"title":"Une interf\u00e9rence dans le dosage de l\u2019insuline r\u00e9v\u00e8le un syndrome auto-immun anti-insuline","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27492703","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Lamy PJ, Sault C, Renard E\nAnn Biol Clin 2016 ; 74:490-494"},{"title":"Vector-borne Transmission of Zika Virus in Europe, Southern France, August 2019","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31718742\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Sandra Giron, Florian Franke, Anne Decoppet, Bernard Cadiou, Thierry Travaglini, Laurence Thirion, Guillaume Durand, Charles Jeannin, Gr\u00e9gory L\u2019Ambert, Gilda Grard, Harold No\u00ebl, Nelly Fournet, Michelle Auzet-Caillaud, Christine Zandotti, Samer Abouka\u00efs, Pascal Chaud, Saby Guedj, Lakri Hamouda, Xavier Naudot, Anne Ovize, Cl\u00e9ment Lazarus, Henriette de Valk, Marie-Claire Paty, Isabelle Leparc-Goffart\nEuro Surveill. 2019 Nov;24(45):1900655."},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Faux-positif-ADNlcT21_L-Druart_012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Faux positif d\u2019ADNlcT21 avec diff\u00e9rentes anomalies chromosomiques confin\u00e9es au placenta\nL Druart, H Dessuant, JF Taly, M Nouchy, L Raymond, S Tapia"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Developpement-panel-15-marqueurs_F.-Rousseau-et-al.-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9veloppement d\u2019un panel de 15 marqueurs pour une identitovigilance\ndes \u00e9chantillons analys\u00e9s par s\u00e9quen\u00e7age haut d\u00e9bit ou sur puces \u00e0 SNP\nF Rousseau, J-F Taly, C Ploton Nicollet, M Taoudi, A Perdriau, L Raymond"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20359-Assises-de-Genetique-2020_B-Quilichini_012020.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Mise en place d\u2019un panel de g\u00e8nes cibl\u00e9s pour les h\u00e9mopathies\nmalignes (NMP-LMMC-SMD-LAM) par NGS : Enjeux M\u00e9dical \/ Scientifique et d\u2019Assurance Qualit\u00e9.\nV Geromel, E Fayolle, P Mouty, R Moulin, N Batail, M-H Felix, B Adde, S Mouty, L Raymond, B Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20362-Assises-de-Gntique-2020_B_Quilichini-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Impact diagnostique, pronostique et th\u00e9ranostique d\u2019un panel de g\u00e8nes\n\u00ab H\u00e9mopathies My\u00e9lo\u00efdes \u00bb r\u00e9alis\u00e9 par NGS : l\u2019exp\u00e9rience du laboratoire Eurofins Biomnis en 2019.\nV. Geromel, P. Mouty, C. Chal, J . Delaunay, S. Sadot-Lebouvier, R. Kaphan, J. Vigvari, J.P. Coadic, E.A. Marin La Meslee, O. Roualdes, C. Bourdin, A. Petit, M. Roumigui\u00e8res, L. Raymond, B.Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 4","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Les_assises_2020_RadoslavaSARAEVA_LAMRI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"21-24 janvier 2020, Tours\nDiagnostics g\u00e9n\u00e9tiques multiples (double hits) par s\u00e9quen\u00e7age Whole Exome (WES) : \u00e0 propos de deux cas.\nR. SARAEVA-LAMRI, A. DORELLE, V. GEROMEL, A. S. LEBRE, P. MOUTY, M. E. NAUD BARREYRE, F. ROUSSEAU, M. TAOUDI, L. MESNARD, L. RAYMOND"},{"title":"10th International Congress on Autoimmunity, Leipzig, April 6-10, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_4.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Should Dense Fine Speckled 70 (DFS70) pattern be reported? Biomnis reference lab experience on 12 619 ANA screening consecutive sera\nGuis L, Ebel A, Leroy J, Michaud S, Pomaredes A, Marcenaro C, Chalouas L"},{"title":"12\u00e8me CFA, Paris, avril 25-28, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":""},{"title":"12\u00e8me Congr\u00e8s de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Paris, mars 22-23, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Jacomo_3.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Les Liquides C\u00e9phalo-Rachidiens : conservation pr\u00e9-analytique \u00e0+ 4 \u00b0C ou \u2013 20 \u00b0C ?\nJacomo V, Schaal O, Fournier P"},{"title":"17\u00e8mes Journ\u00e9es Francophones de Virologie, Paris, avril 9, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"R\u00e9solution des \u00e9checs de g\u00e9notypage de la technique Abbott RealTime HCV Genotype II par un test temps r\u00e9el additionnel\nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ly_8.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of a new high sensitive, qualitative and quantitative Hepatitis B surface antigen assay\nLy TD, Coignard C"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Characterization of samples with genotype 1 without subtype results by Abbott RealTime HCV genotype II using the new Abbott HCV Genotype Plus RUO test \nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"19th Annual Meeting of the European Society for Clinical Virology (ESCV), Lisbon, september, 14\u201317, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/09\/Biomnis_Poster_2016_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to COBAS\u00ae AmpliPrep\/OBAS\u00ae TaqMan\u00ae HIV-1 and HBV tests\nEbel A, Bali C, Guis L, Merlin S"},{"title":"20\u00e8mes Journ\u00e9es de M\u00e9decine Foetale, Morzine, mars 26-28, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015__Becker_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Int\u00e9r\u00eat du D\u00e9pistage Pr\u00e9natal Non Invasif dans le diagnostic des aneuplo\u00efdies 13, 18 et 21 \nBecker M, Eg\u00e9a G, Taoud M, Ahmed Chaouch D, El Mouatassim S"},{"title":"20Th Congress European Hematology Association, Vienna, June 11-14, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Rigollet_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Characterization of normal and pathological lymphoid populations: validation of a 10-colors flow cytometry protocol for routine diagnosis \nRigollet L, Stagnara J, Milhau A, Pellegrina L"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/10\/Biomnis_Poster-Aptima-HIV-1-HBV_Ebel_Sept18.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV-1 Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to Cobas\u00ae 6800\/8800 HIV-1 and HBV tests\nA. Ebel, C. Bali, L. Guis, S. Merlin"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/11\/Poster-IgM-Measles-ESCV-TD-LY-.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of new IgM Measles assay\nT.D. Ly, C. Coignard"},{"title":"24e Journ\u00e9es de m\u00e9decine f\u0153tale, Marseille, 4-5-6 avril 2019","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9pistage de la trisomie 21 par analyse de l\u2019ADN f\u0153tal libre circulant dans le sang maternel : Application dans le cas des grossesses g\u00e9mellaires\nMarc NOUCHY, Nicolas CHATRON, Pascal MOUTY, Francis ROUSSEAU, Barbara ADD\u00c9, Mohamed Taoudi, Caroline DUMONT, Jean-Fran\u00e7ois TALY, Luc DRUART, Sylvie TAPIA, Damien SANLAVILLE, Laure RAYMOND"},{"title":"25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, April 25-28, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of three fully automated assays for the detection of cytomegalovirus IgM and IgG: DiaSorin LIAISON\u00ae XL, Abbott Architect \u00ae and Roche Cobas 6000\u00ae\nBouthry E, Ly TD, Vauloup-Fellous C"},{"title":"27th ECCMID, Vienna Austria, April 22-25, 2017","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Strain-specific estimation of epidemic success provides insights into the transmission dynamics of tuberculosis Rasigade\nJP, Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, P\u00e9rouse de Montclos M, Flandrois JP, Ader F, Supply P, Lina G, Wirth T"},{"title":"29th IUSTI European Conference on Sexually Transmitted Infections, Sitges (Barcelona), 24-26 September, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Prevalence of Mycoplasma genitalium in France and comparison with Chlamydia trachomatis and Neisseria gonorrhoeae as determined by the Mycoplasma genitalium TMA assay \nEbel A, Venard C, Brunengo D, Merlin S"},{"title":"31st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbon, June 14-17, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Force_7.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Blastocysts vitrification during 2 consecutive years: before and after its start significant delivery rate increase within the 1st year \nForce A, Nicollet B, Chomier M, Sergeant P, Lescaille M, Rochigneux S, Robert F, Ginon J, Sergeant MV, Baucher S, Schubert B"},{"title":"35e congr\u00e8s de la SFH, CNIT Paris la D\u00e9fense, avril 1-3, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Becker_4.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"La SNP array : un outil compl\u00e9mentaire pour la caract\u00e9risation des h\u00e9mopathies malignes \nBecker M, Eg\u00e9a G, Camilli K, Robin M, Roumigui\u00e8res M, Rigollet L, Stagnara J, El Mouatassim S"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_14.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Evaluation du nouveau test LAISON\u00ae H. pylori IgG\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_15.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Borr\u00e9liose et index de synth\u00e8se intrath\u00e9cale : bilan biologique r\u00e9trospectif de l\u2019ann\u00e9e 2015\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Ebel_16.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation des performances de la trousse Aptima\u00ae HBV Quant (Hologic)\nEbel A, Bali C, Guis L, Merlin S"},{"title":"37\u00e8me RICAI, Paris, d\u00e9cembre 18-19, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/12\/Biomnis_Poster_2017_Coignard_13.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Confirmation VIH : donn\u00e9es biologiques et \u00e9pid\u00e9miologiques des 3 derni\u00e8res ann\u00e9es dans un laboratoire de biologie sp\u00e9cialis\u00e9e\nCoignard C, Ly TD"},{"title":"38e RICAI, Paris 17-18 d\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-COIGNARD-ROUGEOLE.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Epid\u00e9mie de rougeole 2018 : le s\u00e9rodiagnostic un marqueur simple et performant.\nT.D. Ly, C. Coignard"},{"title":"3e Journ\u00e9e Francophone de Biologie M\u00e9dicale, Monaco, 6-7-8 novembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/11\/1911_poster_A.Ebel_JFBM.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"D\u00e9pistage syst\u00e9matique de Neisseria gonorrhoeae et de C. trachomatis par test d\u2019amplification g\u00e9nique : bilan d\u2019une ann\u00e9e d\u2019exp\u00e9rience\nL. Mine, L. Guis, S. Merlin, A. Ebel"},{"title":"40e RICAI \u2013 R\u00e9union Interdisciplinaire de Chimioth\u00e9rapie Anti-Infectieuse, 14-15 d\u00e9cembre","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Posters\/2012_Poster_SARS-CoV-2_RICAI_C.Coignard.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"S\u00e9rologie SARS-CoV-2 : \u00e9valuation, qualification et choix d\u2019une m\u00e9thode\nCatherine Coignard, Anne EBEL, Yanis BOUAMRA, Didier RIDEY, Carla MARCENARO"},{"title":"42es Journ\u00e9es Nationales \u2013 Congr\u00e8s CNGOF, Strasbourg, 4-7 D\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-EMILE-DPNI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"\u00c9tude de l\u2019usage du DPNI (d\u00e9pistage pr\u00e9natal non invasif) des aneuplo\u00efdies en milieu lib\u00e9ral\nC. Emile, L. Raymond, L. Pellegrina"},{"title":"45\u00e8me Colloque National des Biologistes des H\u00f4pitaux, Paris, juin 22-24, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/06\/Biomnis_Poster_2016-Rabut_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Interf\u00e9rence du traitement par daratumumab (anti-CD38) dans le suivi biologique du my\u00e9lome multiple et dans la recherche d\u2019anticorps anti-\u00e9rythrocytaires : \u00e0 propos d\u2019un cas\nRabut E, Castro-Fernandez A, Le Gall V, Meknache N"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Raymond_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport diagnostique de l\u2019utilisation des puces SNP dans l\u2019\u00e9tude chromosomique des morts f\u0153tales\nRaymond L, Dherbey JL, Rebeyrat-Pichon I, El-Mouatassim S, Egea G"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier, 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_11.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Cas rare d\u2019X-fragile pr\u00e9natal avec r\u00e9traction d\u2019expansion de triplet CGG ? \nMouty P, Raymond L, El Mouatassim S, Liquier A, Druart L, Paris A, Dorian V, Pichon I, Dherbey JL, Eg\u00e9a G"},{"title":"CGRF Ile de R\u00e9, septembre 28-29, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Brunengo_11.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Epid\u00e9miologie qualitative des variants rares de l\u2019H\u00e9moglobine en France m\u00e9tropolitaine au travers de la collaboration HCL \u2013 Eurofins Biomnis\nBrunengo D, Veyrenche N, Louis Chillotti L, Le Flem L"},{"title":"COGEN, Paris, Septembre 25-27, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_El-Mouatassim_11.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"French experience of Non-Invasive Prenatal Testing of trisomy 21, 18 and 13 \nEl Mouatassim S, Taoudi M, Eg\u00e9a G"},{"title":"Congr\u00e8s SFP \/ SFMM, Toulouse, mars 29-31, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/03\/Biomnis_Poster_2017_Chydriotis_1-1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport de 2 tests de d\u00e9pistage pour le diagnostic de la bilharziose et place du Western blot\nChyd\u00e9riotis G, Cart-Tanneur E, Lecuelle C, F\u00e9lix MH"},{"title":"Congr\u00e8s SFTA, Avignon, mai 10-12, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_Petit_2.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Dosage de la Ciclosporine, Tacrolimus, Ev\u00e9rolimus et Sirolimus en LCMSMS avec le coffret MassTox Chromsystems sur Api 4500 ABSciex avec pr\u00e9paration automatis\u00e9e sur T\u00e9can EVO 150\nPetit I, Moussa C, Bonnet K, Bezol A. Havrez S, Gerrier P"},{"title":"EAACI, Helsinki, June 17-21, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_6.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Bp14, an allergen from cupressus sempervirens pollen related to the family of snakin\/gibberellin-regulated proteins\nS\u00e9n\u00e9chal H, Santrucek J, Melcova M, Svoboda P, Zidkova J, Guilloux L, Aizawa T, Couderc R, Charpin D, Poncet P"},{"title":"ESCAIDE 2015, Stockholm, November 11-13, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Chyderiotis_14.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Re-emergence of urinary schistosomiasis in Europe ? Infections acquired in Southern Corsica \u2013 Investigation of a cluster of Schistosoma haematobium infections in 2014\nRamalli L, No\u00ebl H, Ruello M, Maccary A, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Denoyel GA, Succo T, Armengaud A, Paty MC, Heuz\u00e9 G, Mattei J, Th\u00e9ron A, Berry A"},{"title":"ESCV, Stresa, Lake Maggiore, September 13-16, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/10\/Biomnis_Poster_2017_LY_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new chemiluminescent assay to detect and quantify anti-HBs antibodies\nMaillard A, Ly TD, Thibault V"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_LY_3.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new LIAISON\u00ae H. pylori IgG\nLy TD, Coignard C"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Rabut_4.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Red blood cell antibody assays in DARA-treated patients\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"EuroMedLab, Paris, June 22-24, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Early Performance Evaluation of cobas\u00ae HBV, cobas\u00ae HCV and cobas\u00ae HIV-1Quantitative Nucleic Acid Tests for use on the new cobas\u00ae 6800\/8800 Systems\nEbel A, Merlin S, Marins ED G, Canchola J, Njoya M, Simon CO"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/poster-FFER-2018-callec.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Impact de la chirurgie bariatrique sur les param\u00e8tres spermatiques : Revue de la litt\u00e9rature\nR. Callec, B. Schubert, F. Robert, A. Force"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/POSTER-FFER-2018-Force.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Crit\u00e8res d\u2019interpr\u00e9tation du msome pour une optimisation de la prise en charge des patients\nA. Force, M. Chomier, P. Sergeant, J. Ginon, S. Rochigneux, M. Lechatton, M. Pont, R. Callec, F. Robert, B. Schubert"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Lopez.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation externe de la qualit\u00e9 en spermiologie : un nouveau programme pour une \u00e9valuation globale de l\u2019examen\nMarie LOPEZ, Bernard POGGI, Jean Christophe EYNARD, Marie LETY, Benoit SCHUBERT, Andr\u00e9 FORCE"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Schubert.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Influence des conditions de culture sur les r\u00e9sultats en AMP dans une \u00e9tude multicentrique : comparaison d\u2019un incubateur Time Lapse avec les incubateurs tradictionnels\nBeno\u00eet SCHUBERT, Alexandre MARCILLY, Andr\u00e9 FORCE"},{"title":"FFER, Tours, septembre 13-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Force_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Comparaison de la performance de 2 incubateurs (Geri versus Planer) apr\u00e8s randomisation de la cohorte ovocytaire pour chaque patiente\nForce A, Martine Chomier, Philippe Sergeant, Jacqueline Ginon, St\u00e9phanie Rochigneux, Soizic Baucher, M\u00e9lanie Le Chatton, M\u00e9lanie Pont, Beno\u00eet Schubert"},{"title":"FIBA 2016, Dakar, January 13-14, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"ANCA associated HIV infection in Senegal: a serological trap\nArouna O, Niang A, Abiola A, Guis L, Le Flem L, Diene JF, Mboup S"},{"title":"Fort Collins (USA), May 31-June 3, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/05\/Biomnis_Poster_2016_Jacomo_5.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Seoul Virus Infection in Human, France, 2014-2016\nReynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, Nussbaumer T, Jacomo V, Rapt MP, Septfons A, Rollin PE"},{"title":"ISMA, Lisbon, November 19-21, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2015_Guilloux_16.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Ige-cross-reactivity between european hymenoptera and asian hornet (vespa velutina) venom allergens\nLong\u00e9 C, Brazdova A, Brunet JL, Schwartz C, Girodet B, Lavaud F, Birnbaum J, Pham-Thi N, Duchateau M, Chamot-Rooke J, Guilloux L, Selva MA, Couderc R, S\u00e9n\u00e9chal H, Sutra JP, Poncet P"},{"title":"Journ\u00e9es Nationales CNGOF, Montpellier, d\u00e9cembre 7-9, 2016","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Etude pr\u00e9liminaire sur le d\u00e9pistage de la pr\u00e9-\u00e9clampsie au 1er trimestre de la grossesse (Predictor\u00ae)\nWalder R, Galland A, Sault C, Huissoud C"},{"title":"Journ\u00e9es Nationales d\u2019Infectiologie, Nantes, 13-15 juin, 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/05\/Biomnis_Poster_2018_Ebel_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Infections \u00e0 Chlamydia trachomatis : donn\u00e9es \u00e9pid\u00e9miologiques r\u00e9centes dans un laboratoire sp\u00e9cialis\u00e9\nEbel A, Guis L, Merlin S"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Poster-Lyme-RICAI-C.-Coignard-TD-Ly-dec-2019-800x1200.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of the BioPlex 2200 Lyme IgG\/IgM immunoassay system\nC. Coignard, C. Cl\u00e9ment-Vincent, Td. Ly, A. L\u2019hotellier"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/12\/2019-12-17_RICAI.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Sp\u00e9cificit\u00e9 de la s\u00e9rologie chikungunya et surveillance \u00e9pid\u00e9miologique\nC. Calba, F. Franke, E. Brottet, G. Terpant, N. Fournet, A. Ovize, J.D. Poveda, I. Leparc-Goffart, M.C. Paty"},{"title":"SFE, Bordeaux, octobre 5-8, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Sault_13.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Influence de la nature du liquide de rin\u00e7age d\u2019aiguille de cytoponction sur le dosage de la thyroglobuline\nBoux De Casson F, Moal V, Gauchez AS, Moineau MP, Sault C, Schlageter MH, Massart C"},{"title":"SFTS, Bordeaux, septembre 20-22, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Rabut_10.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Recherche et quantification de l\u2019h\u00e9morragie f\u0153to-maternelle par cytom\u00e9trie en flux avec double marquage anti-h\u00e9moglobine F et anti-anhydrase carbonique\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"XXIIIe Colloque ACLF, Montpellier, septembre 20-21, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Syndrome de Currarino atypique avec hexadactylie pr\u00e9-axiale : remaniement complexe en 7q36.3 en pr\u00e9natal\nLiquier A, Becker M, Raymond L, Bourgain A, Amat S, Broussin B, Andr\u00e9 G, Escande F, Nouchy M, Eg\u00e9a G"}]));
sessionStorage.setItem('currentLang', 'fr');render(html`<${RessourcesDynamiques} name="World" />`, document.getElementById('resdyncontainer'));
\n
Pour un diagnostic optimis\u00e9 en cas de malformations foetales<\/p>\n"},{"title":"Le s\u00e9quen\u00e7age Whole Exome dans les maladies d\u2019origine g\u00e9n\u00e9tique (DS34)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS34-Exome.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Les autoanticorps dans le diagnostic et le suivi des maladies auto-immunes (DS4)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS4-Auto-immunite.pdf","date":"27\/04\/2022","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Les maladies transmises par les tiques (DS20)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS20-Maladies_tiques.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Leuc\u00e9mie Aigu\u00eb My\u00e9lo\u00efde (LAM) (DS68)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS68-LAM.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Leuc\u00e9mie my\u00e9lomonocytaire chronique (LMMC) (DS71)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS71-LMMC.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Microbiote intestinal (JU-DS73-PA)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/JU-DS73-PA-Microbiote.pdf","date":"","media_type":"document","profils":"575,576,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux patients"},{"title":"Microbiote intestinal (JU-DS76-PH)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/JU-DS76-HP-Microbiote.pdf","date":null,"media_type":"document","profils":"575,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux professionnels de sant\u00e9"},{"title":"N\u00e9oplasies My\u00e9loprolif\u00e9ratives Diagnostic (DS69)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS69-NMP_diagnostic.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Oncog\u00e9n\u00e9tique - Pr\u00e9dispositions h\u00e9r\u00e9ditaires aux cancers : Int\u00e9r\u00eat du s\u00e9quen\u00e7age de l'exome (DS94)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS94-Oncogenetique_exome.pdf","date":"18\/10\/2023","media_type":"document","profils":"575,","document_type":"le-point-sur","content":""},{"title":"Oncog\u00e9n\u00e9tique constitutionnelle : Utilisation du s\u00e9quen\u00e7age Long-ReadNanopore - l\u2019exemple du g\u00e8ne PMS2 (DS112) ","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS112-Sequencage_long_read_PMS2.pdf","date":"18\/10\/2023","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Panels de g\u00e8nes SPINK1, PRSS1, CTRC, CPA1, CFTR et CASR pour le diagnotsic des pancr\u00e9atites h\u00e9r\u00e9ditaires (DS82)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS82-HP-Pancreatites_hereditaires.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Papillomavirus humains et d\u00e9pistage primaire du cancer du col de l\u2019ut\u00e9rus (DS6)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS6-HPV.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Pneumologie - fiche oncologie (DS83)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS83-Onco-pneumologie.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Prise en charge de la pr\u00e9-\u00e9clampsie (DS18)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS18-Pre-eclampsie.pdf","date":"","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Prise en charge des tumeurs solides en Biopathologie (DS5)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS5-Tumeurs_solides.pdf","date":"","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"PROSIGNA\u00ae (PAM50) (DS79)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS79-HP-PAM50.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"Test d\u2019expression g\u00e9nique pronostique du cancer du sein"},{"title":"Syndromes My\u00e9lodysplasiques (SMD) (DS72)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS72-SMD.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Actualit\u00e9s sur la pr\u00e9-\u00e9clampsie et place de la biologie ","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"\n
Corinne SAULT Rev Med Gene Fam. 2018;2(7):194-8.<\/p>\n"},{"title":"Analyse immunoprot\u00e9omique des allerg\u00e8nes non-hydrosolubles de farines de quatre l\u00e9gumineuses : arachide, soja, s\u00e9same et lentille","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26635049","date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Bouakkadia H, Boutebba A, Haddad I, Vinh J, Guilloux L, Sutra JP, S\u00e9n\u00e9chal H, Poncet P\nAnn Biol Clin 2015 ; 73:690-704"},{"title":"Anticoagulant circulant (ACC) : \u00e0 propos de deux cas","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Le Flem L, Emile C\nSpectra Biologie 2016 ; 220:51-53"},{"title":"Automation of ALK gene rearrangement testing with fluorescence in situ hybridization (FISH): A feasibility study","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25576649","date":"","media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Zwaenepoel k, Merkle D, Cabillic F, Berg E, Belaud-Rotureau MA, Grazioli V, Herelle O, Hummel M, Le Calve M, Lenze D, Mende S, Pauwels P, Quilichini B, Repetti E\nExp Mol Pathol 2015 ; 98:113-118"},{"title":"Characterization of a de novo Supernumerary Neocentric Ring Chromosome Derived from Chromosome 7","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26669311","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Louvrier C, Egea G, Labalme A, Des Portes V, Gazzo S, Callet-Bauchu E, Till M, Sanlaville D, Edery P, Schluth-Bolard C\nCytogenet Genome Res 2015 ; Dec 16"},{"title":"Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays","media_link":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.639675\/full","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Geoffroy Poulet, Fanny Garlan, Sonia Garrigou, Eleonora Zonta, Leonor Benhaim, Marie-Jennifer Carrillon, Audrey Didelot, Delphine Le Corre, Claire Mulot, Philippe Nizard, Frederic Ginot, Audrey Boutonnet-Rodat, Helene Blons, Jean-Baptiste Bachet, Julien Ta\u00efeb, Aziz Zaanan, Vanna Geromel, Laurence Pellegrina, Pierre Laurent-Puig, Shu-Fang Wang-Renault and Valerie Taly\nFrontiers in Oncology 06\/05\/2021"},{"title":"Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26582834","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Mokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM\nJ Clin Microbiol 2016 ; 54:296-299"},{"title":"Chronic hepatitis E in absence of severe immune deficiency","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31327621\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Colson P, Schleinitz N, Vely F, Poveda JD,\u00a0Jacomo V, Demerle C, Borentain P, Gerolami R.Colson P, et al.\nClin Res Hepatol Gastroenterol. 2020 Feb;44(1):e1-e4. doi: 10.1016\/j.clinre.2019.06.015. \nEpub 2019 Jul 18 - PMID: 31327621"},{"title":"Combined Genotypic, Phylogenetic, and Epidemiologic Analyses of Mycobacterium tuberculosis Genetic Diversity in the Rh\u00f4ne Alpes Region, France","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27128522","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Pichat C, Couvin D, Carret G, Fr\u00e9d\u00e9nucci I, Jacomo V, Carricajo A, Boisset S, Dumitrescu O, Flandrois JP, LinaG, Rastogin N\nPlos One 2016"},{"title":"Comparative performance of three rapid HBsAg assays for detection of HBs diagnostic escape mutants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26378274","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Servant-Delmas A,\u00a0Ly TD, Hamon C, Kassim Houdah A, Laperche S\nJ Clin Microbiol 2015 ; 53:3954-3955"},{"title":"Computer-aided sperm analysis, the new key player in routine sperm assessment","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Schubert-Badiou-Force-2019.pdf","date":"","media_type":"document","profils":"579,574,575,","document_type":"publication","content":"\n
B. Schubert, M Badiou, A. Force First International Journal of Andrology \u2013 Andrologia 06\/2019 - DOI: 10.1111\/and.13417<\/p>\n"},{"title":"Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytog\u00e9n\u00e9tique h\u00e9matologique (GFCH)","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27707673","date":null,"media_type":"document","profils":"579,574,575,","document_type":"publication","content":"Daudignon A, Quilichini B, Ameye G, Poirel H, Bastard C, Terr\u00e9 C\nAnn Biol Clin 2016 ; 74:588-595"},{"title":"D\u00e9pistage combin\u00e9 de la trisomie 21 au premier trimestre : \u00e9valuation du sur-risque en cas de \u00df-hCG libre entre 5 et 10 MoM","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Th\u00e8se de M\u00e9decine, Universit\u00e9 Claude Bernar 1;2016,71p\nEtude r\u00e9alis\u00e9e avec les donn\u00e9es du laboratoire Biomnis\nLeport H"},{"title":"D\u00e9pistage multiparam\u00e9trique de la pr\u00e9-\u00e9clampsie au premier trimestre de grossesse : \u00e9tude pr\u00e9liminaire","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Th\u00e8se de m\u00e9decine, UCBL soutenue le 5 juillet 2016\nEtude r\u00e9alis\u00e9e \u00e0 partir des r\u00e9sultats du laboratoire Biomnis (Service T21 Lyon)\nWalder R"},{"title":"Dosage de la ciclosporine, du tacrolimus, de l\u2019\u00e9v\u00e9lorimus et du sirolimus en LC-MS\/MS","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2018_Petit_1-1.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Petit I, Bezol A, Ghacham S, Clavaud K, Havrez S, Moussa C, Emile C, Gerrier P\nSpectra Bio 2018, 234:61-66"},{"title":"Dosages des st\u00e9ro\u00efdes par spectrom\u00e9trie de masse","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25582724","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dufour-Rainfray D, Moal V, Cloix L, Mathieu E, Gauchez AS, Brossaud J, Corcuff JB, Fraissinet F, Collet C, Boux de Casson F, Guilloteau D, Emond P, Reynier P, Groupe de Biologie Sp\u00e9cialis\u00e9e de la SFMN : Agin A, Bach K, Charri\u00e9 A, Chikh K, Desb\u00e8ne C, Dousset B, Georges A, Guenet D, Lacroix I, Lamy PJ, Leban M, Leloupp AG, Massart C, Masson D, Moineau MP, Piketty M, Reix N, Sault C, Schlageter MH, Tse C. \nAnn Biol Clin 2015 ; 73:70-8"},{"title":"Down syndrome maternal serum markers in oocyte donation and other assisted reproductive technologies","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28921586","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Bonnin A, Muller F, Senat MV, Sault C, Galland A, Taieb J, Dreux S, Bouyer J, Benachi A\nPrenat Diagn 2017 ; 37:1155-1159"},{"title":"Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I\/501Y.V1 (B.1.1.7, variant of concern 202012\/01) in France","media_link":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2021.26.9.2100133","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Alexandre Gaymard, Paolo Bosetti, Adeline Feri, Gregory Destras, Vincent Enouf, Alessio Andronico, Sonia Burrel, Sylvie Behillil, Claire Sauvage, Antonin Bal, Florence Morfin, Sylvie Van Der Werf, Laurence Josset, ANRS MIE AC43 COVID-198, French viro COVID group (including Catherine Coignard), Fran\u00e7ois Blanquart, Bruno Coignard, Simon Cauchemez, Bruno Lina\nEurosurveillance 04\/03\/2021 - Volume 26, Issue 9"},{"title":"\u00c9mergence de la leptospirose humaine en France m\u00e9tropolitaine ? Actualit\u00e9s sur la surveillance","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bourhy P, Picardeau M, Septfons A, Trombert S, Cart-Tanneur E\nMed Mal Infect 2017 ; 47 (4s):s150"},{"title":"Evaluation de l\u2019automate Neo\u00ae (Immucor) pour l\u2019immuno-h\u00e9matologie \u00e9rythrocytaire","media_link":"","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
Rabut E, Ahmetkadic D, Malataverne J, Le Flem L Spectra Biologie 2016 ; 223:45-54<\/p>\n"},{"title":"\u00c9valuation de la valeur seuil la plus co\u00fbt-efficace des marqueurs s\u00e9riques du 1er\u00a0trimestre pour l\u2019emploi du test d\u2019ADN circulant dans le d\u00e9pistage de la trisomie\u00a021\u00a0: une analyse m\u00e9dico-\u00e9conomique","media_link":"https:\/\/www.jle.com\/fr\/revues\/abc\/e-docs\/cost_effectiveness_threshold_of_first_trimester_down_syndrome_maternal_serum_screening_for_the_use_of_cell_free_dna_as_a_second_tier_screening_test_320573\/article.phtml","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Marie Blanquet, Sophie Dreux, St\u00e9phanie L\u00e9ger,\u00a0Corinne Sault,\u00a0Charline Mourgues, H\u00e9l\u00e8ne Laurichesse, Didier L\u00e9mery, Fran\u00e7oise Vendittelli, Anne Debost-Legrand, Fran\u00e7oise Muller\nAnnales de Biologie Clinique Volume 79, num\u00e9ro 4, Juillet-Ao\u00fbt 2021"},{"title":"Evaluation of the performance of a new automated HIV combination assay","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29020658","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Ghisetti V, Coignard C, Allice T, Ly TD\nJ Clin Virol 2017 ; 96:80-83"},{"title":"Evaluation of the SLOMYCO Sensititre\u00ae panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27150659","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Chazel M, Marchandin H, Keck N, Terru D, Carri\u00e8re C, Ponsoda M, Jacomo V, Panteix G, Bouzinbi N, Ba\u00f1uls AL, Choisy M, Solassol J, Aubry, Godreuil S\nAnn Clin Microbiol Antimicrob 2016 ; 15:30"},{"title":"Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities","media_link":"http:\/\/www.bloodjournal.org\/content\/132\/Suppl_1\/943?sso-checked=true","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"On Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group\nElise Chapiro, Elodie Pramil, M\u2019boyba Diop, Damien Roos-Weil, Cl\u00e9mentine Dillard, Cl\u00e9mentine Gabillaud, Karim Maloum, Catherine Settegrana, Lucile Baseggio, Jean-Fran\u00e7ois Lesesve, M\u00e9lanie Yon, Ludovic Jondreville, Claude Lesty, Fr\u00e9d\u00e9ric Davi, Magali Le Garff-Tavernier, Nathalie Droin, Philippe Dessen, Caroline Algrin, V\u00e9ronique Leblond, Jean Gabarre, Simon Bouzy, Virginie Eclache, Baptiste Gaillard, Evelyne Callet-Bauchu, Marc Muller, Christine Lefebvre, Nathalie Nadal, Antoine Ittel, St\u00e9phanie Struski, Marie-Agn\u00e8s Collonge-Rame, Benoit Quilichini, Sandra Fert-Ferrer, Nathalie Auger, Isabelle Radford-Weiss, Lena Wagner, Sebastian Scheinost, Thorsten Zenz, Santos A. Susin, Olivier A. Bernard, Florence Nguyen-Khac\nBlood 2018 132:943; doi:"},{"title":"Identification of a polygalacturonase (Cup s 2) as the major CCD-bearing allergen in Cupressus sempervirens pollen","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28439939","date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Shahali Y, Sutra JP, Hilger C, Swiontek K, Haddad I, Vinh J, Guilloux L, Charpin D, S\u00e9n\u00e9chal H, Poncet\nAllergy 2017 ; doi: 10.1111\/all.13191"},{"title":"Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. \u2013 Trends over 10 years","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26518058","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bailly S, Maubon D,\u00a0Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF\nJ Infect\u00a02015 ; Oct 28. pii: S0163-4453(15)00342-4. doi: 10.1016\/j.jinf.2015.09.041"},{"title":"Impact of Including or Removing Nuchal Translucency Measurement on the Detection and False-Positive Rates of First-Trimester Down Syndrome Screening","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26656919","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Spaggiari E, Czerkiewicz I, Sault C, Dreux S, Galland A, Salomon LJ, Ville Y, Muller F\nFetal Diagn Ther 2015 ; Dec 12"},{"title":"Int\u00e9r\u00eat du s\u00e9quen\u00e7age haut d\u00e9bit dans les h\u00e9mopathies my\u00e9lo\u00efdes chroniques : quelles actualit\u00e9s en 2022 ?","media_link":"","date":"01\/09\/2022","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
B. Quilichini Journal de Biologie M\u00e9dicale \/ Volume 11-Num\u00e9ro 42 \/ Juil-Sept 2022<\/p>\n"},{"title":"Interf\u00e9rences s\u00e9rologiques du traitement du my\u00e9lome multiple par daratumumab (anti-CD38) : \u00e0 propos d\u2019un cas","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28540859","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Rabut E, Castro-Fernandez A, Le Gall V, Meknache\nAnn Biol Clin 2017 ; 75:351-355"},{"title":"Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31379011","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Penther D, Etancelin P, Lusina D, Bidet A, Quilichini B, Gaillard B, Rafdord-Weiss I, Mozziconacci MJ, Ittel A, Roche-Lestienne C, Barin C, Soler G, Daudignon A, Nadal N, Chapiro E, Lefebvre C, Godon C, Nadeau G, Mugneret F, Richebourg S, Viailly PJ, Ferret Y, Nguyen-Khac F, Eclache V; Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique\nAm J Hematol 2019 Aug 4. doi: 10.1002\/ajh.25601."},{"title":"Large outbreak of urogenital schistosomiasis acquired in Southern Corsica: monitoring the early signs of the endemicization?","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28669843","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"No\u00ebl H, Ruello M, Maccary A, Pellat C, Sommen C, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Durand J, Ramalli L, Chiappini JD , Malfait P, Berry\nClin Microbiol Infect 2017 ; pii: S1198-743X(17)30350-6. doi: 10.1016\/j.cmi"},{"title":"Les niveaux de preuve des biomarqueurs utilis\u00e9s pour la d\u00e9tection pr\u00e9coce des cancers de la prostate","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27029727","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Lamy PJ, Gauchez AS, Salomon L et al et le Groupe de biologie de la prostate : Sault C et al\nAnn Biol Clin 2016 ; 74:227-232"},{"title":"Marqueurs de d\u00e9pistage et de pr\u00e9diction de la pr\u00e9-\u00e9clampsie : place de la biologie","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Sault C\nJ Biol Med 2017 ; 6:186-190"},{"title":"Non-invasive prenatal testing: what are we missing?\u00a0","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32119166","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fries N, Le Garrec S, Egloff M, Sault C, Dreux S, Mangione R, Salomon LJ, Ville Y. \nUltrasound Obstet Gynecol. Mars 2020 - 2. doi: 10.1002\/uog.22005."},{"title":"Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28189936","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Thibault V, Servant-Delmas A, Ly TD, Roque-Afonso AM, Laperche S\nJ Clin Virol 2017 ; 89:14-21"},{"title":"Persistence of Zika virus in gradient sperm preparation","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29510270","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Cassuto NG, Marras G, Jacomo V, Bouret D\nJ Gynecol Obstet Hum Reprod 2018, pii: S2468-7847(18)30038-2"},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Emile C, Sault C\nSpectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49."},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"12\/12\/2022","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Emile C, Sault C<\/strong>. Spectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49.<\/p>\n"},{"title":"Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Potential+value+of+placental+angiogenic+factors+as+biomarkers+in+preeclampsia+for+clinical+physicians","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Boulanger H, Lef\u00e8vre G, Ahriz Saksi S, Achiche J, Bailleul S, Ekoukou D, Drouin D, Sault C, Stawiarski N, Dupuis E.\nNephrol Ther. 2019 Mar 29"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0755498219304178?via%3Dihub","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Hamdi SM, Sault C, Piver E, Genoux A, Masson D, Guibourdenche J.\nPresse Med . 2019 Oct 29. pii: S0755-4982(19)30417-8. doi: 10.1016\/j.lpm.2019.09.029. PMID:31676218"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/doi.org\/10.1016\/j.lpm.2019.09.029","date":"12\/12\/2019","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Hamdi SM, Sault C<\/strong>, Piver E, Genoux A, Masson D, Guibourdenche J. Presse Med. (2019)<\/p>\n"},{"title":"Preliminary report of an autochthonous Chikungunya outbreak in France, July to September 2017","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29019313","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Calba C, Guerbois-Galla M, Franke F, Jeannin C, Auzet-Caillaud M, Grard G, Pigaglio L, Decoppet A, Weicherding J, Savaill MC, Munoz-Riviero M, Chaud P, Cadiou B, Ramalli L, Fournier P, Noel H, De Lamballerie X, Paty MC, Leparc-Goffart I\nEuro Surveill 2017 ; 22(39):pii=17-00647"},{"title":"Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance","media_link":"https:\/\/www.nature.com\/articles\/s41467-021-23233-6","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"St\u00e9phane Le Vu,\u00a0Gabrielle Jones,\u00a0Fran\u00e7ois Anna,\u00a0Thierry Rose,\u00a0Jean-Baptiste Richard,\u00a0Sibylle Bernard-Stoecklin,\u00a0Sophie Goyard,\u00a0Caroline Demeret,\u00a0Olivier Helynck,\u00a0Nicolas Escriou,\u00a0Marion Gransagne,\u00a0St\u00e9phane Petres,\u00a0Corinne Robin,\u00a0Virgile Monnet,\u00a0Louise Perrin de Facci,\u00a0Marie-Noelle Ungeheuer,\u00a0Lucie L\u00e9on,\u00a0Yvonnick Guillois,\u00a0Laurent Filleul,\u00a0Pierre Charneau,\u00a0Daniel L\u00e9vy-Bruhl,\u00a0Sylvie van der Werf\u00a0&\u00a0Harold Noel\u00a0\nNature Communications volume 21\/05\/2021 12, Article number: 3025 (2021)"},{"title":"Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/30789329\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Tatai C, Berland JL, Claude JB, Westeel E, Hodille E, Fredenucci I, Rasigade JP, Ponsoda M, Jacomo V, Vach\u00e9e A, Gaudart A, Gaillard JL, Roux AL, Ader F, Tararbit K, Terpant G, Bryant JE, Lina G, Dumitrescu O; Lyon TB Study Group.Genestet C, et al.\nEmerg Infect Dis. 2019 Mar;25(3):589-592. doi: 10.3201\/eid2503.181124 - PMID: 30789329"},{"title":"R\u00e9activit\u00e9 crois\u00e9e in silico, in vitro, in vivo","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Guilloux L, Ricard-Blum S\nAllergies alimentaires 2017 ; chapitre 7.5:97-102"},{"title":"Recherche et identification des anticorps antinucl\u00e9aires : analyse du questionnaire europ\u00e9en de l\u2019EASI groupe et confrontation des pratiques fran\u00e7aises aux recommandations internationales","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29623889","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Musset L, Fabien N, Chyderiotis G, Olsson NO, Pham BN, Durey Dragon MA\nAnn Biol Clin 2018, 76 :185-195"},{"title":"Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission.","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31806715\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Paret R, Pichat C, Berland JL, Jacomo V, Carret G, Fredenucci I, Hodille E, Rasigade JP, Boisset S, Carricajo A, Lina G, Ronnaux-Baron AS, Mornex JF, Grando J, S\u00e9n\u00e9chal A, Ader F, Dumitrescu O; Lyon TB study group.Genestet C, et al.\nEur Respir J. 2020 Mar 20;55(3):1901888. doi: 10.1183\/13993003.01888-2019. Print 2020 Mar"},{"title":"Schistosomose en Corse : chronique d\u2019une histoire annonc\u00e9e","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Berry A, Iriart X, Boissier J, Chyd\u00e9riotis G, Debruyne M, Magnaval JF, Fillaux J, Grech-Angelini S, Barr\u00e9-Cardi H, Termignon JL, Macarry A, Noel H\nLa Lettre de l'Infectiologue 2016 ; XXXI n\u00b02:60-64"},{"title":"Screening and identification of antinuclear antibodies (ANA): analysis of the European EASI survey and confrontation of the French routine practice to the international recommandations","media_link":null,"date":null,"media_type":"document","profils":"579,575,574,","document_type":"publication","content":"Musset L, Fabien N, Chyd\u00e9riotis G, Olsson NO, Pham BN, Dragon-Durey MA\nAnn Biol Clin 2017 ;"},{"title":"Surveillance des infections humaines par hantavirus en France m\u00e9tropolitaine, 2012-2016","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Reynes JM, Carli D, Renaudin B, Fizet A, Bour JB, Brodard V, Cart-Tanneur E, Dewilde A, El Hamri M, Fleury H, Hecquet D, Jeulin H, Lechat S, Lemarquand-Bardini M, Lepiller Q, Poveda JD, Raulin O, Twizeyimana E, Van Cauteren D, Velay A, Septfons A, Baize S\nBEH 2017 ; 23:492-499"},{"title":"Surveillance du chikungunya et de la dengue en France m\u00e9tropolitaine, 2014","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resume_Septfons-A_2016_330-70-77.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Septfons A, No\u00ebl H, Leparc-Goffart I, Giron S, Delisle E, Chappert JL, Catelinois O, Franke F, Servas V, Guinard A, Debruyne M, Schaal O, Brichler S, Ninove L, Prat C, Flusin O, Poujol I, Letort MJ, Deniau J, Six C, Rousseau C, De Valk H, Paty MC\nLes Feuillets de Biologie 2016 ; 330:70-77"},{"title":"Surveillance du chikungunya, de la dengue et des infections \u00e0 virus Zika en France m\u00e9tropolitaine, 2017","media_link":"http:\/\/invs.santepubliquefrance.fr\/beh\/2018\/24\/pdf\/2018_24_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fournet N, Franke F, Chaud P, Raguenaud ME, Calba C, Septfons A, Cart-Tanneur E. et al.\nBull Epid\u00e9miol Hebd. 2018;(24):494-503."},{"title":"Testing anti-neutrophil cytoplasmic antibodies (ANCA): analysis of the European EASI survey on the daily practice of the French laboratories","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28958962","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dragon-Durey MA, Fabien N, Chyd\u00e9riotis G, Musset L, Pham BN, Olsson N\nAnn Biol Clin 2017 ; 75:531-541"},{"title":"The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)","media_link":"","date":"06\/09\/2022","media_type":"document","profils":"579,575,574,","document_type":"publication","content":"\n
Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nab\u00e9ra C, Chapiro E, Collonge-Rame MA, Cuccuini W, Douet-Guilbert N, Eclache V, Luquet I, Michaux L, Nadal N, Penther D, Quilichini B<\/strong>, Terre C, Lefebvre C, Troadec MB, V\u00e9ron\u00e8se L. Leukemia. 2022 Jun;36(6):1451-1466. doi: 10.1038\/s41375-022-01561-w. Epub 2022 Apr 16.PMID: 35430613 Review.<\/p>\n"},{"title":"The impact of introducing combined first-trimester trisomy 21 screening in the French population","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26628633","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Eur J Public Health 2015 ; Nov 30"},{"title":"The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34284044\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Maxime Espi, Xavier Charmetant, Thomas Barba, Laetitia Koppe, Caroline Pelletier, Emilie Kalbacher, Elodie Chalencon, Virginie Mathias, Anne Ovize, Emmanuelle Cart-Tanneur, Christine Bouz, Laurence Pellegrina, Emmanuel Morelon, Denis Fouque, Laurent Juillard, Olivier Thaunat\nKidney International 2021 Oct;100(4):928-936. doi: 10.1016\/j.kint.2021.07.005."},{"title":"Thrombop\u00e9nie induite par l\u2019h\u00e9parine (TIH) : \u00e0 propos d\u2019un casLe Flem L, Emile C","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Le Flem L, Emile C, Spectra Biologie 2016 ; 220:49-50<\/p>\n"},{"title":"Une interf\u00e9rence dans le dosage de l\u2019insuline r\u00e9v\u00e8le un syndrome auto-immun anti-insuline","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27492703","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Lamy PJ, Sault C, Renard E\nAnn Biol Clin 2016 ; 74:490-494"},{"title":"Vector-borne Transmission of Zika Virus in Europe, Southern France, August 2019","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31718742\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Sandra Giron, Florian Franke, Anne Decoppet, Bernard Cadiou, Thierry Travaglini, Laurence Thirion, Guillaume Durand, Charles Jeannin, Gr\u00e9gory L\u2019Ambert, Gilda Grard, Harold No\u00ebl, Nelly Fournet, Michelle Auzet-Caillaud, Christine Zandotti, Samer Abouka\u00efs, Pascal Chaud, Saby Guedj, Lakri Hamouda, Xavier Naudot, Anne Ovize, Cl\u00e9ment Lazarus, Henriette de Valk, Marie-Claire Paty, Isabelle Leparc-Goffart\nEuro Surveill. 2019 Nov;24(45):1900655."},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Faux-positif-ADNlcT21_L-Druart_012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Faux positif d\u2019ADNlcT21 avec diff\u00e9rentes anomalies chromosomiques confin\u00e9es au placenta\nL Druart, H Dessuant, JF Taly, M Nouchy, L Raymond, S Tapia"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Developpement-panel-15-marqueurs_F.-Rousseau-et-al.-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9veloppement d\u2019un panel de 15 marqueurs pour une identitovigilance\ndes \u00e9chantillons analys\u00e9s par s\u00e9quen\u00e7age haut d\u00e9bit ou sur puces \u00e0 SNP\nF Rousseau, J-F Taly, C Ploton Nicollet, M Taoudi, A Perdriau, L Raymond"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20359-Assises-de-Genetique-2020_B-Quilichini_012020.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Mise en place d\u2019un panel de g\u00e8nes cibl\u00e9s pour les h\u00e9mopathies\nmalignes (NMP-LMMC-SMD-LAM) par NGS : Enjeux M\u00e9dical \/ Scientifique et d\u2019Assurance Qualit\u00e9.\nV Geromel, E Fayolle, P Mouty, R Moulin, N Batail, M-H Felix, B Adde, S Mouty, L Raymond, B Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20362-Assises-de-Gntique-2020_B_Quilichini-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Impact diagnostique, pronostique et th\u00e9ranostique d\u2019un panel de g\u00e8nes\n\u00ab H\u00e9mopathies My\u00e9lo\u00efdes \u00bb r\u00e9alis\u00e9 par NGS : l\u2019exp\u00e9rience du laboratoire Eurofins Biomnis en 2019.\nV. Geromel, P. Mouty, C. Chal, J . Delaunay, S. Sadot-Lebouvier, R. Kaphan, J. Vigvari, J.P. Coadic, E.A. Marin La Meslee, O. Roualdes, C. Bourdin, A. Petit, M. Roumigui\u00e8res, L. Raymond, B.Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 4","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Les_assises_2020_RadoslavaSARAEVA_LAMRI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"21-24 janvier 2020, Tours\nDiagnostics g\u00e9n\u00e9tiques multiples (double hits) par s\u00e9quen\u00e7age Whole Exome (WES) : \u00e0 propos de deux cas.\nR. SARAEVA-LAMRI, A. DORELLE, V. GEROMEL, A. S. LEBRE, P. MOUTY, M. E. NAUD BARREYRE, F. ROUSSEAU, M. TAOUDI, L. MESNARD, L. RAYMOND"},{"title":"10th International Congress on Autoimmunity, Leipzig, April 6-10, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_4.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Should Dense Fine Speckled 70 (DFS70) pattern be reported? Biomnis reference lab experience on 12 619 ANA screening consecutive sera\nGuis L, Ebel A, Leroy J, Michaud S, Pomaredes A, Marcenaro C, Chalouas L"},{"title":"12\u00e8me CFA, Paris, avril 25-28, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":""},{"title":"12\u00e8me Congr\u00e8s de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Paris, mars 22-23, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Jacomo_3.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Les Liquides C\u00e9phalo-Rachidiens : conservation pr\u00e9-analytique \u00e0+ 4 \u00b0C ou \u2013 20 \u00b0C ?\nJacomo V, Schaal O, Fournier P"},{"title":"17\u00e8mes Journ\u00e9es Francophones de Virologie, Paris, avril 9, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"R\u00e9solution des \u00e9checs de g\u00e9notypage de la technique Abbott RealTime HCV Genotype II par un test temps r\u00e9el additionnel\nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ly_8.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of a new high sensitive, qualitative and quantitative Hepatitis B surface antigen assay\nLy TD, Coignard C"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Characterization of samples with genotype 1 without subtype results by Abbott RealTime HCV genotype II using the new Abbott HCV Genotype Plus RUO test \nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"19th Annual Meeting of the European Society for Clinical Virology (ESCV), Lisbon, september, 14\u201317, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/09\/Biomnis_Poster_2016_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to COBAS\u00ae AmpliPrep\/OBAS\u00ae TaqMan\u00ae HIV-1 and HBV tests\nEbel A, Bali C, Guis L, Merlin S"},{"title":"20\u00e8mes Journ\u00e9es de M\u00e9decine Foetale, Morzine, mars 26-28, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015__Becker_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Int\u00e9r\u00eat du D\u00e9pistage Pr\u00e9natal Non Invasif dans le diagnostic des aneuplo\u00efdies 13, 18 et 21 \nBecker M, Eg\u00e9a G, Taoud M, Ahmed Chaouch D, El Mouatassim S"},{"title":"20Th Congress European Hematology Association, Vienna, June 11-14, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Rigollet_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Characterization of normal and pathological lymphoid populations: validation of a 10-colors flow cytometry protocol for routine diagnosis \nRigollet L, Stagnara J, Milhau A, Pellegrina L"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/10\/Biomnis_Poster-Aptima-HIV-1-HBV_Ebel_Sept18.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV-1 Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to Cobas\u00ae 6800\/8800 HIV-1 and HBV tests\nA. Ebel, C. Bali, L. Guis, S. Merlin"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/11\/Poster-IgM-Measles-ESCV-TD-LY-.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of new IgM Measles assay\nT.D. Ly, C. Coignard"},{"title":"24e Journ\u00e9es de m\u00e9decine f\u0153tale, Marseille, 4-5-6 avril 2019","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9pistage de la trisomie 21 par analyse de l\u2019ADN f\u0153tal libre circulant dans le sang maternel : Application dans le cas des grossesses g\u00e9mellaires\nMarc NOUCHY, Nicolas CHATRON, Pascal MOUTY, Francis ROUSSEAU, Barbara ADD\u00c9, Mohamed Taoudi, Caroline DUMONT, Jean-Fran\u00e7ois TALY, Luc DRUART, Sylvie TAPIA, Damien SANLAVILLE, Laure RAYMOND"},{"title":"25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, April 25-28, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of three fully automated assays for the detection of cytomegalovirus IgM and IgG: DiaSorin LIAISON\u00ae XL, Abbott Architect \u00ae and Roche Cobas 6000\u00ae\nBouthry E, Ly TD, Vauloup-Fellous C"},{"title":"27th ECCMID, Vienna Austria, April 22-25, 2017","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Strain-specific estimation of epidemic success provides insights into the transmission dynamics of tuberculosis Rasigade\nJP, Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, P\u00e9rouse de Montclos M, Flandrois JP, Ader F, Supply P, Lina G, Wirth T"},{"title":"29th IUSTI European Conference on Sexually Transmitted Infections, Sitges (Barcelona), 24-26 September, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Prevalence of Mycoplasma genitalium in France and comparison with Chlamydia trachomatis and Neisseria gonorrhoeae as determined by the Mycoplasma genitalium TMA assay \nEbel A, Venard C, Brunengo D, Merlin S"},{"title":"31st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbon, June 14-17, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Force_7.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Blastocysts vitrification during 2 consecutive years: before and after its start significant delivery rate increase within the 1st year \nForce A, Nicollet B, Chomier M, Sergeant P, Lescaille M, Rochigneux S, Robert F, Ginon J, Sergeant MV, Baucher S, Schubert B"},{"title":"35e congr\u00e8s de la SFH, CNIT Paris la D\u00e9fense, avril 1-3, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Becker_4.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"La SNP array : un outil compl\u00e9mentaire pour la caract\u00e9risation des h\u00e9mopathies malignes \nBecker M, Eg\u00e9a G, Camilli K, Robin M, Roumigui\u00e8res M, Rigollet L, Stagnara J, El Mouatassim S"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_14.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Evaluation du nouveau test LAISON\u00ae H. pylori IgG\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_15.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Borr\u00e9liose et index de synth\u00e8se intrath\u00e9cale : bilan biologique r\u00e9trospectif de l\u2019ann\u00e9e 2015\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Ebel_16.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation des performances de la trousse Aptima\u00ae HBV Quant (Hologic)\nEbel A, Bali C, Guis L, Merlin S"},{"title":"37\u00e8me RICAI, Paris, d\u00e9cembre 18-19, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/12\/Biomnis_Poster_2017_Coignard_13.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Confirmation VIH : donn\u00e9es biologiques et \u00e9pid\u00e9miologiques des 3 derni\u00e8res ann\u00e9es dans un laboratoire de biologie sp\u00e9cialis\u00e9e\nCoignard C, Ly TD"},{"title":"38e RICAI, Paris 17-18 d\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-COIGNARD-ROUGEOLE.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Epid\u00e9mie de rougeole 2018 : le s\u00e9rodiagnostic un marqueur simple et performant.\nT.D. Ly, C. Coignard"},{"title":"3e Journ\u00e9e Francophone de Biologie M\u00e9dicale, Monaco, 6-7-8 novembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/11\/1911_poster_A.Ebel_JFBM.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"D\u00e9pistage syst\u00e9matique de Neisseria gonorrhoeae et de C. trachomatis par test d\u2019amplification g\u00e9nique : bilan d\u2019une ann\u00e9e d\u2019exp\u00e9rience\nL. Mine, L. Guis, S. Merlin, A. Ebel"},{"title":"40e RICAI \u2013 R\u00e9union Interdisciplinaire de Chimioth\u00e9rapie Anti-Infectieuse, 14-15 d\u00e9cembre","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Posters\/2012_Poster_SARS-CoV-2_RICAI_C.Coignard.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"S\u00e9rologie SARS-CoV-2 : \u00e9valuation, qualification et choix d\u2019une m\u00e9thode\nCatherine Coignard, Anne EBEL, Yanis BOUAMRA, Didier RIDEY, Carla MARCENARO"},{"title":"42es Journ\u00e9es Nationales \u2013 Congr\u00e8s CNGOF, Strasbourg, 4-7 D\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-EMILE-DPNI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"\u00c9tude de l\u2019usage du DPNI (d\u00e9pistage pr\u00e9natal non invasif) des aneuplo\u00efdies en milieu lib\u00e9ral\nC. Emile, L. Raymond, L. Pellegrina"},{"title":"45\u00e8me Colloque National des Biologistes des H\u00f4pitaux, Paris, juin 22-24, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/06\/Biomnis_Poster_2016-Rabut_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Interf\u00e9rence du traitement par daratumumab (anti-CD38) dans le suivi biologique du my\u00e9lome multiple et dans la recherche d\u2019anticorps anti-\u00e9rythrocytaires : \u00e0 propos d\u2019un cas\nRabut E, Castro-Fernandez A, Le Gall V, Meknache N"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Raymond_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport diagnostique de l\u2019utilisation des puces SNP dans l\u2019\u00e9tude chromosomique des morts f\u0153tales\nRaymond L, Dherbey JL, Rebeyrat-Pichon I, El-Mouatassim S, Egea G"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier, 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_11.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Cas rare d\u2019X-fragile pr\u00e9natal avec r\u00e9traction d\u2019expansion de triplet CGG ? \nMouty P, Raymond L, El Mouatassim S, Liquier A, Druart L, Paris A, Dorian V, Pichon I, Dherbey JL, Eg\u00e9a G"},{"title":"CGRF Ile de R\u00e9, septembre 28-29, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Brunengo_11.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Epid\u00e9miologie qualitative des variants rares de l\u2019H\u00e9moglobine en France m\u00e9tropolitaine au travers de la collaboration HCL \u2013 Eurofins Biomnis\nBrunengo D, Veyrenche N, Louis Chillotti L, Le Flem L"},{"title":"COGEN, Paris, Septembre 25-27, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_El-Mouatassim_11.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"French experience of Non-Invasive Prenatal Testing of trisomy 21, 18 and 13 \nEl Mouatassim S, Taoudi M, Eg\u00e9a G"},{"title":"Congr\u00e8s SFP \/ SFMM, Toulouse, mars 29-31, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/03\/Biomnis_Poster_2017_Chydriotis_1-1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport de 2 tests de d\u00e9pistage pour le diagnostic de la bilharziose et place du Western blot\nChyd\u00e9riotis G, Cart-Tanneur E, Lecuelle C, F\u00e9lix MH"},{"title":"Congr\u00e8s SFTA, Avignon, mai 10-12, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_Petit_2.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Dosage de la Ciclosporine, Tacrolimus, Ev\u00e9rolimus et Sirolimus en LCMSMS avec le coffret MassTox Chromsystems sur Api 4500 ABSciex avec pr\u00e9paration automatis\u00e9e sur T\u00e9can EVO 150\nPetit I, Moussa C, Bonnet K, Bezol A. Havrez S, Gerrier P"},{"title":"EAACI, Helsinki, June 17-21, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_6.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Bp14, an allergen from cupressus sempervirens pollen related to the family of snakin\/gibberellin-regulated proteins\nS\u00e9n\u00e9chal H, Santrucek J, Melcova M, Svoboda P, Zidkova J, Guilloux L, Aizawa T, Couderc R, Charpin D, Poncet P"},{"title":"ESCAIDE 2015, Stockholm, November 11-13, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Chyderiotis_14.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Re-emergence of urinary schistosomiasis in Europe ? Infections acquired in Southern Corsica \u2013 Investigation of a cluster of Schistosoma haematobium infections in 2014\nRamalli L, No\u00ebl H, Ruello M, Maccary A, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Denoyel GA, Succo T, Armengaud A, Paty MC, Heuz\u00e9 G, Mattei J, Th\u00e9ron A, Berry A"},{"title":"ESCV, Stresa, Lake Maggiore, September 13-16, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/10\/Biomnis_Poster_2017_LY_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new chemiluminescent assay to detect and quantify anti-HBs antibodies\nMaillard A, Ly TD, Thibault V"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_LY_3.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new LIAISON\u00ae H. pylori IgG\nLy TD, Coignard C"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Rabut_4.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Red blood cell antibody assays in DARA-treated patients\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"EuroMedLab, Paris, June 22-24, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Early Performance Evaluation of cobas\u00ae HBV, cobas\u00ae HCV and cobas\u00ae HIV-1Quantitative Nucleic Acid Tests for use on the new cobas\u00ae 6800\/8800 Systems\nEbel A, Merlin S, Marins ED G, Canchola J, Njoya M, Simon CO"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/poster-FFER-2018-callec.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Impact de la chirurgie bariatrique sur les param\u00e8tres spermatiques : Revue de la litt\u00e9rature\nR. Callec, B. Schubert, F. Robert, A. Force"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/POSTER-FFER-2018-Force.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Crit\u00e8res d\u2019interpr\u00e9tation du msome pour une optimisation de la prise en charge des patients\nA. Force, M. Chomier, P. Sergeant, J. Ginon, S. Rochigneux, M. Lechatton, M. Pont, R. Callec, F. Robert, B. Schubert"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Lopez.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation externe de la qualit\u00e9 en spermiologie : un nouveau programme pour une \u00e9valuation globale de l\u2019examen\nMarie LOPEZ, Bernard POGGI, Jean Christophe EYNARD, Marie LETY, Benoit SCHUBERT, Andr\u00e9 FORCE"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Schubert.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Influence des conditions de culture sur les r\u00e9sultats en AMP dans une \u00e9tude multicentrique : comparaison d\u2019un incubateur Time Lapse avec les incubateurs tradictionnels\nBeno\u00eet SCHUBERT, Alexandre MARCILLY, Andr\u00e9 FORCE"},{"title":"FFER, Tours, septembre 13-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Force_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Comparaison de la performance de 2 incubateurs (Geri versus Planer) apr\u00e8s randomisation de la cohorte ovocytaire pour chaque patiente\nForce A, Martine Chomier, Philippe Sergeant, Jacqueline Ginon, St\u00e9phanie Rochigneux, Soizic Baucher, M\u00e9lanie Le Chatton, M\u00e9lanie Pont, Beno\u00eet Schubert"},{"title":"FIBA 2016, Dakar, January 13-14, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"ANCA associated HIV infection in Senegal: a serological trap\nArouna O, Niang A, Abiola A, Guis L, Le Flem L, Diene JF, Mboup S"},{"title":"Fort Collins (USA), May 31-June 3, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/05\/Biomnis_Poster_2016_Jacomo_5.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Seoul Virus Infection in Human, France, 2014-2016\nReynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, Nussbaumer T, Jacomo V, Rapt MP, Septfons A, Rollin PE"},{"title":"ISMA, Lisbon, November 19-21, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2015_Guilloux_16.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Ige-cross-reactivity between european hymenoptera and asian hornet (vespa velutina) venom allergens\nLong\u00e9 C, Brazdova A, Brunet JL, Schwartz C, Girodet B, Lavaud F, Birnbaum J, Pham-Thi N, Duchateau M, Chamot-Rooke J, Guilloux L, Selva MA, Couderc R, S\u00e9n\u00e9chal H, Sutra JP, Poncet P"},{"title":"Journ\u00e9es Nationales CNGOF, Montpellier, d\u00e9cembre 7-9, 2016","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Etude pr\u00e9liminaire sur le d\u00e9pistage de la pr\u00e9-\u00e9clampsie au 1er trimestre de la grossesse (Predictor\u00ae)\nWalder R, Galland A, Sault C, Huissoud C"},{"title":"Journ\u00e9es Nationales d\u2019Infectiologie, Nantes, 13-15 juin, 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/05\/Biomnis_Poster_2018_Ebel_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Infections \u00e0 Chlamydia trachomatis : donn\u00e9es \u00e9pid\u00e9miologiques r\u00e9centes dans un laboratoire sp\u00e9cialis\u00e9\nEbel A, Guis L, Merlin S"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Poster-Lyme-RICAI-C.-Coignard-TD-Ly-dec-2019-800x1200.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of the BioPlex 2200 Lyme IgG\/IgM immunoassay system\nC. Coignard, C. Cl\u00e9ment-Vincent, Td. Ly, A. L\u2019hotellier"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/12\/2019-12-17_RICAI.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Sp\u00e9cificit\u00e9 de la s\u00e9rologie chikungunya et surveillance \u00e9pid\u00e9miologique\nC. Calba, F. Franke, E. Brottet, G. Terpant, N. Fournet, A. Ovize, J.D. Poveda, I. Leparc-Goffart, M.C. Paty"},{"title":"SFE, Bordeaux, octobre 5-8, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Sault_13.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Influence de la nature du liquide de rin\u00e7age d\u2019aiguille de cytoponction sur le dosage de la thyroglobuline\nBoux De Casson F, Moal V, Gauchez AS, Moineau MP, Sault C, Schlageter MH, Massart C"},{"title":"SFTS, Bordeaux, septembre 20-22, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Rabut_10.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Recherche et quantification de l\u2019h\u00e9morragie f\u0153to-maternelle par cytom\u00e9trie en flux avec double marquage anti-h\u00e9moglobine F et anti-anhydrase carbonique\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"XXIIIe Colloque ACLF, Montpellier, septembre 20-21, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Syndrome de Currarino atypique avec hexadactylie pr\u00e9-axiale : remaniement complexe en 7q36.3 en pr\u00e9natal\nLiquier A, Becker M, Raymond L, Bourgain A, Amat S, Broussin B, Andr\u00e9 G, Escande F, Nouchy M, Eg\u00e9a G"}]));
sessionStorage.setItem('currentLang', 'fr');render(html`<${RessourcesDynamiques} name="World" />`, document.getElementById('resdyncontainer'));
\n
Le test de d\u00e9pistage pr\u00e9natal sur simple prise de sang maternel<\/p>\n"},{"title":"D\u00e9termination pr\u00e9natale du g\u00e9notype RHD f\u0153tal \u00e0 partir du sang maternel (DS37HP)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS37-HP-Rhesus_D_foetal.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic des infections \u00e0 Mycobact\u00e9ries (DS1)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS1-Mycobacteries.pdf","date":"26\/10\/2022","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic et suivi des N\u00e9oplasies My\u00e9lo\u00efdes Chroniques (DS2)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS2-Neoplasies_myeloides_chroniques.pdf","date":"","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic, pronostic et suivi des Leuc\u00e9mies aigu\u00ebs (DS3)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS3-Leucemies_aigues.pdf","date":"","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic, pronostic et suivi des N\u00e9oplasies Lympho\u00efdes Matures (DS62)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS62-Neoplasies_lymphoides_matures.pdf","date":"","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Digestif- fiche oncologie (DS84)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS84-Onco-digestif.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Exploration g\u00e9n\u00e9tique des n\u00e9phropathies tubulo-interstitielles : challenge technique pour MUC1 ! (DS104)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS104-Nephropathies_MUC1.pdf","date":"032\/04\/2024","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Fibrometer - Scores de fibrose h\u00e9patique (DS46)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS46-Fibrometer.pdf","date":null,"media_type":"document","profils":"575,","document_type":"le-point-sur","content":""},{"title":"Gyn\u00e9cologie - fiche oncologie (DS85)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS84-Onco-digestif.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Juvenalis (JU-DS47)","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/11\/JU-DS47-Juvenalis.pdf","date":null,"media_type":"document","profils":"579,575,574,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux professionnels de sant\u00e9"},{"title":"Juvenalis (JU-DS48)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/JU-DS48-PA.pdf","date":null,"media_type":"document","profils":"575,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux patients"},{"title":"Le s\u00e9quen\u00e7age de l\u2019exome dans l\u2019insuffisance ovarienne pr\u00e9matur\u00e9e : Pour une orientation plus pr\u00e9cise et personnalis\u00e9e des patientes et couples (DS111)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS111-Exome_IOP.pdf","date":"03\/04\/2024","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Le s\u00e9quen\u00e7age de l\u2019exome en contexte pr\u00e9natal (DS108)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS108-Exome_prenatal.pdf","date":"07\/11\/2023","media_type":"document","profils":"575,","document_type":"le-point-sur","content":"\n
Pour un diagnostic optimis\u00e9 en cas de malformations foetales<\/p>\n"},{"title":"Le s\u00e9quen\u00e7age Whole Exome dans les maladies d\u2019origine g\u00e9n\u00e9tique (DS34)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS34-Exome.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Les autoanticorps dans le diagnostic et le suivi des maladies auto-immunes (DS4)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS4-Auto-immunite.pdf","date":"27\/04\/2022","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Les maladies transmises par les tiques (DS20)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS20-Maladies_tiques.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Leuc\u00e9mie Aigu\u00eb My\u00e9lo\u00efde (LAM) (DS68)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS68-LAM.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Leuc\u00e9mie my\u00e9lomonocytaire chronique (LMMC) (DS71)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS71-LMMC.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Microbiote intestinal (JU-DS73-PA)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/JU-DS73-PA-Microbiote.pdf","date":"","media_type":"document","profils":"575,576,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux patients"},{"title":"Microbiote intestinal (JU-DS76-PH)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/JU-DS76-HP-Microbiote.pdf","date":null,"media_type":"document","profils":"575,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux professionnels de sant\u00e9"},{"title":"N\u00e9oplasies My\u00e9loprolif\u00e9ratives Diagnostic (DS69)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS69-NMP_diagnostic.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Oncog\u00e9n\u00e9tique - Pr\u00e9dispositions h\u00e9r\u00e9ditaires aux cancers : Int\u00e9r\u00eat du s\u00e9quen\u00e7age de l'exome (DS94)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS94-Oncogenetique_exome.pdf","date":"18\/10\/2023","media_type":"document","profils":"575,","document_type":"le-point-sur","content":""},{"title":"Oncog\u00e9n\u00e9tique constitutionnelle : Utilisation du s\u00e9quen\u00e7age Long-ReadNanopore - l\u2019exemple du g\u00e8ne PMS2 (DS112) ","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS112-Sequencage_long_read_PMS2.pdf","date":"18\/10\/2023","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Panels de g\u00e8nes SPINK1, PRSS1, CTRC, CPA1, CFTR et CASR pour le diagnotsic des pancr\u00e9atites h\u00e9r\u00e9ditaires (DS82)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS82-HP-Pancreatites_hereditaires.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Papillomavirus humains et d\u00e9pistage primaire du cancer du col de l\u2019ut\u00e9rus (DS6)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS6-HPV.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Pneumologie - fiche oncologie (DS83)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS83-Onco-pneumologie.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Prise en charge de la pr\u00e9-\u00e9clampsie (DS18)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS18-Pre-eclampsie.pdf","date":"","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Prise en charge des tumeurs solides en Biopathologie (DS5)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS5-Tumeurs_solides.pdf","date":"","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"PROSIGNA\u00ae (PAM50) (DS79)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS79-HP-PAM50.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"Test d\u2019expression g\u00e9nique pronostique du cancer du sein"},{"title":"Syndromes My\u00e9lodysplasiques (SMD) (DS72)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS72-SMD.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Actualit\u00e9s sur la pr\u00e9-\u00e9clampsie et place de la biologie ","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"\n
Corinne SAULT Rev Med Gene Fam. 2018;2(7):194-8.<\/p>\n"},{"title":"Analyse immunoprot\u00e9omique des allerg\u00e8nes non-hydrosolubles de farines de quatre l\u00e9gumineuses : arachide, soja, s\u00e9same et lentille","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26635049","date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Bouakkadia H, Boutebba A, Haddad I, Vinh J, Guilloux L, Sutra JP, S\u00e9n\u00e9chal H, Poncet P\nAnn Biol Clin 2015 ; 73:690-704"},{"title":"Anticoagulant circulant (ACC) : \u00e0 propos de deux cas","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Le Flem L, Emile C\nSpectra Biologie 2016 ; 220:51-53"},{"title":"Automation of ALK gene rearrangement testing with fluorescence in situ hybridization (FISH): A feasibility study","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25576649","date":"","media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Zwaenepoel k, Merkle D, Cabillic F, Berg E, Belaud-Rotureau MA, Grazioli V, Herelle O, Hummel M, Le Calve M, Lenze D, Mende S, Pauwels P, Quilichini B, Repetti E\nExp Mol Pathol 2015 ; 98:113-118"},{"title":"Characterization of a de novo Supernumerary Neocentric Ring Chromosome Derived from Chromosome 7","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26669311","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Louvrier C, Egea G, Labalme A, Des Portes V, Gazzo S, Callet-Bauchu E, Till M, Sanlaville D, Edery P, Schluth-Bolard C\nCytogenet Genome Res 2015 ; Dec 16"},{"title":"Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays","media_link":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.639675\/full","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Geoffroy Poulet, Fanny Garlan, Sonia Garrigou, Eleonora Zonta, Leonor Benhaim, Marie-Jennifer Carrillon, Audrey Didelot, Delphine Le Corre, Claire Mulot, Philippe Nizard, Frederic Ginot, Audrey Boutonnet-Rodat, Helene Blons, Jean-Baptiste Bachet, Julien Ta\u00efeb, Aziz Zaanan, Vanna Geromel, Laurence Pellegrina, Pierre Laurent-Puig, Shu-Fang Wang-Renault and Valerie Taly\nFrontiers in Oncology 06\/05\/2021"},{"title":"Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26582834","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Mokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM\nJ Clin Microbiol 2016 ; 54:296-299"},{"title":"Chronic hepatitis E in absence of severe immune deficiency","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31327621\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Colson P, Schleinitz N, Vely F, Poveda JD,\u00a0Jacomo V, Demerle C, Borentain P, Gerolami R.Colson P, et al.\nClin Res Hepatol Gastroenterol. 2020 Feb;44(1):e1-e4. doi: 10.1016\/j.clinre.2019.06.015. \nEpub 2019 Jul 18 - PMID: 31327621"},{"title":"Combined Genotypic, Phylogenetic, and Epidemiologic Analyses of Mycobacterium tuberculosis Genetic Diversity in the Rh\u00f4ne Alpes Region, France","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27128522","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Pichat C, Couvin D, Carret G, Fr\u00e9d\u00e9nucci I, Jacomo V, Carricajo A, Boisset S, Dumitrescu O, Flandrois JP, LinaG, Rastogin N\nPlos One 2016"},{"title":"Comparative performance of three rapid HBsAg assays for detection of HBs diagnostic escape mutants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26378274","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Servant-Delmas A,\u00a0Ly TD, Hamon C, Kassim Houdah A, Laperche S\nJ Clin Microbiol 2015 ; 53:3954-3955"},{"title":"Computer-aided sperm analysis, the new key player in routine sperm assessment","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Schubert-Badiou-Force-2019.pdf","date":"","media_type":"document","profils":"579,574,575,","document_type":"publication","content":"\n
B. Schubert, M Badiou, A. Force First International Journal of Andrology \u2013 Andrologia 06\/2019 - DOI: 10.1111\/and.13417<\/p>\n"},{"title":"Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytog\u00e9n\u00e9tique h\u00e9matologique (GFCH)","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27707673","date":null,"media_type":"document","profils":"579,574,575,","document_type":"publication","content":"Daudignon A, Quilichini B, Ameye G, Poirel H, Bastard C, Terr\u00e9 C\nAnn Biol Clin 2016 ; 74:588-595"},{"title":"D\u00e9pistage combin\u00e9 de la trisomie 21 au premier trimestre : \u00e9valuation du sur-risque en cas de \u00df-hCG libre entre 5 et 10 MoM","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Th\u00e8se de M\u00e9decine, Universit\u00e9 Claude Bernar 1;2016,71p\nEtude r\u00e9alis\u00e9e avec les donn\u00e9es du laboratoire Biomnis\nLeport H"},{"title":"D\u00e9pistage multiparam\u00e9trique de la pr\u00e9-\u00e9clampsie au premier trimestre de grossesse : \u00e9tude pr\u00e9liminaire","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Th\u00e8se de m\u00e9decine, UCBL soutenue le 5 juillet 2016\nEtude r\u00e9alis\u00e9e \u00e0 partir des r\u00e9sultats du laboratoire Biomnis (Service T21 Lyon)\nWalder R"},{"title":"Dosage de la ciclosporine, du tacrolimus, de l\u2019\u00e9v\u00e9lorimus et du sirolimus en LC-MS\/MS","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2018_Petit_1-1.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Petit I, Bezol A, Ghacham S, Clavaud K, Havrez S, Moussa C, Emile C, Gerrier P\nSpectra Bio 2018, 234:61-66"},{"title":"Dosages des st\u00e9ro\u00efdes par spectrom\u00e9trie de masse","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25582724","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dufour-Rainfray D, Moal V, Cloix L, Mathieu E, Gauchez AS, Brossaud J, Corcuff JB, Fraissinet F, Collet C, Boux de Casson F, Guilloteau D, Emond P, Reynier P, Groupe de Biologie Sp\u00e9cialis\u00e9e de la SFMN : Agin A, Bach K, Charri\u00e9 A, Chikh K, Desb\u00e8ne C, Dousset B, Georges A, Guenet D, Lacroix I, Lamy PJ, Leban M, Leloupp AG, Massart C, Masson D, Moineau MP, Piketty M, Reix N, Sault C, Schlageter MH, Tse C. \nAnn Biol Clin 2015 ; 73:70-8"},{"title":"Down syndrome maternal serum markers in oocyte donation and other assisted reproductive technologies","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28921586","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Bonnin A, Muller F, Senat MV, Sault C, Galland A, Taieb J, Dreux S, Bouyer J, Benachi A\nPrenat Diagn 2017 ; 37:1155-1159"},{"title":"Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I\/501Y.V1 (B.1.1.7, variant of concern 202012\/01) in France","media_link":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2021.26.9.2100133","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Alexandre Gaymard, Paolo Bosetti, Adeline Feri, Gregory Destras, Vincent Enouf, Alessio Andronico, Sonia Burrel, Sylvie Behillil, Claire Sauvage, Antonin Bal, Florence Morfin, Sylvie Van Der Werf, Laurence Josset, ANRS MIE AC43 COVID-198, French viro COVID group (including Catherine Coignard), Fran\u00e7ois Blanquart, Bruno Coignard, Simon Cauchemez, Bruno Lina\nEurosurveillance 04\/03\/2021 - Volume 26, Issue 9"},{"title":"\u00c9mergence de la leptospirose humaine en France m\u00e9tropolitaine ? Actualit\u00e9s sur la surveillance","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bourhy P, Picardeau M, Septfons A, Trombert S, Cart-Tanneur E\nMed Mal Infect 2017 ; 47 (4s):s150"},{"title":"Evaluation de l\u2019automate Neo\u00ae (Immucor) pour l\u2019immuno-h\u00e9matologie \u00e9rythrocytaire","media_link":"","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
Rabut E, Ahmetkadic D, Malataverne J, Le Flem L Spectra Biologie 2016 ; 223:45-54<\/p>\n"},{"title":"\u00c9valuation de la valeur seuil la plus co\u00fbt-efficace des marqueurs s\u00e9riques du 1er\u00a0trimestre pour l\u2019emploi du test d\u2019ADN circulant dans le d\u00e9pistage de la trisomie\u00a021\u00a0: une analyse m\u00e9dico-\u00e9conomique","media_link":"https:\/\/www.jle.com\/fr\/revues\/abc\/e-docs\/cost_effectiveness_threshold_of_first_trimester_down_syndrome_maternal_serum_screening_for_the_use_of_cell_free_dna_as_a_second_tier_screening_test_320573\/article.phtml","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Marie Blanquet, Sophie Dreux, St\u00e9phanie L\u00e9ger,\u00a0Corinne Sault,\u00a0Charline Mourgues, H\u00e9l\u00e8ne Laurichesse, Didier L\u00e9mery, Fran\u00e7oise Vendittelli, Anne Debost-Legrand, Fran\u00e7oise Muller\nAnnales de Biologie Clinique Volume 79, num\u00e9ro 4, Juillet-Ao\u00fbt 2021"},{"title":"Evaluation of the performance of a new automated HIV combination assay","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29020658","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Ghisetti V, Coignard C, Allice T, Ly TD\nJ Clin Virol 2017 ; 96:80-83"},{"title":"Evaluation of the SLOMYCO Sensititre\u00ae panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27150659","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Chazel M, Marchandin H, Keck N, Terru D, Carri\u00e8re C, Ponsoda M, Jacomo V, Panteix G, Bouzinbi N, Ba\u00f1uls AL, Choisy M, Solassol J, Aubry, Godreuil S\nAnn Clin Microbiol Antimicrob 2016 ; 15:30"},{"title":"Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities","media_link":"http:\/\/www.bloodjournal.org\/content\/132\/Suppl_1\/943?sso-checked=true","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"On Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group\nElise Chapiro, Elodie Pramil, M\u2019boyba Diop, Damien Roos-Weil, Cl\u00e9mentine Dillard, Cl\u00e9mentine Gabillaud, Karim Maloum, Catherine Settegrana, Lucile Baseggio, Jean-Fran\u00e7ois Lesesve, M\u00e9lanie Yon, Ludovic Jondreville, Claude Lesty, Fr\u00e9d\u00e9ric Davi, Magali Le Garff-Tavernier, Nathalie Droin, Philippe Dessen, Caroline Algrin, V\u00e9ronique Leblond, Jean Gabarre, Simon Bouzy, Virginie Eclache, Baptiste Gaillard, Evelyne Callet-Bauchu, Marc Muller, Christine Lefebvre, Nathalie Nadal, Antoine Ittel, St\u00e9phanie Struski, Marie-Agn\u00e8s Collonge-Rame, Benoit Quilichini, Sandra Fert-Ferrer, Nathalie Auger, Isabelle Radford-Weiss, Lena Wagner, Sebastian Scheinost, Thorsten Zenz, Santos A. Susin, Olivier A. Bernard, Florence Nguyen-Khac\nBlood 2018 132:943; doi:"},{"title":"Identification of a polygalacturonase (Cup s 2) as the major CCD-bearing allergen in Cupressus sempervirens pollen","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28439939","date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Shahali Y, Sutra JP, Hilger C, Swiontek K, Haddad I, Vinh J, Guilloux L, Charpin D, S\u00e9n\u00e9chal H, Poncet\nAllergy 2017 ; doi: 10.1111\/all.13191"},{"title":"Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. \u2013 Trends over 10 years","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26518058","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bailly S, Maubon D,\u00a0Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF\nJ Infect\u00a02015 ; Oct 28. pii: S0163-4453(15)00342-4. doi: 10.1016\/j.jinf.2015.09.041"},{"title":"Impact of Including or Removing Nuchal Translucency Measurement on the Detection and False-Positive Rates of First-Trimester Down Syndrome Screening","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26656919","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Spaggiari E, Czerkiewicz I, Sault C, Dreux S, Galland A, Salomon LJ, Ville Y, Muller F\nFetal Diagn Ther 2015 ; Dec 12"},{"title":"Int\u00e9r\u00eat du s\u00e9quen\u00e7age haut d\u00e9bit dans les h\u00e9mopathies my\u00e9lo\u00efdes chroniques : quelles actualit\u00e9s en 2022 ?","media_link":"","date":"01\/09\/2022","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
B. Quilichini Journal de Biologie M\u00e9dicale \/ Volume 11-Num\u00e9ro 42 \/ Juil-Sept 2022<\/p>\n"},{"title":"Interf\u00e9rences s\u00e9rologiques du traitement du my\u00e9lome multiple par daratumumab (anti-CD38) : \u00e0 propos d\u2019un cas","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28540859","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Rabut E, Castro-Fernandez A, Le Gall V, Meknache\nAnn Biol Clin 2017 ; 75:351-355"},{"title":"Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31379011","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Penther D, Etancelin P, Lusina D, Bidet A, Quilichini B, Gaillard B, Rafdord-Weiss I, Mozziconacci MJ, Ittel A, Roche-Lestienne C, Barin C, Soler G, Daudignon A, Nadal N, Chapiro E, Lefebvre C, Godon C, Nadeau G, Mugneret F, Richebourg S, Viailly PJ, Ferret Y, Nguyen-Khac F, Eclache V; Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique\nAm J Hematol 2019 Aug 4. doi: 10.1002\/ajh.25601."},{"title":"Large outbreak of urogenital schistosomiasis acquired in Southern Corsica: monitoring the early signs of the endemicization?","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28669843","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"No\u00ebl H, Ruello M, Maccary A, Pellat C, Sommen C, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Durand J, Ramalli L, Chiappini JD , Malfait P, Berry\nClin Microbiol Infect 2017 ; pii: S1198-743X(17)30350-6. doi: 10.1016\/j.cmi"},{"title":"Les niveaux de preuve des biomarqueurs utilis\u00e9s pour la d\u00e9tection pr\u00e9coce des cancers de la prostate","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27029727","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Lamy PJ, Gauchez AS, Salomon L et al et le Groupe de biologie de la prostate : Sault C et al\nAnn Biol Clin 2016 ; 74:227-232"},{"title":"Marqueurs de d\u00e9pistage et de pr\u00e9diction de la pr\u00e9-\u00e9clampsie : place de la biologie","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Sault C\nJ Biol Med 2017 ; 6:186-190"},{"title":"Non-invasive prenatal testing: what are we missing?\u00a0","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32119166","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fries N, Le Garrec S, Egloff M, Sault C, Dreux S, Mangione R, Salomon LJ, Ville Y. \nUltrasound Obstet Gynecol. Mars 2020 - 2. doi: 10.1002\/uog.22005."},{"title":"Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28189936","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Thibault V, Servant-Delmas A, Ly TD, Roque-Afonso AM, Laperche S\nJ Clin Virol 2017 ; 89:14-21"},{"title":"Persistence of Zika virus in gradient sperm preparation","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29510270","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Cassuto NG, Marras G, Jacomo V, Bouret D\nJ Gynecol Obstet Hum Reprod 2018, pii: S2468-7847(18)30038-2"},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Emile C, Sault C\nSpectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49."},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"12\/12\/2022","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Emile C, Sault C<\/strong>. Spectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49.<\/p>\n"},{"title":"Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Potential+value+of+placental+angiogenic+factors+as+biomarkers+in+preeclampsia+for+clinical+physicians","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Boulanger H, Lef\u00e8vre G, Ahriz Saksi S, Achiche J, Bailleul S, Ekoukou D, Drouin D, Sault C, Stawiarski N, Dupuis E.\nNephrol Ther. 2019 Mar 29"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0755498219304178?via%3Dihub","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Hamdi SM, Sault C, Piver E, Genoux A, Masson D, Guibourdenche J.\nPresse Med . 2019 Oct 29. pii: S0755-4982(19)30417-8. doi: 10.1016\/j.lpm.2019.09.029. PMID:31676218"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/doi.org\/10.1016\/j.lpm.2019.09.029","date":"12\/12\/2019","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Hamdi SM, Sault C<\/strong>, Piver E, Genoux A, Masson D, Guibourdenche J. Presse Med. (2019)<\/p>\n"},{"title":"Preliminary report of an autochthonous Chikungunya outbreak in France, July to September 2017","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29019313","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Calba C, Guerbois-Galla M, Franke F, Jeannin C, Auzet-Caillaud M, Grard G, Pigaglio L, Decoppet A, Weicherding J, Savaill MC, Munoz-Riviero M, Chaud P, Cadiou B, Ramalli L, Fournier P, Noel H, De Lamballerie X, Paty MC, Leparc-Goffart I\nEuro Surveill 2017 ; 22(39):pii=17-00647"},{"title":"Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance","media_link":"https:\/\/www.nature.com\/articles\/s41467-021-23233-6","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"St\u00e9phane Le Vu,\u00a0Gabrielle Jones,\u00a0Fran\u00e7ois Anna,\u00a0Thierry Rose,\u00a0Jean-Baptiste Richard,\u00a0Sibylle Bernard-Stoecklin,\u00a0Sophie Goyard,\u00a0Caroline Demeret,\u00a0Olivier Helynck,\u00a0Nicolas Escriou,\u00a0Marion Gransagne,\u00a0St\u00e9phane Petres,\u00a0Corinne Robin,\u00a0Virgile Monnet,\u00a0Louise Perrin de Facci,\u00a0Marie-Noelle Ungeheuer,\u00a0Lucie L\u00e9on,\u00a0Yvonnick Guillois,\u00a0Laurent Filleul,\u00a0Pierre Charneau,\u00a0Daniel L\u00e9vy-Bruhl,\u00a0Sylvie van der Werf\u00a0&\u00a0Harold Noel\u00a0\nNature Communications volume 21\/05\/2021 12, Article number: 3025 (2021)"},{"title":"Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/30789329\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Tatai C, Berland JL, Claude JB, Westeel E, Hodille E, Fredenucci I, Rasigade JP, Ponsoda M, Jacomo V, Vach\u00e9e A, Gaudart A, Gaillard JL, Roux AL, Ader F, Tararbit K, Terpant G, Bryant JE, Lina G, Dumitrescu O; Lyon TB Study Group.Genestet C, et al.\nEmerg Infect Dis. 2019 Mar;25(3):589-592. doi: 10.3201\/eid2503.181124 - PMID: 30789329"},{"title":"R\u00e9activit\u00e9 crois\u00e9e in silico, in vitro, in vivo","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Guilloux L, Ricard-Blum S\nAllergies alimentaires 2017 ; chapitre 7.5:97-102"},{"title":"Recherche et identification des anticorps antinucl\u00e9aires : analyse du questionnaire europ\u00e9en de l\u2019EASI groupe et confrontation des pratiques fran\u00e7aises aux recommandations internationales","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29623889","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Musset L, Fabien N, Chyderiotis G, Olsson NO, Pham BN, Durey Dragon MA\nAnn Biol Clin 2018, 76 :185-195"},{"title":"Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission.","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31806715\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Paret R, Pichat C, Berland JL, Jacomo V, Carret G, Fredenucci I, Hodille E, Rasigade JP, Boisset S, Carricajo A, Lina G, Ronnaux-Baron AS, Mornex JF, Grando J, S\u00e9n\u00e9chal A, Ader F, Dumitrescu O; Lyon TB study group.Genestet C, et al.\nEur Respir J. 2020 Mar 20;55(3):1901888. doi: 10.1183\/13993003.01888-2019. Print 2020 Mar"},{"title":"Schistosomose en Corse : chronique d\u2019une histoire annonc\u00e9e","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Berry A, Iriart X, Boissier J, Chyd\u00e9riotis G, Debruyne M, Magnaval JF, Fillaux J, Grech-Angelini S, Barr\u00e9-Cardi H, Termignon JL, Macarry A, Noel H\nLa Lettre de l'Infectiologue 2016 ; XXXI n\u00b02:60-64"},{"title":"Screening and identification of antinuclear antibodies (ANA): analysis of the European EASI survey and confrontation of the French routine practice to the international recommandations","media_link":null,"date":null,"media_type":"document","profils":"579,575,574,","document_type":"publication","content":"Musset L, Fabien N, Chyd\u00e9riotis G, Olsson NO, Pham BN, Dragon-Durey MA\nAnn Biol Clin 2017 ;"},{"title":"Surveillance des infections humaines par hantavirus en France m\u00e9tropolitaine, 2012-2016","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Reynes JM, Carli D, Renaudin B, Fizet A, Bour JB, Brodard V, Cart-Tanneur E, Dewilde A, El Hamri M, Fleury H, Hecquet D, Jeulin H, Lechat S, Lemarquand-Bardini M, Lepiller Q, Poveda JD, Raulin O, Twizeyimana E, Van Cauteren D, Velay A, Septfons A, Baize S\nBEH 2017 ; 23:492-499"},{"title":"Surveillance du chikungunya et de la dengue en France m\u00e9tropolitaine, 2014","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resume_Septfons-A_2016_330-70-77.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Septfons A, No\u00ebl H, Leparc-Goffart I, Giron S, Delisle E, Chappert JL, Catelinois O, Franke F, Servas V, Guinard A, Debruyne M, Schaal O, Brichler S, Ninove L, Prat C, Flusin O, Poujol I, Letort MJ, Deniau J, Six C, Rousseau C, De Valk H, Paty MC\nLes Feuillets de Biologie 2016 ; 330:70-77"},{"title":"Surveillance du chikungunya, de la dengue et des infections \u00e0 virus Zika en France m\u00e9tropolitaine, 2017","media_link":"http:\/\/invs.santepubliquefrance.fr\/beh\/2018\/24\/pdf\/2018_24_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fournet N, Franke F, Chaud P, Raguenaud ME, Calba C, Septfons A, Cart-Tanneur E. et al.\nBull Epid\u00e9miol Hebd. 2018;(24):494-503."},{"title":"Testing anti-neutrophil cytoplasmic antibodies (ANCA): analysis of the European EASI survey on the daily practice of the French laboratories","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28958962","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dragon-Durey MA, Fabien N, Chyd\u00e9riotis G, Musset L, Pham BN, Olsson N\nAnn Biol Clin 2017 ; 75:531-541"},{"title":"The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)","media_link":"","date":"06\/09\/2022","media_type":"document","profils":"579,575,574,","document_type":"publication","content":"\n
Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nab\u00e9ra C, Chapiro E, Collonge-Rame MA, Cuccuini W, Douet-Guilbert N, Eclache V, Luquet I, Michaux L, Nadal N, Penther D, Quilichini B<\/strong>, Terre C, Lefebvre C, Troadec MB, V\u00e9ron\u00e8se L. Leukemia. 2022 Jun;36(6):1451-1466. doi: 10.1038\/s41375-022-01561-w. Epub 2022 Apr 16.PMID: 35430613 Review.<\/p>\n"},{"title":"The impact of introducing combined first-trimester trisomy 21 screening in the French population","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26628633","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Eur J Public Health 2015 ; Nov 30"},{"title":"The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34284044\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Maxime Espi, Xavier Charmetant, Thomas Barba, Laetitia Koppe, Caroline Pelletier, Emilie Kalbacher, Elodie Chalencon, Virginie Mathias, Anne Ovize, Emmanuelle Cart-Tanneur, Christine Bouz, Laurence Pellegrina, Emmanuel Morelon, Denis Fouque, Laurent Juillard, Olivier Thaunat\nKidney International 2021 Oct;100(4):928-936. doi: 10.1016\/j.kint.2021.07.005."},{"title":"Thrombop\u00e9nie induite par l\u2019h\u00e9parine (TIH) : \u00e0 propos d\u2019un casLe Flem L, Emile C","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Le Flem L, Emile C, Spectra Biologie 2016 ; 220:49-50<\/p>\n"},{"title":"Une interf\u00e9rence dans le dosage de l\u2019insuline r\u00e9v\u00e8le un syndrome auto-immun anti-insuline","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27492703","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Lamy PJ, Sault C, Renard E\nAnn Biol Clin 2016 ; 74:490-494"},{"title":"Vector-borne Transmission of Zika Virus in Europe, Southern France, August 2019","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31718742\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Sandra Giron, Florian Franke, Anne Decoppet, Bernard Cadiou, Thierry Travaglini, Laurence Thirion, Guillaume Durand, Charles Jeannin, Gr\u00e9gory L\u2019Ambert, Gilda Grard, Harold No\u00ebl, Nelly Fournet, Michelle Auzet-Caillaud, Christine Zandotti, Samer Abouka\u00efs, Pascal Chaud, Saby Guedj, Lakri Hamouda, Xavier Naudot, Anne Ovize, Cl\u00e9ment Lazarus, Henriette de Valk, Marie-Claire Paty, Isabelle Leparc-Goffart\nEuro Surveill. 2019 Nov;24(45):1900655."},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Faux-positif-ADNlcT21_L-Druart_012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Faux positif d\u2019ADNlcT21 avec diff\u00e9rentes anomalies chromosomiques confin\u00e9es au placenta\nL Druart, H Dessuant, JF Taly, M Nouchy, L Raymond, S Tapia"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Developpement-panel-15-marqueurs_F.-Rousseau-et-al.-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9veloppement d\u2019un panel de 15 marqueurs pour une identitovigilance\ndes \u00e9chantillons analys\u00e9s par s\u00e9quen\u00e7age haut d\u00e9bit ou sur puces \u00e0 SNP\nF Rousseau, J-F Taly, C Ploton Nicollet, M Taoudi, A Perdriau, L Raymond"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20359-Assises-de-Genetique-2020_B-Quilichini_012020.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Mise en place d\u2019un panel de g\u00e8nes cibl\u00e9s pour les h\u00e9mopathies\nmalignes (NMP-LMMC-SMD-LAM) par NGS : Enjeux M\u00e9dical \/ Scientifique et d\u2019Assurance Qualit\u00e9.\nV Geromel, E Fayolle, P Mouty, R Moulin, N Batail, M-H Felix, B Adde, S Mouty, L Raymond, B Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20362-Assises-de-Gntique-2020_B_Quilichini-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Impact diagnostique, pronostique et th\u00e9ranostique d\u2019un panel de g\u00e8nes\n\u00ab H\u00e9mopathies My\u00e9lo\u00efdes \u00bb r\u00e9alis\u00e9 par NGS : l\u2019exp\u00e9rience du laboratoire Eurofins Biomnis en 2019.\nV. Geromel, P. Mouty, C. Chal, J . Delaunay, S. Sadot-Lebouvier, R. Kaphan, J. Vigvari, J.P. Coadic, E.A. Marin La Meslee, O. Roualdes, C. Bourdin, A. Petit, M. Roumigui\u00e8res, L. Raymond, B.Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 4","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Les_assises_2020_RadoslavaSARAEVA_LAMRI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"21-24 janvier 2020, Tours\nDiagnostics g\u00e9n\u00e9tiques multiples (double hits) par s\u00e9quen\u00e7age Whole Exome (WES) : \u00e0 propos de deux cas.\nR. SARAEVA-LAMRI, A. DORELLE, V. GEROMEL, A. S. LEBRE, P. MOUTY, M. E. NAUD BARREYRE, F. ROUSSEAU, M. TAOUDI, L. MESNARD, L. RAYMOND"},{"title":"10th International Congress on Autoimmunity, Leipzig, April 6-10, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_4.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Should Dense Fine Speckled 70 (DFS70) pattern be reported? Biomnis reference lab experience on 12 619 ANA screening consecutive sera\nGuis L, Ebel A, Leroy J, Michaud S, Pomaredes A, Marcenaro C, Chalouas L"},{"title":"12\u00e8me CFA, Paris, avril 25-28, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":""},{"title":"12\u00e8me Congr\u00e8s de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Paris, mars 22-23, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Jacomo_3.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Les Liquides C\u00e9phalo-Rachidiens : conservation pr\u00e9-analytique \u00e0+ 4 \u00b0C ou \u2013 20 \u00b0C ?\nJacomo V, Schaal O, Fournier P"},{"title":"17\u00e8mes Journ\u00e9es Francophones de Virologie, Paris, avril 9, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"R\u00e9solution des \u00e9checs de g\u00e9notypage de la technique Abbott RealTime HCV Genotype II par un test temps r\u00e9el additionnel\nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ly_8.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of a new high sensitive, qualitative and quantitative Hepatitis B surface antigen assay\nLy TD, Coignard C"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Characterization of samples with genotype 1 without subtype results by Abbott RealTime HCV genotype II using the new Abbott HCV Genotype Plus RUO test \nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"19th Annual Meeting of the European Society for Clinical Virology (ESCV), Lisbon, september, 14\u201317, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/09\/Biomnis_Poster_2016_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to COBAS\u00ae AmpliPrep\/OBAS\u00ae TaqMan\u00ae HIV-1 and HBV tests\nEbel A, Bali C, Guis L, Merlin S"},{"title":"20\u00e8mes Journ\u00e9es de M\u00e9decine Foetale, Morzine, mars 26-28, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015__Becker_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Int\u00e9r\u00eat du D\u00e9pistage Pr\u00e9natal Non Invasif dans le diagnostic des aneuplo\u00efdies 13, 18 et 21 \nBecker M, Eg\u00e9a G, Taoud M, Ahmed Chaouch D, El Mouatassim S"},{"title":"20Th Congress European Hematology Association, Vienna, June 11-14, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Rigollet_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Characterization of normal and pathological lymphoid populations: validation of a 10-colors flow cytometry protocol for routine diagnosis \nRigollet L, Stagnara J, Milhau A, Pellegrina L"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/10\/Biomnis_Poster-Aptima-HIV-1-HBV_Ebel_Sept18.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV-1 Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to Cobas\u00ae 6800\/8800 HIV-1 and HBV tests\nA. Ebel, C. Bali, L. Guis, S. Merlin"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/11\/Poster-IgM-Measles-ESCV-TD-LY-.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of new IgM Measles assay\nT.D. Ly, C. Coignard"},{"title":"24e Journ\u00e9es de m\u00e9decine f\u0153tale, Marseille, 4-5-6 avril 2019","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9pistage de la trisomie 21 par analyse de l\u2019ADN f\u0153tal libre circulant dans le sang maternel : Application dans le cas des grossesses g\u00e9mellaires\nMarc NOUCHY, Nicolas CHATRON, Pascal MOUTY, Francis ROUSSEAU, Barbara ADD\u00c9, Mohamed Taoudi, Caroline DUMONT, Jean-Fran\u00e7ois TALY, Luc DRUART, Sylvie TAPIA, Damien SANLAVILLE, Laure RAYMOND"},{"title":"25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, April 25-28, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of three fully automated assays for the detection of cytomegalovirus IgM and IgG: DiaSorin LIAISON\u00ae XL, Abbott Architect \u00ae and Roche Cobas 6000\u00ae\nBouthry E, Ly TD, Vauloup-Fellous C"},{"title":"27th ECCMID, Vienna Austria, April 22-25, 2017","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Strain-specific estimation of epidemic success provides insights into the transmission dynamics of tuberculosis Rasigade\nJP, Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, P\u00e9rouse de Montclos M, Flandrois JP, Ader F, Supply P, Lina G, Wirth T"},{"title":"29th IUSTI European Conference on Sexually Transmitted Infections, Sitges (Barcelona), 24-26 September, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Prevalence of Mycoplasma genitalium in France and comparison with Chlamydia trachomatis and Neisseria gonorrhoeae as determined by the Mycoplasma genitalium TMA assay \nEbel A, Venard C, Brunengo D, Merlin S"},{"title":"31st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbon, June 14-17, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Force_7.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Blastocysts vitrification during 2 consecutive years: before and after its start significant delivery rate increase within the 1st year \nForce A, Nicollet B, Chomier M, Sergeant P, Lescaille M, Rochigneux S, Robert F, Ginon J, Sergeant MV, Baucher S, Schubert B"},{"title":"35e congr\u00e8s de la SFH, CNIT Paris la D\u00e9fense, avril 1-3, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Becker_4.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"La SNP array : un outil compl\u00e9mentaire pour la caract\u00e9risation des h\u00e9mopathies malignes \nBecker M, Eg\u00e9a G, Camilli K, Robin M, Roumigui\u00e8res M, Rigollet L, Stagnara J, El Mouatassim S"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_14.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Evaluation du nouveau test LAISON\u00ae H. pylori IgG\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_15.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Borr\u00e9liose et index de synth\u00e8se intrath\u00e9cale : bilan biologique r\u00e9trospectif de l\u2019ann\u00e9e 2015\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Ebel_16.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation des performances de la trousse Aptima\u00ae HBV Quant (Hologic)\nEbel A, Bali C, Guis L, Merlin S"},{"title":"37\u00e8me RICAI, Paris, d\u00e9cembre 18-19, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/12\/Biomnis_Poster_2017_Coignard_13.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Confirmation VIH : donn\u00e9es biologiques et \u00e9pid\u00e9miologiques des 3 derni\u00e8res ann\u00e9es dans un laboratoire de biologie sp\u00e9cialis\u00e9e\nCoignard C, Ly TD"},{"title":"38e RICAI, Paris 17-18 d\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-COIGNARD-ROUGEOLE.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Epid\u00e9mie de rougeole 2018 : le s\u00e9rodiagnostic un marqueur simple et performant.\nT.D. Ly, C. Coignard"},{"title":"3e Journ\u00e9e Francophone de Biologie M\u00e9dicale, Monaco, 6-7-8 novembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/11\/1911_poster_A.Ebel_JFBM.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"D\u00e9pistage syst\u00e9matique de Neisseria gonorrhoeae et de C. trachomatis par test d\u2019amplification g\u00e9nique : bilan d\u2019une ann\u00e9e d\u2019exp\u00e9rience\nL. Mine, L. Guis, S. Merlin, A. Ebel"},{"title":"40e RICAI \u2013 R\u00e9union Interdisciplinaire de Chimioth\u00e9rapie Anti-Infectieuse, 14-15 d\u00e9cembre","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Posters\/2012_Poster_SARS-CoV-2_RICAI_C.Coignard.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"S\u00e9rologie SARS-CoV-2 : \u00e9valuation, qualification et choix d\u2019une m\u00e9thode\nCatherine Coignard, Anne EBEL, Yanis BOUAMRA, Didier RIDEY, Carla MARCENARO"},{"title":"42es Journ\u00e9es Nationales \u2013 Congr\u00e8s CNGOF, Strasbourg, 4-7 D\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-EMILE-DPNI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"\u00c9tude de l\u2019usage du DPNI (d\u00e9pistage pr\u00e9natal non invasif) des aneuplo\u00efdies en milieu lib\u00e9ral\nC. Emile, L. Raymond, L. Pellegrina"},{"title":"45\u00e8me Colloque National des Biologistes des H\u00f4pitaux, Paris, juin 22-24, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/06\/Biomnis_Poster_2016-Rabut_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Interf\u00e9rence du traitement par daratumumab (anti-CD38) dans le suivi biologique du my\u00e9lome multiple et dans la recherche d\u2019anticorps anti-\u00e9rythrocytaires : \u00e0 propos d\u2019un cas\nRabut E, Castro-Fernandez A, Le Gall V, Meknache N"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Raymond_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport diagnostique de l\u2019utilisation des puces SNP dans l\u2019\u00e9tude chromosomique des morts f\u0153tales\nRaymond L, Dherbey JL, Rebeyrat-Pichon I, El-Mouatassim S, Egea G"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier, 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_11.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Cas rare d\u2019X-fragile pr\u00e9natal avec r\u00e9traction d\u2019expansion de triplet CGG ? \nMouty P, Raymond L, El Mouatassim S, Liquier A, Druart L, Paris A, Dorian V, Pichon I, Dherbey JL, Eg\u00e9a G"},{"title":"CGRF Ile de R\u00e9, septembre 28-29, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Brunengo_11.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Epid\u00e9miologie qualitative des variants rares de l\u2019H\u00e9moglobine en France m\u00e9tropolitaine au travers de la collaboration HCL \u2013 Eurofins Biomnis\nBrunengo D, Veyrenche N, Louis Chillotti L, Le Flem L"},{"title":"COGEN, Paris, Septembre 25-27, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_El-Mouatassim_11.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"French experience of Non-Invasive Prenatal Testing of trisomy 21, 18 and 13 \nEl Mouatassim S, Taoudi M, Eg\u00e9a G"},{"title":"Congr\u00e8s SFP \/ SFMM, Toulouse, mars 29-31, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/03\/Biomnis_Poster_2017_Chydriotis_1-1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport de 2 tests de d\u00e9pistage pour le diagnostic de la bilharziose et place du Western blot\nChyd\u00e9riotis G, Cart-Tanneur E, Lecuelle C, F\u00e9lix MH"},{"title":"Congr\u00e8s SFTA, Avignon, mai 10-12, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_Petit_2.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Dosage de la Ciclosporine, Tacrolimus, Ev\u00e9rolimus et Sirolimus en LCMSMS avec le coffret MassTox Chromsystems sur Api 4500 ABSciex avec pr\u00e9paration automatis\u00e9e sur T\u00e9can EVO 150\nPetit I, Moussa C, Bonnet K, Bezol A. Havrez S, Gerrier P"},{"title":"EAACI, Helsinki, June 17-21, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_6.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Bp14, an allergen from cupressus sempervirens pollen related to the family of snakin\/gibberellin-regulated proteins\nS\u00e9n\u00e9chal H, Santrucek J, Melcova M, Svoboda P, Zidkova J, Guilloux L, Aizawa T, Couderc R, Charpin D, Poncet P"},{"title":"ESCAIDE 2015, Stockholm, November 11-13, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Chyderiotis_14.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Re-emergence of urinary schistosomiasis in Europe ? Infections acquired in Southern Corsica \u2013 Investigation of a cluster of Schistosoma haematobium infections in 2014\nRamalli L, No\u00ebl H, Ruello M, Maccary A, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Denoyel GA, Succo T, Armengaud A, Paty MC, Heuz\u00e9 G, Mattei J, Th\u00e9ron A, Berry A"},{"title":"ESCV, Stresa, Lake Maggiore, September 13-16, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/10\/Biomnis_Poster_2017_LY_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new chemiluminescent assay to detect and quantify anti-HBs antibodies\nMaillard A, Ly TD, Thibault V"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_LY_3.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new LIAISON\u00ae H. pylori IgG\nLy TD, Coignard C"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Rabut_4.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Red blood cell antibody assays in DARA-treated patients\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"EuroMedLab, Paris, June 22-24, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Early Performance Evaluation of cobas\u00ae HBV, cobas\u00ae HCV and cobas\u00ae HIV-1Quantitative Nucleic Acid Tests for use on the new cobas\u00ae 6800\/8800 Systems\nEbel A, Merlin S, Marins ED G, Canchola J, Njoya M, Simon CO"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/poster-FFER-2018-callec.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Impact de la chirurgie bariatrique sur les param\u00e8tres spermatiques : Revue de la litt\u00e9rature\nR. Callec, B. Schubert, F. Robert, A. Force"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/POSTER-FFER-2018-Force.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Crit\u00e8res d\u2019interpr\u00e9tation du msome pour une optimisation de la prise en charge des patients\nA. Force, M. Chomier, P. Sergeant, J. Ginon, S. Rochigneux, M. Lechatton, M. Pont, R. Callec, F. Robert, B. Schubert"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Lopez.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation externe de la qualit\u00e9 en spermiologie : un nouveau programme pour une \u00e9valuation globale de l\u2019examen\nMarie LOPEZ, Bernard POGGI, Jean Christophe EYNARD, Marie LETY, Benoit SCHUBERT, Andr\u00e9 FORCE"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Schubert.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Influence des conditions de culture sur les r\u00e9sultats en AMP dans une \u00e9tude multicentrique : comparaison d\u2019un incubateur Time Lapse avec les incubateurs tradictionnels\nBeno\u00eet SCHUBERT, Alexandre MARCILLY, Andr\u00e9 FORCE"},{"title":"FFER, Tours, septembre 13-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Force_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Comparaison de la performance de 2 incubateurs (Geri versus Planer) apr\u00e8s randomisation de la cohorte ovocytaire pour chaque patiente\nForce A, Martine Chomier, Philippe Sergeant, Jacqueline Ginon, St\u00e9phanie Rochigneux, Soizic Baucher, M\u00e9lanie Le Chatton, M\u00e9lanie Pont, Beno\u00eet Schubert"},{"title":"FIBA 2016, Dakar, January 13-14, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"ANCA associated HIV infection in Senegal: a serological trap\nArouna O, Niang A, Abiola A, Guis L, Le Flem L, Diene JF, Mboup S"},{"title":"Fort Collins (USA), May 31-June 3, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/05\/Biomnis_Poster_2016_Jacomo_5.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Seoul Virus Infection in Human, France, 2014-2016\nReynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, Nussbaumer T, Jacomo V, Rapt MP, Septfons A, Rollin PE"},{"title":"ISMA, Lisbon, November 19-21, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2015_Guilloux_16.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Ige-cross-reactivity between european hymenoptera and asian hornet (vespa velutina) venom allergens\nLong\u00e9 C, Brazdova A, Brunet JL, Schwartz C, Girodet B, Lavaud F, Birnbaum J, Pham-Thi N, Duchateau M, Chamot-Rooke J, Guilloux L, Selva MA, Couderc R, S\u00e9n\u00e9chal H, Sutra JP, Poncet P"},{"title":"Journ\u00e9es Nationales CNGOF, Montpellier, d\u00e9cembre 7-9, 2016","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Etude pr\u00e9liminaire sur le d\u00e9pistage de la pr\u00e9-\u00e9clampsie au 1er trimestre de la grossesse (Predictor\u00ae)\nWalder R, Galland A, Sault C, Huissoud C"},{"title":"Journ\u00e9es Nationales d\u2019Infectiologie, Nantes, 13-15 juin, 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/05\/Biomnis_Poster_2018_Ebel_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Infections \u00e0 Chlamydia trachomatis : donn\u00e9es \u00e9pid\u00e9miologiques r\u00e9centes dans un laboratoire sp\u00e9cialis\u00e9\nEbel A, Guis L, Merlin S"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Poster-Lyme-RICAI-C.-Coignard-TD-Ly-dec-2019-800x1200.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of the BioPlex 2200 Lyme IgG\/IgM immunoassay system\nC. Coignard, C. Cl\u00e9ment-Vincent, Td. Ly, A. L\u2019hotellier"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/12\/2019-12-17_RICAI.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Sp\u00e9cificit\u00e9 de la s\u00e9rologie chikungunya et surveillance \u00e9pid\u00e9miologique\nC. Calba, F. Franke, E. Brottet, G. Terpant, N. Fournet, A. Ovize, J.D. Poveda, I. Leparc-Goffart, M.C. Paty"},{"title":"SFE, Bordeaux, octobre 5-8, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Sault_13.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Influence de la nature du liquide de rin\u00e7age d\u2019aiguille de cytoponction sur le dosage de la thyroglobuline\nBoux De Casson F, Moal V, Gauchez AS, Moineau MP, Sault C, Schlageter MH, Massart C"},{"title":"SFTS, Bordeaux, septembre 20-22, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Rabut_10.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Recherche et quantification de l\u2019h\u00e9morragie f\u0153to-maternelle par cytom\u00e9trie en flux avec double marquage anti-h\u00e9moglobine F et anti-anhydrase carbonique\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"XXIIIe Colloque ACLF, Montpellier, septembre 20-21, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Syndrome de Currarino atypique avec hexadactylie pr\u00e9-axiale : remaniement complexe en 7q36.3 en pr\u00e9natal\nLiquier A, Becker M, Raymond L, Bourgain A, Amat S, Broussin B, Andr\u00e9 G, Escande F, Nouchy M, Eg\u00e9a G"}]));
sessionStorage.setItem('currentLang', 'fr');render(html`<${RessourcesDynamiques} name="World" />`, document.getElementById('resdyncontainer'));
\n
Arr\u00eat\u00e9 du 29 juillet 2022 modifiant l\u2019arr\u00eat\u00e9 du 9 juillet 2022 relatif \u00e0 la vaccination contre le virus Monkeypox et portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale<\/p>\n"},{"title":"Journal Officiel num\u00e9ro 0036 du 17 d\u00e9cembre 2009","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO0036-171209.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 15 d\u00e9cembre 2009 relatif aux controles du respect des valeurs limites biologiques fix\u00e9es \u00e0 l\u2019article R. 4412-152 du code du travail pour les travailleurs expos\u00e9s au plomb et \u00e0 ses compos\u00e9s et aux conditions d\u2019accr\u00e9ditation des laboratoires charg\u00e9s des analyses"},{"title":"Journal Officiel num\u00e9ro 013 du 16 janvier 2014 \u2013 texte 11","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO013-160114-texte-11.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 14 janvier 2014 fixant le mod\u00e8le des documents mentionn\u00e9s au III de l\u2019article R. 2131-2 du code de la sant\u00e9 publique (Mod\u00e8le de refus de consentement)"},{"title":"Journal Officiel num\u00e9ro 013 du 16 janvier 2014 \u2013 texte 5","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO013-160114-texte-5.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"D\u00e9cret no 2014-32 du 14 janvier 2014 relatif aux diagnostics ant\u00e9nataux"},{"title":"Journal Officiel num\u00e9ro 021 du 24 janvier 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/01\/JO021_240121.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 23 janvier 2021 modifiant l\u2019arr\u00eat\u00e9 du 10 juillet 2020 prescrivant les mesures d\u2019organisation et de fonctionnement du syst\u00e8me de sant\u00e9 n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire"},{"title":"Journal Officiel num\u00e9ro 032 du 6 f\u00e9vrier 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/02\/JO032_060221.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 5 f\u00e9vrier 2021 modifiant l\u2019arr\u00eat\u00e9 du 10 juillet 2020 prescrivant les mesures d\u2019organisation et de fonctionnement du syst\u00e8me de sant\u00e9 n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire."},{"title":"Journal Officiel num\u00e9ro 046 du 23 f\u00e9vrier 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/02\/JO046_230221.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 22 f\u00e9vrier 2021 portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale (modification des indications relatives aux pr\u00e9l\u00e8vements salivaires pour la d\u00e9tection du g\u00e9nome du Sars-CoV-2 par RT-PCR)"},{"title":"Journal Officiel num\u00e9ro 117 du 13 mai 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/05\/JO-200513.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du\u00a012 mai 2020\u00a0portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale (inscription de la d\u00e9tection du g\u00e9nome du SARS-CoV-2 par RT PCR)"},{"title":"Journal Officiel num\u00e9ro 129 du 28 mai 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/05\/JO128-280520.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 27 mai 2020 portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale (diagnostic biologique de l\u2019infection par le SARS-CoV-2)"},{"title":"Journal Officiel num\u00e9ro 130 du 7 Juin 2013 (texte 14)","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO130-070613.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 27 mai 2013 d\u00e9finissant les r\u00e8gles de bonnes pratiques applicables \u00e0 l\u2019examen des caract\u00e9ristiques g\u00e9n\u00e9tiques d\u2019une personne \u00e0 des fins m\u00e9dicales"},{"title":"Journal Officiel num\u00e9ro 152 article 23 du 03 juillet 2009","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO152-23-030709.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 23 juin 2009 fixant les r\u00e8gles de bonnes pratiques en mati\u00e8re de d\u00e9pistage et de diagnostic pr\u00e9natals avec utilisation des marqueurs s\u00e9riques maternels de la trisomie 21"},{"title":"Journal Officiel num\u00e9ro 211 du 11 septembre 2010","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO211-110910.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 3 ao\u00fbt 2010 modifiant l\u2019arr\u00eat\u00e9 du 11 avril 2008 relatif aux r\u00e8gles de bonnes pratiques cliniques et biologiques d\u2019assistance m\u00e9dicale \u00e0 la procr\u00e9ation"},{"title":"Journal Officiel num\u00e9ro 294 du 20 d\u00e9cembre 2018","media_link":"https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000037833049\/","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 14 d\u00e9cembre 2018 modifiant l\u2019arr\u00eat\u00e9 du 23 juin 2009 modifi\u00e9 fixant les r\u00e8gles de bonnes pratiques en mati\u00e8re de d\u00e9pistage et de diagnostic pr\u00e9natals avec utilisation des marqueurs s\u00e9riques maternels de trisomie 21"},{"title":"Journal Officiel num\u00e9ro 294 du 20 d\u00e9cembre 2018 - Arr\u00eat\u00e9 du 14 d\u00e9cembre 2018 modifiant l\u2019arr\u00eat\u00e9 du 14 janvier 2014","media_link":"https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000037833049\/","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Fixant le mod\u00e8le des documents mentionn\u00e9s au III de l\u2019article R. 2131-2 du code de la sant\u00e9 publique"},{"title":"Journal Officiel num\u00e9ro 294 du 20 d\u00e9cembre 2018.","media_link":"https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000037833049\/","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 14 d\u00e9cembre 2018 pris en application de l\u2019article R. 2131-2-3 du code de la sant\u00e9 publique"},{"title":"Journal Officiel num\u00e9ro 297 du 09 d\u00e9cembre 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/12\/JO297-091220.pdf.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 8 d\u00e9cembre 2020 modifiant l\u2019arr\u00eat\u00e9 du 10 juillet 2020 prescrivant les mesures d\u2019organisation et de fonctionnement du syst\u00e8me de sant\u00e9 n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire"},{"title":"Journal Officiel num\u00e9ro 301 du 13 d\u00e9cembre 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/12\/JO301_131220.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 12 d\u00e9cembre 2020 portant modification des conditions de remboursement de l\u2019acte de d\u00e9tection du g\u00e9nome du SARS-CoV-2 par amplification g\u00e9nique"},{"title":"Journal Officiel num\u00e9ro 302 du 30 d\u00e9cembre 2011","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO302-301211.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 26 d\u00e9cembre 2011 fixant la liste des centres nationaux de r\u00e9f\u00e9rence pour la lutte contre les maladies transmissibles et des laboratoires associ\u00e9s"},{"title":"Journal Officiel num\u00e9ro 58 du 7 mars 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/JO058-070320.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 7 mars 2020 portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale (inscription de la d\u00e9tection du g\u00e9nome du SARS-CoV-2 par RT PCR)"},{"title":"Comment am\u00e9liorer et acc\u00e9l\u00e9rer le diagnostic des maladies d\u2019origine g\u00e9n\u00e9tique ?","media_link":"https:\/\/www.youtube.com\/embed\/9mjWjvViCkE ","date":"20\/07\/2022","media_type":"video","profils":"574,575,","document_type":"parole-expert","content":""},{"title":"La d\u00e9marche diagnostic en allergologie","media_link":"https:\/\/youtube.com\/embed\/MT-H2HHe1k0","date":null,"media_type":"video","profils":"575,576,574,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur la d\u00e9marche diagnostic en allergologie, expliqu\u00e9 en quelques minutes par le Dr Christine Bouz, biologiste m\u00e9dicale au laboratoire Eurofins Biomnis."},{"title":"La prise en charge biologique des h\u00e9mopathies malignes","media_link":"https:\/\/youtube.com\/embed\/FW0ydxXHhjo","date":null,"media_type":"video","profils":"574,575,576,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur La prise en charge biologique des h\u00e9mopathies malignes, expliqu\u00e9 en quelques minutes par le Dr Beno\u00eet QUILICHINI, biologiste m\u00e9dical au laboratoire Eurofins Biomnis."},{"title":"Le d\u00e9pistage pr\u00e9natal non invasif de la trisomie 21 (DPNI)","media_link":"https:\/\/youtube.com\/embed\/pwH5egBvNWI","date":null,"media_type":"video","profils":"575,574,576,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur le d\u00e9pistage pr\u00e9natal non invasif de la trisomie 21 (DPNI), expliqu\u00e9 en quelques minutes par le Dr Sylvie TAPIA, g\u00e9n\u00e9ticienne au laboratoire Eurofins Biomnis."},{"title":"Le g\u00e9notypage du rh\u00e9sus D foetal","media_link":"https:\/\/youtube.com\/embed\/xHROBADhgAI","date":null,"media_type":"video","profils":"574,576,575,","document_type":"parole-expert","content":"Tout ce qu'il faut savoir sur le g\u00e9notypage du rh\u00e9sus D foetal, expliqu\u00e9 en quelques minutes par le Dr Laurence STROMPF-SILVESTRE, m\u00e9decin biologiste au laboratoire Eurofins Biomnis."},{"title":"Les intol\u00e9rances alimentaires","media_link":"https:\/\/youtube.com\/embed\/jj9iYVJCZuc","date":null,"media_type":"video","profils":"575,576,574,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur les intol\u00e9rances alimentaires, expliqu\u00e9 en quelques minutes par le Dr Emmanuelle CART-TANNEUR, biologiste m\u00e9dical au laboratoire Eurofins Biomnis."},{"title":"Place du test HPV dans le d\u00e9pistage primaire du cancer du col de l\u2019ut\u00e9rus","media_link":"https:\/\/youtube.com\/embed\/PaHkXjzNAsY","date":null,"media_type":"video","profils":"574,576,575,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur le d\u00e9pistage primaire du cancer du col de l\u2019ut\u00e9rus et le test HPV par le Dr Anne EBEL, biologiste m\u00e9dicale au laboratoire Eurofins Biomnis"},{"title":"ABCB1 - Le test g\u00e9n\u00e9tique pour optimiser le traitement de la d\u00e9pression (DS45)\nle choix des antid\u00e9presseurs\ndans le traitement de la d\u00e9pression (DS45-ABCB1)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS45-ABCB1.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux professionnels de sant\u00e9"},{"title":"ALEX\u00ae - Explorateur d\u2019allergies (DS67)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS67-Allergie_Alex.pdf","date":null,"media_type":"document","profils":"579,575,574,","document_type":"le-point-sur","content":""},{"title":"Allergie d\u00e9marche diagnostique (DS10)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS10-Allergie_demarche_diag.pdf","date":null,"media_type":"document","profils":"579,575,574,","document_type":"le-point-sur","content":"Principaux examens et interpr\u00e9tation"},{"title":"Allergie nomenclature (DS9)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS9-Allergie_nomenclature.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Autres tumeurs solides - fiche oncologie (DS86)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS86-Autres_tumeurs.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Biologie de la femme (DS11)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS11-Biologie_femme.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"le-point-sur","content":""},{"title":"Cancer de l\u2019ovaire\nHE4 & score ROMA (DS13)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS13-HE4.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Caract\u00e9risation g\u00e9n\u00e9tique de l\u2019infertilit\u00e9 masculine par s\u00e9quen\u00e7age d\u2019exome - Un nouvel outil de diagnostic (DS66)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS66-Exome_infertilite_masculine.pdf","date":"","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Cardiomyopathies et troubles du rythme (DS88)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS88-HP-Cardiogenetique.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"L'apport de la g\u00e9n\u00e9tique dans la prise en charge des patientes et de leurs familles"},{"title":"D\u00e9pistage de la trisomie 21, 18 et 13 par analyse de l\u2019ADN libre circulant (ADNlc) (DS29-HP)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS29-DPNI_HP_leaflet.pdf","date":"10\/01\/2023","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"\n
Le test de d\u00e9pistage pr\u00e9natal sur simple prise de sang maternel<\/p>\n"},{"title":"D\u00e9termination pr\u00e9natale du g\u00e9notype RHD f\u0153tal \u00e0 partir du sang maternel (DS37HP)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS37-HP-Rhesus_D_foetal.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic des infections \u00e0 Mycobact\u00e9ries (DS1)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS1-Mycobacteries.pdf","date":"26\/10\/2022","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic et suivi des N\u00e9oplasies My\u00e9lo\u00efdes Chroniques (DS2)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS2-Neoplasies_myeloides_chroniques.pdf","date":"","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic, pronostic et suivi des Leuc\u00e9mies aigu\u00ebs (DS3)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS3-Leucemies_aigues.pdf","date":"","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic, pronostic et suivi des N\u00e9oplasies Lympho\u00efdes Matures (DS62)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS62-Neoplasies_lymphoides_matures.pdf","date":"","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Digestif- fiche oncologie (DS84)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS84-Onco-digestif.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Exploration g\u00e9n\u00e9tique des n\u00e9phropathies tubulo-interstitielles : challenge technique pour MUC1 ! (DS104)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS104-Nephropathies_MUC1.pdf","date":"032\/04\/2024","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Fibrometer - Scores de fibrose h\u00e9patique (DS46)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS46-Fibrometer.pdf","date":null,"media_type":"document","profils":"575,","document_type":"le-point-sur","content":""},{"title":"Gyn\u00e9cologie - fiche oncologie (DS85)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS84-Onco-digestif.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Juvenalis (JU-DS47)","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/11\/JU-DS47-Juvenalis.pdf","date":null,"media_type":"document","profils":"579,575,574,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux professionnels de sant\u00e9"},{"title":"Juvenalis (JU-DS48)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/JU-DS48-PA.pdf","date":null,"media_type":"document","profils":"575,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux patients"},{"title":"Le s\u00e9quen\u00e7age de l\u2019exome dans l\u2019insuffisance ovarienne pr\u00e9matur\u00e9e : Pour une orientation plus pr\u00e9cise et personnalis\u00e9e des patientes et couples (DS111)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS111-Exome_IOP.pdf","date":"03\/04\/2024","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Le s\u00e9quen\u00e7age de l\u2019exome en contexte pr\u00e9natal (DS108)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS108-Exome_prenatal.pdf","date":"07\/11\/2023","media_type":"document","profils":"575,","document_type":"le-point-sur","content":"\n
Pour un diagnostic optimis\u00e9 en cas de malformations foetales<\/p>\n"},{"title":"Le s\u00e9quen\u00e7age Whole Exome dans les maladies d\u2019origine g\u00e9n\u00e9tique (DS34)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS34-Exome.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Les autoanticorps dans le diagnostic et le suivi des maladies auto-immunes (DS4)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS4-Auto-immunite.pdf","date":"27\/04\/2022","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Les maladies transmises par les tiques (DS20)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS20-Maladies_tiques.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Leuc\u00e9mie Aigu\u00eb My\u00e9lo\u00efde (LAM) (DS68)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS68-LAM.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Leuc\u00e9mie my\u00e9lomonocytaire chronique (LMMC) (DS71)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS71-LMMC.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Microbiote intestinal (JU-DS73-PA)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/JU-DS73-PA-Microbiote.pdf","date":"","media_type":"document","profils":"575,576,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux patients"},{"title":"Microbiote intestinal (JU-DS76-PH)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/JU-DS76-HP-Microbiote.pdf","date":null,"media_type":"document","profils":"575,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux professionnels de sant\u00e9"},{"title":"N\u00e9oplasies My\u00e9loprolif\u00e9ratives Diagnostic (DS69)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS69-NMP_diagnostic.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Oncog\u00e9n\u00e9tique - Pr\u00e9dispositions h\u00e9r\u00e9ditaires aux cancers : Int\u00e9r\u00eat du s\u00e9quen\u00e7age de l'exome (DS94)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS94-Oncogenetique_exome.pdf","date":"18\/10\/2023","media_type":"document","profils":"575,","document_type":"le-point-sur","content":""},{"title":"Oncog\u00e9n\u00e9tique constitutionnelle : Utilisation du s\u00e9quen\u00e7age Long-ReadNanopore - l\u2019exemple du g\u00e8ne PMS2 (DS112) ","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS112-Sequencage_long_read_PMS2.pdf","date":"18\/10\/2023","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Panels de g\u00e8nes SPINK1, PRSS1, CTRC, CPA1, CFTR et CASR pour le diagnotsic des pancr\u00e9atites h\u00e9r\u00e9ditaires (DS82)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS82-HP-Pancreatites_hereditaires.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Papillomavirus humains et d\u00e9pistage primaire du cancer du col de l\u2019ut\u00e9rus (DS6)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS6-HPV.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Pneumologie - fiche oncologie (DS83)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS83-Onco-pneumologie.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Prise en charge de la pr\u00e9-\u00e9clampsie (DS18)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS18-Pre-eclampsie.pdf","date":"","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Prise en charge des tumeurs solides en Biopathologie (DS5)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS5-Tumeurs_solides.pdf","date":"","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"PROSIGNA\u00ae (PAM50) (DS79)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS79-HP-PAM50.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"Test d\u2019expression g\u00e9nique pronostique du cancer du sein"},{"title":"Syndromes My\u00e9lodysplasiques (SMD) (DS72)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS72-SMD.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Actualit\u00e9s sur la pr\u00e9-\u00e9clampsie et place de la biologie ","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"\n
Corinne SAULT Rev Med Gene Fam. 2018;2(7):194-8.<\/p>\n"},{"title":"Analyse immunoprot\u00e9omique des allerg\u00e8nes non-hydrosolubles de farines de quatre l\u00e9gumineuses : arachide, soja, s\u00e9same et lentille","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26635049","date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Bouakkadia H, Boutebba A, Haddad I, Vinh J, Guilloux L, Sutra JP, S\u00e9n\u00e9chal H, Poncet P\nAnn Biol Clin 2015 ; 73:690-704"},{"title":"Anticoagulant circulant (ACC) : \u00e0 propos de deux cas","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Le Flem L, Emile C\nSpectra Biologie 2016 ; 220:51-53"},{"title":"Automation of ALK gene rearrangement testing with fluorescence in situ hybridization (FISH): A feasibility study","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25576649","date":"","media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Zwaenepoel k, Merkle D, Cabillic F, Berg E, Belaud-Rotureau MA, Grazioli V, Herelle O, Hummel M, Le Calve M, Lenze D, Mende S, Pauwels P, Quilichini B, Repetti E\nExp Mol Pathol 2015 ; 98:113-118"},{"title":"Characterization of a de novo Supernumerary Neocentric Ring Chromosome Derived from Chromosome 7","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26669311","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Louvrier C, Egea G, Labalme A, Des Portes V, Gazzo S, Callet-Bauchu E, Till M, Sanlaville D, Edery P, Schluth-Bolard C\nCytogenet Genome Res 2015 ; Dec 16"},{"title":"Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays","media_link":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.639675\/full","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Geoffroy Poulet, Fanny Garlan, Sonia Garrigou, Eleonora Zonta, Leonor Benhaim, Marie-Jennifer Carrillon, Audrey Didelot, Delphine Le Corre, Claire Mulot, Philippe Nizard, Frederic Ginot, Audrey Boutonnet-Rodat, Helene Blons, Jean-Baptiste Bachet, Julien Ta\u00efeb, Aziz Zaanan, Vanna Geromel, Laurence Pellegrina, Pierre Laurent-Puig, Shu-Fang Wang-Renault and Valerie Taly\nFrontiers in Oncology 06\/05\/2021"},{"title":"Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26582834","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Mokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM\nJ Clin Microbiol 2016 ; 54:296-299"},{"title":"Chronic hepatitis E in absence of severe immune deficiency","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31327621\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Colson P, Schleinitz N, Vely F, Poveda JD,\u00a0Jacomo V, Demerle C, Borentain P, Gerolami R.Colson P, et al.\nClin Res Hepatol Gastroenterol. 2020 Feb;44(1):e1-e4. doi: 10.1016\/j.clinre.2019.06.015. \nEpub 2019 Jul 18 - PMID: 31327621"},{"title":"Combined Genotypic, Phylogenetic, and Epidemiologic Analyses of Mycobacterium tuberculosis Genetic Diversity in the Rh\u00f4ne Alpes Region, France","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27128522","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Pichat C, Couvin D, Carret G, Fr\u00e9d\u00e9nucci I, Jacomo V, Carricajo A, Boisset S, Dumitrescu O, Flandrois JP, LinaG, Rastogin N\nPlos One 2016"},{"title":"Comparative performance of three rapid HBsAg assays for detection of HBs diagnostic escape mutants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26378274","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Servant-Delmas A,\u00a0Ly TD, Hamon C, Kassim Houdah A, Laperche S\nJ Clin Microbiol 2015 ; 53:3954-3955"},{"title":"Computer-aided sperm analysis, the new key player in routine sperm assessment","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Schubert-Badiou-Force-2019.pdf","date":"","media_type":"document","profils":"579,574,575,","document_type":"publication","content":"\n
B. Schubert, M Badiou, A. Force First International Journal of Andrology \u2013 Andrologia 06\/2019 - DOI: 10.1111\/and.13417<\/p>\n"},{"title":"Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytog\u00e9n\u00e9tique h\u00e9matologique (GFCH)","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27707673","date":null,"media_type":"document","profils":"579,574,575,","document_type":"publication","content":"Daudignon A, Quilichini B, Ameye G, Poirel H, Bastard C, Terr\u00e9 C\nAnn Biol Clin 2016 ; 74:588-595"},{"title":"D\u00e9pistage combin\u00e9 de la trisomie 21 au premier trimestre : \u00e9valuation du sur-risque en cas de \u00df-hCG libre entre 5 et 10 MoM","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Th\u00e8se de M\u00e9decine, Universit\u00e9 Claude Bernar 1;2016,71p\nEtude r\u00e9alis\u00e9e avec les donn\u00e9es du laboratoire Biomnis\nLeport H"},{"title":"D\u00e9pistage multiparam\u00e9trique de la pr\u00e9-\u00e9clampsie au premier trimestre de grossesse : \u00e9tude pr\u00e9liminaire","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Th\u00e8se de m\u00e9decine, UCBL soutenue le 5 juillet 2016\nEtude r\u00e9alis\u00e9e \u00e0 partir des r\u00e9sultats du laboratoire Biomnis (Service T21 Lyon)\nWalder R"},{"title":"Dosage de la ciclosporine, du tacrolimus, de l\u2019\u00e9v\u00e9lorimus et du sirolimus en LC-MS\/MS","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2018_Petit_1-1.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Petit I, Bezol A, Ghacham S, Clavaud K, Havrez S, Moussa C, Emile C, Gerrier P\nSpectra Bio 2018, 234:61-66"},{"title":"Dosages des st\u00e9ro\u00efdes par spectrom\u00e9trie de masse","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25582724","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dufour-Rainfray D, Moal V, Cloix L, Mathieu E, Gauchez AS, Brossaud J, Corcuff JB, Fraissinet F, Collet C, Boux de Casson F, Guilloteau D, Emond P, Reynier P, Groupe de Biologie Sp\u00e9cialis\u00e9e de la SFMN : Agin A, Bach K, Charri\u00e9 A, Chikh K, Desb\u00e8ne C, Dousset B, Georges A, Guenet D, Lacroix I, Lamy PJ, Leban M, Leloupp AG, Massart C, Masson D, Moineau MP, Piketty M, Reix N, Sault C, Schlageter MH, Tse C. \nAnn Biol Clin 2015 ; 73:70-8"},{"title":"Down syndrome maternal serum markers in oocyte donation and other assisted reproductive technologies","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28921586","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Bonnin A, Muller F, Senat MV, Sault C, Galland A, Taieb J, Dreux S, Bouyer J, Benachi A\nPrenat Diagn 2017 ; 37:1155-1159"},{"title":"Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I\/501Y.V1 (B.1.1.7, variant of concern 202012\/01) in France","media_link":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2021.26.9.2100133","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Alexandre Gaymard, Paolo Bosetti, Adeline Feri, Gregory Destras, Vincent Enouf, Alessio Andronico, Sonia Burrel, Sylvie Behillil, Claire Sauvage, Antonin Bal, Florence Morfin, Sylvie Van Der Werf, Laurence Josset, ANRS MIE AC43 COVID-198, French viro COVID group (including Catherine Coignard), Fran\u00e7ois Blanquart, Bruno Coignard, Simon Cauchemez, Bruno Lina\nEurosurveillance 04\/03\/2021 - Volume 26, Issue 9"},{"title":"\u00c9mergence de la leptospirose humaine en France m\u00e9tropolitaine ? Actualit\u00e9s sur la surveillance","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bourhy P, Picardeau M, Septfons A, Trombert S, Cart-Tanneur E\nMed Mal Infect 2017 ; 47 (4s):s150"},{"title":"Evaluation de l\u2019automate Neo\u00ae (Immucor) pour l\u2019immuno-h\u00e9matologie \u00e9rythrocytaire","media_link":"","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
Rabut E, Ahmetkadic D, Malataverne J, Le Flem L Spectra Biologie 2016 ; 223:45-54<\/p>\n"},{"title":"\u00c9valuation de la valeur seuil la plus co\u00fbt-efficace des marqueurs s\u00e9riques du 1er\u00a0trimestre pour l\u2019emploi du test d\u2019ADN circulant dans le d\u00e9pistage de la trisomie\u00a021\u00a0: une analyse m\u00e9dico-\u00e9conomique","media_link":"https:\/\/www.jle.com\/fr\/revues\/abc\/e-docs\/cost_effectiveness_threshold_of_first_trimester_down_syndrome_maternal_serum_screening_for_the_use_of_cell_free_dna_as_a_second_tier_screening_test_320573\/article.phtml","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Marie Blanquet, Sophie Dreux, St\u00e9phanie L\u00e9ger,\u00a0Corinne Sault,\u00a0Charline Mourgues, H\u00e9l\u00e8ne Laurichesse, Didier L\u00e9mery, Fran\u00e7oise Vendittelli, Anne Debost-Legrand, Fran\u00e7oise Muller\nAnnales de Biologie Clinique Volume 79, num\u00e9ro 4, Juillet-Ao\u00fbt 2021"},{"title":"Evaluation of the performance of a new automated HIV combination assay","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29020658","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Ghisetti V, Coignard C, Allice T, Ly TD\nJ Clin Virol 2017 ; 96:80-83"},{"title":"Evaluation of the SLOMYCO Sensititre\u00ae panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27150659","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Chazel M, Marchandin H, Keck N, Terru D, Carri\u00e8re C, Ponsoda M, Jacomo V, Panteix G, Bouzinbi N, Ba\u00f1uls AL, Choisy M, Solassol J, Aubry, Godreuil S\nAnn Clin Microbiol Antimicrob 2016 ; 15:30"},{"title":"Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities","media_link":"http:\/\/www.bloodjournal.org\/content\/132\/Suppl_1\/943?sso-checked=true","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"On Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group\nElise Chapiro, Elodie Pramil, M\u2019boyba Diop, Damien Roos-Weil, Cl\u00e9mentine Dillard, Cl\u00e9mentine Gabillaud, Karim Maloum, Catherine Settegrana, Lucile Baseggio, Jean-Fran\u00e7ois Lesesve, M\u00e9lanie Yon, Ludovic Jondreville, Claude Lesty, Fr\u00e9d\u00e9ric Davi, Magali Le Garff-Tavernier, Nathalie Droin, Philippe Dessen, Caroline Algrin, V\u00e9ronique Leblond, Jean Gabarre, Simon Bouzy, Virginie Eclache, Baptiste Gaillard, Evelyne Callet-Bauchu, Marc Muller, Christine Lefebvre, Nathalie Nadal, Antoine Ittel, St\u00e9phanie Struski, Marie-Agn\u00e8s Collonge-Rame, Benoit Quilichini, Sandra Fert-Ferrer, Nathalie Auger, Isabelle Radford-Weiss, Lena Wagner, Sebastian Scheinost, Thorsten Zenz, Santos A. Susin, Olivier A. Bernard, Florence Nguyen-Khac\nBlood 2018 132:943; doi:"},{"title":"Identification of a polygalacturonase (Cup s 2) as the major CCD-bearing allergen in Cupressus sempervirens pollen","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28439939","date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Shahali Y, Sutra JP, Hilger C, Swiontek K, Haddad I, Vinh J, Guilloux L, Charpin D, S\u00e9n\u00e9chal H, Poncet\nAllergy 2017 ; doi: 10.1111\/all.13191"},{"title":"Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. \u2013 Trends over 10 years","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26518058","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bailly S, Maubon D,\u00a0Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF\nJ Infect\u00a02015 ; Oct 28. pii: S0163-4453(15)00342-4. doi: 10.1016\/j.jinf.2015.09.041"},{"title":"Impact of Including or Removing Nuchal Translucency Measurement on the Detection and False-Positive Rates of First-Trimester Down Syndrome Screening","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26656919","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Spaggiari E, Czerkiewicz I, Sault C, Dreux S, Galland A, Salomon LJ, Ville Y, Muller F\nFetal Diagn Ther 2015 ; Dec 12"},{"title":"Int\u00e9r\u00eat du s\u00e9quen\u00e7age haut d\u00e9bit dans les h\u00e9mopathies my\u00e9lo\u00efdes chroniques : quelles actualit\u00e9s en 2022 ?","media_link":"","date":"01\/09\/2022","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
B. Quilichini Journal de Biologie M\u00e9dicale \/ Volume 11-Num\u00e9ro 42 \/ Juil-Sept 2022<\/p>\n"},{"title":"Interf\u00e9rences s\u00e9rologiques du traitement du my\u00e9lome multiple par daratumumab (anti-CD38) : \u00e0 propos d\u2019un cas","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28540859","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Rabut E, Castro-Fernandez A, Le Gall V, Meknache\nAnn Biol Clin 2017 ; 75:351-355"},{"title":"Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31379011","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Penther D, Etancelin P, Lusina D, Bidet A, Quilichini B, Gaillard B, Rafdord-Weiss I, Mozziconacci MJ, Ittel A, Roche-Lestienne C, Barin C, Soler G, Daudignon A, Nadal N, Chapiro E, Lefebvre C, Godon C, Nadeau G, Mugneret F, Richebourg S, Viailly PJ, Ferret Y, Nguyen-Khac F, Eclache V; Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique\nAm J Hematol 2019 Aug 4. doi: 10.1002\/ajh.25601."},{"title":"Large outbreak of urogenital schistosomiasis acquired in Southern Corsica: monitoring the early signs of the endemicization?","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28669843","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"No\u00ebl H, Ruello M, Maccary A, Pellat C, Sommen C, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Durand J, Ramalli L, Chiappini JD , Malfait P, Berry\nClin Microbiol Infect 2017 ; pii: S1198-743X(17)30350-6. doi: 10.1016\/j.cmi"},{"title":"Les niveaux de preuve des biomarqueurs utilis\u00e9s pour la d\u00e9tection pr\u00e9coce des cancers de la prostate","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27029727","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Lamy PJ, Gauchez AS, Salomon L et al et le Groupe de biologie de la prostate : Sault C et al\nAnn Biol Clin 2016 ; 74:227-232"},{"title":"Marqueurs de d\u00e9pistage et de pr\u00e9diction de la pr\u00e9-\u00e9clampsie : place de la biologie","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Sault C\nJ Biol Med 2017 ; 6:186-190"},{"title":"Non-invasive prenatal testing: what are we missing?\u00a0","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32119166","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fries N, Le Garrec S, Egloff M, Sault C, Dreux S, Mangione R, Salomon LJ, Ville Y. \nUltrasound Obstet Gynecol. Mars 2020 - 2. doi: 10.1002\/uog.22005."},{"title":"Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28189936","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Thibault V, Servant-Delmas A, Ly TD, Roque-Afonso AM, Laperche S\nJ Clin Virol 2017 ; 89:14-21"},{"title":"Persistence of Zika virus in gradient sperm preparation","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29510270","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Cassuto NG, Marras G, Jacomo V, Bouret D\nJ Gynecol Obstet Hum Reprod 2018, pii: S2468-7847(18)30038-2"},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Emile C, Sault C\nSpectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49."},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"12\/12\/2022","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Emile C, Sault C<\/strong>. Spectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49.<\/p>\n"},{"title":"Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Potential+value+of+placental+angiogenic+factors+as+biomarkers+in+preeclampsia+for+clinical+physicians","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Boulanger H, Lef\u00e8vre G, Ahriz Saksi S, Achiche J, Bailleul S, Ekoukou D, Drouin D, Sault C, Stawiarski N, Dupuis E.\nNephrol Ther. 2019 Mar 29"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0755498219304178?via%3Dihub","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Hamdi SM, Sault C, Piver E, Genoux A, Masson D, Guibourdenche J.\nPresse Med . 2019 Oct 29. pii: S0755-4982(19)30417-8. doi: 10.1016\/j.lpm.2019.09.029. PMID:31676218"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/doi.org\/10.1016\/j.lpm.2019.09.029","date":"12\/12\/2019","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Hamdi SM, Sault C<\/strong>, Piver E, Genoux A, Masson D, Guibourdenche J. Presse Med. (2019)<\/p>\n"},{"title":"Preliminary report of an autochthonous Chikungunya outbreak in France, July to September 2017","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29019313","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Calba C, Guerbois-Galla M, Franke F, Jeannin C, Auzet-Caillaud M, Grard G, Pigaglio L, Decoppet A, Weicherding J, Savaill MC, Munoz-Riviero M, Chaud P, Cadiou B, Ramalli L, Fournier P, Noel H, De Lamballerie X, Paty MC, Leparc-Goffart I\nEuro Surveill 2017 ; 22(39):pii=17-00647"},{"title":"Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance","media_link":"https:\/\/www.nature.com\/articles\/s41467-021-23233-6","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"St\u00e9phane Le Vu,\u00a0Gabrielle Jones,\u00a0Fran\u00e7ois Anna,\u00a0Thierry Rose,\u00a0Jean-Baptiste Richard,\u00a0Sibylle Bernard-Stoecklin,\u00a0Sophie Goyard,\u00a0Caroline Demeret,\u00a0Olivier Helynck,\u00a0Nicolas Escriou,\u00a0Marion Gransagne,\u00a0St\u00e9phane Petres,\u00a0Corinne Robin,\u00a0Virgile Monnet,\u00a0Louise Perrin de Facci,\u00a0Marie-Noelle Ungeheuer,\u00a0Lucie L\u00e9on,\u00a0Yvonnick Guillois,\u00a0Laurent Filleul,\u00a0Pierre Charneau,\u00a0Daniel L\u00e9vy-Bruhl,\u00a0Sylvie van der Werf\u00a0&\u00a0Harold Noel\u00a0\nNature Communications volume 21\/05\/2021 12, Article number: 3025 (2021)"},{"title":"Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/30789329\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Tatai C, Berland JL, Claude JB, Westeel E, Hodille E, Fredenucci I, Rasigade JP, Ponsoda M, Jacomo V, Vach\u00e9e A, Gaudart A, Gaillard JL, Roux AL, Ader F, Tararbit K, Terpant G, Bryant JE, Lina G, Dumitrescu O; Lyon TB Study Group.Genestet C, et al.\nEmerg Infect Dis. 2019 Mar;25(3):589-592. doi: 10.3201\/eid2503.181124 - PMID: 30789329"},{"title":"R\u00e9activit\u00e9 crois\u00e9e in silico, in vitro, in vivo","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Guilloux L, Ricard-Blum S\nAllergies alimentaires 2017 ; chapitre 7.5:97-102"},{"title":"Recherche et identification des anticorps antinucl\u00e9aires : analyse du questionnaire europ\u00e9en de l\u2019EASI groupe et confrontation des pratiques fran\u00e7aises aux recommandations internationales","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29623889","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Musset L, Fabien N, Chyderiotis G, Olsson NO, Pham BN, Durey Dragon MA\nAnn Biol Clin 2018, 76 :185-195"},{"title":"Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission.","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31806715\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Paret R, Pichat C, Berland JL, Jacomo V, Carret G, Fredenucci I, Hodille E, Rasigade JP, Boisset S, Carricajo A, Lina G, Ronnaux-Baron AS, Mornex JF, Grando J, S\u00e9n\u00e9chal A, Ader F, Dumitrescu O; Lyon TB study group.Genestet C, et al.\nEur Respir J. 2020 Mar 20;55(3):1901888. doi: 10.1183\/13993003.01888-2019. Print 2020 Mar"},{"title":"Schistosomose en Corse : chronique d\u2019une histoire annonc\u00e9e","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Berry A, Iriart X, Boissier J, Chyd\u00e9riotis G, Debruyne M, Magnaval JF, Fillaux J, Grech-Angelini S, Barr\u00e9-Cardi H, Termignon JL, Macarry A, Noel H\nLa Lettre de l'Infectiologue 2016 ; XXXI n\u00b02:60-64"},{"title":"Screening and identification of antinuclear antibodies (ANA): analysis of the European EASI survey and confrontation of the French routine practice to the international recommandations","media_link":null,"date":null,"media_type":"document","profils":"579,575,574,","document_type":"publication","content":"Musset L, Fabien N, Chyd\u00e9riotis G, Olsson NO, Pham BN, Dragon-Durey MA\nAnn Biol Clin 2017 ;"},{"title":"Surveillance des infections humaines par hantavirus en France m\u00e9tropolitaine, 2012-2016","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Reynes JM, Carli D, Renaudin B, Fizet A, Bour JB, Brodard V, Cart-Tanneur E, Dewilde A, El Hamri M, Fleury H, Hecquet D, Jeulin H, Lechat S, Lemarquand-Bardini M, Lepiller Q, Poveda JD, Raulin O, Twizeyimana E, Van Cauteren D, Velay A, Septfons A, Baize S\nBEH 2017 ; 23:492-499"},{"title":"Surveillance du chikungunya et de la dengue en France m\u00e9tropolitaine, 2014","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resume_Septfons-A_2016_330-70-77.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Septfons A, No\u00ebl H, Leparc-Goffart I, Giron S, Delisle E, Chappert JL, Catelinois O, Franke F, Servas V, Guinard A, Debruyne M, Schaal O, Brichler S, Ninove L, Prat C, Flusin O, Poujol I, Letort MJ, Deniau J, Six C, Rousseau C, De Valk H, Paty MC\nLes Feuillets de Biologie 2016 ; 330:70-77"},{"title":"Surveillance du chikungunya, de la dengue et des infections \u00e0 virus Zika en France m\u00e9tropolitaine, 2017","media_link":"http:\/\/invs.santepubliquefrance.fr\/beh\/2018\/24\/pdf\/2018_24_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fournet N, Franke F, Chaud P, Raguenaud ME, Calba C, Septfons A, Cart-Tanneur E. et al.\nBull Epid\u00e9miol Hebd. 2018;(24):494-503."},{"title":"Testing anti-neutrophil cytoplasmic antibodies (ANCA): analysis of the European EASI survey on the daily practice of the French laboratories","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28958962","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dragon-Durey MA, Fabien N, Chyd\u00e9riotis G, Musset L, Pham BN, Olsson N\nAnn Biol Clin 2017 ; 75:531-541"},{"title":"The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)","media_link":"","date":"06\/09\/2022","media_type":"document","profils":"579,575,574,","document_type":"publication","content":"\n
Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nab\u00e9ra C, Chapiro E, Collonge-Rame MA, Cuccuini W, Douet-Guilbert N, Eclache V, Luquet I, Michaux L, Nadal N, Penther D, Quilichini B<\/strong>, Terre C, Lefebvre C, Troadec MB, V\u00e9ron\u00e8se L. Leukemia. 2022 Jun;36(6):1451-1466. doi: 10.1038\/s41375-022-01561-w. Epub 2022 Apr 16.PMID: 35430613 Review.<\/p>\n"},{"title":"The impact of introducing combined first-trimester trisomy 21 screening in the French population","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26628633","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Eur J Public Health 2015 ; Nov 30"},{"title":"The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34284044\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Maxime Espi, Xavier Charmetant, Thomas Barba, Laetitia Koppe, Caroline Pelletier, Emilie Kalbacher, Elodie Chalencon, Virginie Mathias, Anne Ovize, Emmanuelle Cart-Tanneur, Christine Bouz, Laurence Pellegrina, Emmanuel Morelon, Denis Fouque, Laurent Juillard, Olivier Thaunat\nKidney International 2021 Oct;100(4):928-936. doi: 10.1016\/j.kint.2021.07.005."},{"title":"Thrombop\u00e9nie induite par l\u2019h\u00e9parine (TIH) : \u00e0 propos d\u2019un casLe Flem L, Emile C","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Le Flem L, Emile C, Spectra Biologie 2016 ; 220:49-50<\/p>\n"},{"title":"Une interf\u00e9rence dans le dosage de l\u2019insuline r\u00e9v\u00e8le un syndrome auto-immun anti-insuline","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27492703","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Lamy PJ, Sault C, Renard E\nAnn Biol Clin 2016 ; 74:490-494"},{"title":"Vector-borne Transmission of Zika Virus in Europe, Southern France, August 2019","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31718742\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Sandra Giron, Florian Franke, Anne Decoppet, Bernard Cadiou, Thierry Travaglini, Laurence Thirion, Guillaume Durand, Charles Jeannin, Gr\u00e9gory L\u2019Ambert, Gilda Grard, Harold No\u00ebl, Nelly Fournet, Michelle Auzet-Caillaud, Christine Zandotti, Samer Abouka\u00efs, Pascal Chaud, Saby Guedj, Lakri Hamouda, Xavier Naudot, Anne Ovize, Cl\u00e9ment Lazarus, Henriette de Valk, Marie-Claire Paty, Isabelle Leparc-Goffart\nEuro Surveill. 2019 Nov;24(45):1900655."},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Faux-positif-ADNlcT21_L-Druart_012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Faux positif d\u2019ADNlcT21 avec diff\u00e9rentes anomalies chromosomiques confin\u00e9es au placenta\nL Druart, H Dessuant, JF Taly, M Nouchy, L Raymond, S Tapia"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Developpement-panel-15-marqueurs_F.-Rousseau-et-al.-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9veloppement d\u2019un panel de 15 marqueurs pour une identitovigilance\ndes \u00e9chantillons analys\u00e9s par s\u00e9quen\u00e7age haut d\u00e9bit ou sur puces \u00e0 SNP\nF Rousseau, J-F Taly, C Ploton Nicollet, M Taoudi, A Perdriau, L Raymond"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20359-Assises-de-Genetique-2020_B-Quilichini_012020.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Mise en place d\u2019un panel de g\u00e8nes cibl\u00e9s pour les h\u00e9mopathies\nmalignes (NMP-LMMC-SMD-LAM) par NGS : Enjeux M\u00e9dical \/ Scientifique et d\u2019Assurance Qualit\u00e9.\nV Geromel, E Fayolle, P Mouty, R Moulin, N Batail, M-H Felix, B Adde, S Mouty, L Raymond, B Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20362-Assises-de-Gntique-2020_B_Quilichini-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Impact diagnostique, pronostique et th\u00e9ranostique d\u2019un panel de g\u00e8nes\n\u00ab H\u00e9mopathies My\u00e9lo\u00efdes \u00bb r\u00e9alis\u00e9 par NGS : l\u2019exp\u00e9rience du laboratoire Eurofins Biomnis en 2019.\nV. Geromel, P. Mouty, C. Chal, J . Delaunay, S. Sadot-Lebouvier, R. Kaphan, J. Vigvari, J.P. Coadic, E.A. Marin La Meslee, O. Roualdes, C. Bourdin, A. Petit, M. Roumigui\u00e8res, L. Raymond, B.Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 4","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Les_assises_2020_RadoslavaSARAEVA_LAMRI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"21-24 janvier 2020, Tours\nDiagnostics g\u00e9n\u00e9tiques multiples (double hits) par s\u00e9quen\u00e7age Whole Exome (WES) : \u00e0 propos de deux cas.\nR. SARAEVA-LAMRI, A. DORELLE, V. GEROMEL, A. S. LEBRE, P. MOUTY, M. E. NAUD BARREYRE, F. ROUSSEAU, M. TAOUDI, L. MESNARD, L. RAYMOND"},{"title":"10th International Congress on Autoimmunity, Leipzig, April 6-10, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_4.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Should Dense Fine Speckled 70 (DFS70) pattern be reported? Biomnis reference lab experience on 12 619 ANA screening consecutive sera\nGuis L, Ebel A, Leroy J, Michaud S, Pomaredes A, Marcenaro C, Chalouas L"},{"title":"12\u00e8me CFA, Paris, avril 25-28, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":""},{"title":"12\u00e8me Congr\u00e8s de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Paris, mars 22-23, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Jacomo_3.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Les Liquides C\u00e9phalo-Rachidiens : conservation pr\u00e9-analytique \u00e0+ 4 \u00b0C ou \u2013 20 \u00b0C ?\nJacomo V, Schaal O, Fournier P"},{"title":"17\u00e8mes Journ\u00e9es Francophones de Virologie, Paris, avril 9, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"R\u00e9solution des \u00e9checs de g\u00e9notypage de la technique Abbott RealTime HCV Genotype II par un test temps r\u00e9el additionnel\nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ly_8.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of a new high sensitive, qualitative and quantitative Hepatitis B surface antigen assay\nLy TD, Coignard C"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Characterization of samples with genotype 1 without subtype results by Abbott RealTime HCV genotype II using the new Abbott HCV Genotype Plus RUO test \nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"19th Annual Meeting of the European Society for Clinical Virology (ESCV), Lisbon, september, 14\u201317, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/09\/Biomnis_Poster_2016_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to COBAS\u00ae AmpliPrep\/OBAS\u00ae TaqMan\u00ae HIV-1 and HBV tests\nEbel A, Bali C, Guis L, Merlin S"},{"title":"20\u00e8mes Journ\u00e9es de M\u00e9decine Foetale, Morzine, mars 26-28, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015__Becker_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Int\u00e9r\u00eat du D\u00e9pistage Pr\u00e9natal Non Invasif dans le diagnostic des aneuplo\u00efdies 13, 18 et 21 \nBecker M, Eg\u00e9a G, Taoud M, Ahmed Chaouch D, El Mouatassim S"},{"title":"20Th Congress European Hematology Association, Vienna, June 11-14, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Rigollet_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Characterization of normal and pathological lymphoid populations: validation of a 10-colors flow cytometry protocol for routine diagnosis \nRigollet L, Stagnara J, Milhau A, Pellegrina L"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/10\/Biomnis_Poster-Aptima-HIV-1-HBV_Ebel_Sept18.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV-1 Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to Cobas\u00ae 6800\/8800 HIV-1 and HBV tests\nA. Ebel, C. Bali, L. Guis, S. Merlin"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/11\/Poster-IgM-Measles-ESCV-TD-LY-.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of new IgM Measles assay\nT.D. Ly, C. Coignard"},{"title":"24e Journ\u00e9es de m\u00e9decine f\u0153tale, Marseille, 4-5-6 avril 2019","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9pistage de la trisomie 21 par analyse de l\u2019ADN f\u0153tal libre circulant dans le sang maternel : Application dans le cas des grossesses g\u00e9mellaires\nMarc NOUCHY, Nicolas CHATRON, Pascal MOUTY, Francis ROUSSEAU, Barbara ADD\u00c9, Mohamed Taoudi, Caroline DUMONT, Jean-Fran\u00e7ois TALY, Luc DRUART, Sylvie TAPIA, Damien SANLAVILLE, Laure RAYMOND"},{"title":"25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, April 25-28, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of three fully automated assays for the detection of cytomegalovirus IgM and IgG: DiaSorin LIAISON\u00ae XL, Abbott Architect \u00ae and Roche Cobas 6000\u00ae\nBouthry E, Ly TD, Vauloup-Fellous C"},{"title":"27th ECCMID, Vienna Austria, April 22-25, 2017","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Strain-specific estimation of epidemic success provides insights into the transmission dynamics of tuberculosis Rasigade\nJP, Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, P\u00e9rouse de Montclos M, Flandrois JP, Ader F, Supply P, Lina G, Wirth T"},{"title":"29th IUSTI European Conference on Sexually Transmitted Infections, Sitges (Barcelona), 24-26 September, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Prevalence of Mycoplasma genitalium in France and comparison with Chlamydia trachomatis and Neisseria gonorrhoeae as determined by the Mycoplasma genitalium TMA assay \nEbel A, Venard C, Brunengo D, Merlin S"},{"title":"31st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbon, June 14-17, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Force_7.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Blastocysts vitrification during 2 consecutive years: before and after its start significant delivery rate increase within the 1st year \nForce A, Nicollet B, Chomier M, Sergeant P, Lescaille M, Rochigneux S, Robert F, Ginon J, Sergeant MV, Baucher S, Schubert B"},{"title":"35e congr\u00e8s de la SFH, CNIT Paris la D\u00e9fense, avril 1-3, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Becker_4.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"La SNP array : un outil compl\u00e9mentaire pour la caract\u00e9risation des h\u00e9mopathies malignes \nBecker M, Eg\u00e9a G, Camilli K, Robin M, Roumigui\u00e8res M, Rigollet L, Stagnara J, El Mouatassim S"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_14.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Evaluation du nouveau test LAISON\u00ae H. pylori IgG\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_15.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Borr\u00e9liose et index de synth\u00e8se intrath\u00e9cale : bilan biologique r\u00e9trospectif de l\u2019ann\u00e9e 2015\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Ebel_16.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation des performances de la trousse Aptima\u00ae HBV Quant (Hologic)\nEbel A, Bali C, Guis L, Merlin S"},{"title":"37\u00e8me RICAI, Paris, d\u00e9cembre 18-19, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/12\/Biomnis_Poster_2017_Coignard_13.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Confirmation VIH : donn\u00e9es biologiques et \u00e9pid\u00e9miologiques des 3 derni\u00e8res ann\u00e9es dans un laboratoire de biologie sp\u00e9cialis\u00e9e\nCoignard C, Ly TD"},{"title":"38e RICAI, Paris 17-18 d\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-COIGNARD-ROUGEOLE.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Epid\u00e9mie de rougeole 2018 : le s\u00e9rodiagnostic un marqueur simple et performant.\nT.D. Ly, C. Coignard"},{"title":"3e Journ\u00e9e Francophone de Biologie M\u00e9dicale, Monaco, 6-7-8 novembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/11\/1911_poster_A.Ebel_JFBM.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"D\u00e9pistage syst\u00e9matique de Neisseria gonorrhoeae et de C. trachomatis par test d\u2019amplification g\u00e9nique : bilan d\u2019une ann\u00e9e d\u2019exp\u00e9rience\nL. Mine, L. Guis, S. Merlin, A. Ebel"},{"title":"40e RICAI \u2013 R\u00e9union Interdisciplinaire de Chimioth\u00e9rapie Anti-Infectieuse, 14-15 d\u00e9cembre","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Posters\/2012_Poster_SARS-CoV-2_RICAI_C.Coignard.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"S\u00e9rologie SARS-CoV-2 : \u00e9valuation, qualification et choix d\u2019une m\u00e9thode\nCatherine Coignard, Anne EBEL, Yanis BOUAMRA, Didier RIDEY, Carla MARCENARO"},{"title":"42es Journ\u00e9es Nationales \u2013 Congr\u00e8s CNGOF, Strasbourg, 4-7 D\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-EMILE-DPNI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"\u00c9tude de l\u2019usage du DPNI (d\u00e9pistage pr\u00e9natal non invasif) des aneuplo\u00efdies en milieu lib\u00e9ral\nC. Emile, L. Raymond, L. Pellegrina"},{"title":"45\u00e8me Colloque National des Biologistes des H\u00f4pitaux, Paris, juin 22-24, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/06\/Biomnis_Poster_2016-Rabut_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Interf\u00e9rence du traitement par daratumumab (anti-CD38) dans le suivi biologique du my\u00e9lome multiple et dans la recherche d\u2019anticorps anti-\u00e9rythrocytaires : \u00e0 propos d\u2019un cas\nRabut E, Castro-Fernandez A, Le Gall V, Meknache N"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Raymond_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport diagnostique de l\u2019utilisation des puces SNP dans l\u2019\u00e9tude chromosomique des morts f\u0153tales\nRaymond L, Dherbey JL, Rebeyrat-Pichon I, El-Mouatassim S, Egea G"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier, 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_11.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Cas rare d\u2019X-fragile pr\u00e9natal avec r\u00e9traction d\u2019expansion de triplet CGG ? \nMouty P, Raymond L, El Mouatassim S, Liquier A, Druart L, Paris A, Dorian V, Pichon I, Dherbey JL, Eg\u00e9a G"},{"title":"CGRF Ile de R\u00e9, septembre 28-29, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Brunengo_11.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Epid\u00e9miologie qualitative des variants rares de l\u2019H\u00e9moglobine en France m\u00e9tropolitaine au travers de la collaboration HCL \u2013 Eurofins Biomnis\nBrunengo D, Veyrenche N, Louis Chillotti L, Le Flem L"},{"title":"COGEN, Paris, Septembre 25-27, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_El-Mouatassim_11.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"French experience of Non-Invasive Prenatal Testing of trisomy 21, 18 and 13 \nEl Mouatassim S, Taoudi M, Eg\u00e9a G"},{"title":"Congr\u00e8s SFP \/ SFMM, Toulouse, mars 29-31, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/03\/Biomnis_Poster_2017_Chydriotis_1-1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport de 2 tests de d\u00e9pistage pour le diagnostic de la bilharziose et place du Western blot\nChyd\u00e9riotis G, Cart-Tanneur E, Lecuelle C, F\u00e9lix MH"},{"title":"Congr\u00e8s SFTA, Avignon, mai 10-12, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_Petit_2.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Dosage de la Ciclosporine, Tacrolimus, Ev\u00e9rolimus et Sirolimus en LCMSMS avec le coffret MassTox Chromsystems sur Api 4500 ABSciex avec pr\u00e9paration automatis\u00e9e sur T\u00e9can EVO 150\nPetit I, Moussa C, Bonnet K, Bezol A. Havrez S, Gerrier P"},{"title":"EAACI, Helsinki, June 17-21, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_6.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Bp14, an allergen from cupressus sempervirens pollen related to the family of snakin\/gibberellin-regulated proteins\nS\u00e9n\u00e9chal H, Santrucek J, Melcova M, Svoboda P, Zidkova J, Guilloux L, Aizawa T, Couderc R, Charpin D, Poncet P"},{"title":"ESCAIDE 2015, Stockholm, November 11-13, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Chyderiotis_14.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Re-emergence of urinary schistosomiasis in Europe ? Infections acquired in Southern Corsica \u2013 Investigation of a cluster of Schistosoma haematobium infections in 2014\nRamalli L, No\u00ebl H, Ruello M, Maccary A, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Denoyel GA, Succo T, Armengaud A, Paty MC, Heuz\u00e9 G, Mattei J, Th\u00e9ron A, Berry A"},{"title":"ESCV, Stresa, Lake Maggiore, September 13-16, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/10\/Biomnis_Poster_2017_LY_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new chemiluminescent assay to detect and quantify anti-HBs antibodies\nMaillard A, Ly TD, Thibault V"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_LY_3.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new LIAISON\u00ae H. pylori IgG\nLy TD, Coignard C"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Rabut_4.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Red blood cell antibody assays in DARA-treated patients\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"EuroMedLab, Paris, June 22-24, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Early Performance Evaluation of cobas\u00ae HBV, cobas\u00ae HCV and cobas\u00ae HIV-1Quantitative Nucleic Acid Tests for use on the new cobas\u00ae 6800\/8800 Systems\nEbel A, Merlin S, Marins ED G, Canchola J, Njoya M, Simon CO"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/poster-FFER-2018-callec.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Impact de la chirurgie bariatrique sur les param\u00e8tres spermatiques : Revue de la litt\u00e9rature\nR. Callec, B. Schubert, F. Robert, A. Force"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/POSTER-FFER-2018-Force.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Crit\u00e8res d\u2019interpr\u00e9tation du msome pour une optimisation de la prise en charge des patients\nA. Force, M. Chomier, P. Sergeant, J. Ginon, S. Rochigneux, M. Lechatton, M. Pont, R. Callec, F. Robert, B. Schubert"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Lopez.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation externe de la qualit\u00e9 en spermiologie : un nouveau programme pour une \u00e9valuation globale de l\u2019examen\nMarie LOPEZ, Bernard POGGI, Jean Christophe EYNARD, Marie LETY, Benoit SCHUBERT, Andr\u00e9 FORCE"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Schubert.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Influence des conditions de culture sur les r\u00e9sultats en AMP dans une \u00e9tude multicentrique : comparaison d\u2019un incubateur Time Lapse avec les incubateurs tradictionnels\nBeno\u00eet SCHUBERT, Alexandre MARCILLY, Andr\u00e9 FORCE"},{"title":"FFER, Tours, septembre 13-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Force_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Comparaison de la performance de 2 incubateurs (Geri versus Planer) apr\u00e8s randomisation de la cohorte ovocytaire pour chaque patiente\nForce A, Martine Chomier, Philippe Sergeant, Jacqueline Ginon, St\u00e9phanie Rochigneux, Soizic Baucher, M\u00e9lanie Le Chatton, M\u00e9lanie Pont, Beno\u00eet Schubert"},{"title":"FIBA 2016, Dakar, January 13-14, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"ANCA associated HIV infection in Senegal: a serological trap\nArouna O, Niang A, Abiola A, Guis L, Le Flem L, Diene JF, Mboup S"},{"title":"Fort Collins (USA), May 31-June 3, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/05\/Biomnis_Poster_2016_Jacomo_5.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Seoul Virus Infection in Human, France, 2014-2016\nReynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, Nussbaumer T, Jacomo V, Rapt MP, Septfons A, Rollin PE"},{"title":"ISMA, Lisbon, November 19-21, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2015_Guilloux_16.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Ige-cross-reactivity between european hymenoptera and asian hornet (vespa velutina) venom allergens\nLong\u00e9 C, Brazdova A, Brunet JL, Schwartz C, Girodet B, Lavaud F, Birnbaum J, Pham-Thi N, Duchateau M, Chamot-Rooke J, Guilloux L, Selva MA, Couderc R, S\u00e9n\u00e9chal H, Sutra JP, Poncet P"},{"title":"Journ\u00e9es Nationales CNGOF, Montpellier, d\u00e9cembre 7-9, 2016","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Etude pr\u00e9liminaire sur le d\u00e9pistage de la pr\u00e9-\u00e9clampsie au 1er trimestre de la grossesse (Predictor\u00ae)\nWalder R, Galland A, Sault C, Huissoud C"},{"title":"Journ\u00e9es Nationales d\u2019Infectiologie, Nantes, 13-15 juin, 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/05\/Biomnis_Poster_2018_Ebel_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Infections \u00e0 Chlamydia trachomatis : donn\u00e9es \u00e9pid\u00e9miologiques r\u00e9centes dans un laboratoire sp\u00e9cialis\u00e9\nEbel A, Guis L, Merlin S"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Poster-Lyme-RICAI-C.-Coignard-TD-Ly-dec-2019-800x1200.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of the BioPlex 2200 Lyme IgG\/IgM immunoassay system\nC. Coignard, C. Cl\u00e9ment-Vincent, Td. Ly, A. L\u2019hotellier"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/12\/2019-12-17_RICAI.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Sp\u00e9cificit\u00e9 de la s\u00e9rologie chikungunya et surveillance \u00e9pid\u00e9miologique\nC. Calba, F. Franke, E. Brottet, G. Terpant, N. Fournet, A. Ovize, J.D. Poveda, I. Leparc-Goffart, M.C. Paty"},{"title":"SFE, Bordeaux, octobre 5-8, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Sault_13.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Influence de la nature du liquide de rin\u00e7age d\u2019aiguille de cytoponction sur le dosage de la thyroglobuline\nBoux De Casson F, Moal V, Gauchez AS, Moineau MP, Sault C, Schlageter MH, Massart C"},{"title":"SFTS, Bordeaux, septembre 20-22, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Rabut_10.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Recherche et quantification de l\u2019h\u00e9morragie f\u0153to-maternelle par cytom\u00e9trie en flux avec double marquage anti-h\u00e9moglobine F et anti-anhydrase carbonique\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"XXIIIe Colloque ACLF, Montpellier, septembre 20-21, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Syndrome de Currarino atypique avec hexadactylie pr\u00e9-axiale : remaniement complexe en 7q36.3 en pr\u00e9natal\nLiquier A, Becker M, Raymond L, Bourgain A, Amat S, Broussin B, Andr\u00e9 G, Escande F, Nouchy M, Eg\u00e9a G"}]));
sessionStorage.setItem('currentLang', 'fr');render(html`<${RessourcesDynamiques} name="World" />`, document.getElementById('resdyncontainer'));
\n
<\/p>\n"},{"title":"R10 \u2013\u00a0Fiche de suivi de grossesse","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R10-FRC_Suivi-grossesse_Agents-infectieux.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":"Patiente ayant subi une amniocent\u00e8se pour recherche d\u2019agent infectieux ou parasitaire"},{"title":"R12\u00a0\u2013 Renseignements cliniques : Diagnostic de mycobact\u00e9ries","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R12-FRC_Mycobacteries.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"R23\u00a0\u2013 Bon de demande : Etude du g\u00e8ne de la mucoviscidose","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R23-FRC_Mucoviscidose.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"R28\u00a0\u2013 Renseignements cliniques :\u00a0Dengue \/ Chikungunya \/ Zika","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R28-FRC_Dengue_Chikungunya_Zika.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"R35\u00a0\u2013\u00a0Infectiologie","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R35-FRC_Infectiologie.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"R36\u00a0\u2013 Etude du g\u00e8ne de Fi\u00e8vre M\u00e9diterran\u00e9enne Familiale","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R36-FRC_FMF.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"R4\u00a0\u2013 Estimation du risque de pr\u00e9-\u00e9clampsie par l\u2019\u00e9tude des marqueurs s\u00e9riques maternels au 1er trimestre de la grossesse","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R4-FRC_Pre-eclampsie.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"R52\u00a0\u2013 Renseignements cliniques :\u00a0Cotations \u00e0 la nomenclature des PCR (Toxoplasmose, HSV, CMV, EBV, H\u00e9patite Delta et E)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R52-FRC_Cotations_NABM_PCR.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"R53\u00a0\u2013 Diagnostic de la Rougeole par RT-PCR","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R53-FRC_Rougeole.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":"Protocole et renseignements cliniques"},{"title":"R55\u00a0\u2013 Renseignements cliniques : PCR Covid-19 (SARS-CoV-2)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R55-FRC_COVID-19.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"D\u00e9cret n\u00b0 2020-1668 du 23 d\u00e9cembre 2020 modifiant les d\u00e9crets n\u00b0 2020-1262 du 16 octobre 2020 et n\u00b0 2020-1310 du 29 octobre 2020","media_link":"https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000042731199","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Prescrivant les mesures g\u00e9n\u00e9rales n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire"},{"title":"Journal Officiel 052 du 02 mars 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/03\/JO052_02032021.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 1er mars 2021 modifiant l\u2019arr\u00eat\u00e9 du 10 juillet 2020 prescrivant les mesures d\u2019organisation et de fonctionnement du syst\u00e8me de sant\u00e9 n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire."},{"title":"Journal Officiel 124 du 30 mai 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/06\/JO124_300521.pdf.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 29 mai 2021 portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale et portant modification de l\u2019arr\u00eat\u00e9 du 12 d\u00e9cembre 2020 portant modification des conditions de remboursement de l\u2019acte de d\u00e9tection du g\u00e9nome du SARS-CoV-2 par amplification g\u00e9nique"},{"title":"Journal Officiel 156 du 7 juillet 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/07\/JO156_070721.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 6 juillet 2021 modifiant l\u2019arr\u00eat\u00e9 du 1er juin 2021 prescrivant les mesures g\u00e9n\u00e9rales n\u00e9cessaires \u00e0 la gestion de la sortie de crise sanitaire"},{"title":"Journal Officiel 241 du 15 octobre 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/10\/joe_20211015_0241_0063.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 14 octobre 2021 modifiant l\u2019arr\u00eat\u00e9 du 1er juin 2021 prescrivant les mesures g\u00e9n\u00e9rales n\u00e9cessaires \u00e0 la gestion de la sortie de crise sanitaire"},{"title":"Journal Officiel 241 du 15 octobre 2021 - Annexe 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/10\/annexe_1_-_flyer_remboursement_test_covid.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Annexe 1 : Dans quels cas un test de d\u00e9pistage Covid est-il pris en charge par l\u2019Assurance Maladie ?"},{"title":"Journal Officiel 241 du 15 octobre 2021 - Annexe 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/10\/annexe_3_-_tableau_indications_de_prise_en_charge_et_justificatif.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Annexe 3 : Tableau d\u2019indications de prise en charge et justificatifs"},{"title":"Journal Officiel num\u00e9ro 175 du 30 juillet 2022","media_link":"https:\/\/www.legifrance.gouv.fr\/download\/pdf?id=oPOIInpk0Qlz7ZSxTlZ2VKdyGopLnFyQC8g3gUPiDmU=","date":"01\/08\/2022","media_type":"document","profils":"574,579,575,","document_type":"texte-reglementaire","content":"\n
Arr\u00eat\u00e9 du 29 juillet 2022 modifiant l\u2019arr\u00eat\u00e9 du 9 juillet 2022 relatif \u00e0 la vaccination contre le virus Monkeypox et portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale<\/p>\n"},{"title":"Journal Officiel num\u00e9ro 0036 du 17 d\u00e9cembre 2009","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO0036-171209.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 15 d\u00e9cembre 2009 relatif aux controles du respect des valeurs limites biologiques fix\u00e9es \u00e0 l\u2019article R. 4412-152 du code du travail pour les travailleurs expos\u00e9s au plomb et \u00e0 ses compos\u00e9s et aux conditions d\u2019accr\u00e9ditation des laboratoires charg\u00e9s des analyses"},{"title":"Journal Officiel num\u00e9ro 013 du 16 janvier 2014 \u2013 texte 11","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO013-160114-texte-11.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 14 janvier 2014 fixant le mod\u00e8le des documents mentionn\u00e9s au III de l\u2019article R. 2131-2 du code de la sant\u00e9 publique (Mod\u00e8le de refus de consentement)"},{"title":"Journal Officiel num\u00e9ro 013 du 16 janvier 2014 \u2013 texte 5","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO013-160114-texte-5.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"D\u00e9cret no 2014-32 du 14 janvier 2014 relatif aux diagnostics ant\u00e9nataux"},{"title":"Journal Officiel num\u00e9ro 021 du 24 janvier 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/01\/JO021_240121.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 23 janvier 2021 modifiant l\u2019arr\u00eat\u00e9 du 10 juillet 2020 prescrivant les mesures d\u2019organisation et de fonctionnement du syst\u00e8me de sant\u00e9 n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire"},{"title":"Journal Officiel num\u00e9ro 032 du 6 f\u00e9vrier 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/02\/JO032_060221.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 5 f\u00e9vrier 2021 modifiant l\u2019arr\u00eat\u00e9 du 10 juillet 2020 prescrivant les mesures d\u2019organisation et de fonctionnement du syst\u00e8me de sant\u00e9 n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire."},{"title":"Journal Officiel num\u00e9ro 046 du 23 f\u00e9vrier 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/02\/JO046_230221.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 22 f\u00e9vrier 2021 portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale (modification des indications relatives aux pr\u00e9l\u00e8vements salivaires pour la d\u00e9tection du g\u00e9nome du Sars-CoV-2 par RT-PCR)"},{"title":"Journal Officiel num\u00e9ro 117 du 13 mai 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/05\/JO-200513.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du\u00a012 mai 2020\u00a0portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale (inscription de la d\u00e9tection du g\u00e9nome du SARS-CoV-2 par RT PCR)"},{"title":"Journal Officiel num\u00e9ro 129 du 28 mai 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/05\/JO128-280520.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 27 mai 2020 portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale (diagnostic biologique de l\u2019infection par le SARS-CoV-2)"},{"title":"Journal Officiel num\u00e9ro 130 du 7 Juin 2013 (texte 14)","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO130-070613.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 27 mai 2013 d\u00e9finissant les r\u00e8gles de bonnes pratiques applicables \u00e0 l\u2019examen des caract\u00e9ristiques g\u00e9n\u00e9tiques d\u2019une personne \u00e0 des fins m\u00e9dicales"},{"title":"Journal Officiel num\u00e9ro 152 article 23 du 03 juillet 2009","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO152-23-030709.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 23 juin 2009 fixant les r\u00e8gles de bonnes pratiques en mati\u00e8re de d\u00e9pistage et de diagnostic pr\u00e9natals avec utilisation des marqueurs s\u00e9riques maternels de la trisomie 21"},{"title":"Journal Officiel num\u00e9ro 211 du 11 septembre 2010","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO211-110910.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 3 ao\u00fbt 2010 modifiant l\u2019arr\u00eat\u00e9 du 11 avril 2008 relatif aux r\u00e8gles de bonnes pratiques cliniques et biologiques d\u2019assistance m\u00e9dicale \u00e0 la procr\u00e9ation"},{"title":"Journal Officiel num\u00e9ro 294 du 20 d\u00e9cembre 2018","media_link":"https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000037833049\/","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 14 d\u00e9cembre 2018 modifiant l\u2019arr\u00eat\u00e9 du 23 juin 2009 modifi\u00e9 fixant les r\u00e8gles de bonnes pratiques en mati\u00e8re de d\u00e9pistage et de diagnostic pr\u00e9natals avec utilisation des marqueurs s\u00e9riques maternels de trisomie 21"},{"title":"Journal Officiel num\u00e9ro 294 du 20 d\u00e9cembre 2018 - Arr\u00eat\u00e9 du 14 d\u00e9cembre 2018 modifiant l\u2019arr\u00eat\u00e9 du 14 janvier 2014","media_link":"https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000037833049\/","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Fixant le mod\u00e8le des documents mentionn\u00e9s au III de l\u2019article R. 2131-2 du code de la sant\u00e9 publique"},{"title":"Journal Officiel num\u00e9ro 294 du 20 d\u00e9cembre 2018.","media_link":"https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000037833049\/","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 14 d\u00e9cembre 2018 pris en application de l\u2019article R. 2131-2-3 du code de la sant\u00e9 publique"},{"title":"Journal Officiel num\u00e9ro 297 du 09 d\u00e9cembre 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/12\/JO297-091220.pdf.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 8 d\u00e9cembre 2020 modifiant l\u2019arr\u00eat\u00e9 du 10 juillet 2020 prescrivant les mesures d\u2019organisation et de fonctionnement du syst\u00e8me de sant\u00e9 n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire"},{"title":"Journal Officiel num\u00e9ro 301 du 13 d\u00e9cembre 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/12\/JO301_131220.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 12 d\u00e9cembre 2020 portant modification des conditions de remboursement de l\u2019acte de d\u00e9tection du g\u00e9nome du SARS-CoV-2 par amplification g\u00e9nique"},{"title":"Journal Officiel num\u00e9ro 302 du 30 d\u00e9cembre 2011","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO302-301211.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 26 d\u00e9cembre 2011 fixant la liste des centres nationaux de r\u00e9f\u00e9rence pour la lutte contre les maladies transmissibles et des laboratoires associ\u00e9s"},{"title":"Journal Officiel num\u00e9ro 58 du 7 mars 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/JO058-070320.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 7 mars 2020 portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale (inscription de la d\u00e9tection du g\u00e9nome du SARS-CoV-2 par RT PCR)"},{"title":"Comment am\u00e9liorer et acc\u00e9l\u00e9rer le diagnostic des maladies d\u2019origine g\u00e9n\u00e9tique ?","media_link":"https:\/\/www.youtube.com\/embed\/9mjWjvViCkE ","date":"20\/07\/2022","media_type":"video","profils":"574,575,","document_type":"parole-expert","content":""},{"title":"La d\u00e9marche diagnostic en allergologie","media_link":"https:\/\/youtube.com\/embed\/MT-H2HHe1k0","date":null,"media_type":"video","profils":"575,576,574,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur la d\u00e9marche diagnostic en allergologie, expliqu\u00e9 en quelques minutes par le Dr Christine Bouz, biologiste m\u00e9dicale au laboratoire Eurofins Biomnis."},{"title":"La prise en charge biologique des h\u00e9mopathies malignes","media_link":"https:\/\/youtube.com\/embed\/FW0ydxXHhjo","date":null,"media_type":"video","profils":"574,575,576,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur La prise en charge biologique des h\u00e9mopathies malignes, expliqu\u00e9 en quelques minutes par le Dr Beno\u00eet QUILICHINI, biologiste m\u00e9dical au laboratoire Eurofins Biomnis."},{"title":"Le d\u00e9pistage pr\u00e9natal non invasif de la trisomie 21 (DPNI)","media_link":"https:\/\/youtube.com\/embed\/pwH5egBvNWI","date":null,"media_type":"video","profils":"575,574,576,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur le d\u00e9pistage pr\u00e9natal non invasif de la trisomie 21 (DPNI), expliqu\u00e9 en quelques minutes par le Dr Sylvie TAPIA, g\u00e9n\u00e9ticienne au laboratoire Eurofins Biomnis."},{"title":"Le g\u00e9notypage du rh\u00e9sus D foetal","media_link":"https:\/\/youtube.com\/embed\/xHROBADhgAI","date":null,"media_type":"video","profils":"574,576,575,","document_type":"parole-expert","content":"Tout ce qu'il faut savoir sur le g\u00e9notypage du rh\u00e9sus D foetal, expliqu\u00e9 en quelques minutes par le Dr Laurence STROMPF-SILVESTRE, m\u00e9decin biologiste au laboratoire Eurofins Biomnis."},{"title":"Les intol\u00e9rances alimentaires","media_link":"https:\/\/youtube.com\/embed\/jj9iYVJCZuc","date":null,"media_type":"video","profils":"575,576,574,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur les intol\u00e9rances alimentaires, expliqu\u00e9 en quelques minutes par le Dr Emmanuelle CART-TANNEUR, biologiste m\u00e9dical au laboratoire Eurofins Biomnis."},{"title":"Place du test HPV dans le d\u00e9pistage primaire du cancer du col de l\u2019ut\u00e9rus","media_link":"https:\/\/youtube.com\/embed\/PaHkXjzNAsY","date":null,"media_type":"video","profils":"574,576,575,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur le d\u00e9pistage primaire du cancer du col de l\u2019ut\u00e9rus et le test HPV par le Dr Anne EBEL, biologiste m\u00e9dicale au laboratoire Eurofins Biomnis"},{"title":"ABCB1 - Le test g\u00e9n\u00e9tique pour optimiser le traitement de la d\u00e9pression (DS45)\nle choix des antid\u00e9presseurs\ndans le traitement de la d\u00e9pression (DS45-ABCB1)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS45-ABCB1.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux professionnels de sant\u00e9"},{"title":"ALEX\u00ae - Explorateur d\u2019allergies (DS67)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS67-Allergie_Alex.pdf","date":null,"media_type":"document","profils":"579,575,574,","document_type":"le-point-sur","content":""},{"title":"Allergie d\u00e9marche diagnostique (DS10)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS10-Allergie_demarche_diag.pdf","date":null,"media_type":"document","profils":"579,575,574,","document_type":"le-point-sur","content":"Principaux examens et interpr\u00e9tation"},{"title":"Allergie nomenclature (DS9)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS9-Allergie_nomenclature.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Autres tumeurs solides - fiche oncologie (DS86)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS86-Autres_tumeurs.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Biologie de la femme (DS11)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS11-Biologie_femme.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"le-point-sur","content":""},{"title":"Cancer de l\u2019ovaire\nHE4 & score ROMA (DS13)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS13-HE4.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Caract\u00e9risation g\u00e9n\u00e9tique de l\u2019infertilit\u00e9 masculine par s\u00e9quen\u00e7age d\u2019exome - Un nouvel outil de diagnostic (DS66)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS66-Exome_infertilite_masculine.pdf","date":"","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Cardiomyopathies et troubles du rythme (DS88)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS88-HP-Cardiogenetique.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"L'apport de la g\u00e9n\u00e9tique dans la prise en charge des patientes et de leurs familles"},{"title":"D\u00e9pistage de la trisomie 21, 18 et 13 par analyse de l\u2019ADN libre circulant (ADNlc) (DS29-HP)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS29-DPNI_HP_leaflet.pdf","date":"10\/01\/2023","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"\n
Le test de d\u00e9pistage pr\u00e9natal sur simple prise de sang maternel<\/p>\n"},{"title":"D\u00e9termination pr\u00e9natale du g\u00e9notype RHD f\u0153tal \u00e0 partir du sang maternel (DS37HP)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS37-HP-Rhesus_D_foetal.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic des infections \u00e0 Mycobact\u00e9ries (DS1)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS1-Mycobacteries.pdf","date":"26\/10\/2022","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic et suivi des N\u00e9oplasies My\u00e9lo\u00efdes Chroniques (DS2)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS2-Neoplasies_myeloides_chroniques.pdf","date":"","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic, pronostic et suivi des Leuc\u00e9mies aigu\u00ebs (DS3)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS3-Leucemies_aigues.pdf","date":"","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic, pronostic et suivi des N\u00e9oplasies Lympho\u00efdes Matures (DS62)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS62-Neoplasies_lymphoides_matures.pdf","date":"","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Digestif- fiche oncologie (DS84)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS84-Onco-digestif.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Exploration g\u00e9n\u00e9tique des n\u00e9phropathies tubulo-interstitielles : challenge technique pour MUC1 ! (DS104)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS104-Nephropathies_MUC1.pdf","date":"032\/04\/2024","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Fibrometer - Scores de fibrose h\u00e9patique (DS46)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS46-Fibrometer.pdf","date":null,"media_type":"document","profils":"575,","document_type":"le-point-sur","content":""},{"title":"Gyn\u00e9cologie - fiche oncologie (DS85)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS84-Onco-digestif.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Juvenalis (JU-DS47)","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/11\/JU-DS47-Juvenalis.pdf","date":null,"media_type":"document","profils":"579,575,574,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux professionnels de sant\u00e9"},{"title":"Juvenalis (JU-DS48)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/JU-DS48-PA.pdf","date":null,"media_type":"document","profils":"575,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux patients"},{"title":"Le s\u00e9quen\u00e7age de l\u2019exome dans l\u2019insuffisance ovarienne pr\u00e9matur\u00e9e : Pour une orientation plus pr\u00e9cise et personnalis\u00e9e des patientes et couples (DS111)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS111-Exome_IOP.pdf","date":"03\/04\/2024","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Le s\u00e9quen\u00e7age de l\u2019exome en contexte pr\u00e9natal (DS108)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS108-Exome_prenatal.pdf","date":"07\/11\/2023","media_type":"document","profils":"575,","document_type":"le-point-sur","content":"\n
Pour un diagnostic optimis\u00e9 en cas de malformations foetales<\/p>\n"},{"title":"Le s\u00e9quen\u00e7age Whole Exome dans les maladies d\u2019origine g\u00e9n\u00e9tique (DS34)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS34-Exome.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Les autoanticorps dans le diagnostic et le suivi des maladies auto-immunes (DS4)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS4-Auto-immunite.pdf","date":"27\/04\/2022","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Les maladies transmises par les tiques (DS20)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS20-Maladies_tiques.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Leuc\u00e9mie Aigu\u00eb My\u00e9lo\u00efde (LAM) (DS68)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS68-LAM.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Leuc\u00e9mie my\u00e9lomonocytaire chronique (LMMC) (DS71)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS71-LMMC.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Microbiote intestinal (JU-DS73-PA)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/JU-DS73-PA-Microbiote.pdf","date":"","media_type":"document","profils":"575,576,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux patients"},{"title":"Microbiote intestinal (JU-DS76-PH)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/JU-DS76-HP-Microbiote.pdf","date":null,"media_type":"document","profils":"575,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux professionnels de sant\u00e9"},{"title":"N\u00e9oplasies My\u00e9loprolif\u00e9ratives Diagnostic (DS69)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS69-NMP_diagnostic.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Oncog\u00e9n\u00e9tique - Pr\u00e9dispositions h\u00e9r\u00e9ditaires aux cancers : Int\u00e9r\u00eat du s\u00e9quen\u00e7age de l'exome (DS94)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS94-Oncogenetique_exome.pdf","date":"18\/10\/2023","media_type":"document","profils":"575,","document_type":"le-point-sur","content":""},{"title":"Oncog\u00e9n\u00e9tique constitutionnelle : Utilisation du s\u00e9quen\u00e7age Long-ReadNanopore - l\u2019exemple du g\u00e8ne PMS2 (DS112) ","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS112-Sequencage_long_read_PMS2.pdf","date":"18\/10\/2023","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Panels de g\u00e8nes SPINK1, PRSS1, CTRC, CPA1, CFTR et CASR pour le diagnotsic des pancr\u00e9atites h\u00e9r\u00e9ditaires (DS82)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS82-HP-Pancreatites_hereditaires.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Papillomavirus humains et d\u00e9pistage primaire du cancer du col de l\u2019ut\u00e9rus (DS6)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS6-HPV.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Pneumologie - fiche oncologie (DS83)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS83-Onco-pneumologie.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Prise en charge de la pr\u00e9-\u00e9clampsie (DS18)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS18-Pre-eclampsie.pdf","date":"","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Prise en charge des tumeurs solides en Biopathologie (DS5)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS5-Tumeurs_solides.pdf","date":"","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"PROSIGNA\u00ae (PAM50) (DS79)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS79-HP-PAM50.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"Test d\u2019expression g\u00e9nique pronostique du cancer du sein"},{"title":"Syndromes My\u00e9lodysplasiques (SMD) (DS72)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS72-SMD.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Actualit\u00e9s sur la pr\u00e9-\u00e9clampsie et place de la biologie ","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"\n
Corinne SAULT Rev Med Gene Fam. 2018;2(7):194-8.<\/p>\n"},{"title":"Analyse immunoprot\u00e9omique des allerg\u00e8nes non-hydrosolubles de farines de quatre l\u00e9gumineuses : arachide, soja, s\u00e9same et lentille","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26635049","date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Bouakkadia H, Boutebba A, Haddad I, Vinh J, Guilloux L, Sutra JP, S\u00e9n\u00e9chal H, Poncet P\nAnn Biol Clin 2015 ; 73:690-704"},{"title":"Anticoagulant circulant (ACC) : \u00e0 propos de deux cas","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Le Flem L, Emile C\nSpectra Biologie 2016 ; 220:51-53"},{"title":"Automation of ALK gene rearrangement testing with fluorescence in situ hybridization (FISH): A feasibility study","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25576649","date":"","media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Zwaenepoel k, Merkle D, Cabillic F, Berg E, Belaud-Rotureau MA, Grazioli V, Herelle O, Hummel M, Le Calve M, Lenze D, Mende S, Pauwels P, Quilichini B, Repetti E\nExp Mol Pathol 2015 ; 98:113-118"},{"title":"Characterization of a de novo Supernumerary Neocentric Ring Chromosome Derived from Chromosome 7","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26669311","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Louvrier C, Egea G, Labalme A, Des Portes V, Gazzo S, Callet-Bauchu E, Till M, Sanlaville D, Edery P, Schluth-Bolard C\nCytogenet Genome Res 2015 ; Dec 16"},{"title":"Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays","media_link":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.639675\/full","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Geoffroy Poulet, Fanny Garlan, Sonia Garrigou, Eleonora Zonta, Leonor Benhaim, Marie-Jennifer Carrillon, Audrey Didelot, Delphine Le Corre, Claire Mulot, Philippe Nizard, Frederic Ginot, Audrey Boutonnet-Rodat, Helene Blons, Jean-Baptiste Bachet, Julien Ta\u00efeb, Aziz Zaanan, Vanna Geromel, Laurence Pellegrina, Pierre Laurent-Puig, Shu-Fang Wang-Renault and Valerie Taly\nFrontiers in Oncology 06\/05\/2021"},{"title":"Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26582834","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Mokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM\nJ Clin Microbiol 2016 ; 54:296-299"},{"title":"Chronic hepatitis E in absence of severe immune deficiency","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31327621\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Colson P, Schleinitz N, Vely F, Poveda JD,\u00a0Jacomo V, Demerle C, Borentain P, Gerolami R.Colson P, et al.\nClin Res Hepatol Gastroenterol. 2020 Feb;44(1):e1-e4. doi: 10.1016\/j.clinre.2019.06.015. \nEpub 2019 Jul 18 - PMID: 31327621"},{"title":"Combined Genotypic, Phylogenetic, and Epidemiologic Analyses of Mycobacterium tuberculosis Genetic Diversity in the Rh\u00f4ne Alpes Region, France","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27128522","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Pichat C, Couvin D, Carret G, Fr\u00e9d\u00e9nucci I, Jacomo V, Carricajo A, Boisset S, Dumitrescu O, Flandrois JP, LinaG, Rastogin N\nPlos One 2016"},{"title":"Comparative performance of three rapid HBsAg assays for detection of HBs diagnostic escape mutants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26378274","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Servant-Delmas A,\u00a0Ly TD, Hamon C, Kassim Houdah A, Laperche S\nJ Clin Microbiol 2015 ; 53:3954-3955"},{"title":"Computer-aided sperm analysis, the new key player in routine sperm assessment","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Schubert-Badiou-Force-2019.pdf","date":"","media_type":"document","profils":"579,574,575,","document_type":"publication","content":"\n
B. Schubert, M Badiou, A. Force First International Journal of Andrology \u2013 Andrologia 06\/2019 - DOI: 10.1111\/and.13417<\/p>\n"},{"title":"Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytog\u00e9n\u00e9tique h\u00e9matologique (GFCH)","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27707673","date":null,"media_type":"document","profils":"579,574,575,","document_type":"publication","content":"Daudignon A, Quilichini B, Ameye G, Poirel H, Bastard C, Terr\u00e9 C\nAnn Biol Clin 2016 ; 74:588-595"},{"title":"D\u00e9pistage combin\u00e9 de la trisomie 21 au premier trimestre : \u00e9valuation du sur-risque en cas de \u00df-hCG libre entre 5 et 10 MoM","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Th\u00e8se de M\u00e9decine, Universit\u00e9 Claude Bernar 1;2016,71p\nEtude r\u00e9alis\u00e9e avec les donn\u00e9es du laboratoire Biomnis\nLeport H"},{"title":"D\u00e9pistage multiparam\u00e9trique de la pr\u00e9-\u00e9clampsie au premier trimestre de grossesse : \u00e9tude pr\u00e9liminaire","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Th\u00e8se de m\u00e9decine, UCBL soutenue le 5 juillet 2016\nEtude r\u00e9alis\u00e9e \u00e0 partir des r\u00e9sultats du laboratoire Biomnis (Service T21 Lyon)\nWalder R"},{"title":"Dosage de la ciclosporine, du tacrolimus, de l\u2019\u00e9v\u00e9lorimus et du sirolimus en LC-MS\/MS","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2018_Petit_1-1.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Petit I, Bezol A, Ghacham S, Clavaud K, Havrez S, Moussa C, Emile C, Gerrier P\nSpectra Bio 2018, 234:61-66"},{"title":"Dosages des st\u00e9ro\u00efdes par spectrom\u00e9trie de masse","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25582724","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dufour-Rainfray D, Moal V, Cloix L, Mathieu E, Gauchez AS, Brossaud J, Corcuff JB, Fraissinet F, Collet C, Boux de Casson F, Guilloteau D, Emond P, Reynier P, Groupe de Biologie Sp\u00e9cialis\u00e9e de la SFMN : Agin A, Bach K, Charri\u00e9 A, Chikh K, Desb\u00e8ne C, Dousset B, Georges A, Guenet D, Lacroix I, Lamy PJ, Leban M, Leloupp AG, Massart C, Masson D, Moineau MP, Piketty M, Reix N, Sault C, Schlageter MH, Tse C. \nAnn Biol Clin 2015 ; 73:70-8"},{"title":"Down syndrome maternal serum markers in oocyte donation and other assisted reproductive technologies","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28921586","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Bonnin A, Muller F, Senat MV, Sault C, Galland A, Taieb J, Dreux S, Bouyer J, Benachi A\nPrenat Diagn 2017 ; 37:1155-1159"},{"title":"Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I\/501Y.V1 (B.1.1.7, variant of concern 202012\/01) in France","media_link":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2021.26.9.2100133","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Alexandre Gaymard, Paolo Bosetti, Adeline Feri, Gregory Destras, Vincent Enouf, Alessio Andronico, Sonia Burrel, Sylvie Behillil, Claire Sauvage, Antonin Bal, Florence Morfin, Sylvie Van Der Werf, Laurence Josset, ANRS MIE AC43 COVID-198, French viro COVID group (including Catherine Coignard), Fran\u00e7ois Blanquart, Bruno Coignard, Simon Cauchemez, Bruno Lina\nEurosurveillance 04\/03\/2021 - Volume 26, Issue 9"},{"title":"\u00c9mergence de la leptospirose humaine en France m\u00e9tropolitaine ? Actualit\u00e9s sur la surveillance","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bourhy P, Picardeau M, Septfons A, Trombert S, Cart-Tanneur E\nMed Mal Infect 2017 ; 47 (4s):s150"},{"title":"Evaluation de l\u2019automate Neo\u00ae (Immucor) pour l\u2019immuno-h\u00e9matologie \u00e9rythrocytaire","media_link":"","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
Rabut E, Ahmetkadic D, Malataverne J, Le Flem L Spectra Biologie 2016 ; 223:45-54<\/p>\n"},{"title":"\u00c9valuation de la valeur seuil la plus co\u00fbt-efficace des marqueurs s\u00e9riques du 1er\u00a0trimestre pour l\u2019emploi du test d\u2019ADN circulant dans le d\u00e9pistage de la trisomie\u00a021\u00a0: une analyse m\u00e9dico-\u00e9conomique","media_link":"https:\/\/www.jle.com\/fr\/revues\/abc\/e-docs\/cost_effectiveness_threshold_of_first_trimester_down_syndrome_maternal_serum_screening_for_the_use_of_cell_free_dna_as_a_second_tier_screening_test_320573\/article.phtml","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Marie Blanquet, Sophie Dreux, St\u00e9phanie L\u00e9ger,\u00a0Corinne Sault,\u00a0Charline Mourgues, H\u00e9l\u00e8ne Laurichesse, Didier L\u00e9mery, Fran\u00e7oise Vendittelli, Anne Debost-Legrand, Fran\u00e7oise Muller\nAnnales de Biologie Clinique Volume 79, num\u00e9ro 4, Juillet-Ao\u00fbt 2021"},{"title":"Evaluation of the performance of a new automated HIV combination assay","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29020658","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Ghisetti V, Coignard C, Allice T, Ly TD\nJ Clin Virol 2017 ; 96:80-83"},{"title":"Evaluation of the SLOMYCO Sensititre\u00ae panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27150659","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Chazel M, Marchandin H, Keck N, Terru D, Carri\u00e8re C, Ponsoda M, Jacomo V, Panteix G, Bouzinbi N, Ba\u00f1uls AL, Choisy M, Solassol J, Aubry, Godreuil S\nAnn Clin Microbiol Antimicrob 2016 ; 15:30"},{"title":"Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities","media_link":"http:\/\/www.bloodjournal.org\/content\/132\/Suppl_1\/943?sso-checked=true","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"On Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group\nElise Chapiro, Elodie Pramil, M\u2019boyba Diop, Damien Roos-Weil, Cl\u00e9mentine Dillard, Cl\u00e9mentine Gabillaud, Karim Maloum, Catherine Settegrana, Lucile Baseggio, Jean-Fran\u00e7ois Lesesve, M\u00e9lanie Yon, Ludovic Jondreville, Claude Lesty, Fr\u00e9d\u00e9ric Davi, Magali Le Garff-Tavernier, Nathalie Droin, Philippe Dessen, Caroline Algrin, V\u00e9ronique Leblond, Jean Gabarre, Simon Bouzy, Virginie Eclache, Baptiste Gaillard, Evelyne Callet-Bauchu, Marc Muller, Christine Lefebvre, Nathalie Nadal, Antoine Ittel, St\u00e9phanie Struski, Marie-Agn\u00e8s Collonge-Rame, Benoit Quilichini, Sandra Fert-Ferrer, Nathalie Auger, Isabelle Radford-Weiss, Lena Wagner, Sebastian Scheinost, Thorsten Zenz, Santos A. Susin, Olivier A. Bernard, Florence Nguyen-Khac\nBlood 2018 132:943; doi:"},{"title":"Identification of a polygalacturonase (Cup s 2) as the major CCD-bearing allergen in Cupressus sempervirens pollen","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28439939","date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Shahali Y, Sutra JP, Hilger C, Swiontek K, Haddad I, Vinh J, Guilloux L, Charpin D, S\u00e9n\u00e9chal H, Poncet\nAllergy 2017 ; doi: 10.1111\/all.13191"},{"title":"Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. \u2013 Trends over 10 years","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26518058","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bailly S, Maubon D,\u00a0Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF\nJ Infect\u00a02015 ; Oct 28. pii: S0163-4453(15)00342-4. doi: 10.1016\/j.jinf.2015.09.041"},{"title":"Impact of Including or Removing Nuchal Translucency Measurement on the Detection and False-Positive Rates of First-Trimester Down Syndrome Screening","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26656919","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Spaggiari E, Czerkiewicz I, Sault C, Dreux S, Galland A, Salomon LJ, Ville Y, Muller F\nFetal Diagn Ther 2015 ; Dec 12"},{"title":"Int\u00e9r\u00eat du s\u00e9quen\u00e7age haut d\u00e9bit dans les h\u00e9mopathies my\u00e9lo\u00efdes chroniques : quelles actualit\u00e9s en 2022 ?","media_link":"","date":"01\/09\/2022","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
B. Quilichini Journal de Biologie M\u00e9dicale \/ Volume 11-Num\u00e9ro 42 \/ Juil-Sept 2022<\/p>\n"},{"title":"Interf\u00e9rences s\u00e9rologiques du traitement du my\u00e9lome multiple par daratumumab (anti-CD38) : \u00e0 propos d\u2019un cas","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28540859","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Rabut E, Castro-Fernandez A, Le Gall V, Meknache\nAnn Biol Clin 2017 ; 75:351-355"},{"title":"Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31379011","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Penther D, Etancelin P, Lusina D, Bidet A, Quilichini B, Gaillard B, Rafdord-Weiss I, Mozziconacci MJ, Ittel A, Roche-Lestienne C, Barin C, Soler G, Daudignon A, Nadal N, Chapiro E, Lefebvre C, Godon C, Nadeau G, Mugneret F, Richebourg S, Viailly PJ, Ferret Y, Nguyen-Khac F, Eclache V; Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique\nAm J Hematol 2019 Aug 4. doi: 10.1002\/ajh.25601."},{"title":"Large outbreak of urogenital schistosomiasis acquired in Southern Corsica: monitoring the early signs of the endemicization?","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28669843","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"No\u00ebl H, Ruello M, Maccary A, Pellat C, Sommen C, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Durand J, Ramalli L, Chiappini JD , Malfait P, Berry\nClin Microbiol Infect 2017 ; pii: S1198-743X(17)30350-6. doi: 10.1016\/j.cmi"},{"title":"Les niveaux de preuve des biomarqueurs utilis\u00e9s pour la d\u00e9tection pr\u00e9coce des cancers de la prostate","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27029727","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Lamy PJ, Gauchez AS, Salomon L et al et le Groupe de biologie de la prostate : Sault C et al\nAnn Biol Clin 2016 ; 74:227-232"},{"title":"Marqueurs de d\u00e9pistage et de pr\u00e9diction de la pr\u00e9-\u00e9clampsie : place de la biologie","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Sault C\nJ Biol Med 2017 ; 6:186-190"},{"title":"Non-invasive prenatal testing: what are we missing?\u00a0","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32119166","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fries N, Le Garrec S, Egloff M, Sault C, Dreux S, Mangione R, Salomon LJ, Ville Y. \nUltrasound Obstet Gynecol. Mars 2020 - 2. doi: 10.1002\/uog.22005."},{"title":"Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28189936","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Thibault V, Servant-Delmas A, Ly TD, Roque-Afonso AM, Laperche S\nJ Clin Virol 2017 ; 89:14-21"},{"title":"Persistence of Zika virus in gradient sperm preparation","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29510270","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Cassuto NG, Marras G, Jacomo V, Bouret D\nJ Gynecol Obstet Hum Reprod 2018, pii: S2468-7847(18)30038-2"},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Emile C, Sault C\nSpectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49."},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"12\/12\/2022","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Emile C, Sault C<\/strong>. Spectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49.<\/p>\n"},{"title":"Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Potential+value+of+placental+angiogenic+factors+as+biomarkers+in+preeclampsia+for+clinical+physicians","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Boulanger H, Lef\u00e8vre G, Ahriz Saksi S, Achiche J, Bailleul S, Ekoukou D, Drouin D, Sault C, Stawiarski N, Dupuis E.\nNephrol Ther. 2019 Mar 29"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0755498219304178?via%3Dihub","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Hamdi SM, Sault C, Piver E, Genoux A, Masson D, Guibourdenche J.\nPresse Med . 2019 Oct 29. pii: S0755-4982(19)30417-8. doi: 10.1016\/j.lpm.2019.09.029. PMID:31676218"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/doi.org\/10.1016\/j.lpm.2019.09.029","date":"12\/12\/2019","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Hamdi SM, Sault C<\/strong>, Piver E, Genoux A, Masson D, Guibourdenche J. Presse Med. (2019)<\/p>\n"},{"title":"Preliminary report of an autochthonous Chikungunya outbreak in France, July to September 2017","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29019313","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Calba C, Guerbois-Galla M, Franke F, Jeannin C, Auzet-Caillaud M, Grard G, Pigaglio L, Decoppet A, Weicherding J, Savaill MC, Munoz-Riviero M, Chaud P, Cadiou B, Ramalli L, Fournier P, Noel H, De Lamballerie X, Paty MC, Leparc-Goffart I\nEuro Surveill 2017 ; 22(39):pii=17-00647"},{"title":"Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance","media_link":"https:\/\/www.nature.com\/articles\/s41467-021-23233-6","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"St\u00e9phane Le Vu,\u00a0Gabrielle Jones,\u00a0Fran\u00e7ois Anna,\u00a0Thierry Rose,\u00a0Jean-Baptiste Richard,\u00a0Sibylle Bernard-Stoecklin,\u00a0Sophie Goyard,\u00a0Caroline Demeret,\u00a0Olivier Helynck,\u00a0Nicolas Escriou,\u00a0Marion Gransagne,\u00a0St\u00e9phane Petres,\u00a0Corinne Robin,\u00a0Virgile Monnet,\u00a0Louise Perrin de Facci,\u00a0Marie-Noelle Ungeheuer,\u00a0Lucie L\u00e9on,\u00a0Yvonnick Guillois,\u00a0Laurent Filleul,\u00a0Pierre Charneau,\u00a0Daniel L\u00e9vy-Bruhl,\u00a0Sylvie van der Werf\u00a0&\u00a0Harold Noel\u00a0\nNature Communications volume 21\/05\/2021 12, Article number: 3025 (2021)"},{"title":"Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/30789329\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Tatai C, Berland JL, Claude JB, Westeel E, Hodille E, Fredenucci I, Rasigade JP, Ponsoda M, Jacomo V, Vach\u00e9e A, Gaudart A, Gaillard JL, Roux AL, Ader F, Tararbit K, Terpant G, Bryant JE, Lina G, Dumitrescu O; Lyon TB Study Group.Genestet C, et al.\nEmerg Infect Dis. 2019 Mar;25(3):589-592. doi: 10.3201\/eid2503.181124 - PMID: 30789329"},{"title":"R\u00e9activit\u00e9 crois\u00e9e in silico, in vitro, in vivo","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Guilloux L, Ricard-Blum S\nAllergies alimentaires 2017 ; chapitre 7.5:97-102"},{"title":"Recherche et identification des anticorps antinucl\u00e9aires : analyse du questionnaire europ\u00e9en de l\u2019EASI groupe et confrontation des pratiques fran\u00e7aises aux recommandations internationales","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29623889","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Musset L, Fabien N, Chyderiotis G, Olsson NO, Pham BN, Durey Dragon MA\nAnn Biol Clin 2018, 76 :185-195"},{"title":"Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission.","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31806715\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Paret R, Pichat C, Berland JL, Jacomo V, Carret G, Fredenucci I, Hodille E, Rasigade JP, Boisset S, Carricajo A, Lina G, Ronnaux-Baron AS, Mornex JF, Grando J, S\u00e9n\u00e9chal A, Ader F, Dumitrescu O; Lyon TB study group.Genestet C, et al.\nEur Respir J. 2020 Mar 20;55(3):1901888. doi: 10.1183\/13993003.01888-2019. Print 2020 Mar"},{"title":"Schistosomose en Corse : chronique d\u2019une histoire annonc\u00e9e","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Berry A, Iriart X, Boissier J, Chyd\u00e9riotis G, Debruyne M, Magnaval JF, Fillaux J, Grech-Angelini S, Barr\u00e9-Cardi H, Termignon JL, Macarry A, Noel H\nLa Lettre de l'Infectiologue 2016 ; XXXI n\u00b02:60-64"},{"title":"Screening and identification of antinuclear antibodies (ANA): analysis of the European EASI survey and confrontation of the French routine practice to the international recommandations","media_link":null,"date":null,"media_type":"document","profils":"579,575,574,","document_type":"publication","content":"Musset L, Fabien N, Chyd\u00e9riotis G, Olsson NO, Pham BN, Dragon-Durey MA\nAnn Biol Clin 2017 ;"},{"title":"Surveillance des infections humaines par hantavirus en France m\u00e9tropolitaine, 2012-2016","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Reynes JM, Carli D, Renaudin B, Fizet A, Bour JB, Brodard V, Cart-Tanneur E, Dewilde A, El Hamri M, Fleury H, Hecquet D, Jeulin H, Lechat S, Lemarquand-Bardini M, Lepiller Q, Poveda JD, Raulin O, Twizeyimana E, Van Cauteren D, Velay A, Septfons A, Baize S\nBEH 2017 ; 23:492-499"},{"title":"Surveillance du chikungunya et de la dengue en France m\u00e9tropolitaine, 2014","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resume_Septfons-A_2016_330-70-77.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Septfons A, No\u00ebl H, Leparc-Goffart I, Giron S, Delisle E, Chappert JL, Catelinois O, Franke F, Servas V, Guinard A, Debruyne M, Schaal O, Brichler S, Ninove L, Prat C, Flusin O, Poujol I, Letort MJ, Deniau J, Six C, Rousseau C, De Valk H, Paty MC\nLes Feuillets de Biologie 2016 ; 330:70-77"},{"title":"Surveillance du chikungunya, de la dengue et des infections \u00e0 virus Zika en France m\u00e9tropolitaine, 2017","media_link":"http:\/\/invs.santepubliquefrance.fr\/beh\/2018\/24\/pdf\/2018_24_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fournet N, Franke F, Chaud P, Raguenaud ME, Calba C, Septfons A, Cart-Tanneur E. et al.\nBull Epid\u00e9miol Hebd. 2018;(24):494-503."},{"title":"Testing anti-neutrophil cytoplasmic antibodies (ANCA): analysis of the European EASI survey on the daily practice of the French laboratories","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28958962","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dragon-Durey MA, Fabien N, Chyd\u00e9riotis G, Musset L, Pham BN, Olsson N\nAnn Biol Clin 2017 ; 75:531-541"},{"title":"The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)","media_link":"","date":"06\/09\/2022","media_type":"document","profils":"579,575,574,","document_type":"publication","content":"\n
Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nab\u00e9ra C, Chapiro E, Collonge-Rame MA, Cuccuini W, Douet-Guilbert N, Eclache V, Luquet I, Michaux L, Nadal N, Penther D, Quilichini B<\/strong>, Terre C, Lefebvre C, Troadec MB, V\u00e9ron\u00e8se L. Leukemia. 2022 Jun;36(6):1451-1466. doi: 10.1038\/s41375-022-01561-w. Epub 2022 Apr 16.PMID: 35430613 Review.<\/p>\n"},{"title":"The impact of introducing combined first-trimester trisomy 21 screening in the French population","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26628633","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Eur J Public Health 2015 ; Nov 30"},{"title":"The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34284044\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Maxime Espi, Xavier Charmetant, Thomas Barba, Laetitia Koppe, Caroline Pelletier, Emilie Kalbacher, Elodie Chalencon, Virginie Mathias, Anne Ovize, Emmanuelle Cart-Tanneur, Christine Bouz, Laurence Pellegrina, Emmanuel Morelon, Denis Fouque, Laurent Juillard, Olivier Thaunat\nKidney International 2021 Oct;100(4):928-936. doi: 10.1016\/j.kint.2021.07.005."},{"title":"Thrombop\u00e9nie induite par l\u2019h\u00e9parine (TIH) : \u00e0 propos d\u2019un casLe Flem L, Emile C","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Le Flem L, Emile C, Spectra Biologie 2016 ; 220:49-50<\/p>\n"},{"title":"Une interf\u00e9rence dans le dosage de l\u2019insuline r\u00e9v\u00e8le un syndrome auto-immun anti-insuline","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27492703","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Lamy PJ, Sault C, Renard E\nAnn Biol Clin 2016 ; 74:490-494"},{"title":"Vector-borne Transmission of Zika Virus in Europe, Southern France, August 2019","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31718742\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Sandra Giron, Florian Franke, Anne Decoppet, Bernard Cadiou, Thierry Travaglini, Laurence Thirion, Guillaume Durand, Charles Jeannin, Gr\u00e9gory L\u2019Ambert, Gilda Grard, Harold No\u00ebl, Nelly Fournet, Michelle Auzet-Caillaud, Christine Zandotti, Samer Abouka\u00efs, Pascal Chaud, Saby Guedj, Lakri Hamouda, Xavier Naudot, Anne Ovize, Cl\u00e9ment Lazarus, Henriette de Valk, Marie-Claire Paty, Isabelle Leparc-Goffart\nEuro Surveill. 2019 Nov;24(45):1900655."},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Faux-positif-ADNlcT21_L-Druart_012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Faux positif d\u2019ADNlcT21 avec diff\u00e9rentes anomalies chromosomiques confin\u00e9es au placenta\nL Druart, H Dessuant, JF Taly, M Nouchy, L Raymond, S Tapia"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Developpement-panel-15-marqueurs_F.-Rousseau-et-al.-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9veloppement d\u2019un panel de 15 marqueurs pour une identitovigilance\ndes \u00e9chantillons analys\u00e9s par s\u00e9quen\u00e7age haut d\u00e9bit ou sur puces \u00e0 SNP\nF Rousseau, J-F Taly, C Ploton Nicollet, M Taoudi, A Perdriau, L Raymond"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20359-Assises-de-Genetique-2020_B-Quilichini_012020.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Mise en place d\u2019un panel de g\u00e8nes cibl\u00e9s pour les h\u00e9mopathies\nmalignes (NMP-LMMC-SMD-LAM) par NGS : Enjeux M\u00e9dical \/ Scientifique et d\u2019Assurance Qualit\u00e9.\nV Geromel, E Fayolle, P Mouty, R Moulin, N Batail, M-H Felix, B Adde, S Mouty, L Raymond, B Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20362-Assises-de-Gntique-2020_B_Quilichini-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Impact diagnostique, pronostique et th\u00e9ranostique d\u2019un panel de g\u00e8nes\n\u00ab H\u00e9mopathies My\u00e9lo\u00efdes \u00bb r\u00e9alis\u00e9 par NGS : l\u2019exp\u00e9rience du laboratoire Eurofins Biomnis en 2019.\nV. Geromel, P. Mouty, C. Chal, J . Delaunay, S. Sadot-Lebouvier, R. Kaphan, J. Vigvari, J.P. Coadic, E.A. Marin La Meslee, O. Roualdes, C. Bourdin, A. Petit, M. Roumigui\u00e8res, L. Raymond, B.Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 4","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Les_assises_2020_RadoslavaSARAEVA_LAMRI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"21-24 janvier 2020, Tours\nDiagnostics g\u00e9n\u00e9tiques multiples (double hits) par s\u00e9quen\u00e7age Whole Exome (WES) : \u00e0 propos de deux cas.\nR. SARAEVA-LAMRI, A. DORELLE, V. GEROMEL, A. S. LEBRE, P. MOUTY, M. E. NAUD BARREYRE, F. ROUSSEAU, M. TAOUDI, L. MESNARD, L. RAYMOND"},{"title":"10th International Congress on Autoimmunity, Leipzig, April 6-10, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_4.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Should Dense Fine Speckled 70 (DFS70) pattern be reported? Biomnis reference lab experience on 12 619 ANA screening consecutive sera\nGuis L, Ebel A, Leroy J, Michaud S, Pomaredes A, Marcenaro C, Chalouas L"},{"title":"12\u00e8me CFA, Paris, avril 25-28, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":""},{"title":"12\u00e8me Congr\u00e8s de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Paris, mars 22-23, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Jacomo_3.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Les Liquides C\u00e9phalo-Rachidiens : conservation pr\u00e9-analytique \u00e0+ 4 \u00b0C ou \u2013 20 \u00b0C ?\nJacomo V, Schaal O, Fournier P"},{"title":"17\u00e8mes Journ\u00e9es Francophones de Virologie, Paris, avril 9, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"R\u00e9solution des \u00e9checs de g\u00e9notypage de la technique Abbott RealTime HCV Genotype II par un test temps r\u00e9el additionnel\nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ly_8.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of a new high sensitive, qualitative and quantitative Hepatitis B surface antigen assay\nLy TD, Coignard C"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Characterization of samples with genotype 1 without subtype results by Abbott RealTime HCV genotype II using the new Abbott HCV Genotype Plus RUO test \nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"19th Annual Meeting of the European Society for Clinical Virology (ESCV), Lisbon, september, 14\u201317, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/09\/Biomnis_Poster_2016_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to COBAS\u00ae AmpliPrep\/OBAS\u00ae TaqMan\u00ae HIV-1 and HBV tests\nEbel A, Bali C, Guis L, Merlin S"},{"title":"20\u00e8mes Journ\u00e9es de M\u00e9decine Foetale, Morzine, mars 26-28, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015__Becker_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Int\u00e9r\u00eat du D\u00e9pistage Pr\u00e9natal Non Invasif dans le diagnostic des aneuplo\u00efdies 13, 18 et 21 \nBecker M, Eg\u00e9a G, Taoud M, Ahmed Chaouch D, El Mouatassim S"},{"title":"20Th Congress European Hematology Association, Vienna, June 11-14, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Rigollet_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Characterization of normal and pathological lymphoid populations: validation of a 10-colors flow cytometry protocol for routine diagnosis \nRigollet L, Stagnara J, Milhau A, Pellegrina L"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/10\/Biomnis_Poster-Aptima-HIV-1-HBV_Ebel_Sept18.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV-1 Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to Cobas\u00ae 6800\/8800 HIV-1 and HBV tests\nA. Ebel, C. Bali, L. Guis, S. Merlin"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/11\/Poster-IgM-Measles-ESCV-TD-LY-.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of new IgM Measles assay\nT.D. Ly, C. Coignard"},{"title":"24e Journ\u00e9es de m\u00e9decine f\u0153tale, Marseille, 4-5-6 avril 2019","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9pistage de la trisomie 21 par analyse de l\u2019ADN f\u0153tal libre circulant dans le sang maternel : Application dans le cas des grossesses g\u00e9mellaires\nMarc NOUCHY, Nicolas CHATRON, Pascal MOUTY, Francis ROUSSEAU, Barbara ADD\u00c9, Mohamed Taoudi, Caroline DUMONT, Jean-Fran\u00e7ois TALY, Luc DRUART, Sylvie TAPIA, Damien SANLAVILLE, Laure RAYMOND"},{"title":"25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, April 25-28, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of three fully automated assays for the detection of cytomegalovirus IgM and IgG: DiaSorin LIAISON\u00ae XL, Abbott Architect \u00ae and Roche Cobas 6000\u00ae\nBouthry E, Ly TD, Vauloup-Fellous C"},{"title":"27th ECCMID, Vienna Austria, April 22-25, 2017","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Strain-specific estimation of epidemic success provides insights into the transmission dynamics of tuberculosis Rasigade\nJP, Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, P\u00e9rouse de Montclos M, Flandrois JP, Ader F, Supply P, Lina G, Wirth T"},{"title":"29th IUSTI European Conference on Sexually Transmitted Infections, Sitges (Barcelona), 24-26 September, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Prevalence of Mycoplasma genitalium in France and comparison with Chlamydia trachomatis and Neisseria gonorrhoeae as determined by the Mycoplasma genitalium TMA assay \nEbel A, Venard C, Brunengo D, Merlin S"},{"title":"31st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbon, June 14-17, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Force_7.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Blastocysts vitrification during 2 consecutive years: before and after its start significant delivery rate increase within the 1st year \nForce A, Nicollet B, Chomier M, Sergeant P, Lescaille M, Rochigneux S, Robert F, Ginon J, Sergeant MV, Baucher S, Schubert B"},{"title":"35e congr\u00e8s de la SFH, CNIT Paris la D\u00e9fense, avril 1-3, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Becker_4.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"La SNP array : un outil compl\u00e9mentaire pour la caract\u00e9risation des h\u00e9mopathies malignes \nBecker M, Eg\u00e9a G, Camilli K, Robin M, Roumigui\u00e8res M, Rigollet L, Stagnara J, El Mouatassim S"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_14.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Evaluation du nouveau test LAISON\u00ae H. pylori IgG\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_15.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Borr\u00e9liose et index de synth\u00e8se intrath\u00e9cale : bilan biologique r\u00e9trospectif de l\u2019ann\u00e9e 2015\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Ebel_16.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation des performances de la trousse Aptima\u00ae HBV Quant (Hologic)\nEbel A, Bali C, Guis L, Merlin S"},{"title":"37\u00e8me RICAI, Paris, d\u00e9cembre 18-19, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/12\/Biomnis_Poster_2017_Coignard_13.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Confirmation VIH : donn\u00e9es biologiques et \u00e9pid\u00e9miologiques des 3 derni\u00e8res ann\u00e9es dans un laboratoire de biologie sp\u00e9cialis\u00e9e\nCoignard C, Ly TD"},{"title":"38e RICAI, Paris 17-18 d\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-COIGNARD-ROUGEOLE.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Epid\u00e9mie de rougeole 2018 : le s\u00e9rodiagnostic un marqueur simple et performant.\nT.D. Ly, C. Coignard"},{"title":"3e Journ\u00e9e Francophone de Biologie M\u00e9dicale, Monaco, 6-7-8 novembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/11\/1911_poster_A.Ebel_JFBM.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"D\u00e9pistage syst\u00e9matique de Neisseria gonorrhoeae et de C. trachomatis par test d\u2019amplification g\u00e9nique : bilan d\u2019une ann\u00e9e d\u2019exp\u00e9rience\nL. Mine, L. Guis, S. Merlin, A. Ebel"},{"title":"40e RICAI \u2013 R\u00e9union Interdisciplinaire de Chimioth\u00e9rapie Anti-Infectieuse, 14-15 d\u00e9cembre","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Posters\/2012_Poster_SARS-CoV-2_RICAI_C.Coignard.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"S\u00e9rologie SARS-CoV-2 : \u00e9valuation, qualification et choix d\u2019une m\u00e9thode\nCatherine Coignard, Anne EBEL, Yanis BOUAMRA, Didier RIDEY, Carla MARCENARO"},{"title":"42es Journ\u00e9es Nationales \u2013 Congr\u00e8s CNGOF, Strasbourg, 4-7 D\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-EMILE-DPNI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"\u00c9tude de l\u2019usage du DPNI (d\u00e9pistage pr\u00e9natal non invasif) des aneuplo\u00efdies en milieu lib\u00e9ral\nC. Emile, L. Raymond, L. Pellegrina"},{"title":"45\u00e8me Colloque National des Biologistes des H\u00f4pitaux, Paris, juin 22-24, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/06\/Biomnis_Poster_2016-Rabut_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Interf\u00e9rence du traitement par daratumumab (anti-CD38) dans le suivi biologique du my\u00e9lome multiple et dans la recherche d\u2019anticorps anti-\u00e9rythrocytaires : \u00e0 propos d\u2019un cas\nRabut E, Castro-Fernandez A, Le Gall V, Meknache N"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Raymond_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport diagnostique de l\u2019utilisation des puces SNP dans l\u2019\u00e9tude chromosomique des morts f\u0153tales\nRaymond L, Dherbey JL, Rebeyrat-Pichon I, El-Mouatassim S, Egea G"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier, 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_11.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Cas rare d\u2019X-fragile pr\u00e9natal avec r\u00e9traction d\u2019expansion de triplet CGG ? \nMouty P, Raymond L, El Mouatassim S, Liquier A, Druart L, Paris A, Dorian V, Pichon I, Dherbey JL, Eg\u00e9a G"},{"title":"CGRF Ile de R\u00e9, septembre 28-29, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Brunengo_11.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Epid\u00e9miologie qualitative des variants rares de l\u2019H\u00e9moglobine en France m\u00e9tropolitaine au travers de la collaboration HCL \u2013 Eurofins Biomnis\nBrunengo D, Veyrenche N, Louis Chillotti L, Le Flem L"},{"title":"COGEN, Paris, Septembre 25-27, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_El-Mouatassim_11.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"French experience of Non-Invasive Prenatal Testing of trisomy 21, 18 and 13 \nEl Mouatassim S, Taoudi M, Eg\u00e9a G"},{"title":"Congr\u00e8s SFP \/ SFMM, Toulouse, mars 29-31, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/03\/Biomnis_Poster_2017_Chydriotis_1-1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport de 2 tests de d\u00e9pistage pour le diagnostic de la bilharziose et place du Western blot\nChyd\u00e9riotis G, Cart-Tanneur E, Lecuelle C, F\u00e9lix MH"},{"title":"Congr\u00e8s SFTA, Avignon, mai 10-12, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_Petit_2.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Dosage de la Ciclosporine, Tacrolimus, Ev\u00e9rolimus et Sirolimus en LCMSMS avec le coffret MassTox Chromsystems sur Api 4500 ABSciex avec pr\u00e9paration automatis\u00e9e sur T\u00e9can EVO 150\nPetit I, Moussa C, Bonnet K, Bezol A. Havrez S, Gerrier P"},{"title":"EAACI, Helsinki, June 17-21, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_6.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Bp14, an allergen from cupressus sempervirens pollen related to the family of snakin\/gibberellin-regulated proteins\nS\u00e9n\u00e9chal H, Santrucek J, Melcova M, Svoboda P, Zidkova J, Guilloux L, Aizawa T, Couderc R, Charpin D, Poncet P"},{"title":"ESCAIDE 2015, Stockholm, November 11-13, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Chyderiotis_14.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Re-emergence of urinary schistosomiasis in Europe ? Infections acquired in Southern Corsica \u2013 Investigation of a cluster of Schistosoma haematobium infections in 2014\nRamalli L, No\u00ebl H, Ruello M, Maccary A, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Denoyel GA, Succo T, Armengaud A, Paty MC, Heuz\u00e9 G, Mattei J, Th\u00e9ron A, Berry A"},{"title":"ESCV, Stresa, Lake Maggiore, September 13-16, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/10\/Biomnis_Poster_2017_LY_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new chemiluminescent assay to detect and quantify anti-HBs antibodies\nMaillard A, Ly TD, Thibault V"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_LY_3.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new LIAISON\u00ae H. pylori IgG\nLy TD, Coignard C"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Rabut_4.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Red blood cell antibody assays in DARA-treated patients\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"EuroMedLab, Paris, June 22-24, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Early Performance Evaluation of cobas\u00ae HBV, cobas\u00ae HCV and cobas\u00ae HIV-1Quantitative Nucleic Acid Tests for use on the new cobas\u00ae 6800\/8800 Systems\nEbel A, Merlin S, Marins ED G, Canchola J, Njoya M, Simon CO"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/poster-FFER-2018-callec.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Impact de la chirurgie bariatrique sur les param\u00e8tres spermatiques : Revue de la litt\u00e9rature\nR. Callec, B. Schubert, F. Robert, A. Force"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/POSTER-FFER-2018-Force.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Crit\u00e8res d\u2019interpr\u00e9tation du msome pour une optimisation de la prise en charge des patients\nA. Force, M. Chomier, P. Sergeant, J. Ginon, S. Rochigneux, M. Lechatton, M. Pont, R. Callec, F. Robert, B. Schubert"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Lopez.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation externe de la qualit\u00e9 en spermiologie : un nouveau programme pour une \u00e9valuation globale de l\u2019examen\nMarie LOPEZ, Bernard POGGI, Jean Christophe EYNARD, Marie LETY, Benoit SCHUBERT, Andr\u00e9 FORCE"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Schubert.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Influence des conditions de culture sur les r\u00e9sultats en AMP dans une \u00e9tude multicentrique : comparaison d\u2019un incubateur Time Lapse avec les incubateurs tradictionnels\nBeno\u00eet SCHUBERT, Alexandre MARCILLY, Andr\u00e9 FORCE"},{"title":"FFER, Tours, septembre 13-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Force_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Comparaison de la performance de 2 incubateurs (Geri versus Planer) apr\u00e8s randomisation de la cohorte ovocytaire pour chaque patiente\nForce A, Martine Chomier, Philippe Sergeant, Jacqueline Ginon, St\u00e9phanie Rochigneux, Soizic Baucher, M\u00e9lanie Le Chatton, M\u00e9lanie Pont, Beno\u00eet Schubert"},{"title":"FIBA 2016, Dakar, January 13-14, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"ANCA associated HIV infection in Senegal: a serological trap\nArouna O, Niang A, Abiola A, Guis L, Le Flem L, Diene JF, Mboup S"},{"title":"Fort Collins (USA), May 31-June 3, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/05\/Biomnis_Poster_2016_Jacomo_5.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Seoul Virus Infection in Human, France, 2014-2016\nReynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, Nussbaumer T, Jacomo V, Rapt MP, Septfons A, Rollin PE"},{"title":"ISMA, Lisbon, November 19-21, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2015_Guilloux_16.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Ige-cross-reactivity between european hymenoptera and asian hornet (vespa velutina) venom allergens\nLong\u00e9 C, Brazdova A, Brunet JL, Schwartz C, Girodet B, Lavaud F, Birnbaum J, Pham-Thi N, Duchateau M, Chamot-Rooke J, Guilloux L, Selva MA, Couderc R, S\u00e9n\u00e9chal H, Sutra JP, Poncet P"},{"title":"Journ\u00e9es Nationales CNGOF, Montpellier, d\u00e9cembre 7-9, 2016","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Etude pr\u00e9liminaire sur le d\u00e9pistage de la pr\u00e9-\u00e9clampsie au 1er trimestre de la grossesse (Predictor\u00ae)\nWalder R, Galland A, Sault C, Huissoud C"},{"title":"Journ\u00e9es Nationales d\u2019Infectiologie, Nantes, 13-15 juin, 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/05\/Biomnis_Poster_2018_Ebel_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Infections \u00e0 Chlamydia trachomatis : donn\u00e9es \u00e9pid\u00e9miologiques r\u00e9centes dans un laboratoire sp\u00e9cialis\u00e9\nEbel A, Guis L, Merlin S"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Poster-Lyme-RICAI-C.-Coignard-TD-Ly-dec-2019-800x1200.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of the BioPlex 2200 Lyme IgG\/IgM immunoassay system\nC. Coignard, C. Cl\u00e9ment-Vincent, Td. Ly, A. L\u2019hotellier"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/12\/2019-12-17_RICAI.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Sp\u00e9cificit\u00e9 de la s\u00e9rologie chikungunya et surveillance \u00e9pid\u00e9miologique\nC. Calba, F. Franke, E. Brottet, G. Terpant, N. Fournet, A. Ovize, J.D. Poveda, I. Leparc-Goffart, M.C. Paty"},{"title":"SFE, Bordeaux, octobre 5-8, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Sault_13.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Influence de la nature du liquide de rin\u00e7age d\u2019aiguille de cytoponction sur le dosage de la thyroglobuline\nBoux De Casson F, Moal V, Gauchez AS, Moineau MP, Sault C, Schlageter MH, Massart C"},{"title":"SFTS, Bordeaux, septembre 20-22, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Rabut_10.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Recherche et quantification de l\u2019h\u00e9morragie f\u0153to-maternelle par cytom\u00e9trie en flux avec double marquage anti-h\u00e9moglobine F et anti-anhydrase carbonique\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"XXIIIe Colloque ACLF, Montpellier, septembre 20-21, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Syndrome de Currarino atypique avec hexadactylie pr\u00e9-axiale : remaniement complexe en 7q36.3 en pr\u00e9natal\nLiquier A, Becker M, Raymond L, Bourgain A, Amat S, Broussin B, Andr\u00e9 G, Escande F, Nouchy M, Eg\u00e9a G"}]));
sessionStorage.setItem('currentLang', 'fr');render(html`<${RessourcesDynamiques} name="World" />`, document.getElementById('resdyncontainer'));
\n
<\/p>\n\n\n\n
<\/p>\n"},{"title":"R10 \u2013\u00a0Fiche de suivi de grossesse","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R10-FRC_Suivi-grossesse_Agents-infectieux.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":"Patiente ayant subi une amniocent\u00e8se pour recherche d\u2019agent infectieux ou parasitaire"},{"title":"R12\u00a0\u2013 Renseignements cliniques : Diagnostic de mycobact\u00e9ries","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R12-FRC_Mycobacteries.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"R23\u00a0\u2013 Bon de demande : Etude du g\u00e8ne de la mucoviscidose","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R23-FRC_Mucoviscidose.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"R28\u00a0\u2013 Renseignements cliniques :\u00a0Dengue \/ Chikungunya \/ Zika","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R28-FRC_Dengue_Chikungunya_Zika.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"R35\u00a0\u2013\u00a0Infectiologie","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R35-FRC_Infectiologie.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"R36\u00a0\u2013 Etude du g\u00e8ne de Fi\u00e8vre M\u00e9diterran\u00e9enne Familiale","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R36-FRC_FMF.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"R4\u00a0\u2013 Estimation du risque de pr\u00e9-\u00e9clampsie par l\u2019\u00e9tude des marqueurs s\u00e9riques maternels au 1er trimestre de la grossesse","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R4-FRC_Pre-eclampsie.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"R52\u00a0\u2013 Renseignements cliniques :\u00a0Cotations \u00e0 la nomenclature des PCR (Toxoplasmose, HSV, CMV, EBV, H\u00e9patite Delta et E)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R52-FRC_Cotations_NABM_PCR.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"R53\u00a0\u2013 Diagnostic de la Rougeole par RT-PCR","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R53-FRC_Rougeole.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":"Protocole et renseignements cliniques"},{"title":"R55\u00a0\u2013 Renseignements cliniques : PCR Covid-19 (SARS-CoV-2)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/R55-FRC_COVID-19.pdf","date":null,"media_type":"document","profils":"575,","document_type":"document","content":""},{"title":"D\u00e9cret n\u00b0 2020-1668 du 23 d\u00e9cembre 2020 modifiant les d\u00e9crets n\u00b0 2020-1262 du 16 octobre 2020 et n\u00b0 2020-1310 du 29 octobre 2020","media_link":"https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000042731199","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Prescrivant les mesures g\u00e9n\u00e9rales n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire"},{"title":"Journal Officiel 052 du 02 mars 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/03\/JO052_02032021.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 1er mars 2021 modifiant l\u2019arr\u00eat\u00e9 du 10 juillet 2020 prescrivant les mesures d\u2019organisation et de fonctionnement du syst\u00e8me de sant\u00e9 n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire."},{"title":"Journal Officiel 124 du 30 mai 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/06\/JO124_300521.pdf.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 29 mai 2021 portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale et portant modification de l\u2019arr\u00eat\u00e9 du 12 d\u00e9cembre 2020 portant modification des conditions de remboursement de l\u2019acte de d\u00e9tection du g\u00e9nome du SARS-CoV-2 par amplification g\u00e9nique"},{"title":"Journal Officiel 156 du 7 juillet 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/07\/JO156_070721.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 6 juillet 2021 modifiant l\u2019arr\u00eat\u00e9 du 1er juin 2021 prescrivant les mesures g\u00e9n\u00e9rales n\u00e9cessaires \u00e0 la gestion de la sortie de crise sanitaire"},{"title":"Journal Officiel 241 du 15 octobre 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/10\/joe_20211015_0241_0063.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 14 octobre 2021 modifiant l\u2019arr\u00eat\u00e9 du 1er juin 2021 prescrivant les mesures g\u00e9n\u00e9rales n\u00e9cessaires \u00e0 la gestion de la sortie de crise sanitaire"},{"title":"Journal Officiel 241 du 15 octobre 2021 - Annexe 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/10\/annexe_1_-_flyer_remboursement_test_covid.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Annexe 1 : Dans quels cas un test de d\u00e9pistage Covid est-il pris en charge par l\u2019Assurance Maladie ?"},{"title":"Journal Officiel 241 du 15 octobre 2021 - Annexe 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/10\/annexe_3_-_tableau_indications_de_prise_en_charge_et_justificatif.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Annexe 3 : Tableau d\u2019indications de prise en charge et justificatifs"},{"title":"Journal Officiel num\u00e9ro 175 du 30 juillet 2022","media_link":"https:\/\/www.legifrance.gouv.fr\/download\/pdf?id=oPOIInpk0Qlz7ZSxTlZ2VKdyGopLnFyQC8g3gUPiDmU=","date":"01\/08\/2022","media_type":"document","profils":"574,579,575,","document_type":"texte-reglementaire","content":"\n
Arr\u00eat\u00e9 du 29 juillet 2022 modifiant l\u2019arr\u00eat\u00e9 du 9 juillet 2022 relatif \u00e0 la vaccination contre le virus Monkeypox et portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale<\/p>\n"},{"title":"Journal Officiel num\u00e9ro 0036 du 17 d\u00e9cembre 2009","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO0036-171209.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 15 d\u00e9cembre 2009 relatif aux controles du respect des valeurs limites biologiques fix\u00e9es \u00e0 l\u2019article R. 4412-152 du code du travail pour les travailleurs expos\u00e9s au plomb et \u00e0 ses compos\u00e9s et aux conditions d\u2019accr\u00e9ditation des laboratoires charg\u00e9s des analyses"},{"title":"Journal Officiel num\u00e9ro 013 du 16 janvier 2014 \u2013 texte 11","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO013-160114-texte-11.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 14 janvier 2014 fixant le mod\u00e8le des documents mentionn\u00e9s au III de l\u2019article R. 2131-2 du code de la sant\u00e9 publique (Mod\u00e8le de refus de consentement)"},{"title":"Journal Officiel num\u00e9ro 013 du 16 janvier 2014 \u2013 texte 5","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO013-160114-texte-5.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"D\u00e9cret no 2014-32 du 14 janvier 2014 relatif aux diagnostics ant\u00e9nataux"},{"title":"Journal Officiel num\u00e9ro 021 du 24 janvier 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/01\/JO021_240121.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 23 janvier 2021 modifiant l\u2019arr\u00eat\u00e9 du 10 juillet 2020 prescrivant les mesures d\u2019organisation et de fonctionnement du syst\u00e8me de sant\u00e9 n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire"},{"title":"Journal Officiel num\u00e9ro 032 du 6 f\u00e9vrier 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/02\/JO032_060221.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 5 f\u00e9vrier 2021 modifiant l\u2019arr\u00eat\u00e9 du 10 juillet 2020 prescrivant les mesures d\u2019organisation et de fonctionnement du syst\u00e8me de sant\u00e9 n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire."},{"title":"Journal Officiel num\u00e9ro 046 du 23 f\u00e9vrier 2021","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2021\/02\/JO046_230221.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 22 f\u00e9vrier 2021 portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale (modification des indications relatives aux pr\u00e9l\u00e8vements salivaires pour la d\u00e9tection du g\u00e9nome du Sars-CoV-2 par RT-PCR)"},{"title":"Journal Officiel num\u00e9ro 117 du 13 mai 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/05\/JO-200513.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du\u00a012 mai 2020\u00a0portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale (inscription de la d\u00e9tection du g\u00e9nome du SARS-CoV-2 par RT PCR)"},{"title":"Journal Officiel num\u00e9ro 129 du 28 mai 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/05\/JO128-280520.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 27 mai 2020 portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale (diagnostic biologique de l\u2019infection par le SARS-CoV-2)"},{"title":"Journal Officiel num\u00e9ro 130 du 7 Juin 2013 (texte 14)","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO130-070613.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 27 mai 2013 d\u00e9finissant les r\u00e8gles de bonnes pratiques applicables \u00e0 l\u2019examen des caract\u00e9ristiques g\u00e9n\u00e9tiques d\u2019une personne \u00e0 des fins m\u00e9dicales"},{"title":"Journal Officiel num\u00e9ro 152 article 23 du 03 juillet 2009","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO152-23-030709.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 23 juin 2009 fixant les r\u00e8gles de bonnes pratiques en mati\u00e8re de d\u00e9pistage et de diagnostic pr\u00e9natals avec utilisation des marqueurs s\u00e9riques maternels de la trisomie 21"},{"title":"Journal Officiel num\u00e9ro 211 du 11 septembre 2010","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO211-110910.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 3 ao\u00fbt 2010 modifiant l\u2019arr\u00eat\u00e9 du 11 avril 2008 relatif aux r\u00e8gles de bonnes pratiques cliniques et biologiques d\u2019assistance m\u00e9dicale \u00e0 la procr\u00e9ation"},{"title":"Journal Officiel num\u00e9ro 294 du 20 d\u00e9cembre 2018","media_link":"https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000037833049\/","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 14 d\u00e9cembre 2018 modifiant l\u2019arr\u00eat\u00e9 du 23 juin 2009 modifi\u00e9 fixant les r\u00e8gles de bonnes pratiques en mati\u00e8re de d\u00e9pistage et de diagnostic pr\u00e9natals avec utilisation des marqueurs s\u00e9riques maternels de trisomie 21"},{"title":"Journal Officiel num\u00e9ro 294 du 20 d\u00e9cembre 2018 - Arr\u00eat\u00e9 du 14 d\u00e9cembre 2018 modifiant l\u2019arr\u00eat\u00e9 du 14 janvier 2014","media_link":"https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000037833049\/","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Fixant le mod\u00e8le des documents mentionn\u00e9s au III de l\u2019article R. 2131-2 du code de la sant\u00e9 publique"},{"title":"Journal Officiel num\u00e9ro 294 du 20 d\u00e9cembre 2018.","media_link":"https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000037833049\/","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 14 d\u00e9cembre 2018 pris en application de l\u2019article R. 2131-2-3 du code de la sant\u00e9 publique"},{"title":"Journal Officiel num\u00e9ro 297 du 09 d\u00e9cembre 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/12\/JO297-091220.pdf.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 8 d\u00e9cembre 2020 modifiant l\u2019arr\u00eat\u00e9 du 10 juillet 2020 prescrivant les mesures d\u2019organisation et de fonctionnement du syst\u00e8me de sant\u00e9 n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire"},{"title":"Journal Officiel num\u00e9ro 301 du 13 d\u00e9cembre 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/12\/JO301_131220.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 12 d\u00e9cembre 2020 portant modification des conditions de remboursement de l\u2019acte de d\u00e9tection du g\u00e9nome du SARS-CoV-2 par amplification g\u00e9nique"},{"title":"Journal Officiel num\u00e9ro 302 du 30 d\u00e9cembre 2011","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/JO\/JO302-301211.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 26 d\u00e9cembre 2011 fixant la liste des centres nationaux de r\u00e9f\u00e9rence pour la lutte contre les maladies transmissibles et des laboratoires associ\u00e9s"},{"title":"Journal Officiel num\u00e9ro 58 du 7 mars 2020","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/JO058-070320.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"texte-reglementaire","content":"Arr\u00eat\u00e9 du 7 mars 2020 portant modification de la liste des actes et prestations mentionn\u00e9e \u00e0 l\u2019article L. 162-1-7 du code de la s\u00e9curit\u00e9 sociale (inscription de la d\u00e9tection du g\u00e9nome du SARS-CoV-2 par RT PCR)"},{"title":"Comment am\u00e9liorer et acc\u00e9l\u00e9rer le diagnostic des maladies d\u2019origine g\u00e9n\u00e9tique ?","media_link":"https:\/\/www.youtube.com\/embed\/9mjWjvViCkE ","date":"20\/07\/2022","media_type":"video","profils":"574,575,","document_type":"parole-expert","content":""},{"title":"La d\u00e9marche diagnostic en allergologie","media_link":"https:\/\/youtube.com\/embed\/MT-H2HHe1k0","date":null,"media_type":"video","profils":"575,576,574,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur la d\u00e9marche diagnostic en allergologie, expliqu\u00e9 en quelques minutes par le Dr Christine Bouz, biologiste m\u00e9dicale au laboratoire Eurofins Biomnis."},{"title":"La prise en charge biologique des h\u00e9mopathies malignes","media_link":"https:\/\/youtube.com\/embed\/FW0ydxXHhjo","date":null,"media_type":"video","profils":"574,575,576,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur La prise en charge biologique des h\u00e9mopathies malignes, expliqu\u00e9 en quelques minutes par le Dr Beno\u00eet QUILICHINI, biologiste m\u00e9dical au laboratoire Eurofins Biomnis."},{"title":"Le d\u00e9pistage pr\u00e9natal non invasif de la trisomie 21 (DPNI)","media_link":"https:\/\/youtube.com\/embed\/pwH5egBvNWI","date":null,"media_type":"video","profils":"575,574,576,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur le d\u00e9pistage pr\u00e9natal non invasif de la trisomie 21 (DPNI), expliqu\u00e9 en quelques minutes par le Dr Sylvie TAPIA, g\u00e9n\u00e9ticienne au laboratoire Eurofins Biomnis."},{"title":"Le g\u00e9notypage du rh\u00e9sus D foetal","media_link":"https:\/\/youtube.com\/embed\/xHROBADhgAI","date":null,"media_type":"video","profils":"574,576,575,","document_type":"parole-expert","content":"Tout ce qu'il faut savoir sur le g\u00e9notypage du rh\u00e9sus D foetal, expliqu\u00e9 en quelques minutes par le Dr Laurence STROMPF-SILVESTRE, m\u00e9decin biologiste au laboratoire Eurofins Biomnis."},{"title":"Les intol\u00e9rances alimentaires","media_link":"https:\/\/youtube.com\/embed\/jj9iYVJCZuc","date":null,"media_type":"video","profils":"575,576,574,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur les intol\u00e9rances alimentaires, expliqu\u00e9 en quelques minutes par le Dr Emmanuelle CART-TANNEUR, biologiste m\u00e9dical au laboratoire Eurofins Biomnis."},{"title":"Place du test HPV dans le d\u00e9pistage primaire du cancer du col de l\u2019ut\u00e9rus","media_link":"https:\/\/youtube.com\/embed\/PaHkXjzNAsY","date":null,"media_type":"video","profils":"574,576,575,","document_type":"parole-expert","content":"Tout ce qu\u2019il faut savoir sur le d\u00e9pistage primaire du cancer du col de l\u2019ut\u00e9rus et le test HPV par le Dr Anne EBEL, biologiste m\u00e9dicale au laboratoire Eurofins Biomnis"},{"title":"ABCB1 - Le test g\u00e9n\u00e9tique pour optimiser le traitement de la d\u00e9pression (DS45)\nle choix des antid\u00e9presseurs\ndans le traitement de la d\u00e9pression (DS45-ABCB1)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS45-ABCB1.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux professionnels de sant\u00e9"},{"title":"ALEX\u00ae - Explorateur d\u2019allergies (DS67)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS67-Allergie_Alex.pdf","date":null,"media_type":"document","profils":"579,575,574,","document_type":"le-point-sur","content":""},{"title":"Allergie d\u00e9marche diagnostique (DS10)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS10-Allergie_demarche_diag.pdf","date":null,"media_type":"document","profils":"579,575,574,","document_type":"le-point-sur","content":"Principaux examens et interpr\u00e9tation"},{"title":"Allergie nomenclature (DS9)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS9-Allergie_nomenclature.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Autres tumeurs solides - fiche oncologie (DS86)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS86-Autres_tumeurs.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Biologie de la femme (DS11)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS11-Biologie_femme.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"le-point-sur","content":""},{"title":"Cancer de l\u2019ovaire\nHE4 & score ROMA (DS13)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS13-HE4.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Caract\u00e9risation g\u00e9n\u00e9tique de l\u2019infertilit\u00e9 masculine par s\u00e9quen\u00e7age d\u2019exome - Un nouvel outil de diagnostic (DS66)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS66-Exome_infertilite_masculine.pdf","date":"","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Cardiomyopathies et troubles du rythme (DS88)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS88-HP-Cardiogenetique.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"L'apport de la g\u00e9n\u00e9tique dans la prise en charge des patientes et de leurs familles"},{"title":"D\u00e9pistage de la trisomie 21, 18 et 13 par analyse de l\u2019ADN libre circulant (ADNlc) (DS29-HP)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS29-DPNI_HP_leaflet.pdf","date":"10\/01\/2023","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"\n
Le test de d\u00e9pistage pr\u00e9natal sur simple prise de sang maternel<\/p>\n"},{"title":"D\u00e9termination pr\u00e9natale du g\u00e9notype RHD f\u0153tal \u00e0 partir du sang maternel (DS37HP)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS37-HP-Rhesus_D_foetal.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic des infections \u00e0 Mycobact\u00e9ries (DS1)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS1-Mycobacteries.pdf","date":"26\/10\/2022","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic et suivi des N\u00e9oplasies My\u00e9lo\u00efdes Chroniques (DS2)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS2-Neoplasies_myeloides_chroniques.pdf","date":"","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic, pronostic et suivi des Leuc\u00e9mies aigu\u00ebs (DS3)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS3-Leucemies_aigues.pdf","date":"","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Diagnostic, pronostic et suivi des N\u00e9oplasies Lympho\u00efdes Matures (DS62)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS62-Neoplasies_lymphoides_matures.pdf","date":"","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Digestif- fiche oncologie (DS84)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS84-Onco-digestif.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Exploration g\u00e9n\u00e9tique des n\u00e9phropathies tubulo-interstitielles : challenge technique pour MUC1 ! (DS104)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS104-Nephropathies_MUC1.pdf","date":"032\/04\/2024","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Fibrometer - Scores de fibrose h\u00e9patique (DS46)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS46-Fibrometer.pdf","date":null,"media_type":"document","profils":"575,","document_type":"le-point-sur","content":""},{"title":"Gyn\u00e9cologie - fiche oncologie (DS85)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS84-Onco-digestif.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Juvenalis (JU-DS47)","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/11\/JU-DS47-Juvenalis.pdf","date":null,"media_type":"document","profils":"579,575,574,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux professionnels de sant\u00e9"},{"title":"Juvenalis (JU-DS48)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/JU-DS48-PA.pdf","date":null,"media_type":"document","profils":"575,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux patients"},{"title":"Le s\u00e9quen\u00e7age de l\u2019exome dans l\u2019insuffisance ovarienne pr\u00e9matur\u00e9e : Pour une orientation plus pr\u00e9cise et personnalis\u00e9e des patientes et couples (DS111)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS111-Exome_IOP.pdf","date":"03\/04\/2024","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Le s\u00e9quen\u00e7age de l\u2019exome en contexte pr\u00e9natal (DS108)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS108-Exome_prenatal.pdf","date":"07\/11\/2023","media_type":"document","profils":"575,","document_type":"le-point-sur","content":"\n
Pour un diagnostic optimis\u00e9 en cas de malformations foetales<\/p>\n"},{"title":"Le s\u00e9quen\u00e7age Whole Exome dans les maladies d\u2019origine g\u00e9n\u00e9tique (DS34)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS34-Exome.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Les autoanticorps dans le diagnostic et le suivi des maladies auto-immunes (DS4)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS4-Auto-immunite.pdf","date":"27\/04\/2022","media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Les maladies transmises par les tiques (DS20)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS20-Maladies_tiques.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Leuc\u00e9mie Aigu\u00eb My\u00e9lo\u00efde (LAM) (DS68)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS68-LAM.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Leuc\u00e9mie my\u00e9lomonocytaire chronique (LMMC) (DS71)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS71-LMMC.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Microbiote intestinal (JU-DS73-PA)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/JU-DS73-PA-Microbiote.pdf","date":"","media_type":"document","profils":"575,576,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux patients"},{"title":"Microbiote intestinal (JU-DS76-PH)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/JU-DS76-HP-Microbiote.pdf","date":null,"media_type":"document","profils":"575,","document_type":"le-point-sur","content":"Brochure destin\u00e9e aux professionnels de sant\u00e9"},{"title":"N\u00e9oplasies My\u00e9loprolif\u00e9ratives Diagnostic (DS69)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS69-NMP_diagnostic.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Oncog\u00e9n\u00e9tique - Pr\u00e9dispositions h\u00e9r\u00e9ditaires aux cancers : Int\u00e9r\u00eat du s\u00e9quen\u00e7age de l'exome (DS94)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS94-Oncogenetique_exome.pdf","date":"18\/10\/2023","media_type":"document","profils":"575,","document_type":"le-point-sur","content":""},{"title":"Oncog\u00e9n\u00e9tique constitutionnelle : Utilisation du s\u00e9quen\u00e7age Long-ReadNanopore - l\u2019exemple du g\u00e8ne PMS2 (DS112) ","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS112-Sequencage_long_read_PMS2.pdf","date":"18\/10\/2023","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Panels de g\u00e8nes SPINK1, PRSS1, CTRC, CPA1, CFTR et CASR pour le diagnotsic des pancr\u00e9atites h\u00e9r\u00e9ditaires (DS82)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS82-HP-Pancreatites_hereditaires.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Papillomavirus humains et d\u00e9pistage primaire du cancer du col de l\u2019ut\u00e9rus (DS6)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS6-HPV.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Pneumologie - fiche oncologie (DS83)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS83-Onco-pneumologie.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":""},{"title":"Prise en charge de la pr\u00e9-\u00e9clampsie (DS18)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS18-Pre-eclampsie.pdf","date":"","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"Prise en charge des tumeurs solides en Biopathologie (DS5)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS5-Tumeurs_solides.pdf","date":"","media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":""},{"title":"PROSIGNA\u00ae (PAM50) (DS79)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS79-HP-PAM50.pdf","date":null,"media_type":"document","profils":"575,574,","document_type":"le-point-sur","content":"Test d\u2019expression g\u00e9nique pronostique du cancer du sein"},{"title":"Syndromes My\u00e9lodysplasiques (SMD) (DS72)","media_link":"https:\/\/www.eurofins-biomnis.com\/referentiel\/liendoc\/renseignements\/DS72-SMD.pdf","date":null,"media_type":"document","profils":"574,575,","document_type":"le-point-sur","content":"Fiche panel"},{"title":"Actualit\u00e9s sur la pr\u00e9-\u00e9clampsie et place de la biologie ","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"\n
Corinne SAULT Rev Med Gene Fam. 2018;2(7):194-8.<\/p>\n"},{"title":"Analyse immunoprot\u00e9omique des allerg\u00e8nes non-hydrosolubles de farines de quatre l\u00e9gumineuses : arachide, soja, s\u00e9same et lentille","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26635049","date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Bouakkadia H, Boutebba A, Haddad I, Vinh J, Guilloux L, Sutra JP, S\u00e9n\u00e9chal H, Poncet P\nAnn Biol Clin 2015 ; 73:690-704"},{"title":"Anticoagulant circulant (ACC) : \u00e0 propos de deux cas","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Le Flem L, Emile C\nSpectra Biologie 2016 ; 220:51-53"},{"title":"Automation of ALK gene rearrangement testing with fluorescence in situ hybridization (FISH): A feasibility study","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25576649","date":"","media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Zwaenepoel k, Merkle D, Cabillic F, Berg E, Belaud-Rotureau MA, Grazioli V, Herelle O, Hummel M, Le Calve M, Lenze D, Mende S, Pauwels P, Quilichini B, Repetti E\nExp Mol Pathol 2015 ; 98:113-118"},{"title":"Characterization of a de novo Supernumerary Neocentric Ring Chromosome Derived from Chromosome 7","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26669311","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Louvrier C, Egea G, Labalme A, Des Portes V, Gazzo S, Callet-Bauchu E, Till M, Sanlaville D, Edery P, Schluth-Bolard C\nCytogenet Genome Res 2015 ; Dec 16"},{"title":"Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays","media_link":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.639675\/full","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Geoffroy Poulet, Fanny Garlan, Sonia Garrigou, Eleonora Zonta, Leonor Benhaim, Marie-Jennifer Carrillon, Audrey Didelot, Delphine Le Corre, Claire Mulot, Philippe Nizard, Frederic Ginot, Audrey Boutonnet-Rodat, Helene Blons, Jean-Baptiste Bachet, Julien Ta\u00efeb, Aziz Zaanan, Vanna Geromel, Laurence Pellegrina, Pierre Laurent-Puig, Shu-Fang Wang-Renault and Valerie Taly\nFrontiers in Oncology 06\/05\/2021"},{"title":"Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26582834","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Mokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM\nJ Clin Microbiol 2016 ; 54:296-299"},{"title":"Chronic hepatitis E in absence of severe immune deficiency","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31327621\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Colson P, Schleinitz N, Vely F, Poveda JD,\u00a0Jacomo V, Demerle C, Borentain P, Gerolami R.Colson P, et al.\nClin Res Hepatol Gastroenterol. 2020 Feb;44(1):e1-e4. doi: 10.1016\/j.clinre.2019.06.015. \nEpub 2019 Jul 18 - PMID: 31327621"},{"title":"Combined Genotypic, Phylogenetic, and Epidemiologic Analyses of Mycobacterium tuberculosis Genetic Diversity in the Rh\u00f4ne Alpes Region, France","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27128522","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Pichat C, Couvin D, Carret G, Fr\u00e9d\u00e9nucci I, Jacomo V, Carricajo A, Boisset S, Dumitrescu O, Flandrois JP, LinaG, Rastogin N\nPlos One 2016"},{"title":"Comparative performance of three rapid HBsAg assays for detection of HBs diagnostic escape mutants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26378274","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Servant-Delmas A,\u00a0Ly TD, Hamon C, Kassim Houdah A, Laperche S\nJ Clin Microbiol 2015 ; 53:3954-3955"},{"title":"Computer-aided sperm analysis, the new key player in routine sperm assessment","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Schubert-Badiou-Force-2019.pdf","date":"","media_type":"document","profils":"579,574,575,","document_type":"publication","content":"\n
B. Schubert, M Badiou, A. Force First International Journal of Andrology \u2013 Andrologia 06\/2019 - DOI: 10.1111\/and.13417<\/p>\n"},{"title":"Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytog\u00e9n\u00e9tique h\u00e9matologique (GFCH)","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27707673","date":null,"media_type":"document","profils":"579,574,575,","document_type":"publication","content":"Daudignon A, Quilichini B, Ameye G, Poirel H, Bastard C, Terr\u00e9 C\nAnn Biol Clin 2016 ; 74:588-595"},{"title":"D\u00e9pistage combin\u00e9 de la trisomie 21 au premier trimestre : \u00e9valuation du sur-risque en cas de \u00df-hCG libre entre 5 et 10 MoM","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Th\u00e8se de M\u00e9decine, Universit\u00e9 Claude Bernar 1;2016,71p\nEtude r\u00e9alis\u00e9e avec les donn\u00e9es du laboratoire Biomnis\nLeport H"},{"title":"D\u00e9pistage multiparam\u00e9trique de la pr\u00e9-\u00e9clampsie au premier trimestre de grossesse : \u00e9tude pr\u00e9liminaire","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Th\u00e8se de m\u00e9decine, UCBL soutenue le 5 juillet 2016\nEtude r\u00e9alis\u00e9e \u00e0 partir des r\u00e9sultats du laboratoire Biomnis (Service T21 Lyon)\nWalder R"},{"title":"Dosage de la ciclosporine, du tacrolimus, de l\u2019\u00e9v\u00e9lorimus et du sirolimus en LC-MS\/MS","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2018_Petit_1-1.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Petit I, Bezol A, Ghacham S, Clavaud K, Havrez S, Moussa C, Emile C, Gerrier P\nSpectra Bio 2018, 234:61-66"},{"title":"Dosages des st\u00e9ro\u00efdes par spectrom\u00e9trie de masse","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25582724","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dufour-Rainfray D, Moal V, Cloix L, Mathieu E, Gauchez AS, Brossaud J, Corcuff JB, Fraissinet F, Collet C, Boux de Casson F, Guilloteau D, Emond P, Reynier P, Groupe de Biologie Sp\u00e9cialis\u00e9e de la SFMN : Agin A, Bach K, Charri\u00e9 A, Chikh K, Desb\u00e8ne C, Dousset B, Georges A, Guenet D, Lacroix I, Lamy PJ, Leban M, Leloupp AG, Massart C, Masson D, Moineau MP, Piketty M, Reix N, Sault C, Schlageter MH, Tse C. \nAnn Biol Clin 2015 ; 73:70-8"},{"title":"Down syndrome maternal serum markers in oocyte donation and other assisted reproductive technologies","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28921586","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Bonnin A, Muller F, Senat MV, Sault C, Galland A, Taieb J, Dreux S, Bouyer J, Benachi A\nPrenat Diagn 2017 ; 37:1155-1159"},{"title":"Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I\/501Y.V1 (B.1.1.7, variant of concern 202012\/01) in France","media_link":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2021.26.9.2100133","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Alexandre Gaymard, Paolo Bosetti, Adeline Feri, Gregory Destras, Vincent Enouf, Alessio Andronico, Sonia Burrel, Sylvie Behillil, Claire Sauvage, Antonin Bal, Florence Morfin, Sylvie Van Der Werf, Laurence Josset, ANRS MIE AC43 COVID-198, French viro COVID group (including Catherine Coignard), Fran\u00e7ois Blanquart, Bruno Coignard, Simon Cauchemez, Bruno Lina\nEurosurveillance 04\/03\/2021 - Volume 26, Issue 9"},{"title":"\u00c9mergence de la leptospirose humaine en France m\u00e9tropolitaine ? Actualit\u00e9s sur la surveillance","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bourhy P, Picardeau M, Septfons A, Trombert S, Cart-Tanneur E\nMed Mal Infect 2017 ; 47 (4s):s150"},{"title":"Evaluation de l\u2019automate Neo\u00ae (Immucor) pour l\u2019immuno-h\u00e9matologie \u00e9rythrocytaire","media_link":"","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
Rabut E, Ahmetkadic D, Malataverne J, Le Flem L Spectra Biologie 2016 ; 223:45-54<\/p>\n"},{"title":"\u00c9valuation de la valeur seuil la plus co\u00fbt-efficace des marqueurs s\u00e9riques du 1er\u00a0trimestre pour l\u2019emploi du test d\u2019ADN circulant dans le d\u00e9pistage de la trisomie\u00a021\u00a0: une analyse m\u00e9dico-\u00e9conomique","media_link":"https:\/\/www.jle.com\/fr\/revues\/abc\/e-docs\/cost_effectiveness_threshold_of_first_trimester_down_syndrome_maternal_serum_screening_for_the_use_of_cell_free_dna_as_a_second_tier_screening_test_320573\/article.phtml","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Marie Blanquet, Sophie Dreux, St\u00e9phanie L\u00e9ger,\u00a0Corinne Sault,\u00a0Charline Mourgues, H\u00e9l\u00e8ne Laurichesse, Didier L\u00e9mery, Fran\u00e7oise Vendittelli, Anne Debost-Legrand, Fran\u00e7oise Muller\nAnnales de Biologie Clinique Volume 79, num\u00e9ro 4, Juillet-Ao\u00fbt 2021"},{"title":"Evaluation of the performance of a new automated HIV combination assay","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29020658","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Ghisetti V, Coignard C, Allice T, Ly TD\nJ Clin Virol 2017 ; 96:80-83"},{"title":"Evaluation of the SLOMYCO Sensititre\u00ae panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27150659","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Chazel M, Marchandin H, Keck N, Terru D, Carri\u00e8re C, Ponsoda M, Jacomo V, Panteix G, Bouzinbi N, Ba\u00f1uls AL, Choisy M, Solassol J, Aubry, Godreuil S\nAnn Clin Microbiol Antimicrob 2016 ; 15:30"},{"title":"Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities","media_link":"http:\/\/www.bloodjournal.org\/content\/132\/Suppl_1\/943?sso-checked=true","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"On Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group\nElise Chapiro, Elodie Pramil, M\u2019boyba Diop, Damien Roos-Weil, Cl\u00e9mentine Dillard, Cl\u00e9mentine Gabillaud, Karim Maloum, Catherine Settegrana, Lucile Baseggio, Jean-Fran\u00e7ois Lesesve, M\u00e9lanie Yon, Ludovic Jondreville, Claude Lesty, Fr\u00e9d\u00e9ric Davi, Magali Le Garff-Tavernier, Nathalie Droin, Philippe Dessen, Caroline Algrin, V\u00e9ronique Leblond, Jean Gabarre, Simon Bouzy, Virginie Eclache, Baptiste Gaillard, Evelyne Callet-Bauchu, Marc Muller, Christine Lefebvre, Nathalie Nadal, Antoine Ittel, St\u00e9phanie Struski, Marie-Agn\u00e8s Collonge-Rame, Benoit Quilichini, Sandra Fert-Ferrer, Nathalie Auger, Isabelle Radford-Weiss, Lena Wagner, Sebastian Scheinost, Thorsten Zenz, Santos A. Susin, Olivier A. Bernard, Florence Nguyen-Khac\nBlood 2018 132:943; doi:"},{"title":"Identification of a polygalacturonase (Cup s 2) as the major CCD-bearing allergen in Cupressus sempervirens pollen","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28439939","date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Shahali Y, Sutra JP, Hilger C, Swiontek K, Haddad I, Vinh J, Guilloux L, Charpin D, S\u00e9n\u00e9chal H, Poncet\nAllergy 2017 ; doi: 10.1111\/all.13191"},{"title":"Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. \u2013 Trends over 10 years","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26518058","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Bailly S, Maubon D,\u00a0Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF\nJ Infect\u00a02015 ; Oct 28. pii: S0163-4453(15)00342-4. doi: 10.1016\/j.jinf.2015.09.041"},{"title":"Impact of Including or Removing Nuchal Translucency Measurement on the Detection and False-Positive Rates of First-Trimester Down Syndrome Screening","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26656919","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Spaggiari E, Czerkiewicz I, Sault C, Dreux S, Galland A, Salomon LJ, Ville Y, Muller F\nFetal Diagn Ther 2015 ; Dec 12"},{"title":"Int\u00e9r\u00eat du s\u00e9quen\u00e7age haut d\u00e9bit dans les h\u00e9mopathies my\u00e9lo\u00efdes chroniques : quelles actualit\u00e9s en 2022 ?","media_link":"","date":"01\/09\/2022","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"\n
B. Quilichini Journal de Biologie M\u00e9dicale \/ Volume 11-Num\u00e9ro 42 \/ Juil-Sept 2022<\/p>\n"},{"title":"Interf\u00e9rences s\u00e9rologiques du traitement du my\u00e9lome multiple par daratumumab (anti-CD38) : \u00e0 propos d\u2019un cas","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28540859","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Rabut E, Castro-Fernandez A, Le Gall V, Meknache\nAnn Biol Clin 2017 ; 75:351-355"},{"title":"Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31379011","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Penther D, Etancelin P, Lusina D, Bidet A, Quilichini B, Gaillard B, Rafdord-Weiss I, Mozziconacci MJ, Ittel A, Roche-Lestienne C, Barin C, Soler G, Daudignon A, Nadal N, Chapiro E, Lefebvre C, Godon C, Nadeau G, Mugneret F, Richebourg S, Viailly PJ, Ferret Y, Nguyen-Khac F, Eclache V; Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique\nAm J Hematol 2019 Aug 4. doi: 10.1002\/ajh.25601."},{"title":"Large outbreak of urogenital schistosomiasis acquired in Southern Corsica: monitoring the early signs of the endemicization?","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28669843","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"No\u00ebl H, Ruello M, Maccary A, Pellat C, Sommen C, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Durand J, Ramalli L, Chiappini JD , Malfait P, Berry\nClin Microbiol Infect 2017 ; pii: S1198-743X(17)30350-6. doi: 10.1016\/j.cmi"},{"title":"Les niveaux de preuve des biomarqueurs utilis\u00e9s pour la d\u00e9tection pr\u00e9coce des cancers de la prostate","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27029727","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Lamy PJ, Gauchez AS, Salomon L et al et le Groupe de biologie de la prostate : Sault C et al\nAnn Biol Clin 2016 ; 74:227-232"},{"title":"Marqueurs de d\u00e9pistage et de pr\u00e9diction de la pr\u00e9-\u00e9clampsie : place de la biologie","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Sault C\nJ Biol Med 2017 ; 6:186-190"},{"title":"Non-invasive prenatal testing: what are we missing?\u00a0","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32119166","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fries N, Le Garrec S, Egloff M, Sault C, Dreux S, Mangione R, Salomon LJ, Ville Y. \nUltrasound Obstet Gynecol. Mars 2020 - 2. doi: 10.1002\/uog.22005."},{"title":"Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28189936","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Thibault V, Servant-Delmas A, Ly TD, Roque-Afonso AM, Laperche S\nJ Clin Virol 2017 ; 89:14-21"},{"title":"Persistence of Zika virus in gradient sperm preparation","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29510270","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Cassuto NG, Marras G, Jacomo V, Bouret D\nJ Gynecol Obstet Hum Reprod 2018, pii: S2468-7847(18)30038-2"},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"","media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Emile C, Sault C\nSpectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49."},{"title":"Place de la biologie dans le d\u00e9pistage et la pr\u00e9diction de la pr\u00e9-\u00e9clampsie au cours de la grossesse","media_link":"","date":"12\/12\/2022","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Emile C, Sault C<\/strong>. Spectra diagnostic n\u00b07 Janvier \u2013 f\u00e9vrier \u2013 mars 2020 p45 \u00e0 49.<\/p>\n"},{"title":"Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians","media_link":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Potential+value+of+placental+angiogenic+factors+as+biomarkers+in+preeclampsia+for+clinical+physicians","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Boulanger H, Lef\u00e8vre G, Ahriz Saksi S, Achiche J, Bailleul S, Ekoukou D, Drouin D, Sault C, Stawiarski N, Dupuis E.\nNephrol Ther. 2019 Mar 29"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0755498219304178?via%3Dihub","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Hamdi SM, Sault C, Piver E, Genoux A, Masson D, Guibourdenche J.\nPresse Med . 2019 Oct 29. pii: S0755-4982(19)30417-8. doi: 10.1016\/j.lpm.2019.09.029. PMID:31676218"},{"title":"Pr\u00e9\u00e9clampsie : faut-il int\u00e9grer dans la pratique courante les biomarqueurs de d\u00e9pistage et de pronostic ?","media_link":"https:\/\/doi.org\/10.1016\/j.lpm.2019.09.029","date":"12\/12\/2019","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Hamdi SM, Sault C<\/strong>, Piver E, Genoux A, Masson D, Guibourdenche J. Presse Med. (2019)<\/p>\n"},{"title":"Preliminary report of an autochthonous Chikungunya outbreak in France, July to September 2017","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29019313","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Calba C, Guerbois-Galla M, Franke F, Jeannin C, Auzet-Caillaud M, Grard G, Pigaglio L, Decoppet A, Weicherding J, Savaill MC, Munoz-Riviero M, Chaud P, Cadiou B, Ramalli L, Fournier P, Noel H, De Lamballerie X, Paty MC, Leparc-Goffart I\nEuro Surveill 2017 ; 22(39):pii=17-00647"},{"title":"Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance","media_link":"https:\/\/www.nature.com\/articles\/s41467-021-23233-6","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"St\u00e9phane Le Vu,\u00a0Gabrielle Jones,\u00a0Fran\u00e7ois Anna,\u00a0Thierry Rose,\u00a0Jean-Baptiste Richard,\u00a0Sibylle Bernard-Stoecklin,\u00a0Sophie Goyard,\u00a0Caroline Demeret,\u00a0Olivier Helynck,\u00a0Nicolas Escriou,\u00a0Marion Gransagne,\u00a0St\u00e9phane Petres,\u00a0Corinne Robin,\u00a0Virgile Monnet,\u00a0Louise Perrin de Facci,\u00a0Marie-Noelle Ungeheuer,\u00a0Lucie L\u00e9on,\u00a0Yvonnick Guillois,\u00a0Laurent Filleul,\u00a0Pierre Charneau,\u00a0Daniel L\u00e9vy-Bruhl,\u00a0Sylvie van der Werf\u00a0&\u00a0Harold Noel\u00a0\nNature Communications volume 21\/05\/2021 12, Article number: 3025 (2021)"},{"title":"Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/30789329\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Tatai C, Berland JL, Claude JB, Westeel E, Hodille E, Fredenucci I, Rasigade JP, Ponsoda M, Jacomo V, Vach\u00e9e A, Gaudart A, Gaillard JL, Roux AL, Ader F, Tararbit K, Terpant G, Bryant JE, Lina G, Dumitrescu O; Lyon TB Study Group.Genestet C, et al.\nEmerg Infect Dis. 2019 Mar;25(3):589-592. doi: 10.3201\/eid2503.181124 - PMID: 30789329"},{"title":"R\u00e9activit\u00e9 crois\u00e9e in silico, in vitro, in vivo","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Guilloux L, Ricard-Blum S\nAllergies alimentaires 2017 ; chapitre 7.5:97-102"},{"title":"Recherche et identification des anticorps antinucl\u00e9aires : analyse du questionnaire europ\u00e9en de l\u2019EASI groupe et confrontation des pratiques fran\u00e7aises aux recommandations internationales","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29623889","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Musset L, Fabien N, Chyderiotis G, Olsson NO, Pham BN, Durey Dragon MA\nAnn Biol Clin 2018, 76 :185-195"},{"title":"Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission.","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31806715\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Genestet C, Paret R, Pichat C, Berland JL, Jacomo V, Carret G, Fredenucci I, Hodille E, Rasigade JP, Boisset S, Carricajo A, Lina G, Ronnaux-Baron AS, Mornex JF, Grando J, S\u00e9n\u00e9chal A, Ader F, Dumitrescu O; Lyon TB study group.Genestet C, et al.\nEur Respir J. 2020 Mar 20;55(3):1901888. doi: 10.1183\/13993003.01888-2019. Print 2020 Mar"},{"title":"Schistosomose en Corse : chronique d\u2019une histoire annonc\u00e9e","media_link":null,"date":null,"media_type":"document","profils":"574,579,575,","document_type":"publication","content":"Berry A, Iriart X, Boissier J, Chyd\u00e9riotis G, Debruyne M, Magnaval JF, Fillaux J, Grech-Angelini S, Barr\u00e9-Cardi H, Termignon JL, Macarry A, Noel H\nLa Lettre de l'Infectiologue 2016 ; XXXI n\u00b02:60-64"},{"title":"Screening and identification of antinuclear antibodies (ANA): analysis of the European EASI survey and confrontation of the French routine practice to the international recommandations","media_link":null,"date":null,"media_type":"document","profils":"579,575,574,","document_type":"publication","content":"Musset L, Fabien N, Chyd\u00e9riotis G, Olsson NO, Pham BN, Dragon-Durey MA\nAnn Biol Clin 2017 ;"},{"title":"Surveillance des infections humaines par hantavirus en France m\u00e9tropolitaine, 2012-2016","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resum-2017_Cart-Tanneur_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Reynes JM, Carli D, Renaudin B, Fizet A, Bour JB, Brodard V, Cart-Tanneur E, Dewilde A, El Hamri M, Fleury H, Hecquet D, Jeulin H, Lechat S, Lemarquand-Bardini M, Lepiller Q, Poveda JD, Raulin O, Twizeyimana E, Van Cauteren D, Velay A, Septfons A, Baize S\nBEH 2017 ; 23:492-499"},{"title":"Surveillance du chikungunya et de la dengue en France m\u00e9tropolitaine, 2014","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Publications\/Biomnis_Resume_Septfons-A_2016_330-70-77.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Septfons A, No\u00ebl H, Leparc-Goffart I, Giron S, Delisle E, Chappert JL, Catelinois O, Franke F, Servas V, Guinard A, Debruyne M, Schaal O, Brichler S, Ninove L, Prat C, Flusin O, Poujol I, Letort MJ, Deniau J, Six C, Rousseau C, De Valk H, Paty MC\nLes Feuillets de Biologie 2016 ; 330:70-77"},{"title":"Surveillance du chikungunya, de la dengue et des infections \u00e0 virus Zika en France m\u00e9tropolitaine, 2017","media_link":"http:\/\/invs.santepubliquefrance.fr\/beh\/2018\/24\/pdf\/2018_24_1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Fournet N, Franke F, Chaud P, Raguenaud ME, Calba C, Septfons A, Cart-Tanneur E. et al.\nBull Epid\u00e9miol Hebd. 2018;(24):494-503."},{"title":"Testing anti-neutrophil cytoplasmic antibodies (ANCA): analysis of the European EASI survey on the daily practice of the French laboratories","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28958962","date":null,"media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Dragon-Durey MA, Fabien N, Chyd\u00e9riotis G, Musset L, Pham BN, Olsson N\nAnn Biol Clin 2017 ; 75:531-541"},{"title":"The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)","media_link":"","date":"06\/09\/2022","media_type":"document","profils":"579,575,574,","document_type":"publication","content":"\n
Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nab\u00e9ra C, Chapiro E, Collonge-Rame MA, Cuccuini W, Douet-Guilbert N, Eclache V, Luquet I, Michaux L, Nadal N, Penther D, Quilichini B<\/strong>, Terre C, Lefebvre C, Troadec MB, V\u00e9ron\u00e8se L. Leukemia. 2022 Jun;36(6):1451-1466. doi: 10.1038\/s41375-022-01561-w. Epub 2022 Apr 16.PMID: 35430613 Review.<\/p>\n"},{"title":"The impact of introducing combined first-trimester trisomy 21 screening in the French population","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26628633","date":null,"media_type":"document","profils":"574,575,579,","document_type":"publication","content":"Eur J Public Health 2015 ; Nov 30"},{"title":"The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/34284044\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Maxime Espi, Xavier Charmetant, Thomas Barba, Laetitia Koppe, Caroline Pelletier, Emilie Kalbacher, Elodie Chalencon, Virginie Mathias, Anne Ovize, Emmanuelle Cart-Tanneur, Christine Bouz, Laurence Pellegrina, Emmanuel Morelon, Denis Fouque, Laurent Juillard, Olivier Thaunat\nKidney International 2021 Oct;100(4):928-936. doi: 10.1016\/j.kint.2021.07.005."},{"title":"Thrombop\u00e9nie induite par l\u2019h\u00e9parine (TIH) : \u00e0 propos d\u2019un casLe Flem L, Emile C","media_link":"","date":"","media_type":"document","profils":"574,579,575,","document_type":"publication","content":"\n
Le Flem L, Emile C, Spectra Biologie 2016 ; 220:49-50<\/p>\n"},{"title":"Une interf\u00e9rence dans le dosage de l\u2019insuline r\u00e9v\u00e8le un syndrome auto-immun anti-insuline","media_link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27492703","date":"","media_type":"document","profils":"575,574,579,","document_type":"publication","content":"Lamy PJ, Sault C, Renard E\nAnn Biol Clin 2016 ; 74:490-494"},{"title":"Vector-borne Transmission of Zika Virus in Europe, Southern France, August 2019","media_link":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31718742\/","date":null,"media_type":"document","profils":"575,579,574,","document_type":"publication","content":"Sandra Giron, Florian Franke, Anne Decoppet, Bernard Cadiou, Thierry Travaglini, Laurence Thirion, Guillaume Durand, Charles Jeannin, Gr\u00e9gory L\u2019Ambert, Gilda Grard, Harold No\u00ebl, Nelly Fournet, Michelle Auzet-Caillaud, Christine Zandotti, Samer Abouka\u00efs, Pascal Chaud, Saby Guedj, Lakri Hamouda, Xavier Naudot, Anne Ovize, Cl\u00e9ment Lazarus, Henriette de Valk, Marie-Claire Paty, Isabelle Leparc-Goffart\nEuro Surveill. 2019 Nov;24(45):1900655."},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Faux-positif-ADNlcT21_L-Druart_012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Faux positif d\u2019ADNlcT21 avec diff\u00e9rentes anomalies chromosomiques confin\u00e9es au placenta\nL Druart, H Dessuant, JF Taly, M Nouchy, L Raymond, S Tapia"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Developpement-panel-15-marqueurs_F.-Rousseau-et-al.-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9veloppement d\u2019un panel de 15 marqueurs pour une identitovigilance\ndes \u00e9chantillons analys\u00e9s par s\u00e9quen\u00e7age haut d\u00e9bit ou sur puces \u00e0 SNP\nF Rousseau, J-F Taly, C Ploton Nicollet, M Taoudi, A Perdriau, L Raymond"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20359-Assises-de-Genetique-2020_B-Quilichini_012020.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Mise en place d\u2019un panel de g\u00e8nes cibl\u00e9s pour les h\u00e9mopathies\nmalignes (NMP-LMMC-SMD-LAM) par NGS : Enjeux M\u00e9dical \/ Scientifique et d\u2019Assurance Qualit\u00e9.\nV Geromel, E Fayolle, P Mouty, R Moulin, N Batail, M-H Felix, B Adde, S Mouty, L Raymond, B Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/20362-Assises-de-Gntique-2020_B_Quilichini-012020.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Impact diagnostique, pronostique et th\u00e9ranostique d\u2019un panel de g\u00e8nes\n\u00ab H\u00e9mopathies My\u00e9lo\u00efdes \u00bb r\u00e9alis\u00e9 par NGS : l\u2019exp\u00e9rience du laboratoire Eurofins Biomnis en 2019.\nV. Geromel, P. Mouty, C. Chal, J . Delaunay, S. Sadot-Lebouvier, R. Kaphan, J. Vigvari, J.P. Coadic, E.A. Marin La Meslee, O. Roualdes, C. Bourdin, A. Petit, M. Roumigui\u00e8res, L. Raymond, B.Quilichini"},{"title":"10e Assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, 21-24 janvier 2020, Tours - 4","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Les_assises_2020_RadoslavaSARAEVA_LAMRI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"21-24 janvier 2020, Tours\nDiagnostics g\u00e9n\u00e9tiques multiples (double hits) par s\u00e9quen\u00e7age Whole Exome (WES) : \u00e0 propos de deux cas.\nR. SARAEVA-LAMRI, A. DORELLE, V. GEROMEL, A. S. LEBRE, P. MOUTY, M. E. NAUD BARREYRE, F. ROUSSEAU, M. TAOUDI, L. MESNARD, L. RAYMOND"},{"title":"10th International Congress on Autoimmunity, Leipzig, April 6-10, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_4.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Should Dense Fine Speckled 70 (DFS70) pattern be reported? Biomnis reference lab experience on 12 619 ANA screening consecutive sera\nGuis L, Ebel A, Leroy J, Michaud S, Pomaredes A, Marcenaro C, Chalouas L"},{"title":"12\u00e8me CFA, Paris, avril 25-28, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":""},{"title":"12\u00e8me Congr\u00e8s de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie, Paris, mars 22-23, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Jacomo_3.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Les Liquides C\u00e9phalo-Rachidiens : conservation pr\u00e9-analytique \u00e0+ 4 \u00b0C ou \u2013 20 \u00b0C ?\nJacomo V, Schaal O, Fournier P"},{"title":"17\u00e8mes Journ\u00e9es Francophones de Virologie, Paris, avril 9, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"R\u00e9solution des \u00e9checs de g\u00e9notypage de la technique Abbott RealTime HCV Genotype II par un test temps r\u00e9el additionnel\nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ly_8.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of a new high sensitive, qualitative and quantitative Hepatitis B surface antigen assay\nLy TD, Coignard C"},{"title":"18th Annual Meeting of the European Society for Clinical Virology, Edinburgh, September 9-12, 2015 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Characterization of samples with genotype 1 without subtype results by Abbott RealTime HCV genotype II using the new Abbott HCV Genotype Plus RUO test \nMokhtari C, Ebel A, Reinhardt B, Merlin S, Proust S, Roque-Afonso AM"},{"title":"19th Annual Meeting of the European Society for Clinical Virology (ESCV), Lisbon, september, 14\u201317, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/09\/Biomnis_Poster_2016_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to COBAS\u00ae AmpliPrep\/OBAS\u00ae TaqMan\u00ae HIV-1 and HBV tests\nEbel A, Bali C, Guis L, Merlin S"},{"title":"20\u00e8mes Journ\u00e9es de M\u00e9decine Foetale, Morzine, mars 26-28, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015__Becker_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Int\u00e9r\u00eat du D\u00e9pistage Pr\u00e9natal Non Invasif dans le diagnostic des aneuplo\u00efdies 13, 18 et 21 \nBecker M, Eg\u00e9a G, Taoud M, Ahmed Chaouch D, El Mouatassim S"},{"title":"20Th Congress European Hematology Association, Vienna, June 11-14, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Rigollet_5.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Characterization of normal and pathological lymphoid populations: validation of a 10-colors flow cytometry protocol for routine diagnosis \nRigollet L, Stagnara J, Milhau A, Pellegrina L"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/10\/Biomnis_Poster-Aptima-HIV-1-HBV_Ebel_Sept18.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Performance Evaluation of the Aptima\u00ae HIV-1 Quant Dx and Aptima\u00ae HBV Quant assays on the fully automated Panther in comparison to Cobas\u00ae 6800\/8800 HIV-1 and HBV tests\nA. Ebel, C. Bali, L. Guis, S. Merlin"},{"title":"21st Annual European Society for Clinical Virology (ESCV) meeting, Athens 23 \u2013 26 September 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/11\/Poster-IgM-Measles-ESCV-TD-LY-.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of new IgM Measles assay\nT.D. Ly, C. Coignard"},{"title":"24e Journ\u00e9es de m\u00e9decine f\u0153tale, Marseille, 4-5-6 avril 2019","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"D\u00e9pistage de la trisomie 21 par analyse de l\u2019ADN f\u0153tal libre circulant dans le sang maternel : Application dans le cas des grossesses g\u00e9mellaires\nMarc NOUCHY, Nicolas CHATRON, Pascal MOUTY, Francis ROUSSEAU, Barbara ADD\u00c9, Mohamed Taoudi, Caroline DUMONT, Jean-Fran\u00e7ois TALY, Luc DRUART, Sylvie TAPIA, Damien SANLAVILLE, Laure RAYMOND"},{"title":"25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, April 25-28, 2015","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of three fully automated assays for the detection of cytomegalovirus IgM and IgG: DiaSorin LIAISON\u00ae XL, Abbott Architect \u00ae and Roche Cobas 6000\u00ae\nBouthry E, Ly TD, Vauloup-Fellous C"},{"title":"27th ECCMID, Vienna Austria, April 22-25, 2017","media_link":null,"date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Strain-specific estimation of epidemic success provides insights into the transmission dynamics of tuberculosis Rasigade\nJP, Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, P\u00e9rouse de Montclos M, Flandrois JP, Ader F, Supply P, Lina G, Wirth T"},{"title":"29th IUSTI European Conference on Sexually Transmitted Infections, Sitges (Barcelona), 24-26 September, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_10.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Prevalence of Mycoplasma genitalium in France and comparison with Chlamydia trachomatis and Neisseria gonorrhoeae as determined by the Mycoplasma genitalium TMA assay \nEbel A, Venard C, Brunengo D, Merlin S"},{"title":"31st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbon, June 14-17, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Force_7.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Blastocysts vitrification during 2 consecutive years: before and after its start significant delivery rate increase within the 1st year \nForce A, Nicollet B, Chomier M, Sergeant P, Lescaille M, Rochigneux S, Robert F, Ginon J, Sergeant MV, Baucher S, Schubert B"},{"title":"35e congr\u00e8s de la SFH, CNIT Paris la D\u00e9fense, avril 1-3, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Becker_4.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"La SNP array : un outil compl\u00e9mentaire pour la caract\u00e9risation des h\u00e9mopathies malignes \nBecker M, Eg\u00e9a G, Camilli K, Robin M, Roumigui\u00e8res M, Rigollet L, Stagnara J, El Mouatassim S"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_14.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Evaluation du nouveau test LAISON\u00ae H. pylori IgG\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Coignard_15.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Borr\u00e9liose et index de synth\u00e8se intrath\u00e9cale : bilan biologique r\u00e9trospectif de l\u2019ann\u00e9e 2015\nCoignard C, Ly TD"},{"title":"36\u00e8me RICAI, Paris, d\u00e9cembre 12-13, 2016 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/12\/Biomnis_Poster_2016_Ebel_16.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation des performances de la trousse Aptima\u00ae HBV Quant (Hologic)\nEbel A, Bali C, Guis L, Merlin S"},{"title":"37\u00e8me RICAI, Paris, d\u00e9cembre 18-19, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/12\/Biomnis_Poster_2017_Coignard_13.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Confirmation VIH : donn\u00e9es biologiques et \u00e9pid\u00e9miologiques des 3 derni\u00e8res ann\u00e9es dans un laboratoire de biologie sp\u00e9cialis\u00e9e\nCoignard C, Ly TD"},{"title":"38e RICAI, Paris 17-18 d\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-COIGNARD-ROUGEOLE.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Epid\u00e9mie de rougeole 2018 : le s\u00e9rodiagnostic un marqueur simple et performant.\nT.D. Ly, C. Coignard"},{"title":"3e Journ\u00e9e Francophone de Biologie M\u00e9dicale, Monaco, 6-7-8 novembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/11\/1911_poster_A.Ebel_JFBM.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"D\u00e9pistage syst\u00e9matique de Neisseria gonorrhoeae et de C. trachomatis par test d\u2019amplification g\u00e9nique : bilan d\u2019une ann\u00e9e d\u2019exp\u00e9rience\nL. Mine, L. Guis, S. Merlin, A. Ebel"},{"title":"40e RICAI \u2013 R\u00e9union Interdisciplinaire de Chimioth\u00e9rapie Anti-Infectieuse, 14-15 d\u00e9cembre","media_link":"https:\/\/www.eurofins-biomnis.com\/DOC-Biomnis\/Posters\/2012_Poster_SARS-CoV-2_RICAI_C.Coignard.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"S\u00e9rologie SARS-CoV-2 : \u00e9valuation, qualification et choix d\u2019une m\u00e9thode\nCatherine Coignard, Anne EBEL, Yanis BOUAMRA, Didier RIDEY, Carla MARCENARO"},{"title":"42es Journ\u00e9es Nationales \u2013 Congr\u00e8s CNGOF, Strasbourg, 4-7 D\u00e9cembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/12\/POSTER-EMILE-DPNI.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"\u00c9tude de l\u2019usage du DPNI (d\u00e9pistage pr\u00e9natal non invasif) des aneuplo\u00efdies en milieu lib\u00e9ral\nC. Emile, L. Raymond, L. Pellegrina"},{"title":"45\u00e8me Colloque National des Biologistes des H\u00f4pitaux, Paris, juin 22-24, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/06\/Biomnis_Poster_2016-Rabut_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Interf\u00e9rence du traitement par daratumumab (anti-CD38) dans le suivi biologique du my\u00e9lome multiple et dans la recherche d\u2019anticorps anti-\u00e9rythrocytaires : \u00e0 propos d\u2019un cas\nRabut E, Castro-Fernandez A, Le Gall V, Meknache N"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Raymond_2.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport diagnostique de l\u2019utilisation des puces SNP dans l\u2019\u00e9tude chromosomique des morts f\u0153tales\nRaymond L, Dherbey JL, Rebeyrat-Pichon I, El-Mouatassim S, Egea G"},{"title":"8\u00e8mes Assises de G\u00e9n\u00e9tique humaine et m\u00e9dicale, Lyon, f\u00e9vrier, 3-5, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_11.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Cas rare d\u2019X-fragile pr\u00e9natal avec r\u00e9traction d\u2019expansion de triplet CGG ? \nMouty P, Raymond L, El Mouatassim S, Liquier A, Druart L, Paris A, Dorian V, Pichon I, Dherbey JL, Eg\u00e9a G"},{"title":"CGRF Ile de R\u00e9, septembre 28-29, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Brunengo_11.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Epid\u00e9miologie qualitative des variants rares de l\u2019H\u00e9moglobine en France m\u00e9tropolitaine au travers de la collaboration HCL \u2013 Eurofins Biomnis\nBrunengo D, Veyrenche N, Louis Chillotti L, Le Flem L"},{"title":"COGEN, Paris, Septembre 25-27, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_El-Mouatassim_11.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"French experience of Non-Invasive Prenatal Testing of trisomy 21, 18 and 13 \nEl Mouatassim S, Taoudi M, Eg\u00e9a G"},{"title":"Congr\u00e8s SFP \/ SFMM, Toulouse, mars 29-31, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/03\/Biomnis_Poster_2017_Chydriotis_1-1.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Apport de 2 tests de d\u00e9pistage pour le diagnostic de la bilharziose et place du Western blot\nChyd\u00e9riotis G, Cart-Tanneur E, Lecuelle C, F\u00e9lix MH"},{"title":"Congr\u00e8s SFTA, Avignon, mai 10-12, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_Petit_2.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Dosage de la Ciclosporine, Tacrolimus, Ev\u00e9rolimus et Sirolimus en LCMSMS avec le coffret MassTox Chromsystems sur Api 4500 ABSciex avec pr\u00e9paration automatis\u00e9e sur T\u00e9can EVO 150\nPetit I, Moussa C, Bonnet K, Bezol A. Havrez S, Gerrier P"},{"title":"EAACI, Helsinki, June 17-21, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Guilloux_6.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Bp14, an allergen from cupressus sempervirens pollen related to the family of snakin\/gibberellin-regulated proteins\nS\u00e9n\u00e9chal H, Santrucek J, Melcova M, Svoboda P, Zidkova J, Guilloux L, Aizawa T, Couderc R, Charpin D, Poncet P"},{"title":"ESCAIDE 2015, Stockholm, November 11-13, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Chyderiotis_14.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Re-emergence of urinary schistosomiasis in Europe ? Infections acquired in Southern Corsica \u2013 Investigation of a cluster of Schistosoma haematobium infections in 2014\nRamalli L, No\u00ebl H, Ruello M, Maccary A, Boissier J, Barr\u00e9-Cardi H, Fillaux J, Termignon JL, Debruyne M, Chyderiotis G, Denoyel GA, Succo T, Armengaud A, Paty MC, Heuz\u00e9 G, Mattei J, Th\u00e9ron A, Berry A"},{"title":"ESCV, Stresa, Lake Maggiore, September 13-16, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/10\/Biomnis_Poster_2017_LY_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new chemiluminescent assay to detect and quantify anti-HBs antibodies\nMaillard A, Ly TD, Thibault V"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/05\/Biomnis_Poster_2017_LY_3.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Performance of a new LIAISON\u00ae H. pylori IgG\nLy TD, Coignard C"},{"title":"EUROMEDLAB, Athens, June 11-15, 2017 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2017_Rabut_4.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Red blood cell antibody assays in DARA-treated patients\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"EuroMedLab, Paris, June 22-24, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2015\/11\/Biomnis_Poster_2015_Ebel_6.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Early Performance Evaluation of cobas\u00ae HBV, cobas\u00ae HCV and cobas\u00ae HIV-1Quantitative Nucleic Acid Tests for use on the new cobas\u00ae 6800\/8800 Systems\nEbel A, Merlin S, Marins ED G, Canchola J, Njoya M, Simon CO"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/poster-FFER-2018-callec.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Impact de la chirurgie bariatrique sur les param\u00e8tres spermatiques : Revue de la litt\u00e9rature\nR. Callec, B. Schubert, F. Robert, A. Force"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 1","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/POSTER-FFER-2018-Force.pdf","date":null,"media_type":"document","profils":"579,574,575,","document_type":"poster","content":"Crit\u00e8res d\u2019interpr\u00e9tation du msome pour une optimisation de la prise en charge des patients\nA. Force, M. Chomier, P. Sergeant, J. Ginon, S. Rochigneux, M. Lechatton, M. Pont, R. Callec, F. Robert, B. Schubert"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Lopez.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation externe de la qualit\u00e9 en spermiologie : un nouveau programme pour une \u00e9valuation globale de l\u2019examen\nMarie LOPEZ, Bernard POGGI, Jean Christophe EYNARD, Marie LETY, Benoit SCHUBERT, Andr\u00e9 FORCE"},{"title":"F\u00e9d\u00e9ration Fran\u00e7aise d\u2019Etude de la Reproduction, 12-14 septembre 2018 - 3","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/03\/Poster-FFER-2018-Schubert.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Influence des conditions de culture sur les r\u00e9sultats en AMP dans une \u00e9tude multicentrique : comparaison d\u2019un incubateur Time Lapse avec les incubateurs tradictionnels\nBeno\u00eet SCHUBERT, Alexandre MARCILLY, Andr\u00e9 FORCE"},{"title":"FFER, Tours, septembre 13-15, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Force_9.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Comparaison de la performance de 2 incubateurs (Geri versus Planer) apr\u00e8s randomisation de la cohorte ovocytaire pour chaque patiente\nForce A, Martine Chomier, Philippe Sergeant, Jacqueline Ginon, St\u00e9phanie Rochigneux, Soizic Baucher, M\u00e9lanie Le Chatton, M\u00e9lanie Pont, Beno\u00eet Schubert"},{"title":"FIBA 2016, Dakar, January 13-14, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/03\/Biomnis_Poster_2016_Guis_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"ANCA associated HIV infection in Senegal: a serological trap\nArouna O, Niang A, Abiola A, Guis L, Le Flem L, Diene JF, Mboup S"},{"title":"Fort Collins (USA), May 31-June 3, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/05\/Biomnis_Poster_2016_Jacomo_5.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Seoul Virus Infection in Human, France, 2014-2016\nReynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, Nussbaumer T, Jacomo V, Rapt MP, Septfons A, Rollin PE"},{"title":"ISMA, Lisbon, November 19-21, 2015","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/06\/Biomnis_Poster_2015_Guilloux_16.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Ige-cross-reactivity between european hymenoptera and asian hornet (vespa velutina) venom allergens\nLong\u00e9 C, Brazdova A, Brunet JL, Schwartz C, Girodet B, Lavaud F, Birnbaum J, Pham-Thi N, Duchateau M, Chamot-Rooke J, Guilloux L, Selva MA, Couderc R, S\u00e9n\u00e9chal H, Sutra JP, Poncet P"},{"title":"Journ\u00e9es Nationales CNGOF, Montpellier, d\u00e9cembre 7-9, 2016","media_link":null,"date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Etude pr\u00e9liminaire sur le d\u00e9pistage de la pr\u00e9-\u00e9clampsie au 1er trimestre de la grossesse (Predictor\u00ae)\nWalder R, Galland A, Sault C, Huissoud C"},{"title":"Journ\u00e9es Nationales d\u2019Infectiologie, Nantes, 13-15 juin, 2018","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2018\/05\/Biomnis_Poster_2018_Ebel_1.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Infections \u00e0 Chlamydia trachomatis : donn\u00e9es \u00e9pid\u00e9miologiques r\u00e9centes dans un laboratoire sp\u00e9cialis\u00e9\nEbel A, Guis L, Merlin S"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2020\/01\/Poster-Lyme-RICAI-C.-Coignard-TD-Ly-dec-2019-800x1200.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Evaluation of the BioPlex 2200 Lyme IgG\/IgM immunoassay system\nC. Coignard, C. Cl\u00e9ment-Vincent, Td. Ly, A. L\u2019hotellier"},{"title":"RICAI 2019, Paris, 16-17 d\u00e9cembre 2019 - 2","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2019\/12\/2019-12-17_RICAI.pdf","date":null,"media_type":"document","profils":"575,579,574,","document_type":"poster","content":"Sp\u00e9cificit\u00e9 de la s\u00e9rologie chikungunya et surveillance \u00e9pid\u00e9miologique\nC. Calba, F. Franke, E. Brottet, G. Terpant, N. Fournet, A. Ovize, J.D. Poveda, I. Leparc-Goffart, M.C. Paty"},{"title":"SFE, Bordeaux, octobre 5-8, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Sault_13.pdf","date":null,"media_type":"document","profils":"575,574,579,","document_type":"poster","content":"Influence de la nature du liquide de rin\u00e7age d\u2019aiguille de cytoponction sur le dosage de la thyroglobuline\nBoux De Casson F, Moal V, Gauchez AS, Moineau MP, Sault C, Schlageter MH, Massart C"},{"title":"SFTS, Bordeaux, septembre 20-22, 2017","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2017\/09\/Biomnis_Poster_2017_Rabut_10.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Recherche et quantification de l\u2019h\u00e9morragie f\u0153to-maternelle par cytom\u00e9trie en flux avec double marquage anti-h\u00e9moglobine F et anti-anhydrase carbonique\nRabut E, Castro-Fernandez A, Meknache N"},{"title":"XXIIIe Colloque ACLF, Montpellier, septembre 20-21, 2016","media_link":"https:\/\/www.eurofins-biomnis.com\/wp-content\/uploads\/2016\/11\/Biomnis_Poster_2016_Liquier_12.pdf","date":null,"media_type":"document","profils":"574,575,579,","document_type":"poster","content":"Syndrome de Currarino atypique avec hexadactylie pr\u00e9-axiale : remaniement complexe en 7q36.3 en pr\u00e9natal\nLiquier A, Becker M, Raymond L, Bourgain A, Amat S, Broussin B, Andr\u00e9 G, Escande F, Nouchy M, Eg\u00e9a G"}]));
sessionStorage.setItem('currentLang', 'fr');render(html`<${RessourcesDynamiques} name="World" />`, document.getElementById('resdyncontainer'));
Certaines ressources mises à votre disposition vous sont particulièrement destinées. Ce sont des bons de demande d’analyse destinés à être rempli par vos soins lors de votre consultation, mais aussi des ressources bibliographiques et beaucoup d’autres.
Mettez à jour votre navigateur pour consulter ce site
